Gene_set	Term	Overlap	P-value	Adjusted P-value	Odds Ratio	Combined Score	Genes
c2.all.v2024.1.Hs.symbols.gmt	ABBUD_LIF_SIGNALING_1_UP	1/43	1.669802e-01	3.123952e-01	8.325826e+00	1.490223e+01	LCN2
c2.all.v2024.1.Hs.symbols.gmt	ABE_INNER_EAR	4/43	3.282274e-05	8.055088e-04	2.776914e+01	2.866994e+02	RPS5;RPL32;RPL28;RPL21
c2.all.v2024.1.Hs.symbols.gmt	ACEVEDO_LIVER_CANCER_DN	5/540	7.940030e-02	2.220291e-01	2.474568e+00	6.268708e+00	PPP1R15A;TCIM;RACK1;RPL3;DNAJA1
c2.all.v2024.1.Hs.symbols.gmt	ACEVEDO_LIVER_CANCER_UP	6/972	2.298786e-01	3.643821e-01	1.605902e+00	2.361004e+00	LCN2;NUCB2;RPL23A;LYZ;RPL23;RPL13A
c2.all.v2024.1.Hs.symbols.gmt	ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_DN	2/222	2.421375e-01	3.711234e-01	2.681682e+00	3.803293e+00	ANKRD36B;NUCB2
c2.all.v2024.1.Hs.symbols.gmt	ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_UP	1/290	7.103502e-01	7.472468e-01	1.208584e+00	4.133323e-01	AGR2
c2.all.v2024.1.Hs.symbols.gmt	ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_UP	2/139	1.175025e-01	2.710169e-01	4.316757e+00	9.243454e+00	SERPINB3;SERPINB4
c2.all.v2024.1.Hs.symbols.gmt	ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN	2/274	3.235621e-01	4.305453e-01	2.164790e+00	2.442672e+00	PPP1R15A;TCIM
c2.all.v2024.1.Hs.symbols.gmt	ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_UP	10/863	3.559202e-03	3.421427e-02	3.093115e+00	1.743966e+01	UBB;HSPH1;LCN2;RPL10A;RPL15;RPL23A;LYZ;NUCB2;RPS5;RPS15A
c2.all.v2024.1.Hs.symbols.gmt	ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN	4/873	5.086145e-01	5.800819e-01	1.214043e+00	8.207720e-01	ANKRD36B;H3P6;ERICH3;GPX1
c2.all.v2024.1.Hs.symbols.gmt	ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_DN	2/354	4.436837e-01	5.275413e-01	1.667357e+00	1.354966e+00	PPP1R15A;DNAJA1
c2.all.v2024.1.Hs.symbols.gmt	ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_UP	2/173	1.666999e-01	3.123952e-01	3.455598e+00	6.190912e+00	RPL27A;RPL23
c2.all.v2024.1.Hs.symbols.gmt	ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN	2/74	3.937255e-02	1.669332e-01	8.211184e+00	2.656060e+01	ATF3;CXCL8
c2.all.v2024.1.Hs.symbols.gmt	AFFAR_YY1_TARGETS_DN	2/260	3.017308e-01	4.138136e-01	2.283496e+00	2.736131e+00	SFTPC;LYZ
c2.all.v2024.1.Hs.symbols.gmt	AFFAR_YY1_TARGETS_UP	3/199	5.261560e-02	1.861898e-01	4.263616e+00	1.255525e+01	PPP1R15A;SERPINB3;CFTR
c2.all.v2024.1.Hs.symbols.gmt	AGARWAL_AKT_PATHWAY_TARGETS	1/11	4.562907e-02	1.752896e-01	3.374866e+01	1.041892e+02	MT-CO2
c2.all.v2024.1.Hs.symbols.gmt	AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_UP	1/303	7.261054e-01	7.592260e-01	1.155955e+00	3.699751e-01	RPL13A
c2.all.v2024.1.Hs.symbols.gmt	AIGNER_ZEB1_TARGETS	2/35	9.644661e-03	7.084071e-02	1.780194e+01	8.262503e+01	MUC1;TSPAN1
c2.all.v2024.1.Hs.symbols.gmt	AIYAR_COBRA1_TARGETS_UP	2/40	1.247157e-02	8.365174e-02	1.548649e+01	6.789746e+01	GADD45A;PIP
c2.all.v2024.1.Hs.symbols.gmt	AKL_HTLV1_INFECTION_DN	1/69	2.542306e-01	3.790744e-01	5.159569e+00	7.066100e+00	AKAP9
c2.all.v2024.1.Hs.symbols.gmt	ALCALA_APOPTOSIS	1/87	3.092745e-01	4.183830e-01	4.082563e+00	4.790994e+00	RPL10A
c2.all.v2024.1.Hs.symbols.gmt	ALFANO_MYC_TARGETS	1/239	6.394007e-01	6.885854e-01	1.470454e+00	6.576221e-01	PPP1R15A
c2.all.v2024.1.Hs.symbols.gmt	ALONSO_METASTASIS_UP	1/194	5.626810e-01	6.276751e-01	1.816151e+00	1.044364e+00	RPL10A
c2.all.v2024.1.Hs.symbols.gmt	ALTEMEIER_RESPONSE_TO_LPS_WITH_MECHANICAL_VENTILATION	1/125	4.126214e-01	5.015899e-01	2.831583e+00	2.506587e+00	ATF3
c2.all.v2024.1.Hs.symbols.gmt	AMIT_DELAYED_EARLY_GENES	1/18	7.358684e-02	2.123128e-01	2.024278e+01	5.281927e+01	ATF3
c2.all.v2024.1.Hs.symbols.gmt	AMIT_EGF_RESPONSE_120_HELA	3/68	3.022492e-03	3.090647e-02	1.286735e+01	7.465217e+01	CXCL8;GADD45A;TCIM
c2.all.v2024.1.Hs.symbols.gmt	AMIT_EGF_RESPONSE_20_HELA	1/12	4.967357e-02	1.805210e-01	3.081260e+01	9.250813e+01	PPP1R15A
c2.all.v2024.1.Hs.symbols.gmt	AMIT_EGF_RESPONSE_40_HELA	2/42	1.369162e-02	8.925226e-02	1.472039e+01	6.316476e+01	ATF3;PPP1R15A
c2.all.v2024.1.Hs.symbols.gmt	AMIT_EGF_RESPONSE_60_HELA	1/47	1.810327e-01	3.241495e-01	7.608246e+00	1.300308e+01	HSPH1
c2.all.v2024.1.Hs.symbols.gmt	AMIT_EGF_RESPONSE_60_MCF10A	2/39	1.188044e-02	8.179077e-02	1.590018e+01	7.048330e+01	GADD45A;CXCL8
c2.all.v2024.1.Hs.symbols.gmt	AMIT_SERUM_RESPONSE_120_MCF10A	1/65	2.414213e-01	3.702976e-01	5.480537e+00	7.789005e+00	GADD45A
c2.all.v2024.1.Hs.symbols.gmt	AMIT_SERUM_RESPONSE_40_MCF10A	1/32	1.270940e-01	2.774918e-01	1.123886e+01	2.318384e+01	ATF3
c2.all.v2024.1.Hs.symbols.gmt	AMIT_SERUM_RESPONSE_480_MCF10A	1/39	1.526892e-01	3.016190e-01	9.192513e+00	1.727596e+01	S100P
c2.all.v2024.1.Hs.symbols.gmt	AMIT_SERUM_RESPONSE_60_MCF10A	1/58	2.184790e-01	3.549433e-01	6.149686e+00	9.354074e+00	CXCL8
c2.all.v2024.1.Hs.symbols.gmt	AMUNDSON_RESPONSE_TO_ARSENITE	5/219	2.409168e-03	2.590477e-02	6.269732e+00	3.779692e+01	NEAT1;ATF3;DNAJA1;LYZ;GOLGB1
c2.all.v2024.1.Hs.symbols.gmt	ANDERSEN_CHOLANGIOCARCINOMA_CLASS2	2/175	1.696998e-01	3.169148e-01	3.415453e+00	6.058071e+00	S100P;TSPAN1
c2.all.v2024.1.Hs.symbols.gmt	ANDERSEN_LIVER_CANCER_KRT19_UP	4/35	1.429150e-05	3.635617e-04	3.483425e+01	3.886056e+02	RPL3;RPL13A;RPL27A;RPL10A
c2.all.v2024.1.Hs.symbols.gmt	APPIERTO_RESPONSE_TO_FENRETINIDE_DN	1/51	1.948505e-01	3.350851e-01	7.004342e+00	1.145576e+01	TMSB4X
c2.all.v2024.1.Hs.symbols.gmt	APPIERTO_RESPONSE_TO_FENRETINIDE_UP	1/38	1.490787e-01	3.001720e-01	9.438075e+00	1.796331e+01	AKAP9
c2.all.v2024.1.Hs.symbols.gmt	APRELIKOVA_BRCA1_TARGETS	2/48	1.764599e-02	1.039817e-01	1.281749e+01	5.174739e+01	HSP90AA1;DNAJA1
c2.all.v2024.1.Hs.symbols.gmt	AUNG_GASTRIC_CANCER	1/52	1.982688e-01	3.398429e-01	6.868023e+00	1.111336e+01	MMP10
c2.all.v2024.1.Hs.symbols.gmt	AZARE_NEOPLASTIC_TRANSFORMATION_BY_STAT3_UP	1/126	4.151235e-01	5.028732e-01	2.808893e+00	2.469520e+00	NEAT1
c2.all.v2024.1.Hs.symbols.gmt	BAELDE_DIABETIC_NEPHROPATHY_DN	3/437	2.825705e-01	3.988105e-01	1.907242e+00	2.410425e+00	HSP90AA1;DNAJA1;GADD45A
c2.all.v2024.1.Hs.symbols.gmt	BAELDE_DIABETIC_NEPHROPATHY_UP	2/89	5.482016e-02	1.891562e-01	6.798919e+00	1.974200e+01	FTL;LYZ
c2.all.v2024.1.Hs.symbols.gmt	BAE_BRCA1_TARGETS_UP	1/71	2.605548e-01	3.835690e-01	5.012743e+00	6.741850e+00	TMSB4X
c2.all.v2024.1.Hs.symbols.gmt	BAFNA_MUC4_TARGETS_UP	1/5	2.100202e-02	1.155942e-01	7.876827e+01	3.042926e+02	GAS5
c2.all.v2024.1.Hs.symbols.gmt	BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_DN	1/160	4.941985e-01	5.673628e-01	2.206712e+00	1.555330e+00	FTL
c2.all.v2024.1.Hs.symbols.gmt	BARIS_THYROID_CANCER_DN	1/59	2.217980e-01	3.578273e-01	6.044289e+00	9.102627e+00	RPL13A
c2.all.v2024.1.Hs.symbols.gmt	BARRIER_CANCER_RELAPSE_NORMAL_SAMPLE_DN	1/31	1.233756e-01	2.740804e-01	1.160787e+01	2.428973e+01	PPP1R15A
c2.all.v2024.1.Hs.symbols.gmt	BARRIER_CANCER_RELAPSE_TUMOR_SAMPLE_UP	1/16	6.568265e-02	2.009003e-01	2.285682e+01	6.223731e+01	CXCL8
c2.all.v2024.1.Hs.symbols.gmt	BASAKI_YBX1_TARGETS_DN	7/398	1.520346e-03	1.801956e-02	4.752600e+00	3.083875e+01	ANKRD36B;LCN2;MUC1;NEAT1;RPL31;DNAH12;TSPAN1
c2.all.v2024.1.Hs.symbols.gmt	BASSO_CD40_SIGNALING_UP	1/103	3.548162e-01	4.560360e-01	3.442781e+00	3.567256e+00	TMSB4X
c2.all.v2024.1.Hs.symbols.gmt	BECKER_TAMOXIFEN_RESISTANCE_DN	2/54	2.202297e-02	1.190153e-01	1.134955e+01	4.330613e+01	TCN1;CXCL8
c2.all.v2024.1.Hs.symbols.gmt	BENPORATH_CYCLING_GENES	5/648	1.405568e-01	2.920236e-01	2.048942e+00	4.020319e+00	GADD45A;MUC1;SERPINB3;RPL27A;RPL13A
c2.all.v2024.1.Hs.symbols.gmt	BENPORATH_EED_TARGETS	2/1059	9.427422e-01	9.500291e-01	5.377676e-01	3.170810e-02	ATF3;CFTR
c2.all.v2024.1.Hs.symbols.gmt	BENPORATH_ES_WITH_H3K27ME3	2/1115	9.533561e-01	9.588722e-01	5.093630e-01	2.433061e-02	ATF3;SFTPC
c2.all.v2024.1.Hs.symbols.gmt	BENPORATH_MYC_MAX_TARGETS	8/775	1.704303e-02	1.021602e-01	2.731152e+00	1.112129e+01	RPS29;TMSB4X;AKAP9;RPL27A;RPL31;RPL15;RPS5;RPL32
c2.all.v2024.1.Hs.symbols.gmt	BENPORATH_MYC_TARGETS_WITH_EBOX	5/230	2.974982e-03	3.057050e-02	5.960894e+00	3.467760e+01	MUC1;RPL27A;HSP90AA1;RPL23A;RPL13A
c2.all.v2024.1.Hs.symbols.gmt	BENPORATH_NANOG_TARGETS	4/988	6.072877e-01	6.615155e-01	1.066422e+00	5.318807e-01	RPL21;RPL32;CFAP298;LINGO1
c2.all.v2024.1.Hs.symbols.gmt	BENPORATH_NOS_TARGETS	1/179	5.336793e-01	6.014344e-01	1.970116e+00	1.237155e+00	LINGO1
c2.all.v2024.1.Hs.symbols.gmt	BENPORATH_OCT4_TARGETS	2/290	3.483045e-01	4.515619e-01	2.043234e+00	2.154954e+00	RPL32;LINGO1
c2.all.v2024.1.Hs.symbols.gmt	BENPORATH_PRC2_TARGETS	1/650	9.392100e-01	9.469271e-01	5.298070e-01	3.322745e-02	ATF3
c2.all.v2024.1.Hs.symbols.gmt	BENPORATH_SOX2_TARGETS	6/734	9.141927e-02	2.367331e-01	2.154543e+00	5.154312e+00	RPS29;PPP1R15A;RPL15;LINGO1;ATF3;FTL
c2.all.v2024.1.Hs.symbols.gmt	BENPORATH_SUZ12_TARGETS	2/1035	9.375311e-01	9.465753e-01	5.508832e-01	3.553491e-02	ATF3;CFTR
c2.all.v2024.1.Hs.symbols.gmt	BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_UP	2/29	6.690229e-03	5.347057e-02	2.169189e+01	1.086136e+02	ATF3;CP
c2.all.v2024.1.Hs.symbols.gmt	BERENJENO_TRANSFORMED_BY_RHOA_DN	1/398	8.181804e-01	8.419952e-01	8.758551e-01	1.757600e-01	NUCB2
c2.all.v2024.1.Hs.symbols.gmt	BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_DN	1/30	1.196416e-01	2.710169e-01	1.200190e+01	2.548310e+01	HSPH1
c2.all.v2024.1.Hs.symbols.gmt	BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_UP	1/20	8.142487e-02	2.220291e-01	1.816495e+01	4.555906e+01	GADD45A
c2.all.v2024.1.Hs.symbols.gmt	BERENJENO_TRANSFORMED_BY_RHOA_REVERSIBLY_DN	1/30	1.196416e-01	2.710169e-01	1.200190e+01	2.548310e+01	TMSB4X
c2.all.v2024.1.Hs.symbols.gmt	BERENJENO_TRANSFORMED_BY_RHOA_UP	5/550	8.431714e-02	2.270101e-01	2.428078e+00	6.005051e+00	TMSB4X;GADD45A;HSPH1;HSP90AA1;RPL32
c2.all.v2024.1.Hs.symbols.gmt	BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN	1/46	1.775417e-01	3.214861e-01	7.775812e+00	1.344088e+01	RPL31
c2.all.v2024.1.Hs.symbols.gmt	BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_DN	5/126	1.996938e-04	3.821663e-03	1.111582e+01	9.469265e+01	RPL10A;RPS2;RPL31;RPL3;VMO1
c2.all.v2024.1.Hs.symbols.gmt	BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_UP	1/122	4.050514e-01	4.964379e-01	2.901895e+00	2.622562e+00	HSP90AA1
c2.all.v2024.1.Hs.symbols.gmt	BHAT_ESR1_TARGETS_NOT_VIA_AKT1_UP	1/211	5.933968e-01	6.514872e-01	1.668182e+00	8.706110e-01	MSMB
c2.all.v2024.1.Hs.symbols.gmt	BHAT_ESR1_TARGETS_VIA_AKT1_UP	2/281	3.344186e-01	4.401332e-01	2.109897e+00	2.311101e+00	ATF3;MSMB
c2.all.v2024.1.Hs.symbols.gmt	BIDUS_METASTASIS_DN	1/154	4.810570e-01	5.581117e-01	2.293595e+00	1.678383e+00	PIP
c2.all.v2024.1.Hs.symbols.gmt	BIDUS_METASTASIS_UP	1/221	6.104575e-01	6.632366e-01	1.591800e+00	7.856278e-01	HSP90AA1
c2.all.v2024.1.Hs.symbols.gmt	BILANGES_RAPAMYCIN_SENSITIVE_GENES	1/37	1.454530e-01	2.960146e-01	9.697092e+00	1.869504e+01	RPL23A
c2.all.v2024.1.Hs.symbols.gmt	BILANGES_RAPAMYCIN_SENSITIVE_VIA_TSC1_AND_TSC2	3/69	3.150270e-03	3.203170e-02	1.267328e+01	7.300149e+01	RPL3;RPL31;RPL10A
c2.all.v2024.1.Hs.symbols.gmt	BILANGES_SERUM_AND_RAPAMYCIN_SENSITIVE_GENES	11/69	6.420573e-15	5.823181e-13	5.188920e+01	1.695701e+03	RPL21;RPL28;RPL15;RACK1;RPL27A;RPL32;RPL23;RPS5;RPL13A;RPS3;RPL18A
c2.all.v2024.1.Hs.symbols.gmt	BILANGES_SERUM_RESPONSE_TRANSLATION	5/34	3.091742e-07	1.111961e-05	4.597377e+01	6.891174e+02	RPL21;RACK1;RPS5;RPS3;RPL18A
c2.all.v2024.1.Hs.symbols.gmt	BILANGES_SERUM_SENSITIVE_GENES	2/80	4.532280e-02	1.752896e-01	7.581511e+00	2.345678e+01	RPL31;RPL10A
c2.all.v2024.1.Hs.symbols.gmt	BILD_E2F3_ONCOGENIC_SIGNATURE	1/248	6.530639e-01	7.000469e-01	1.416399e+00	6.034999e-01	GAS5
c2.all.v2024.1.Hs.symbols.gmt	BILD_HRAS_ONCOGENIC_SIGNATURE	3/252	9.166917e-02	2.367331e-01	3.349792e+00	8.004561e+00	PPP1R15A;SERPINB3;CXCL8
c2.all.v2024.1.Hs.symbols.gmt	BILD_SRC_ONCOGENIC_SIGNATURE	2/59	2.597644e-02	1.324862e-01	1.036028e+01	3.782089e+01	PPP1R15A;HSPH1
c2.all.v2024.1.Hs.symbols.gmt	BIOCARTA_AKAPCENTROSOME_PATHWAY	1/14	5.771174e-02	1.926187e-01	2.624540e+01	7.485960e+01	AKAP9
c2.all.v2024.1.Hs.symbols.gmt	BIOCARTA_AKT_PATHWAY	1/22	8.919728e-02	2.334470e-01	1.647370e+01	3.981536e+01	HSP90AA1
c2.all.v2024.1.Hs.symbols.gmt	BIOCARTA_ATM_PATHWAY	1/20	8.142487e-02	2.220291e-01	1.816495e+01	4.555906e+01	GADD45A
c2.all.v2024.1.Hs.symbols.gmt	BIOCARTA_CFTR_PATHWAY	1/11	4.562907e-02	1.752896e-01	3.374866e+01	1.041892e+02	CFTR
c2.all.v2024.1.Hs.symbols.gmt	BIOCARTA_CYTOKINE_PATHWAY	1/19	7.751409e-02	2.176237e-01	1.914771e+01	4.896635e+01	CXCL8
c2.all.v2024.1.Hs.symbols.gmt	BIOCARTA_FLUMAZENIL_PATHWAY	1/9	3.748893e-02	1.619087e-01	4.169330e+01	1.369087e+02	GPX1
c2.all.v2024.1.Hs.symbols.gmt	BIOCARTA_FREE_PATHWAY	2/10	7.813473e-04	1.149312e-02	7.024006e+01	5.025319e+02	CXCL8;GPX1
c2.all.v2024.1.Hs.symbols.gmt	BIOCARTA_G2_PATHWAY	1/24	9.690462e-02	2.420875e-01	1.507032e+01	3.517454e+01	GADD45A
c2.all.v2024.1.Hs.symbols.gmt	BIOCARTA_GCR_PATHWAY	1/17	6.964305e-02	2.057725e-01	2.147059e+01	5.720564e+01	HSP90AA1
c2.all.v2024.1.Hs.symbols.gmt	BIOCARTA_GRANULOCYTES_PATHWAY	1/15	6.170557e-02	1.980274e-01	2.443426e+01	6.805873e+01	CXCL8
c2.all.v2024.1.Hs.symbols.gmt	BIOCARTA_HIF_PATHWAY	1/15	6.170557e-02	1.980274e-01	2.443426e+01	6.805873e+01	HSP90AA1
c2.all.v2024.1.Hs.symbols.gmt	BIOCARTA_IL17_PATHWAY	1/15	6.170557e-02	1.980274e-01	2.443426e+01	6.805873e+01	CXCL8
c2.all.v2024.1.Hs.symbols.gmt	BIOCARTA_INFLAM_PATHWAY	1/29	1.158918e-01	2.689103e-01	1.242359e+01	2.677405e+01	CXCL8
c2.all.v2024.1.Hs.symbols.gmt	BIOCARTA_LAIR_PATHWAY	1/17	6.964305e-02	2.057725e-01	2.147059e+01	5.720564e+01	CXCL8
c2.all.v2024.1.Hs.symbols.gmt	BIOCARTA_LYM_PATHWAY	1/14	5.771174e-02	1.926187e-01	2.624540e+01	7.485960e+01	CXCL8
c2.all.v2024.1.Hs.symbols.gmt	BIOCARTA_NO1_PATHWAY	1/28	1.121262e-01	2.639902e-01	1.287594e+01	2.817422e+01	HSP90AA1
c2.all.v2024.1.Hs.symbols.gmt	BIOCARTA_NTHI_PATHWAY	1/23	9.305905e-02	2.367331e-01	1.574082e+01	3.737691e+01	CXCL8
c2.all.v2024.1.Hs.symbols.gmt	BIOCARTA_P53HYPOXIA_PATHWAY	2/21	3.537385e-03	3.416197e-02	3.060222e+01	1.727302e+02	HSP90AA1;GADD45A
c2.all.v2024.1.Hs.symbols.gmt	BIOCARTA_P53_PATHWAY	1/16	6.568265e-02	2.009003e-01	2.285682e+01	6.223731e+01	GADD45A
c2.all.v2024.1.Hs.symbols.gmt	BIOCARTA_PEPI_PATHWAY	1/8	3.339314e-02	1.542150e-01	4.725455e+01	1.606373e+02	CXCL8
c2.all.v2024.1.Hs.symbols.gmt	BIOCARTA_PPARA_PATHWAY	1/52	1.982688e-01	3.398429e-01	6.868023e+00	1.111336e+01	HSP90AA1
c2.all.v2024.1.Hs.symbols.gmt	BIOCARTA_STEM_PATHWAY	1/15	6.170557e-02	1.980274e-01	2.443426e+01	6.805873e+01	CXCL8
c2.all.v2024.1.Hs.symbols.gmt	BIOCARTA_TEL_PATHWAY	1/17	6.964305e-02	2.057725e-01	2.147059e+01	5.720564e+01	HSP90AA1
c2.all.v2024.1.Hs.symbols.gmt	BLALOCK_ALZHEIMERS_DISEASE_DN	5/1248	6.148081e-01	6.672683e-01	1.030658e+00	5.013584e-01	HSPH1;RPL31;RPL15;HSP90AA1;DNAJA1
c2.all.v2024.1.Hs.symbols.gmt	BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_DN	3/166	3.359290e-02	1.546905e-01	5.131883e+00	1.741474e+01	HSP90AA1;DNAJA1;HSPH1
c2.all.v2024.1.Hs.symbols.gmt	BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP	2/389	4.925869e-01	5.667603e-01	1.514316e+00	1.072263e+00	PABPC3;AKAP9
c2.all.v2024.1.Hs.symbols.gmt	BLALOCK_ALZHEIMERS_DISEASE_UP	14/1671	1.052536e-02	7.590949e-02	2.221423e+00	1.011629e+01	PPP1R15A;RPL39;SERPINB4;MUC1;PABPC3;AKAP9;RPL28;RPL37A;RPL31;SFTPC;HSP90AA1;GOLGB1;FTL;RPL13A
c2.all.v2024.1.Hs.symbols.gmt	BLANCO_MELO_BETA_INTERFERON_TREATED_BRONCHIAL_EPITHELIAL_CELLS_DN	2/217	2.343148e-01	3.662742e-01	2.744529e+00	3.982557e+00	TCN1;SERPINB3
c2.all.v2024.1.Hs.symbols.gmt	BLANCO_MELO_BETA_INTERFERON_TREATED_BRONCHIAL_EPITHELIAL_CELLS_UP	1/378	8.017712e-01	8.287882e-01	9.231080e-01	2.039441e-01	CXCL8
c2.all.v2024.1.Hs.symbols.gmt	BLANCO_MELO_BRONCHIAL_EPITHELIAL_CELLS_INFLUENZA_A_DEL_NS1_INFECTION_UP	1/644	9.375941e-01	9.465753e-01	5.348965e-01	3.446772e-02	DNAJA1
c2.all.v2024.1.Hs.symbols.gmt	BLANCO_MELO_BRONCHIAL_EPITHELIAL_CELLS_INFLUENZA_A_INFECTION_DN	1/81	2.913885e-01	4.054946e-01	4.388049e+00	5.410894e+00	RPL39
c2.all.v2024.1.Hs.symbols.gmt	BLANCO_MELO_BRONCHIAL_EPITHELIAL_CELLS_INFLUENZA_A_INFECTION_UP	1/137	4.419601e-01	5.259148e-01	2.581242e+00	2.107677e+00	SERPINB4
c2.all.v2024.1.Hs.symbols.gmt	BLANCO_MELO_COVID19_BRONCHIAL_EPITHELIAL_CELLS_SARS_COV_2_INFECTION_DN	1/59	2.217980e-01	3.578273e-01	6.044289e+00	9.102627e+00	TCN1
c2.all.v2024.1.Hs.symbols.gmt	BLANCO_MELO_COVID19_BRONCHIAL_EPITHELIAL_CELLS_SARS_COV_2_INFECTION_UP	3/144	2.335686e-02	1.249293e-01	5.935720e+00	2.229970e+01	CXCL8;TCIM;S100P
c2.all.v2024.1.Hs.symbols.gmt	BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_A594_ACE2_EXPRESSING_CELLS_RUXOLITINIB_UP	4/486	1.512653e-01	3.016190e-01	2.227676e+00	4.207456e+00	ATF3;PPP1R15A;GADD45A;CXCL8
c2.all.v2024.1.Hs.symbols.gmt	BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_A594_ACE2_EXPRESSING_CELLS_UP	5/545	8.183877e-02	2.225758e-01	2.451108e+00	6.135134e+00	PPP1R15A;GADD45A;TCIM;ATF3;CXCL8
c2.all.v2024.1.Hs.symbols.gmt	BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_A594_CELLS_UP	6/86	1.758978e-06	5.241755e-05	2.008917e+01	2.661971e+02	SERPINB4;SERPINB3;ATF3;MMP10;GAS5;CXCL8
c2.all.v2024.1.Hs.symbols.gmt	BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_CALU3_CELLS_UP	6/339	3.208867e-03	3.203170e-02	4.793391e+00	2.752287e+01	PPP1R15A;GADD45A;TCIM;NEAT1;ATF3;CXCL8
c2.all.v2024.1.Hs.symbols.gmt	BLANCO_MELO_COVID19_SARS_COV_2_LOW_MOI_INFECTION_A594_ACE2_EXPRESSING_CELLS_UP	3/174	3.780606e-02	1.626051e-01	4.890710e+00	1.601847e+01	ATF3;PPP1R15A;CXCL8
c2.all.v2024.1.Hs.symbols.gmt	BLANCO_MELO_COVID19_SARS_COV_2_POS_PATIENT_LUNG_TISSUE_UP	3/174	3.780606e-02	1.626051e-01	4.890710e+00	1.601847e+01	TCN1;DNAAF1;S100P
c2.all.v2024.1.Hs.symbols.gmt	BLANCO_MELO_HUMAN_PARAINFLUENZA_VIRUS_3_INFECTION_A594_CELLS_DN	1/123	4.075854e-01	4.983723e-01	2.878075e+00	2.583086e+00	VMO1
c2.all.v2024.1.Hs.symbols.gmt	BLANCO_MELO_HUMAN_PARAINFLUENZA_VIRUS_3_INFECTION_A594_CELLS_UP	2/204	2.140640e-01	3.519958e-01	2.922456e+00	4.504909e+00	ATF3;PPP1R15A
c2.all.v2024.1.Hs.symbols.gmt	BLANCO_MELO_INFLUENZA_A_INFECTION_A594_CELLS_DN	2/118	8.941715e-02	2.334470e-01	5.099756e+00	1.231307e+01	NEAT1;RPL39
c2.all.v2024.1.Hs.symbols.gmt	BLANCO_MELO_INFLUENZA_A_INFECTION_A594_CELLS_UP	1/41	1.598648e-01	3.051033e-01	8.737770e+00	1.602006e+01	CXCL8
c2.all.v2024.1.Hs.symbols.gmt	BLANCO_MELO_MERS_COV_INFECTION_MCR5_CELLS_UP	2/299	3.620964e-01	4.614602e-01	1.980604e+00	2.011986e+00	DNAH12;PPP1R15A
c2.all.v2024.1.Hs.symbols.gmt	BLANCO_MELO_RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_A594_CELLS_DN	1/119	3.973850e-01	4.916637e-01	2.975767e+00	2.746186e+00	VMO1
c2.all.v2024.1.Hs.symbols.gmt	BLANCO_MELO_RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_A594_CELLS_UP	4/286	3.341572e-02	1.542150e-01	3.839994e+00	1.305110e+01	ATF3;MMP10;PPP1R15A;CXCL8
c2.all.v2024.1.Hs.symbols.gmt	BLUM_RESPONSE_TO_SALIRASIB_DN	1/341	7.674591e-01	7.956857e-01	1.025160e+00	2.713291e-01	HSP90AA1
c2.all.v2024.1.Hs.symbols.gmt	BLUM_RESPONSE_TO_SALIRASIB_UP	5/245	3.893800e-03	3.658769e-02	5.585280e+00	3.098920e+01	PPP1R15A;GADD45A;ATF3;MMP10;GOLGB1
c2.all.v2024.1.Hs.symbols.gmt	BOCHKIS_FOXA2_TARGETS	2/434	5.514025e-01	6.160823e-01	1.353945e+00	8.059901e-01	FTL;RPL21
c2.all.v2024.1.Hs.symbols.gmt	BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_UP	1/46	1.775417e-01	3.214861e-01	7.775812e+00	1.344088e+01	RPS5
c2.all.v2024.1.Hs.symbols.gmt	BONOME_OVARIAN_CANCER_SURVIVAL_OPTIMAL_DEBULKING	2/237	2.656650e-01	3.875365e-01	2.509152e+00	3.325930e+00	UBB;CP
c2.all.v2024.1.Hs.symbols.gmt	BOQUEST_STEM_CELL_CULTURED_VS_FRESH_UP	6/427	9.631639e-03	7.084071e-02	3.777302e+00	1.753689e+01	PPP1R15A;ANKRD36B;TCIM;ATF3;MT-ND4;CXCL8
c2.all.v2024.1.Hs.symbols.gmt	BORCZUK_MALIGNANT_MESOTHELIOMA_DN	1/106	3.630183e-01	4.614602e-01	3.344426e+00	3.388913e+00	NEAT1
c2.all.v2024.1.Hs.symbols.gmt	BORCZUK_MALIGNANT_MESOTHELIOMA_UP	2/310	3.788076e-01	4.737366e-01	1.909019e+00	1.853136e+00	DNAJA1;RPS15A
c2.all.v2024.1.Hs.symbols.gmt	BORLAK_LIVER_CANCER_EGF_UP	1/53	2.016727e-01	3.434199e-01	6.736898e+00	1.078651e+01	ATF3
c2.all.v2024.1.Hs.symbols.gmt	BOSCO_EPITHELIAL_DIFFERENTIATION_MODULE	2/69	3.466363e-02	1.575345e-01	8.821421e+00	2.965819e+01	MUC1;LCN2
c2.all.v2024.1.Hs.symbols.gmt	BOUDOUKHA_BOUND_BY_IGF2BP2	1/108	3.684290e-01	4.655014e-01	3.281905e+00	3.277006e+00	GAS5
c2.all.v2024.1.Hs.symbols.gmt	BOYAULT_LIVER_CANCER_SUBCLASS_G1_DN	1/40	1.562845e-01	3.038299e-01	8.959385e+00	1.662931e+01	GADD45A
c2.all.v2024.1.Hs.symbols.gmt	BOYLAN_MULTIPLE_MYELOMA_C_D_DN	5/276	6.409259e-03	5.182060e-02	4.940533e+00	2.494975e+01	LCN2;LTF;RSPH1;CP;LYZ
c2.all.v2024.1.Hs.symbols.gmt	BOYLAN_MULTIPLE_MYELOMA_C_D_UP	2/143	1.230803e-01	2.740804e-01	4.193964e+00	8.786011e+00	CFAP298;RPL23
c2.all.v2024.1.Hs.symbols.gmt	BOYLAN_MULTIPLE_MYELOMA_C_UP	1/50	1.914179e-01	3.321944e-01	7.146168e+00	1.181473e+01	GAS5
c2.all.v2024.1.Hs.symbols.gmt	BOYLAN_MULTIPLE_MYELOMA_D_CLUSTER_DN	1/37	1.454530e-01	2.960146e-01	9.697092e+00	1.869504e+01	RSPH1
c2.all.v2024.1.Hs.symbols.gmt	BOYLAN_MULTIPLE_MYELOMA_D_UP	1/92	3.238378e-01	4.305453e-01	3.858596e+00	4.350615e+00	NAPSA
c2.all.v2024.1.Hs.symbols.gmt	BOYLAN_MULTIPLE_MYELOMA_PCA1_UP	4/122	1.810801e-03	2.052898e-02	9.223232e+00	5.823536e+01	CP;LYZ;LCN2;LTF
c2.all.v2024.1.Hs.symbols.gmt	BOYLAN_MULTIPLE_MYELOMA_PCA3_DN	1/71	2.605548e-01	3.835690e-01	5.012743e+00	6.741850e+00	RSPH1
c2.all.v2024.1.Hs.symbols.gmt	BOYLAN_MULTIPLE_MYELOMA_PCA3_UP	1/82	2.944010e-01	4.075119e-01	4.334011e+00	5.299683e+00	ATF3
c2.all.v2024.1.Hs.symbols.gmt	BRACHAT_RESPONSE_TO_CAMPTOTHECIN_DN	1/42	1.634300e-01	3.095469e-01	8.526835e+00	1.544526e+01	RPL3
c2.all.v2024.1.Hs.symbols.gmt	BROCKE_APOPTOSIS_REVERSED_BY_IL6	2/146	1.273057e-01	2.774918e-01	4.106331e+00	8.463822e+00	GADD45A;MUC1
c2.all.v2024.1.Hs.symbols.gmt	BROWNE_HCMV_INFECTION_12HR_UP	1/112	3.791143e-01	4.738361e-01	3.163593e+00	3.068425e+00	CXCL8
c2.all.v2024.1.Hs.symbols.gmt	BROWNE_HCMV_INFECTION_14HR_UP	1/156	4.854746e-01	5.613637e-01	2.263889e+00	1.635950e+00	SYNE2
c2.all.v2024.1.Hs.symbols.gmt	BROWNE_HCMV_INFECTION_18HR_UP	1/172	5.195017e-01	5.892771e-01	2.051184e+00	1.343290e+00	CXCL8
c2.all.v2024.1.Hs.symbols.gmt	BROWNE_HCMV_INFECTION_1HR_DN	1/218	6.054150e-01	6.601650e-01	1.613978e+00	8.099602e-01	PIP
c2.all.v2024.1.Hs.symbols.gmt	BROWNE_HCMV_INFECTION_1HR_UP	1/51	1.948505e-01	3.350851e-01	7.004342e+00	1.145576e+01	CXCL8
c2.all.v2024.1.Hs.symbols.gmt	BROWNE_HCMV_INFECTION_20HR_UP	2/235	2.625253e-01	3.854743e-01	2.530876e+00	3.384813e+00	DNAJA1;LCN2
c2.all.v2024.1.Hs.symbols.gmt	BROWNE_HCMV_INFECTION_24HR_DN	1/145	4.607088e-01	5.411659e-01	2.437448e+00	1.888995e+00	UBB
c2.all.v2024.1.Hs.symbols.gmt	BROWNE_HCMV_INFECTION_24HR_UP	1/146	4.630082e-01	5.422993e-01	2.420585e+00	1.863876e+00	CXCL8
c2.all.v2024.1.Hs.symbols.gmt	BROWNE_HCMV_INFECTION_2HR_UP	2/40	1.247157e-02	8.365174e-02	1.548649e+01	6.789746e+01	ATF3;CXCL8
c2.all.v2024.1.Hs.symbols.gmt	BROWNE_HCMV_INFECTION_30MIN_UP	1/54	2.050624e-01	3.444123e-01	6.610675e+00	1.047423e+01	LCN2
c2.all.v2024.1.Hs.symbols.gmt	BROWNE_HCMV_INFECTION_48HR_DN	3/482	3.347167e-01	4.401332e-01	1.724662e+00	1.887592e+00	PIP;MUC1;RPL23
c2.all.v2024.1.Hs.symbols.gmt	BROWNE_HCMV_INFECTION_48HR_UP	1/180	5.356706e-01	6.033525e-01	1.959051e+00	1.222910e+00	ATF3
c2.all.v2024.1.Hs.symbols.gmt	BROWNE_HCMV_INFECTION_4HR_DN	2/252	2.892038e-01	4.038012e-01	2.357285e+00	2.924504e+00	GADD45A;PIP
c2.all.v2024.1.Hs.symbols.gmt	BROWNE_HCMV_INFECTION_4HR_UP	1/50	1.914179e-01	3.321944e-01	7.146168e+00	1.181473e+01	LCN2
c2.all.v2024.1.Hs.symbols.gmt	BROWNE_HCMV_INFECTION_8HR_UP	2/105	7.322290e-02	2.123128e-01	5.743700e+00	1.501545e+01	DNAJA1;LYZ
c2.all.v2024.1.Hs.symbols.gmt	BROWN_MYELOID_CELL_DEVELOPMENT_DN	3/133	1.898803e-02	1.086270e-01	6.439273e+00	2.552493e+01	GAS5;HSPH1;RPL23
c2.all.v2024.1.Hs.symbols.gmt	BROWN_MYELOID_CELL_DEVELOPMENT_UP	3/167	3.410535e-02	1.567043e-01	5.100453e+00	1.723087e+01	RACK1;NEAT1;LCN2
c2.all.v2024.1.Hs.symbols.gmt	BRUECKNER_TARGETS_OF_MIRLET7A3_DN	1/76	2.761341e-01	3.945313e-01	4.679711e+00	6.022174e+00	HSP90AA1
c2.all.v2024.1.Hs.symbols.gmt	BRUINS_UVC_RESPONSE_LATE	4/1136	7.153190e-01	7.515729e-01	9.205591e-01	3.084118e-01	FTL;MMP10;CFAP298;HOATZ
c2.all.v2024.1.Hs.symbols.gmt	BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_A	4/899	5.318960e-01	6.007229e-01	1.177351e+00	7.432701e-01	ATF3;NEAT1;SYNE2;SFTPC
c2.all.v2024.1.Hs.symbols.gmt	BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_B	6/554	3.035236e-02	1.445549e-01	2.885698e+00	1.008517e+01	TMSB4X;CFAP298;LCN2;BPIFA1;HOATZ;GAS5
c2.all.v2024.1.Hs.symbols.gmt	BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_C	2/91	5.701846e-02	1.926187e-01	6.646384e+00	1.903777e+01	LYZ;HSPH1
c2.all.v2024.1.Hs.symbols.gmt	BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_D	1/279	6.963209e-01	7.343404e-01	1.256953e+00	4.549476e-01	SCGB3A1
c2.all.v2024.1.Hs.symbols.gmt	BURTON_ADIPOGENESIS_11	1/52	1.982688e-01	3.398429e-01	6.868023e+00	1.111336e+01	GADD45A
c2.all.v2024.1.Hs.symbols.gmt	BURTON_ADIPOGENESIS_2	1/71	2.605548e-01	3.835690e-01	5.012743e+00	6.741850e+00	HSPH1
c2.all.v2024.1.Hs.symbols.gmt	BURTON_ADIPOGENESIS_6	1/191	5.570271e-01	6.220335e-01	1.845004e+00	1.079588e+00	LCN2
c2.all.v2024.1.Hs.symbols.gmt	BURTON_ADIPOGENESIS_PEAK_AT_0HR	2/64	3.019419e-02	1.441306e-01	9.529297e+00	3.335355e+01	NEAT1;GADD45A
c2.all.v2024.1.Hs.symbols.gmt	BURTON_ADIPOGENESIS_PEAK_AT_24HR	1/44	1.705155e-01	3.170190e-01	8.134059e+00	1.438857e+01	LCN2
c2.all.v2024.1.Hs.symbols.gmt	BURTON_ADIPOGENESIS_PEAK_AT_2HR	1/46	1.775417e-01	3.214861e-01	7.775812e+00	1.344088e+01	PPP1R15A
c2.all.v2024.1.Hs.symbols.gmt	BURTON_ADIPOGENESIS_PEAK_AT_8HR	1/39	1.526892e-01	3.016190e-01	9.192513e+00	1.727596e+01	HSPH1
c2.all.v2024.1.Hs.symbols.gmt	BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN	1/647	9.384073e-01	9.465753e-01	5.323399e-01	3.384147e-02	TSPAN1
c2.all.v2024.1.Hs.symbols.gmt	BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP	11/822	7.074151e-04	1.069325e-02	3.612830e+00	2.620708e+01	PPP1R15A;GADD45A;HSPH1;AKAP9;ATF3;MMP10;HSP90AA1;DNAJA1;GOLGB1;FTL;CXCL8
c2.all.v2024.1.Hs.symbols.gmt	BYSTROEM_CORRELATED_WITH_IL5_UP	1/41	1.598648e-01	3.051033e-01	8.737770e+00	1.602006e+01	NUCB2
c2.all.v2024.1.Hs.symbols.gmt	BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_TRANS	1/786	9.665248e-01	9.697791e-01	4.352996e-01	1.482123e-02	CP
c2.all.v2024.1.Hs.symbols.gmt	BYSTRYKH_HEMATOPOIESIS_STEM_CELL_SCP2_QTL_TRANS	1/27	1.083448e-01	2.588857e-01	1.336243e+01	2.969714e+01	SFTPC
c2.all.v2024.1.Hs.symbols.gmt	CAFFAREL_RESPONSE_TO_THC_24HR_3_UP	1/8	3.339314e-02	1.542150e-01	4.725455e+01	1.606373e+02	RPS2
c2.all.v2024.1.Hs.symbols.gmt	CAFFAREL_RESPONSE_TO_THC_24HR_5_DN	1/56	2.117989e-01	3.500892e-01	6.371875e+00	9.889900e+00	NEAT1
c2.all.v2024.1.Hs.symbols.gmt	CAFFAREL_RESPONSE_TO_THC_24HR_5_UP	2/33	8.605657e-03	6.530781e-02	1.893393e+01	9.003721e+01	RPS2;NUCB2
c2.all.v2024.1.Hs.symbols.gmt	CAFFAREL_RESPONSE_TO_THC_8HR_5_DN	2/12	1.139667e-03	1.495185e-02	5.685586e+01	3.853132e+02	DNAJA1;HSPH1
c2.all.v2024.1.Hs.symbols.gmt	CAFFAREL_RESPONSE_TO_THC_8HR_5_UP	2/15	1.798165e-03	2.049711e-02	4.421522e+01	2.794839e+02	NEAT1;GOLGB1
c2.all.v2024.1.Hs.symbols.gmt	CAFFAREL_RESPONSE_TO_THC_DN	2/32	8.106295e-03	6.286146e-02	1.955560e+01	9.416247e+01	DNAJA1;HSPH1
c2.all.v2024.1.Hs.symbols.gmt	CAFFAREL_RESPONSE_TO_THC_UP	3/32	3.339214e-04	5.617420e-03	2.861656e+01	2.290643e+02	NEAT1;RPS2;NUCB2
c2.all.v2024.1.Hs.symbols.gmt	CAIRO_HEPATOBLASTOMA_CLASSES_UP	8/612	4.453757e-03	3.987355e-02	3.494088e+00	1.891702e+01	RPL10A;RPL28;RPL37A;RPL15;RACK1;RPL23;RPS3;RPL18A
c2.all.v2024.1.Hs.symbols.gmt	CAIRO_HEPATOBLASTOMA_POOR_SURVIVAL	1/16	6.568265e-02	2.009003e-01	2.285682e+01	6.223731e+01	RPL10A
c2.all.v2024.1.Hs.symbols.gmt	CAIRO_HEPATOBLASTOMA_UP	1/213	5.968670e-01	6.535773e-01	1.652331e+00	8.527034e-01	LYZ
c2.all.v2024.1.Hs.symbols.gmt	CAIRO_LIVER_DEVELOPMENT_DN	3/225	7.054192e-02	2.078396e-01	3.760926e+00	9.972276e+00	LYZ;LCN2;LTF
c2.all.v2024.1.Hs.symbols.gmt	CAIRO_LIVER_DEVELOPMENT_UP	1/166	5.070107e-01	5.785691e-01	2.126129e+00	1.444116e+00	SYNE2
c2.all.v2024.1.Hs.symbols.gmt	CARRILLOREIXACH_HEPATOBLASTOMA_VS_NORMAL_DN	3/1257	9.071711e-01	9.195136e-01	6.355764e-01	6.192053e-02	CP;TSPAN1;CFTR
c2.all.v2024.1.Hs.symbols.gmt	CARRILLOREIXACH_HEPATOBLASTOMA_VS_NORMAL_UP	18/891	3.146268e-08	1.562647e-06	5.876318e+00	1.015102e+02	RPL10A;RPL28;RPL37A;RPS2;RPL31;LINGO1;RPL3;RACK1;GAS5;RPS27;RPL23A;HSP90AA1;LYZ;RPL23;RPS5;RPL13A;RPS3;RPL18A
c2.all.v2024.1.Hs.symbols.gmt	CARRILLOREIXACH_MRS3_VS_LOWER_RISK_HEPATOBLASTOMA_DN	1/168	5.112097e-01	5.814522e-01	2.100551e+00	1.409418e+00	TMSB4X
c2.all.v2024.1.Hs.symbols.gmt	CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN	3/669	5.419697e-01	6.084762e-01	1.230041e+00	7.534558e-01	RPL3;HSP90AA1;MUC1
c2.all.v2024.1.Hs.symbols.gmt	CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_UP	2/174	1.681987e-01	3.143929e-01	3.435409e+00	6.123992e+00	S100P;MT-ND4
c2.all.v2024.1.Hs.symbols.gmt	CASTELLANO_NRAS_TARGETS_UP	1/72	2.636969e-01	3.854743e-01	4.942411e+00	6.588010e+00	LCN2
c2.all.v2024.1.Hs.symbols.gmt	CAVARD_LIVER_CANCER_MALIGNANT_VS_BENIGN	1/32	1.270940e-01	2.774918e-01	1.123886e+01	2.318384e+01	RPL13A
c2.all.v2024.1.Hs.symbols.gmt	CEBALLOS_TARGETS_OF_TP53_AND_MYC_UP	1/19	7.751409e-02	2.176237e-01	1.914771e+01	4.896635e+01	HSPH1
c2.all.v2024.1.Hs.symbols.gmt	CERVERA_SDHB_TARGETS_1_DN	1/36	1.418120e-01	2.920236e-01	9.970701e+00	1.947530e+01	LYZ
c2.all.v2024.1.Hs.symbols.gmt	CERVERA_SDHB_TARGETS_2	1/115	3.870107e-01	4.816852e-01	3.080284e+00	2.924122e+00	CXCL8
c2.all.v2024.1.Hs.symbols.gmt	CHANDRAN_METASTASIS_DN	1/316	7.410123e-01	7.728758e-01	1.107664e+00	3.320090e-01	ATF3
c2.all.v2024.1.Hs.symbols.gmt	CHANDRAN_METASTASIS_TOP50_UP	1/37	1.454530e-01	2.960146e-01	9.697092e+00	1.869504e+01	HSP90AA1
c2.all.v2024.1.Hs.symbols.gmt	CHANDRAN_METASTASIS_UP	1/209	5.898970e-01	6.486690e-01	1.684338e+00	8.890060e-01	NEAT1
c2.all.v2024.1.Hs.symbols.gmt	CHANG_IMMORTALIZED_BY_HPV31_DN	1/60	2.251031e-01	3.589947e-01	5.942435e+00	8.861339e+00	LCN2
c2.all.v2024.1.Hs.symbols.gmt	CHANG_IMMORTALIZED_BY_HPV31_UP	1/73	2.668259e-01	3.878738e-01	4.874018e+00	6.439352e+00	CP
c2.all.v2024.1.Hs.symbols.gmt	CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_UP	3/126	1.646785e-02	1.007388e-01	6.806420e+00	2.794951e+01	MUC1;LCN2;S100P
c2.all.v2024.1.Hs.symbols.gmt	CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN	1/457	8.591564e-01	8.772395e-01	7.605824e-01	1.154597e-01	ANXA2P2
c2.all.v2024.1.Hs.symbols.gmt	CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_UP	3/385	2.235540e-01	3.589947e-01	2.171728e+00	3.253470e+00	RSPH1;AGR2;NUCB2
c2.all.v2024.1.Hs.symbols.gmt	CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN	2/465	5.890915e-01	6.484670e-01	1.261582e+00	6.675960e-01	GADD45A;ANXA2P2
c2.all.v2024.1.Hs.symbols.gmt	CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_UP	5/455	4.417295e-02	1.752896e-01	2.953063e+00	9.212500e+00	MUC1;RSPH1;TSPAN1;AGR2;S100P
c2.all.v2024.1.Hs.symbols.gmt	CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_DN	1/106	3.630183e-01	4.614602e-01	3.344426e+00	3.388913e+00	TMSB4X
c2.all.v2024.1.Hs.symbols.gmt	CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_UP	2/50	1.905920e-02	1.086270e-01	1.228782e+01	4.866231e+01	HSP90AA1;DNAJA1
c2.all.v2024.1.Hs.symbols.gmt	CHEBOTAEV_GR_TARGETS_UP	1/77	2.792107e-01	3.967531e-01	4.618329e+00	5.892011e+00	SERPINB4
c2.all.v2024.1.Hs.symbols.gmt	CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_DN	3/408	2.493903e-01	3.769769e-01	2.046377e+00	2.841878e+00	UBB;LCN2;TSPAN1
c2.all.v2024.1.Hs.symbols.gmt	CHENG_RESPONSE_TO_NICKEL_ACETATE	2/45	1.561449e-02	9.752044e-02	1.370332e+01	5.699974e+01	HSP90AA1;CP
c2.all.v2024.1.Hs.symbols.gmt	CHEN_HOXA5_TARGETS_6HR_UP	1/10	4.156755e-02	1.693553e-01	3.730284e+01	1.186393e+02	CXCL8
c2.all.v2024.1.Hs.symbols.gmt	CHEN_HOXA5_TARGETS_9HR_UP	2/223	2.437037e-01	3.725015e-01	2.669453e+00	3.768739e+00	ATF3;CXCL8
c2.all.v2024.1.Hs.symbols.gmt	CHEN_LIVER_METABOLISM_QTL_CIS	1/95	3.324294e-01	4.388910e-01	3.735591e+00	4.114110e+00	GAS5
c2.all.v2024.1.Hs.symbols.gmt	CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP	1/102	3.520590e-01	4.541713e-01	3.476858e+00	3.629689e+00	ATF3
c2.all.v2024.1.Hs.symbols.gmt	CHEN_METABOLIC_SYNDROM_NETWORK	3/1242	9.027649e-01	9.154923e-01	6.437308e-01	6.584924e-02	ATF3;TMSB4X;LYZ
c2.all.v2024.1.Hs.symbols.gmt	CHEOK_RESPONSE_TO_HD_MTX_UP	1/23	9.305905e-02	2.367331e-01	1.574082e+01	3.737691e+01	LYZ
c2.all.v2024.1.Hs.symbols.gmt	CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_LD_MTX_DN	1/20	8.142487e-02	2.220291e-01	1.816495e+01	4.555906e+01	LCN2
c2.all.v2024.1.Hs.symbols.gmt	CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN	2/170	1.622183e-01	3.087476e-01	3.517604e+00	6.397861e+00	CP;S100P
c2.all.v2024.1.Hs.symbols.gmt	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP	1/179	5.336793e-01	6.014344e-01	1.970116e+00	1.237155e+00	S100P
c2.all.v2024.1.Hs.symbols.gmt	CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_DN	3/194	4.945819e-02	1.805210e-01	4.375936e+00	1.315681e+01	DNAJA1;LYZ;RACK1
c2.all.v2024.1.Hs.symbols.gmt	CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_UP	1/86	3.063248e-01	4.155997e-01	4.130500e+00	4.886833e+00	CP
c2.all.v2024.1.Hs.symbols.gmt	CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_UP	2/59	2.597644e-02	1.324862e-01	1.036028e+01	3.782089e+01	TMSB4X;GADD45A
c2.all.v2024.1.Hs.symbols.gmt	CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_DN	1/141	4.514137e-01	5.326069e-01	2.507298e+00	1.994233e+00	ATF3
c2.all.v2024.1.Hs.symbols.gmt	CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_UP	1/128	4.200961e-01	5.065436e-01	2.764580e+00	2.397642e+00	TMSB4X
c2.all.v2024.1.Hs.symbols.gmt	CHIARETTI_T_ALL_REFRACTORY_TO_THERAPY	1/30	1.196416e-01	2.710169e-01	1.200190e+01	2.548310e+01	CXCL8
c2.all.v2024.1.Hs.symbols.gmt	CHIBA_RESPONSE_TO_TSA	1/45	1.740360e-01	3.187349e-01	7.950910e+00	1.390211e+01	NEAT1
c2.all.v2024.1.Hs.symbols.gmt	CHIBA_RESPONSE_TO_TSA_DN	1/21	8.531924e-02	2.270101e-01	1.727807e+01	4.252748e+01	CXCL8
c2.all.v2024.1.Hs.symbols.gmt	CHICAS_RB1_TARGETS_CONFLUENT	1/567	9.126707e-01	9.241898e-01	6.097814e-01	5.572191e-02	ANXA2P2
c2.all.v2024.1.Hs.symbols.gmt	CHICAS_RB1_TARGETS_LOW_SERUM	1/103	3.548162e-01	4.560360e-01	3.442781e+00	3.567256e+00	SYNE2
c2.all.v2024.1.Hs.symbols.gmt	CHICAS_RB1_TARGETS_SENESCENT	4/565	2.179183e-01	3.549433e-01	1.907258e+00	2.905966e+00	MMP10;SERPINB3;SERPINB4;NUCB2
c2.all.v2024.1.Hs.symbols.gmt	CHIN_BREAST_CANCER_COPY_NUMBER_UP	1/28	1.121262e-01	2.639902e-01	1.287594e+01	2.817422e+01	MT-CO2
c2.all.v2024.1.Hs.symbols.gmt	CHNG_MULTIPLE_MYELOMA_HYPERPLOID_UP	7/54	2.935449e-09	1.611407e-07	3.979218e+01	7.817733e+02	RPL21;RPL28;RPL15;RPL27A;RPL32;RPL13A;RPS3
c2.all.v2024.1.Hs.symbols.gmt	CHOI_ATL_STAGE_PREDICTOR	1/44	1.705155e-01	3.170190e-01	8.134059e+00	1.438857e+01	FTL
c2.all.v2024.1.Hs.symbols.gmt	CHO_NR4A1_TARGETS	2/32	8.106295e-03	6.286146e-02	1.955560e+01	9.416247e+01	ATF3;PPP1R15A
c2.all.v2024.1.Hs.symbols.gmt	CHYLA_CBFA2T3_TARGETS_DN	2/246	2.797929e-01	3.973098e-01	2.415796e+00	3.077013e+00	LCN2;LTF
c2.all.v2024.1.Hs.symbols.gmt	COLDREN_GEFITINIB_RESISTANCE_DN	2/230	2.546782e-01	3.794705e-01	2.586847e+00	3.538172e+00	AGR2;TSPAN1
c2.all.v2024.1.Hs.symbols.gmt	COLDREN_GEFITINIB_RESISTANCE_UP	1/86	3.063248e-01	4.155997e-01	4.130500e+00	4.886833e+00	GAS5
c2.all.v2024.1.Hs.symbols.gmt	COLINA_TARGETS_OF_4EBP1_AND_4EBP2	2/359	4.508277e-01	5.325179e-01	1.643659e+00	1.309454e+00	CP;LCN2
c2.all.v2024.1.Hs.symbols.gmt	COLLIS_PRKDC_SUBSTRATES	1/17	6.964305e-02	2.057725e-01	2.147059e+01	5.720564e+01	HSP90AA1
c2.all.v2024.1.Hs.symbols.gmt	CONCANNON_APOPTOSIS_BY_EPOXOMICIN_DN	1/176	5.276546e-01	5.965786e-01	2.004068e+00	1.281227e+00	TMSB4X
c2.all.v2024.1.Hs.symbols.gmt	CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP	5/239	3.504840e-03	3.416197e-02	5.729759e+00	3.239383e+01	PPP1R15A;GADD45A;HSPH1;NEAT1;ATF3
c2.all.v2024.1.Hs.symbols.gmt	COULOUARN_TEMPORAL_TGFB1_SIGNATURE_DN	1/138	4.443385e-01	5.275413e-01	2.562353e+00	2.078500e+00	GADD45A
c2.all.v2024.1.Hs.symbols.gmt	COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP	1/109	3.711172e-01	4.672001e-01	3.251509e+00	3.223017e+00	TMSB4X
c2.all.v2024.1.Hs.symbols.gmt	COWLING_MYCN_TARGETS	1/43	1.669802e-01	3.123952e-01	8.325826e+00	1.490223e+01	MMP10
c2.all.v2024.1.Hs.symbols.gmt	CREIGHTON_AKT1_SIGNALING_VIA_MTOR_DN	1/23	9.305905e-02	2.367331e-01	1.574082e+01	3.737691e+01	TSPAN1
c2.all.v2024.1.Hs.symbols.gmt	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_1	1/534	8.991806e-01	9.127449e-01	6.484922e-01	6.891615e-02	GAS5
c2.all.v2024.1.Hs.symbols.gmt	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_2	7/471	3.887422e-03	3.658769e-02	3.992219e+00	2.215685e+01	CFAP298;SNTN;DNAAF1;LINGO1;RSPH1;DNAH12;HSP90AA1
c2.all.v2024.1.Hs.symbols.gmt	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_3	11/726	2.494622e-04	4.564721e-03	4.116049e+00	3.414758e+01	TCN1;LCN2;BPIFA1;S100P;MUC1;BPIFB1;CP;LYZ;GOLGB1;CXCL8;TSPAN1
c2.all.v2024.1.Hs.symbols.gmt	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_4	2/307	3.742670e-01	4.694653e-01	1.928031e+00	1.894842e+00	TCN1;RPL28
c2.all.v2024.1.Hs.symbols.gmt	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_5	4/491	1.552241e-01	3.038299e-01	2.204318e+00	4.106392e+00	AGR2;MUC1;TSPAN1;NUCB2
c2.all.v2024.1.Hs.symbols.gmt	CROMER_METASTASIS_UP	1/73	2.668259e-01	3.878738e-01	4.874018e+00	6.439352e+00	CXCL8
c2.all.v2024.1.Hs.symbols.gmt	CROMER_TUMORIGENESIS_DN	4/49	5.526781e-05	1.253137e-03	2.410072e+01	2.362671e+02	MUC1;S100P;MSMB;NUCB2
c2.all.v2024.1.Hs.symbols.gmt	CROMER_TUMORIGENESIS_UP	2/58	2.516419e-02	1.299319e-01	1.054413e+01	3.882699e+01	MMP10;CXCL8
c2.all.v2024.1.Hs.symbols.gmt	CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN	2/97	6.379344e-02	2.009003e-01	6.227112e+00	1.713767e+01	PPP1R15A;SFTPB
c2.all.v2024.1.Hs.symbols.gmt	CROONQUIST_STROMAL_STIMULATION_UP	3/56	1.734093e-03	1.998518e-02	1.576207e+01	1.002037e+02	TMSB4X;PPP1R15A;SFTPB
c2.all.v2024.1.Hs.symbols.gmt	CUI_GLUCOSE_DEPRIVATION	1/61	2.283943e-01	3.623045e-01	5.843947e+00	8.629651e+00	GADD45A
c2.all.v2024.1.Hs.symbols.gmt	CUI_TCF21_TARGETS_2_DN	5/854	2.952260e-01	4.083829e-01	1.537181e+00	1.875382e+00	GADD45A;TCIM;NEAT1;HSP90AA1;LYZ
c2.all.v2024.1.Hs.symbols.gmt	CUI_TCF21_TARGETS_2_UP	3/437	2.825705e-01	3.988105e-01	1.907242e+00	2.410425e+00	SYNE2;RACK1;CFTR
c2.all.v2024.1.Hs.symbols.gmt	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN	1/466	8.645456e-01	8.810171e-01	7.455671e-01	1.085182e-01	AKAP9
c2.all.v2024.1.Hs.symbols.gmt	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_UP	1/75	2.730444e-01	3.925366e-01	4.742741e+00	6.156651e+00	ATF3
c2.all.v2024.1.Hs.symbols.gmt	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	2/856	8.822801e-01	8.982120e-01	6.719434e-01	8.415801e-02	SYNE2;AKAP9
c2.all.v2024.1.Hs.symbols.gmt	DACOSTA_UV_RESPONSE_VIA_ERCC3_UP	3/318	1.523814e-01	3.016190e-01	2.641042e+00	4.968773e+00	ATF3;RPS15A;RPL23
c2.all.v2024.1.Hs.symbols.gmt	DAIRKEE_CANCER_PRONE_RESPONSE_BPA_E2	1/118	3.948078e-01	4.896368e-01	3.001229e+00	2.789211e+00	RPL15
c2.all.v2024.1.Hs.symbols.gmt	DALESSIO_TSA_RESPONSE	2/26	5.399779e-03	4.578837e-02	2.435135e+01	1.271481e+02	ATF3;PPP1R15A
c2.all.v2024.1.Hs.symbols.gmt	DANG_BOUND_BY_MYC	10/1061	1.430961e-02	9.219811e-02	2.487275e+00	1.056302e+01	RPS29;MUC1;AKAP9;RPL27A;RPL31;RPL15;RPL3;RPL32;RPS5;RPL13A
c2.all.v2024.1.Hs.symbols.gmt	DANG_MYC_TARGETS_UP	4/130	2.282424e-03	2.505862e-02	8.636800e+00	5.253349e+01	RPL3;RPL32;RPS5;RPL27A
c2.all.v2024.1.Hs.symbols.gmt	DANG_REGULATED_BY_MYC_DN	5/251	4.312796e-03	3.877798e-02	5.447834e+00	2.966982e+01	TMSB4X;PPP1R15A;GADD45A;LYZ;FTL
c2.all.v2024.1.Hs.symbols.gmt	DARWICHE_PAPILLOMA_RISK_HIGH_DN	2/185	1.848312e-01	3.267440e-01	3.227852e+00	5.449622e+00	CP;LYZ
c2.all.v2024.1.Hs.symbols.gmt	DARWICHE_PAPILLOMA_RISK_HIGH_UP	3/154	2.776261e-02	1.388796e-01	5.541398e+00	1.986073e+01	FTL;RPL39;SERPINB4
c2.all.v2024.1.Hs.symbols.gmt	DARWICHE_PAPILLOMA_RISK_LOW_DN	2/172	1.652036e-01	3.121510e-01	3.476024e+00	6.258849e+00	CP;LYZ
c2.all.v2024.1.Hs.symbols.gmt	DARWICHE_PAPILLOMA_RISK_LOW_UP	3/168	3.462186e-02	1.575345e-01	5.069404e+00	1.704977e+01	FTL;RPL39;SERPINB4
c2.all.v2024.1.Hs.symbols.gmt	DARWICHE_SKIN_TUMOR_PROMOTER_DN	3/194	4.945819e-02	1.805210e-01	4.375936e+00	1.315681e+01	RPL39;SERPINB4;CP
c2.all.v2024.1.Hs.symbols.gmt	DARWICHE_SKIN_TUMOR_PROMOTER_UP	2/147	1.287218e-01	2.795512e-01	4.077923e+00	8.360156e+00	FTL;LYZ
c2.all.v2024.1.Hs.symbols.gmt	DARWICHE_SQUAMOUS_CELL_CARCINOMA_DN	2/186	1.863554e-01	3.283977e-01	3.210210e+00	5.393474e+00	CP;SERPINB4
c2.all.v2024.1.Hs.symbols.gmt	DARWICHE_SQUAMOUS_CELL_CARCINOMA_UP	3/153	2.730346e-02	1.379056e-01	5.578472e+00	2.008664e+01	FTL;RPL39;LYZ
c2.all.v2024.1.Hs.symbols.gmt	DASU_IL6_SIGNALING_UP	1/61	2.283943e-01	3.623045e-01	5.843947e+00	8.629651e+00	CXCL8
c2.all.v2024.1.Hs.symbols.gmt	DAUER_STAT3_TARGETS_UP	2/48	1.764599e-02	1.039817e-01	1.281749e+01	5.174739e+01	ATF3;SERPINB3
c2.all.v2024.1.Hs.symbols.gmt	DAVICIONI_MOLECULAR_ARMS_VS_ERMS_UP	2/340	4.234186e-01	5.096661e-01	1.737435e+00	1.493141e+00	SYNE2;GADD45A
c2.all.v2024.1.Hs.symbols.gmt	DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_UP	1/60	2.251031e-01	3.589947e-01	5.942435e+00	8.861339e+00	GADD45A
c2.all.v2024.1.Hs.symbols.gmt	DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_UP	1/64	2.381851e-01	3.674956e-01	5.567098e+00	7.987156e+00	GADD45A
c2.all.v2024.1.Hs.symbols.gmt	DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP	1/258	6.676451e-01	7.120182e-01	1.360770e+00	5.497494e-01	GADD45A
c2.all.v2024.1.Hs.symbols.gmt	DAVIES_MULTIPLE_MYELOMA_VS_MGUS_DN	1/26	1.045474e-01	2.529999e-01	1.388707e+01	3.135860e+01	TMSB4X
c2.all.v2024.1.Hs.symbols.gmt	DAZARD_RESPONSE_TO_UV_NHEK_DN	1/300	7.225466e-01	7.562630e-01	1.167695e+00	3.794697e-01	AKAP9
c2.all.v2024.1.Hs.symbols.gmt	DAZARD_RESPONSE_TO_UV_NHEK_UP	12/223	1.823315e-10	1.226915e-08	1.567985e+01	3.516236e+02	TCN1;PPP1R15A;ANXA2P3;GADD45A;RPL37A;RPS2;RPL31;RACK1;ATF3;MMP10;RPS27;CXCL8
c2.all.v2024.1.Hs.symbols.gmt	DAZARD_RESPONSE_TO_UV_SCC_UP	3/105	1.010472e-02	7.370086e-02	8.208743e+00	3.771714e+01	ATF3;GADD45A;CXCL8
c2.all.v2024.1.Hs.symbols.gmt	DAZARD_UV_RESPONSE_CLUSTER_G1	4/62	1.395238e-04	2.798526e-03	1.873396e+01	1.663065e+02	RPL37A;RPS27;RPL31;ANXA2P3
c2.all.v2024.1.Hs.symbols.gmt	DAZARD_UV_RESPONSE_CLUSTER_G2	3/30	2.750120e-04	4.823952e-03	3.070055e+01	2.517044e+02	ATF3;GADD45A;CXCL8
c2.all.v2024.1.Hs.symbols.gmt	DAZARD_UV_RESPONSE_CLUSTER_G28	3/20	7.962692e-05	1.730227e-03	4.826557e+01	4.555381e+02	ATF3;GADD45A;CXCL8
c2.all.v2024.1.Hs.symbols.gmt	DAZARD_UV_RESPONSE_CLUSTER_G3	1/14	5.771174e-02	1.926187e-01	2.624540e+01	7.485960e+01	PPP1R15A
c2.all.v2024.1.Hs.symbols.gmt	DAZARD_UV_RESPONSE_CLUSTER_G4	1/20	8.142487e-02	2.220291e-01	1.816495e+01	4.555906e+01	MMP10
c2.all.v2024.1.Hs.symbols.gmt	DAZARD_UV_RESPONSE_CLUSTER_G5	2/12	1.139667e-03	1.495185e-02	5.685586e+01	3.853132e+02	RPS2;RACK1
c2.all.v2024.1.Hs.symbols.gmt	DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN	1/276	6.923794e-01	7.305531e-01	1.270815e+00	4.671787e-01	RPL3
c2.all.v2024.1.Hs.symbols.gmt	DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP	4/300	3.875261e-02	1.659917e-01	3.656331e+00	1.188511e+01	ATF3;PPP1R15A;GADD45A;CXCL8
c2.all.v2024.1.Hs.symbols.gmt	DEBOSSCHER_NFKB_TARGETS_REPRESSED_BY_GLUCOCORTICOIDS	1/21	8.531924e-02	2.270101e-01	1.727807e+01	4.252748e+01	CXCL8
c2.all.v2024.1.Hs.symbols.gmt	DELACROIX_RARG_BOUND_MEF	4/366	7.011224e-02	2.068658e-01	2.981574e+00	7.924003e+00	FTL;RPL13A;CP;RPL10A
c2.all.v2024.1.Hs.symbols.gmt	DELACROIX_RAR_BOUND_ES	3/465	3.149756e-01	4.222062e-01	1.789461e+00	2.067293e+00	ATF3;RPS15A;MUC1
c2.all.v2024.1.Hs.symbols.gmt	DELACROIX_RAR_TARGETS_UP	1/47	1.810327e-01	3.241495e-01	7.608246e+00	1.300308e+01	CP
c2.all.v2024.1.Hs.symbols.gmt	DELLA_RESPONSE_TO_TSA_AND_BUTYRATE	1/21	8.531924e-02	2.270101e-01	1.727807e+01	4.252748e+01	GADD45A
c2.all.v2024.1.Hs.symbols.gmt	DELPUECH_FOXO3_TARGETS_DN	1/40	1.562845e-01	3.038299e-01	8.959385e+00	1.662931e+01	GADD45A
c2.all.v2024.1.Hs.symbols.gmt	DELPUECH_FOXO3_TARGETS_UP	1/65	2.414213e-01	3.702976e-01	5.480537e+00	7.789005e+00	S100P
c2.all.v2024.1.Hs.symbols.gmt	DELYS_THYROID_CANCER_DN	2/233	2.593859e-01	3.835690e-01	2.552974e+00	3.445081e+00	LTF;NUCB2
c2.all.v2024.1.Hs.symbols.gmt	DELYS_THYROID_CANCER_UP	6/445	1.163621e-02	8.118106e-02	3.619592e+00	1.612034e+01	GPX1;LCN2;MUC1;SFTPB;AGR2;CXCL8
c2.all.v2024.1.Hs.symbols.gmt	DEMAGALHAES_AGING_UP	1/54	2.050624e-01	3.444123e-01	6.610675e+00	1.047423e+01	LYZ
c2.all.v2024.1.Hs.symbols.gmt	DESERT_PERIPORTAL_HEPATOCELLULAR_CARCINOMA_SUBCLASS_UP	1/159	4.920314e-01	5.664335e-01	2.220736e+00	1.574974e+00	GADD45A
c2.all.v2024.1.Hs.symbols.gmt	DESERT_PERIVENOUS_HEPATOCELLULAR_CARCINOMA_SUBCLASS_UP	1/155	4.832705e-01	5.600568e-01	2.278646e+00	1.656983e+00	LCN2
c2.all.v2024.1.Hs.symbols.gmt	DESERT_STEM_CELL_HEPATOCELLULAR_CARCINOMA_SUBCLASS_UP	3/242	8.356172e-02	2.263763e-01	3.491256e+00	8.665889e+00	RPS3;CXCL8;TCIM
c2.all.v2024.1.Hs.symbols.gmt	DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_UP	4/368	7.121976e-02	2.092457e-01	2.964941e+00	7.833329e+00	ATF3;PPP1R15A;RPL28;BPIFA1
c2.all.v2024.1.Hs.symbols.gmt	DIAZ_CHRONIC_MYELOGENOUS_LEUKEMIA_DN	4/116	1.504887e-03	1.793826e-02	9.717790e+00	6.315628e+01	RPL32;RPL39;RPL23A;RPL18A
c2.all.v2024.1.Hs.symbols.gmt	DIAZ_CHRONIC_MYELOGENOUS_LEUKEMIA_UP	2/1399	9.840619e-01	9.850063e-01	4.003578e-01	6.432332e-03	HSPH1;RPL31
c2.all.v2024.1.Hs.symbols.gmt	DING_LUNG_CANCER_EXPRESSION_BY_COPY_NUMBER	1/100	3.465095e-01	4.500740e-01	3.547067e+00	3.759341e+00	AKAP9
c2.all.v2024.1.Hs.symbols.gmt	DIRMEIER_LMP1_RESPONSE_EARLY	1/62	2.316716e-01	3.644548e-01	5.748663e+00	8.407042e+00	PPP1R15A
c2.all.v2024.1.Hs.symbols.gmt	DIRMEIER_LMP1_RESPONSE_LATE_DN	1/30	1.196416e-01	2.710169e-01	1.200190e+01	2.548310e+01	RPS5
c2.all.v2024.1.Hs.symbols.gmt	DISTECHE_ESCAPED_FROM_X_INACTIVATION	1/13	5.370110e-02	1.861898e-01	2.834631e+01	8.289373e+01	TMSB4X
c2.all.v2024.1.Hs.symbols.gmt	DITTMER_PTHLH_TARGETS_DN	1/70	2.573993e-01	3.818884e-01	5.085100e+00	6.901124e+00	HSP90AA1
c2.all.v2024.1.Hs.symbols.gmt	DOANE_BREAST_CANCER_CLASSES_UP	2/72	3.746101e-02	1.619087e-01	8.444892e+00	2.773686e+01	AGR2;PIP
c2.all.v2024.1.Hs.symbols.gmt	DOANE_BREAST_CANCER_ESR1_DN	1/47	1.810327e-01	3.241495e-01	7.608246e+00	1.300308e+01	CXCL8
c2.all.v2024.1.Hs.symbols.gmt	DOANE_BREAST_CANCER_ESR1_UP	4/111	1.279111e-03	1.624977e-02	1.017209e+01	6.776232e+01	AGR2;PIP;MUC1;TSPAN1
c2.all.v2024.1.Hs.symbols.gmt	DOANE_RESPONSE_TO_ANDROGEN_DN	2/242	2.735147e-01	3.926715e-01	2.456425e+00	3.184510e+00	RPS2;AKAP9
c2.all.v2024.1.Hs.symbols.gmt	DOANE_RESPONSE_TO_ANDROGEN_UP	3/185	4.401920e-02	1.752896e-01	4.593622e+00	1.434648e+01	PIP;HSPH1;S100P
c2.all.v2024.1.Hs.symbols.gmt	DODD_NASOPHARYNGEAL_CARCINOMA_DN	23/1816	1.443756e-06	4.364747e-05	3.721124e+00	5.004265e+01	CFAP298;VMO1;LCN2;LTF;MSMB;ANXA2P2;ERICH3;MUC1;CCDC146;AGR2;DNAAF1;RSPH1;CP;NUCB2;TSPAN1;SERPINB4;SNTN;BPIFB1;SERPINB3;HOATZ;DNAH12;SCGB1A1;S100P
c2.all.v2024.1.Hs.symbols.gmt	DODD_NASOPHARYNGEAL_CARCINOMA_UP	4/1407	8.544389e-01	8.728499e-01	7.332084e-01	1.153412e-01	GAS5;RPL37A;RPL31;RPS15A
c2.all.v2024.1.Hs.symbols.gmt	DORSAM_HOXA9_TARGETS_UP	1/35	1.381557e-01	2.876176e-01	1.026017e+01	2.030872e+01	RPL27A
c2.all.v2024.1.Hs.symbols.gmt	DUNNE_TARGETS_OF_AML1_MTG8_FUSION_UP	2/53	2.126512e-02	1.161232e-01	1.157045e+01	4.455420e+01	LYZ;NUCB2
c2.all.v2024.1.Hs.symbols.gmt	DURCHDEWALD_SKIN_CARCINOGENESIS_DN	1/265	6.774895e-01	7.192076e-01	1.324333e+00	5.156440e-01	MMP10
c2.all.v2024.1.Hs.symbols.gmt	DUTERTRE_ESTRADIOL_RESPONSE_24HR_DN	1/504	8.851386e-01	9.006825e-01	6.880871e-01	8.395425e-02	GADD45A
c2.all.v2024.1.Hs.symbols.gmt	DUTERTRE_ESTRADIOL_RESPONSE_6HR_UP	1/228	6.219766e-01	6.732969e-01	1.542328e+00	7.323790e-01	RPL32
c2.all.v2024.1.Hs.symbols.gmt	ELLWOOD_MYC_TARGETS_UP	1/13	5.370110e-02	1.861898e-01	2.834631e+01	8.289373e+01	RPL37A
c2.all.v2024.1.Hs.symbols.gmt	ELVIDGE_HIF1A_AND_HIF2A_TARGETS_UP	1/41	1.598648e-01	3.051033e-01	8.737770e+00	1.602006e+01	HSPH1
c2.all.v2024.1.Hs.symbols.gmt	ELVIDGE_HIF1A_TARGETS_UP	2/67	3.284644e-02	1.542150e-01	9.091603e+00	3.105612e+01	DNAJA1;HSPH1
c2.all.v2024.1.Hs.symbols.gmt	ELVIDGE_HYPOXIA_BY_DMOG_UP	1/132	4.299161e-01	5.151091e-01	2.679998e+00	2.262361e+00	ATF3
c2.all.v2024.1.Hs.symbols.gmt	ELVIDGE_HYPOXIA_DN	2/147	1.287218e-01	2.795512e-01	4.077923e+00	8.360156e+00	DNAJA1;HSPH1
c2.all.v2024.1.Hs.symbols.gmt	ELVIDGE_HYPOXIA_UP	2/171	1.637097e-01	3.096087e-01	3.496691e+00	6.327825e+00	ATF3;MT-ND4
c2.all.v2024.1.Hs.symbols.gmt	ENGELMANN_CANCER_PROGENITORS_DN	1/69	2.542306e-01	3.790744e-01	5.159569e+00	7.066100e+00	S100P
c2.all.v2024.1.Hs.symbols.gmt	ENK_UV_RESPONSE_EPIDERMIS_DN	3/512	3.694895e-01	4.665587e-01	1.620859e+00	1.613781e+00	ATF3;RPL31;HSPH1
c2.all.v2024.1.Hs.symbols.gmt	ENK_UV_RESPONSE_EPIDERMIS_UP	2/296	3.575103e-01	4.592159e-01	2.001055e+00	2.058268e+00	SERPINB3;S100P
c2.all.v2024.1.Hs.symbols.gmt	ENK_UV_RESPONSE_KERATINOCYTE_DN	2/481	6.076203e-01	6.615324e-01	1.218584e+00	6.071045e-01	DNAJA1;RACK1
c2.all.v2024.1.Hs.symbols.gmt	ENK_UV_RESPONSE_KERATINOCYTE_UP	14/533	5.375204e-08	2.491706e-06	7.482176e+00	1.252433e+02	UBB;PPP1R15A;GADD45A;MUC1;RPL10A;RPL28;RACK1;ATF3;MMP10;DNAJA1;RPS5;RPS3;RPL18A;TSPAN1
c2.all.v2024.1.Hs.symbols.gmt	EPPERT_HSC_R	1/127	4.176151e-01	5.044268e-01	2.786561e+00	2.433212e+00	RPL31
c2.all.v2024.1.Hs.symbols.gmt	EPPERT_PROGENITOR	1/138	4.443385e-01	5.275413e-01	2.562353e+00	2.078500e+00	HSP90AA1
c2.all.v2024.1.Hs.symbols.gmt	FALVELLA_SMOKERS_WITH_LUNG_CANCER	1/81	2.913885e-01	4.054946e-01	4.388049e+00	5.410894e+00	NEAT1
c2.all.v2024.1.Hs.symbols.gmt	FARMER_BREAST_CANCER_APOCRINE_VS_BASAL	2/329	4.072391e-01	4.983723e-01	1.796699e+00	1.614073e+00	PIP;AKAP9
c2.all.v2024.1.Hs.symbols.gmt	FARMER_BREAST_CANCER_APOCRINE_VS_LUMINAL	2/327	4.042743e-01	4.960683e-01	1.807905e+00	1.637350e+00	CXCL8;PIP
c2.all.v2024.1.Hs.symbols.gmt	FARMER_BREAST_CANCER_BASAL_VS_LULMINAL	3/329	1.635286e-01	3.095469e-01	2.550774e+00	4.618859e+00	AGR2;CXCL8;TSPAN1
c2.all.v2024.1.Hs.symbols.gmt	FARMER_BREAST_CANCER_CLUSTER_6	1/14	5.771174e-02	1.926187e-01	2.624540e+01	7.485960e+01	AGR2
c2.all.v2024.1.Hs.symbols.gmt	FEKIR_HEPARG_SIDE_POP_VS_HEPARG_DN	1/107	3.657293e-01	4.632128e-01	3.312872e+00	3.332291e+00	RPS3
c2.all.v2024.1.Hs.symbols.gmt	FEKIR_HEPARG_SIDE_POP_VS_HEPARG_UP	2/90	5.591546e-02	1.912125e-01	6.721790e+00	1.938507e+01	ATF3;MT-ND4
c2.all.v2024.1.Hs.symbols.gmt	FERNANDEZ_BOUND_BY_MYC	3/181	4.170409e-02	1.695804e-01	4.697418e+00	1.492443e+01	RPL13A;RPL27A;MUC1
c2.all.v2024.1.Hs.symbols.gmt	FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_UP	1/89	3.151367e-01	4.222062e-01	3.989939e+00	4.607378e+00	NUCB2
c2.all.v2024.1.Hs.symbols.gmt	FERRARI_RESPONSE_TO_FENRETINIDE_UP	2/22	3.880433e-03	3.658769e-02	2.910811e+01	1.616026e+02	ATF3;NEAT1
c2.all.v2024.1.Hs.symbols.gmt	FEVR_CTNNB1_TARGETS_DN	2/555	6.851674e-01	7.251441e-01	1.052052e+00	3.977726e-01	RPL3;RPL32
c2.all.v2024.1.Hs.symbols.gmt	FEVR_CTNNB1_TARGETS_UP	8/688	8.805360e-03	6.655066e-02	3.092885e+00	1.463675e+01	SYNE2;GADD45A;MUC1;ATF3;MMP10;SFTPC;NUCB2;AGR2
c2.all.v2024.1.Hs.symbols.gmt	FIGUEROA_AML_METHYLATION_CLUSTER_3_DN	1/40	1.562845e-01	3.038299e-01	8.959385e+00	1.662931e+01	PPP1R15A
c2.all.v2024.1.Hs.symbols.gmt	FISCHER_DIRECT_P53_TARGETS_META_ANALYSIS	4/311	4.326999e-02	1.740511e-01	3.523757e+00	1.106564e+01	ATF3;GADD45A;GPX1;AKAP9
c2.all.v2024.1.Hs.symbols.gmt	FISCHER_DREAM_TARGETS	2/969	9.208211e-01	9.310872e-01	5.903066e-01	4.869410e-02	HSP90AA1;GADD45A
c2.all.v2024.1.Hs.symbols.gmt	FISCHER_G1_S_CELL_CYCLE	1/200	5.737754e-01	6.369854e-01	1.761047e+00	9.782919e-01	TCIM
c2.all.v2024.1.Hs.symbols.gmt	FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP	3/568	4.334179e-01	5.181145e-01	1.456562e+00	1.217763e+00	DNAJA1;LYZ;RACK1
c2.all.v2024.1.Hs.symbols.gmt	FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP	2/88	5.373264e-02	1.861898e-01	6.877832e+00	2.010895e+01	LCN2;LTF
c2.all.v2024.1.Hs.symbols.gmt	FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP	4/154	4.192770e-03	3.848016e-02	7.251574e+00	3.969797e+01	RPS29;PPP1R15A;RACK1;RPL23
c2.all.v2024.1.Hs.symbols.gmt	FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN	3/51	1.322803e-03	1.642480e-02	1.739096e+01	1.152673e+02	PPP1R15A;RPL28;RPS2
c2.all.v2024.1.Hs.symbols.gmt	FLORIO_NEOCORTEX_BASAL_RADIAL_GLIA_UP	1/384	8.068420e-01	8.319686e-01	9.084146e-01	1.949706e-01	LYZ
c2.all.v2024.1.Hs.symbols.gmt	FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_UP	3/52	1.399509e-03	1.717280e-02	1.703886e+01	1.119731e+02	RPS5;RPL37A;RPL13A
c2.all.v2024.1.Hs.symbols.gmt	FOROUTAN_INTEGRATED_TGFB_EMT_DN	6/74	7.219111e-07	2.390328e-05	2.362130e+01	3.340375e+02	SYNE2;LCN2;CP;TSPAN1;AGR2;S100P
c2.all.v2024.1.Hs.symbols.gmt	FOROUTAN_INTEGRATED_TGFB_EMT_UP	1/120	3.999512e-01	4.927929e-01	2.950731e+00	2.704087e+00	MMP10
c2.all.v2024.1.Hs.symbols.gmt	FOROUTAN_PRODRANK_TGFB_EMT_DN	3/82	5.118374e-03	4.430261e-02	1.059467e+01	5.588600e+01	AGR2;MUC1;S100P
c2.all.v2024.1.Hs.symbols.gmt	FOROUTAN_PRODRANK_TGFB_EMT_UP	1/185	5.455015e-01	6.117829e-01	1.905526e+00	1.154843e+00	MMP10
c2.all.v2024.1.Hs.symbols.gmt	FOROUTAN_TGFB_EMT_DN	7/108	3.839574e-07	1.334892e-05	1.857635e+01	2.744236e+02	SYNE2;MUC1;LCN2;CP;TSPAN1;AGR2;S100P
c2.all.v2024.1.Hs.symbols.gmt	FOROUTAN_TGFB_EMT_UP	1/192	5.589197e-01	6.238130e-01	1.835286e+00	1.067676e+00	MMP10
c2.all.v2024.1.Hs.symbols.gmt	FORTSCHEGGER_PHF8_TARGETS_DN	2/783	8.489573e-01	8.681005e-01	7.372344e-01	1.207194e-01	RPL27A;MUC1
c2.all.v2024.1.Hs.symbols.gmt	FOSTER_KDM1A_TARGETS_DN	1/202	5.774113e-01	6.396601e-01	1.743408e+00	9.574806e-01	AKAP9
c2.all.v2024.1.Hs.symbols.gmt	FOSTER_TOLERANT_MACROPHAGE_DN	1/418	8.332445e-01	8.562306e-01	8.331295e-01	1.519862e-01	CP
c2.all.v2024.1.Hs.symbols.gmt	FOSTER_TOLERANT_MACROPHAGE_UP	2/166	1.562787e-01	3.038299e-01	3.603795e+00	6.689055e+00	CP;LCN2
c2.all.v2024.1.Hs.symbols.gmt	FRASOR_RESPONSE_TO_ESTRADIOL_DN	1/78	2.822744e-01	3.988105e-01	4.558530e+00	5.765973e+00	MUC1
c2.all.v2024.1.Hs.symbols.gmt	FRASOR_TAMOXIFEN_RESPONSE_DN	1/12	4.967357e-02	1.805210e-01	3.081260e+01	9.250813e+01	TMSB4X
c2.all.v2024.1.Hs.symbols.gmt	FREDERICK_PRKCI_TARGETS	1/10	4.156755e-02	1.693553e-01	3.730284e+01	1.186393e+02	MMP10
c2.all.v2024.1.Hs.symbols.gmt	FUJII_YBX1_TARGETS_UP	1/43	1.669802e-01	3.123952e-01	8.325826e+00	1.490223e+01	MUC1
c2.all.v2024.1.Hs.symbols.gmt	FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN	2/458	5.807869e-01	6.420358e-01	1.281342e+00	6.962443e-01	NEAT1;DNAAF1
c2.all.v2024.1.Hs.symbols.gmt	FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP	4/585	2.359552e-01	3.674956e-01	1.839950e+00	2.657097e+00	GAS5;MMP10;RPL10A;CXCL8
c2.all.v2024.1.Hs.symbols.gmt	FU_INTERACT_WITH_ALKBH8	1/13	5.370110e-02	1.861898e-01	2.834631e+01	8.289373e+01	HSP90AA1
c2.all.v2024.1.Hs.symbols.gmt	GABRIELY_MIR21_TARGETS	1/289	7.091017e-01	7.466866e-01	1.212829e+00	4.169175e-01	SYNE2
c2.all.v2024.1.Hs.symbols.gmt	GAJATE_RESPONSE_TO_TRABECTEDIN_UP	4/66	1.779464e-04	3.437002e-03	1.753180e+01	1.513701e+02	ATF3;S100P;GADD45A;NUCB2
c2.all.v2024.1.Hs.symbols.gmt	GALINDO_IMMUNE_RESPONSE_TO_ENTEROTOXIN	2/79	4.430917e-02	1.752896e-01	7.679686e+00	2.393423e+01	UBB;GADD45A
c2.all.v2024.1.Hs.symbols.gmt	GALI_TP53_TARGETS_APOPTOTIC_UP	1/8	3.339314e-02	1.542150e-01	4.725455e+01	1.606373e+02	GADD45A
c2.all.v2024.1.Hs.symbols.gmt	GALLUZZI_PREVENT_MITOCHONDIAL_PERMEABILIZATION	1/14	5.771174e-02	1.926187e-01	2.624540e+01	7.485960e+01	MUC1
c2.all.v2024.1.Hs.symbols.gmt	GAL_LEUKEMIC_STEM_CELL_DN	3/237	7.963060e-02	2.220291e-01	3.566512e+00	9.024547e+00	DNAAF1;LYZ;S100P
c2.all.v2024.1.Hs.symbols.gmt	GAL_LEUKEMIC_STEM_CELL_UP	1/130	4.250268e-01	5.107177e-01	2.721636e+00	2.328640e+00	SERPINB4
c2.all.v2024.1.Hs.symbols.gmt	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_UP	4/139	2.907194e-03	3.002182e-02	8.059836e+00	4.707401e+01	ATF3;DNAJA1;HSPH1;CXCL8
c2.all.v2024.1.Hs.symbols.gmt	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREY_DN	1/80	2.883633e-01	4.028974e-01	4.443447e+00	5.525578e+00	TCIM
c2.all.v2024.1.Hs.symbols.gmt	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_MAGENTA_UP	3/29	2.482711e-04	4.564721e-03	3.186050e+01	2.644737e+02	DNAJA1;PPP1R15A;UBB
c2.all.v2024.1.Hs.symbols.gmt	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_PURPLE_DN	1/13	5.370110e-02	1.861898e-01	2.834631e+01	8.289373e+01	GAS5
c2.all.v2024.1.Hs.symbols.gmt	GARY_CD5_TARGETS_DN	3/440	2.860300e-01	4.008908e-01	1.893902e+00	2.370519e+00	GAS5;DNAJA1;HSPH1
c2.all.v2024.1.Hs.symbols.gmt	GARY_CD5_TARGETS_UP	5/473	5.064437e-02	1.834100e-01	2.837244e+00	8.463291e+00	NEAT1;RPL31;GAS5;NUCB2;RPL13A
c2.all.v2024.1.Hs.symbols.gmt	GAURNIER_PSMD4_TARGETS	1/73	2.668259e-01	3.878738e-01	4.874018e+00	6.439352e+00	CXCL8
c2.all.v2024.1.Hs.symbols.gmt	GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_DN	2/95	6.150575e-02	1.980274e-01	6.360890e+00	1.773813e+01	ATF3;LYZ
c2.all.v2024.1.Hs.symbols.gmt	GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_UP	2/195	2.001503e-01	3.425050e-01	3.059641e+00	4.922004e+00	ERICH3;RPL15
c2.all.v2024.1.Hs.symbols.gmt	GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_UP	1/174	5.235954e-01	5.929533e-01	2.027354e+00	1.311771e+00	RPS15A
c2.all.v2024.1.Hs.symbols.gmt	GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_UP	1/98	3.409131e-01	4.450218e-01	3.620156e+00	3.895750e+00	CP
c2.all.v2024.1.Hs.symbols.gmt	GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_DN	1/35	1.381557e-01	2.876176e-01	1.026017e+01	2.030872e+01	GADD45A
c2.all.v2024.1.Hs.symbols.gmt	GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP	2/245	2.782236e-01	3.967016e-01	2.425828e+00	3.103435e+00	MMP10;AGR2
c2.all.v2024.1.Hs.symbols.gmt	GAVIN_FOXP3_TARGETS_CLUSTER_P7	1/91	3.209496e-01	4.283435e-01	3.901409e+00	4.433839e+00	DNAH12
c2.all.v2024.1.Hs.symbols.gmt	GAVIN_FOXP3_TARGETS_CLUSTER_T4	1/97	3.380971e-01	4.430092e-01	3.657837e+00	3.966639e+00	NUCB2
c2.all.v2024.1.Hs.symbols.gmt	GAVIN_FOXP3_TARGETS_CLUSTER_T7	2/101	6.845368e-02	2.057725e-01	5.975689e+00	1.602440e+01	FTL;RPL32
c2.all.v2024.1.Hs.symbols.gmt	GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN	2/471	5.961138e-01	6.534384e-01	1.245114e+00	6.441271e-01	RPL28;LCN2
c2.all.v2024.1.Hs.symbols.gmt	GAZDA_DIAMOND_BLACKFAN_ANEMIA_MYELOID_DN	1/41	1.598648e-01	3.051033e-01	8.737770e+00	1.602006e+01	RPL28
c2.all.v2024.1.Hs.symbols.gmt	GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_DN	1/66	2.446439e-01	3.725015e-01	5.396620e+00	7.598181e+00	NUCB2
c2.all.v2024.1.Hs.symbols.gmt	GEISS_RESPONSE_TO_DSRNA_UP	1/39	1.526892e-01	3.016190e-01	9.192513e+00	1.727596e+01	ATF3
c2.all.v2024.1.Hs.symbols.gmt	GENTILE_UV_HIGH_DOSE_DN	2/289	3.467660e-01	4.501269e-01	2.050435e+00	2.171626e+00	ATF3;GADD45A
c2.all.v2024.1.Hs.symbols.gmt	GENTILE_UV_HIGH_DOSE_UP	2/23	4.238325e-03	3.848016e-02	2.775299e+01	1.516309e+02	ATF3;GADD45A
c2.all.v2024.1.Hs.symbols.gmt	GEORGES_TARGETS_OF_MIR192_AND_MIR215	1/892	9.790287e-01	9.809097e-01	3.816346e-01	8.088470e-03	NUCB2
c2.all.v2024.1.Hs.symbols.gmt	GERHOLD_ADIPOGENESIS_UP	1/48	1.845090e-01	3.264510e-01	7.447734e+00	1.258710e+01	GADD45A
c2.all.v2024.1.Hs.symbols.gmt	GERY_CEBP_TARGETS	5/131	2.393318e-04	4.497712e-03	1.067403e+01	8.899647e+01	PPP1R15A;HSPH1;LCN2;ATF3;LYZ
c2.all.v2024.1.Hs.symbols.gmt	GHANDHI_BYSTANDER_IRRADIATION_DN	1/12	4.967357e-02	1.805210e-01	3.081260e+01	9.250813e+01	S100P
c2.all.v2024.1.Hs.symbols.gmt	GHANDHI_BYSTANDER_IRRADIATION_UP	3/84	5.473640e-03	4.604038e-02	1.033374e+01	5.381615e+01	MMP10;CXCL8;TCIM
c2.all.v2024.1.Hs.symbols.gmt	GHANDHI_DIRECT_IRRADIATION_DN	1/35	1.381557e-01	2.876176e-01	1.026017e+01	2.030872e+01	S100P
c2.all.v2024.1.Hs.symbols.gmt	GHANDHI_DIRECT_IRRADIATION_UP	4/105	1.040831e-03	1.419067e-02	1.077634e+01	7.400905e+01	MMP10;CXCL8;GADD45A;TCIM
c2.all.v2024.1.Hs.symbols.gmt	GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_UP	1/110	3.737942e-01	4.694369e-01	3.221669e+00	3.170283e+00	HSP90AA1
c2.all.v2024.1.Hs.symbols.gmt	GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN	2/338	4.204932e-01	5.067295e-01	1.747922e+00	1.514272e+00	GAS5;SFTPC
c2.all.v2024.1.Hs.symbols.gmt	GNATENKO_PLATELET_SIGNATURE	2/44	1.496131e-02	9.469072e-02	1.402639e+01	5.894293e+01	TMSB4X;GPX1
c2.all.v2024.1.Hs.symbols.gmt	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN	1/1102	9.917539e-01	9.917539e-01	3.058178e-01	2.532269e-03	ATF3
c2.all.v2024.1.Hs.symbols.gmt	GOLDRATH_ANTIGEN_RESPONSE	1/366	7.912310e-01	8.187043e-01	9.539419e-01	2.233801e-01	NAPSA
c2.all.v2024.1.Hs.symbols.gmt	GOLUB_ALL_VS_AML_DN	2/23	4.238325e-03	3.848016e-02	2.775299e+01	1.516309e+02	LYZ;CXCL8
c2.all.v2024.1.Hs.symbols.gmt	GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN	1/208	5.881359e-01	6.477569e-01	1.692533e+00	8.983916e-01	CFTR
c2.all.v2024.1.Hs.symbols.gmt	GOUYER_TATI_TARGETS_UP	2/10	7.813473e-04	1.149312e-02	7.024006e+01	5.025319e+02	CXCL8;LCN2
c2.all.v2024.1.Hs.symbols.gmt	GOZGIT_ESR1_TARGETS_DN	9/786	6.099004e-03	5.008867e-02	3.047017e+00	1.553866e+01	TMSB4X;LCN2;NEAT1;MSMB;CP;NUCB2;AGR2;SCGB1A1;TSPAN1
c2.all.v2024.1.Hs.symbols.gmt	GRADE_COLON_AND_RECTAL_CANCER_UP	1/290	7.103502e-01	7.472468e-01	1.208584e+00	4.133323e-01	PABPC3
c2.all.v2024.1.Hs.symbols.gmt	GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_DN	3/1776	9.835388e-01	9.849553e-01	4.383863e-01	7.276432e-03	RPL3;NEAT1;GAS5
c2.all.v2024.1.Hs.symbols.gmt	GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP	6/1151	3.614812e-01	4.614602e-01	1.343481e+00	1.367053e+00	PPP1R15A;GADD45A;TCIM;ATF3;RPS27;DNAJA1
c2.all.v2024.1.Hs.symbols.gmt	GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_UP	3/567	4.322938e-01	5.171286e-01	1.459210e+00	1.223766e+00	CP;GADD45A;TCIM
c2.all.v2024.1.Hs.symbols.gmt	GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_DN	3/776	6.431163e-01	6.918724e-01	1.054595e+00	4.655297e-01	RPL3;CFAP298;GAS5
c2.all.v2024.1.Hs.symbols.gmt	GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP	1/611	9.279170e-01	9.378076e-01	5.646770e-01	4.224515e-02	PPP1R15A
c2.all.v2024.1.Hs.symbols.gmt	GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_UP	1/218	6.054150e-01	6.601650e-01	1.613978e+00	8.099602e-01	CP
c2.all.v2024.1.Hs.symbols.gmt	GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN	3/94	7.470123e-03	5.924972e-02	9.200185e+00	4.505187e+01	NEAT1;RPL31;CXCL8
c2.all.v2024.1.Hs.symbols.gmt	GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP	1/24	9.690462e-02	2.420875e-01	1.507032e+01	3.517454e+01	CXCL8
c2.all.v2024.1.Hs.symbols.gmt	GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP	1/59	2.217980e-01	3.578273e-01	6.044289e+00	9.102627e+00	CXCL8
c2.all.v2024.1.Hs.symbols.gmt	GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP	1/64	2.381851e-01	3.674956e-01	5.567098e+00	7.987156e+00	NEAT1
c2.all.v2024.1.Hs.symbols.gmt	GREGORY_SYNTHETIC_LETHAL_WITH_IMATINIB	1/145	4.607088e-01	5.411659e-01	2.437448e+00	1.888995e+00	RPL21
c2.all.v2024.1.Hs.symbols.gmt	GRESHOCK_CANCER_COPY_NUMBER_UP	2/323	3.983243e-01	4.922420e-01	1.830734e+00	1.685170e+00	HSP90AA1;MUC1
c2.all.v2024.1.Hs.symbols.gmt	GROSS_ELK3_TARGETS_UP	1/27	1.083448e-01	2.588857e-01	1.336243e+01	2.969714e+01	GPX1
c2.all.v2024.1.Hs.symbols.gmt	GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_UP	2/143	1.230803e-01	2.740804e-01	4.193964e+00	8.786011e+00	ATF3;TCIM
c2.all.v2024.1.Hs.symbols.gmt	GROSS_HYPOXIA_VIA_ELK3_DN	3/155	2.822588e-02	1.405231e-01	5.504811e+00	1.963850e+01	PPP1R15A;GADD45A;TCIM
c2.all.v2024.1.Hs.symbols.gmt	GROSS_HYPOXIA_VIA_ELK3_ONLY_UP	2/34	9.118486e-03	6.793272e-02	1.835052e+01	8.620068e+01	PPP1R15A;GADD45A
c2.all.v2024.1.Hs.symbols.gmt	GROSS_HYPOXIA_VIA_ELK3_UP	1/210	5.916506e-01	6.502546e-01	1.676222e+00	8.797466e-01	GPX1
c2.all.v2024.1.Hs.symbols.gmt	GROSS_HYPOXIA_VIA_HIF1A_DN	1/110	3.737942e-01	4.694369e-01	3.221669e+00	3.170283e+00	TCIM
c2.all.v2024.1.Hs.symbols.gmt	GRUETZMANN_PANCREATIC_CANCER_DN	2/200	2.078673e-01	3.470081e-01	2.981891e+00	4.684120e+00	RPL32;NUCB2
c2.all.v2024.1.Hs.symbols.gmt	GRUETZMANN_PANCREATIC_CANCER_UP	6/359	4.242779e-03	3.848016e-02	4.518040e+00	2.467996e+01	GADD45A;GPX1;LCN2;ATF3;DNAJA1;S100P
c2.all.v2024.1.Hs.symbols.gmt	GRYDER_PAX3FOXO1_ENHANCERS_IN_TADS	4/1009	6.239950e-01	6.751315e-01	1.043111e+00	4.919447e-01	ATF3;RPL23A;GADD45A;HSPH1
c2.all.v2024.1.Hs.symbols.gmt	GRYDER_PAX3FOXO1_ENHANCERS_KO_DOWN	4/438	1.154253e-01	2.689103e-01	2.479264e+00	5.353057e+00	ATF3;RPL23A;GADD45A;HSPH1
c2.all.v2024.1.Hs.symbols.gmt	GRYDER_PAX3FOXO1_TOP_ENHANCERS	3/441	2.871840e-01	4.020576e-01	1.889495e+00	2.357395e+00	ATF3;RPL23A;HSPH1
c2.all.v2024.1.Hs.symbols.gmt	GUILLAUMOND_KLF10_TARGETS_DN	1/30	1.196416e-01	2.710169e-01	1.200190e+01	2.548310e+01	TMSB4X
c2.all.v2024.1.Hs.symbols.gmt	GUILLAUMOND_KLF10_TARGETS_UP	1/50	1.914179e-01	3.321944e-01	7.146168e+00	1.181473e+01	LCN2
c2.all.v2024.1.Hs.symbols.gmt	GUO_TARGETS_OF_IRS1_AND_IRS2	3/97	8.142313e-03	6.290690e-02	8.906901e+00	4.284826e+01	HSP90AA1;DNAJA1;HSPH1
c2.all.v2024.1.Hs.symbols.gmt	GU_PDEF_TARGETS_UP	1/71	2.605548e-01	3.835690e-01	5.012743e+00	6.741850e+00	SERPINB3
c2.all.v2024.1.Hs.symbols.gmt	HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_DN	1/64	2.381851e-01	3.674956e-01	5.567098e+00	7.987156e+00	LYZ
c2.all.v2024.1.Hs.symbols.gmt	HAHTOLA_CTCL_CUTANEOUS	2/26	5.399779e-03	4.578837e-02	2.435135e+01	1.271481e+02	RPL31;S100P
c2.all.v2024.1.Hs.symbols.gmt	HAHTOLA_CTCL_PATHOGENESIS	1/15	6.170557e-02	1.980274e-01	2.443426e+01	6.805873e+01	S100P
c2.all.v2024.1.Hs.symbols.gmt	HAHTOLA_MYCOSIS_FUNGOIDES_CD4_DN	3/115	1.291285e-02	8.524116e-02	7.475677e+00	3.251570e+01	NUCB2;RPL31;MT-ND4
c2.all.v2024.1.Hs.symbols.gmt	HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP	3/63	2.431736e-03	2.601334e-02	1.393393e+01	8.387041e+01	ATF3;PPP1R15A;CXCL8
c2.all.v2024.1.Hs.symbols.gmt	HAHTOLA_MYCOSIS_FUNGOIDES_DN	1/17	6.964305e-02	2.057725e-01	2.147059e+01	5.720564e+01	RPL31
c2.all.v2024.1.Hs.symbols.gmt	HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_UP	2/177	1.727090e-01	3.187349e-01	3.376222e+00	5.929143e+00	RPL23;MT-ND4
c2.all.v2024.1.Hs.symbols.gmt	HAHTOLA_MYCOSIS_FUNGOIDES_UP	1/18	7.358684e-02	2.123128e-01	2.024278e+01	5.281927e+01	S100P
c2.all.v2024.1.Hs.symbols.gmt	HAHTOLA_SEZARY_SYNDROM_UP	2/99	6.610963e-02	2.016150e-01	6.098822e+00	1.656709e+01	GOLGB1;S100P
c2.all.v2024.1.Hs.symbols.gmt	HALMOS_CEBPA_TARGETS_DN	1/45	1.740360e-01	3.187349e-01	7.950910e+00	1.390211e+01	GADD45A
c2.all.v2024.1.Hs.symbols.gmt	HALMOS_CEBPA_TARGETS_UP	1/49	1.879707e-01	3.283977e-01	7.293842e+00	1.219143e+01	CXCL8
c2.all.v2024.1.Hs.symbols.gmt	HAMAI_APOPTOSIS_VIA_TRAIL_UP	7/656	2.140401e-02	1.165764e-01	2.830683e+00	1.088165e+01	SYNE2;HSPH1;SFTPC;HSP90AA1;DNAJA1;GOLGB1;NUCB2
c2.all.v2024.1.Hs.symbols.gmt	HAN_JNK_SINGALING_DN	2/40	1.247157e-02	8.365174e-02	1.548649e+01	6.789746e+01	CP;LCN2
c2.all.v2024.1.Hs.symbols.gmt	HAN_SATB1_TARGETS_DN	4/388	8.278601e-02	2.248589e-01	2.808131e+00	6.996449e+00	MMP10;AGR2;TCIM;S100P
c2.all.v2024.1.Hs.symbols.gmt	HAN_SATB1_TARGETS_UP	5/425	3.455697e-02	1.575345e-01	3.168129e+00	1.066122e+01	TCIM;NEAT1;MMP10;CXCL8;S100P
c2.all.v2024.1.Hs.symbols.gmt	HARRIS_HYPOXIA	3/81	4.946121e-03	4.344205e-02	1.073012e+01	5.696782e+01	FTL;CP;CXCL8
c2.all.v2024.1.Hs.symbols.gmt	HEBERT_MATRISOME_TNBC_LUNG_METASTASIS	1/23	9.305905e-02	2.367331e-01	1.574082e+01	3.737691e+01	SFTPA1
c2.all.v2024.1.Hs.symbols.gmt	HECKER_IFNB1_TARGETS	1/95	3.324294e-01	4.388910e-01	3.735591e+00	4.114110e+00	CXCL8
c2.all.v2024.1.Hs.symbols.gmt	HEDENFALK_BREAST_CANCER_BRACX_UP	3/19	6.789114e-05	1.490746e-03	5.119308e+01	4.913309e+02	RPS5;RPL31;RPL15
c2.all.v2024.1.Hs.symbols.gmt	HEDVAT_ELF4_TARGETS_UP	1/12	4.967357e-02	1.805210e-01	3.081260e+01	9.250813e+01	CXCL8
c2.all.v2024.1.Hs.symbols.gmt	HEIDENBLAD_AMPLIFIED_IN_PANCREATIC_CANCER	1/57	2.151460e-01	3.519958e-01	6.258814e+00	9.616282e+00	AKAP9
c2.all.v2024.1.Hs.symbols.gmt	HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS	2/77	4.230794e-02	1.707048e-01	7.883837e+00	2.493485e+01	GADD45A;CXCL8
c2.all.v2024.1.Hs.symbols.gmt	HELLER_HDAC_TARGETS_DN	4/293	3.602652e-02	1.619087e-01	3.745942e+00	1.244964e+01	ATF3;PPP1R15A;GADD45A;HSPH1
c2.all.v2024.1.Hs.symbols.gmt	HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN	4/282	3.197545e-02	1.509068e-01	3.895861e+00	1.341262e+01	ATF3;PPP1R15A;GADD45A;HSPH1
c2.all.v2024.1.Hs.symbols.gmt	HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP	1/461	8.615773e-01	8.788510e-01	7.538365e-01	1.123145e-01	FTL
c2.all.v2024.1.Hs.symbols.gmt	HELLER_HDAC_TARGETS_UP	2/317	3.893497e-01	4.837791e-01	1.866064e+00	1.760216e+00	NEAT1;FTL
c2.all.v2024.1.Hs.symbols.gmt	HELLER_SILENCED_BY_METHYLATION_DN	4/107	1.116449e-03	1.492893e-02	1.056714e+01	7.183120e+01	ATF3;PPP1R15A;NEAT1;HSPH1
c2.all.v2024.1.Hs.symbols.gmt	HELLER_SILENCED_BY_METHYLATION_UP	3/283	1.187393e-01	2.710169e-01	2.975356e+00	6.339962e+00	RPS2;MUC1;S100P
c2.all.v2024.1.Hs.symbols.gmt	HENDRICKS_SMARCA4_TARGETS_DN	2/49	1.834678e-02	1.069033e-01	1.254708e+01	5.016702e+01	AGR2;SFTPB
c2.all.v2024.1.Hs.symbols.gmt	HENDRICKS_SMARCA4_TARGETS_UP	1/54	2.050624e-01	3.444123e-01	6.610675e+00	1.047423e+01	GADD45A
c2.all.v2024.1.Hs.symbols.gmt	HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_UP	1/61	2.283943e-01	3.623045e-01	5.843947e+00	8.629651e+00	GADD45A
c2.all.v2024.1.Hs.symbols.gmt	HESS_TARGETS_OF_HOXA9_AND_MEIS1_DN	2/84	4.946205e-02	1.805210e-01	7.212613e+00	2.168508e+01	LYZ;LCN2
c2.all.v2024.1.Hs.symbols.gmt	HESS_TARGETS_OF_HOXA9_AND_MEIS1_UP	2/69	3.466363e-02	1.575345e-01	8.821421e+00	2.965819e+01	GAS5;NUCB2
c2.all.v2024.1.Hs.symbols.gmt	HILLION_HMGA1B_TARGETS	1/86	3.063248e-01	4.155997e-01	4.130500e+00	4.886833e+00	RPL21
c2.all.v2024.1.Hs.symbols.gmt	HILLION_HMGA1_TARGETS	1/84	3.003881e-01	4.122431e-01	4.229818e+00	5.087119e+00	RPL21
c2.all.v2024.1.Hs.symbols.gmt	HINATA_NFKB_TARGETS_FIBROBLAST_UP	2/81	4.634500e-02	1.773865e-01	7.485807e+00	2.299372e+01	GADD45A;CXCL8
c2.all.v2024.1.Hs.symbols.gmt	HINATA_NFKB_TARGETS_KERATINOCYTE_UP	2/84	4.946205e-02	1.805210e-01	7.212613e+00	2.168508e+01	GADD45A;CXCL8
c2.all.v2024.1.Hs.symbols.gmt	HOEBEKE_LYMPHOID_STEM_CELL_DN	2/88	5.373264e-02	1.861898e-01	6.877832e+00	2.010895e+01	RPS27;GADD45A
c2.all.v2024.1.Hs.symbols.gmt	HOEGERKORP_CD44_TARGETS_TEMPORAL_DN	2/25	4.998126e-03	4.344205e-02	2.538873e+01	1.345271e+02	LYZ;NUCB2
c2.all.v2024.1.Hs.symbols.gmt	HOELZEL_NF1_TARGETS_DN	1/118	3.948078e-01	4.896368e-01	3.001229e+00	2.789211e+00	CP
c2.all.v2024.1.Hs.symbols.gmt	HOFFMAN_CLOCK_TARGETS_DN	1/10	4.156755e-02	1.693553e-01	3.730284e+01	1.186393e+02	S100P
c2.all.v2024.1.Hs.symbols.gmt	HOFMANN_CELL_LYMPHOMA_UP	1/48	1.845090e-01	3.264510e-01	7.447734e+00	1.258710e+01	CXCL8
c2.all.v2024.1.Hs.symbols.gmt	HOFMANN_MYELODYSPLASTIC_SYNDROM_LOW_RISK_DN	1/29	1.158918e-01	2.689103e-01	1.242359e+01	2.677405e+01	TSPAN1
c2.all.v2024.1.Hs.symbols.gmt	HOFMANN_MYELODYSPLASTIC_SYNDROM_LOW_RISK_UP	1/21	8.531924e-02	2.270101e-01	1.727807e+01	4.252748e+01	ATF3
c2.all.v2024.1.Hs.symbols.gmt	HOLLEMAN_ASPARAGINASE_RESISTANCE_ALL_UP	2/23	4.238325e-03	3.848016e-02	2.775299e+01	1.516309e+02	RPL3;RPS3
c2.all.v2024.1.Hs.symbols.gmt	HOLLEMAN_ASPARAGINASE_RESISTANCE_B_ALL_UP	5/28	1.114131e-07	4.648153e-06	5.772745e+01	9.242176e+02	RACK1;RPL3;RPS5;RPL13A;RPS3
c2.all.v2024.1.Hs.symbols.gmt	HOLLEMAN_VINCRISTINE_RESISTANCE_ALL_DN	4/20	1.388344e-06	4.258948e-05	6.654696e+01	8.975454e+02	RPS15A;RPL23A;RPS2;RPL31
c2.all.v2024.1.Hs.symbols.gmt	HOLLEMAN_VINCRISTINE_RESISTANCE_B_ALL_DN	1/16	6.568265e-02	2.009003e-01	2.285682e+01	6.223731e+01	RPS15A
c2.all.v2024.1.Hs.symbols.gmt	HOLLERN_EMT_BREAST_TUMOR_DN	1/123	4.075854e-01	4.983723e-01	2.878075e+00	2.583086e+00	LTF
c2.all.v2024.1.Hs.symbols.gmt	HOLLMANN_APOPTOSIS_VIA_CD40_DN	1/267	6.802488e-01	7.206698e-01	1.314274e+00	5.063854e-01	ANXA2P2
c2.all.v2024.1.Hs.symbols.gmt	HOLLMANN_APOPTOSIS_VIA_CD40_UP	1/203	5.792178e-01	6.406406e-01	1.734720e+00	9.472902e-01	HSPH1
c2.all.v2024.1.Hs.symbols.gmt	HONMA_DOCETAXEL_RESISTANCE	1/35	1.381557e-01	2.876176e-01	1.026017e+01	2.030872e+01	RACK1
c2.all.v2024.1.Hs.symbols.gmt	HOOI_ST7_TARGETS_DN	3/115	1.291285e-02	8.524116e-02	7.475677e+00	3.251570e+01	TCN1;MMP10;ANKRD36B
c2.all.v2024.1.Hs.symbols.gmt	HOOI_ST7_TARGETS_UP	1/93	3.267137e-01	4.335400e-01	3.816708e+00	4.269640e+00	ATF3
c2.all.v2024.1.Hs.symbols.gmt	HORIUCHI_WTAP_TARGETS_DN	4/320	4.717843e-02	1.793569e-01	3.422141e+00	1.045060e+01	RPL3;RPL13A;RPL15;HSP90AA1
c2.all.v2024.1.Hs.symbols.gmt	HORIUCHI_WTAP_TARGETS_UP	2/309	3.772955e-01	4.721286e-01	1.915315e+00	1.866909e+00	ATF3;TCIM
c2.all.v2024.1.Hs.symbols.gmt	HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_UP	1/62	2.316716e-01	3.644548e-01	5.748663e+00	8.407042e+00	GOLGB1
c2.all.v2024.1.Hs.symbols.gmt	HOSHIDA_LIVER_CANCER_SUBCLASS_S1	2/235	2.625253e-01	3.854743e-01	2.530876e+00	3.384813e+00	TMSB4X;LTF
c2.all.v2024.1.Hs.symbols.gmt	HOSHIDA_LIVER_CANCER_SUBCLASS_S2	3/115	1.291285e-02	8.524116e-02	7.475677e+00	3.251570e+01	RPS5;RPS27;RPL31
c2.all.v2024.1.Hs.symbols.gmt	HOSHIDA_LIVER_CANCER_SUBCLASS_S3	1/266	6.788720e-01	7.199426e-01	1.319285e+00	5.109888e-01	CP
c2.all.v2024.1.Hs.symbols.gmt	HOUNKPE_HOUSEKEEPING_GENES	2/1129	9.557034e-01	9.607697e-01	5.027027e-01	2.277631e-02	DNAJA1;RPL15
c2.all.v2024.1.Hs.symbols.gmt	HOUSTIS_ROS	1/36	1.418120e-01	2.920236e-01	9.970701e+00	1.947530e+01	CP
c2.all.v2024.1.Hs.symbols.gmt	HSIAO_HOUSEKEEPING_GENES	24/397	2.688483e-21	3.505110e-19	2.021418e+01	9.574509e+02	RPS29;UBB;RPL37A;RPS2;RPL31;RPL3;RPS27;RPS3;TMSB4X;RPL21;RPL28;RACK1;RPL13A;RPL39;RPL23;RPS5;FTL;RPL18A;RPS15A;RPL10A;RPL27A;HSP90AA1;RPL23A;RPL32
c2.all.v2024.1.Hs.symbols.gmt	HSIAO_LIVER_SPECIFIC_GENES	1/249	6.545500e-01	7.002007e-01	1.410635e+00	5.978373e-01	CP
c2.all.v2024.1.Hs.symbols.gmt	HUANG_GATA2_TARGETS_UP	3/152	2.684843e-02	1.359365e-01	5.616043e+00	2.031630e+01	GPX1;LYZ;NAPSA
c2.all.v2024.1.Hs.symbols.gmt	HUI_MAPK14_TARGETS_UP	1/19	7.751409e-02	2.176237e-01	1.914771e+01	4.896635e+01	GADD45A
c2.all.v2024.1.Hs.symbols.gmt	HUMMERICH_MALIGNANT_SKIN_TUMOR_UP	1/19	7.751409e-02	2.176237e-01	1.914771e+01	4.896635e+01	LTF
c2.all.v2024.1.Hs.symbols.gmt	HUMMERICH_SKIN_CANCER_PROGRESSION_DN	1/103	3.548162e-01	4.560360e-01	3.442781e+00	3.567256e+00	LYZ
c2.all.v2024.1.Hs.symbols.gmt	HUMMERICH_SKIN_CANCER_PROGRESSION_UP	1/88	3.122118e-01	4.209914e-01	4.035722e+00	4.697877e+00	LCN2
c2.all.v2024.1.Hs.symbols.gmt	HUPER_BREAST_BASAL_VS_LUMINAL_DN	1/58	2.184790e-01	3.549433e-01	6.149686e+00	9.354074e+00	LCN2
c2.all.v2024.1.Hs.symbols.gmt	HUPER_BREAST_BASAL_VS_LUMINAL_UP	2/53	2.126512e-02	1.161232e-01	1.157045e+01	4.455420e+01	MMP10;S100P
c2.all.v2024.1.Hs.symbols.gmt	HUTTMANN_B_CLL_POOR_SURVIVAL_DN	1/59	2.217980e-01	3.578273e-01	6.044289e+00	9.102627e+00	NUCB2
c2.all.v2024.1.Hs.symbols.gmt	HUTTMANN_B_CLL_POOR_SURVIVAL_UP	3/284	1.196580e-01	2.710169e-01	2.964651e+00	6.294302e+00	PPP1R15A;SFTPB;BPIFA1
c2.all.v2024.1.Hs.symbols.gmt	HU_GENOTOXIC_DAMAGE_24HR	3/37	5.151456e-04	8.079652e-03	2.446369e+01	1.852161e+02	RPL3;DNAJA1;RPL10A
c2.all.v2024.1.Hs.symbols.gmt	HWANG_PROSTATE_CANCER_MARKERS	2/28	6.245956e-03	5.069675e-02	2.251147e+01	1.142642e+02	AGR2;MUC1
c2.all.v2024.1.Hs.symbols.gmt	IBRAHIM_NRF1_DOWN	2/167	1.577596e-01	3.051033e-01	3.581857e+00	6.614553e+00	GAS5;ANKRD36B
c2.all.v2024.1.Hs.symbols.gmt	IBRAHIM_NRF1_UP	3/420	2.630539e-01	3.854743e-01	1.986460e+00	2.652711e+00	FTL;DNAJA1;HSPH1
c2.all.v2024.1.Hs.symbols.gmt	IBRAHIM_NRF2_UP	4/533	1.899402e-01	3.315609e-01	2.025527e+00	3.364493e+00	FTL;PPP1R15A;DNAJA1;NUCB2
c2.all.v2024.1.Hs.symbols.gmt	ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_UP	3/141	2.211574e-02	1.192079e-01	6.065120e+00	2.311700e+01	TMSB4X;LYZ;LTF
c2.all.v2024.1.Hs.symbols.gmt	ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_UP	3/115	1.291285e-02	8.524116e-02	7.475677e+00	3.251570e+01	TMSB4X;LYZ;AKAP9
c2.all.v2024.1.Hs.symbols.gmt	IGARASHI_ATF4_TARGETS_DN	2/98	6.494801e-02	2.009003e-01	6.162302e+00	1.684877e+01	AGR2;S100P
c2.all.v2024.1.Hs.symbols.gmt	IGLESIAS_E2F_TARGETS_UP	3/144	2.335686e-02	1.249293e-01	5.935720e+00	2.229970e+01	AGR2;DNAJA1;LYZ
c2.all.v2024.1.Hs.symbols.gmt	IKEDA_MIR133_TARGETS_UP	1/44	1.705155e-01	3.170190e-01	8.134059e+00	1.438857e+01	AKAP9
c2.all.v2024.1.Hs.symbols.gmt	INGA_TP53_TARGETS	1/16	6.568265e-02	2.009003e-01	2.285682e+01	6.223731e+01	GADD45A
c2.all.v2024.1.Hs.symbols.gmt	INGRAM_SHH_TARGETS_UP	3/125	1.612426e-02	9.951245e-02	6.862295e+00	2.832364e+01	FTL;CP;GADD45A
c2.all.v2024.1.Hs.symbols.gmt	IRITANI_MAD1_TARGETS_DN	1/46	1.775417e-01	3.214861e-01	7.775812e+00	1.344088e+01	GAS5
c2.all.v2024.1.Hs.symbols.gmt	IVANOVA_HEMATOPOIESIS_LATE_PROGENITOR	2/516	6.459560e-01	6.942113e-01	1.133848e+00	4.955187e-01	HSPH1;NUCB2
c2.all.v2024.1.Hs.symbols.gmt	IVANOVA_HEMATOPOIESIS_MATURE_CELL	2/298	3.605690e-01	4.614602e-01	1.987375e+00	2.027266e+00	FTL;GADD45A
c2.all.v2024.1.Hs.symbols.gmt	IVANOVA_HEMATOPOIESIS_STEM_CELL_AND_PROGENITOR	1/574	9.152939e-01	9.263964e-01	6.021428e-01	5.329570e-02	MUC1
c2.all.v2024.1.Hs.symbols.gmt	IVANOVA_HEMATOPOIESIS_STEM_CELL_LONG_TERM	1/217	6.037199e-01	6.596960e-01	1.621506e+00	8.182850e-01	AKAP9
c2.all.v2024.1.Hs.symbols.gmt	IVANOVA_HEMATOPOIESIS_STEM_CELL_SHORT_TERM	1/22	8.919728e-02	2.334470e-01	1.647370e+01	3.981536e+01	TSPAN1
c2.all.v2024.1.Hs.symbols.gmt	IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_UP	3/192	4.822223e-02	1.805210e-01	4.422524e+00	1.340881e+01	CP;SFTPA1;NUCB2
c2.all.v2024.1.Hs.symbols.gmt	IWANAGA_CARCINOGENESIS_BY_KRAS_UP	2/177	1.727090e-01	3.187349e-01	3.376222e+00	5.929143e+00	RPS5;TCIM
c2.all.v2024.1.Hs.symbols.gmt	IYENGAR_RESPONSE_TO_ADIPOCYTE_FACTORS	1/10	4.156755e-02	1.693553e-01	3.730284e+01	1.186393e+02	ATF3
c2.all.v2024.1.Hs.symbols.gmt	JAATINEN_HEMATOPOIETIC_STEM_CELL_DN	2/235	2.625253e-01	3.854743e-01	2.530876e+00	3.384813e+00	LYZ;LTF
c2.all.v2024.1.Hs.symbols.gmt	JAATINEN_HEMATOPOIETIC_STEM_CELL_UP	1/323	7.487036e-01	7.801178e-01	1.083273e+00	3.135123e-01	RPS15A
c2.all.v2024.1.Hs.symbols.gmt	JACKSON_DNMT1_TARGETS_UP	1/84	3.003881e-01	4.122431e-01	4.229818e+00	5.087119e+00	HSPH1
c2.all.v2024.1.Hs.symbols.gmt	JAEGER_METASTASIS_DN	4/260	2.471892e-02	1.292323e-01	4.234274e+00	1.566760e+01	SERPINB3;SERPINB4;LTF;S100P
c2.all.v2024.1.Hs.symbols.gmt	JAZAG_TGFB1_SIGNALING_VIA_SMAD4_DN	1/65	2.414213e-01	3.702976e-01	5.480537e+00	7.789005e+00	RPL13A
c2.all.v2024.1.Hs.symbols.gmt	JAZAG_TGFB1_SIGNALING_VIA_SMAD4_UP	1/107	3.657293e-01	4.632128e-01	3.312872e+00	3.332291e+00	RACK1
c2.all.v2024.1.Hs.symbols.gmt	JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN	1/62	2.316716e-01	3.644548e-01	5.748663e+00	8.407042e+00	ATF3
c2.all.v2024.1.Hs.symbols.gmt	JEON_SMAD6_TARGETS_UP	1/24	9.690462e-02	2.420875e-01	1.507032e+01	3.517454e+01	CXCL8
c2.all.v2024.1.Hs.symbols.gmt	JIANG_AGING_HYPOTHALAMUS_UP	1/49	1.879707e-01	3.283977e-01	7.293842e+00	1.219143e+01	GAS5
c2.all.v2024.1.Hs.symbols.gmt	JIANG_HYPOXIA_NORMAL	1/200	5.737754e-01	6.369854e-01	1.761047e+00	9.782919e-01	PPP1R15A
c2.all.v2024.1.Hs.symbols.gmt	JIANG_MELANOMA_TRM10_LAMINA_PROPRIA	1/91	3.209496e-01	4.283435e-01	3.901409e+00	4.433839e+00	NUCB2
c2.all.v2024.1.Hs.symbols.gmt	JIANG_MELANOMA_TRM11_CD8	1/49	1.879707e-01	3.283977e-01	7.293842e+00	1.219143e+01	MT-ND4
c2.all.v2024.1.Hs.symbols.gmt	JIANG_MELANOMA_TRM1_CD8	5/177	9.441482e-04	1.312995e-02	7.811238e+00	5.440705e+01	UBB;PPP1R15A;HSPH1;HSP90AA1;DNAJA1
c2.all.v2024.1.Hs.symbols.gmt	JIANG_MELANOMA_TRM2_CD8	5/146	3.946930e-04	6.382400e-03	9.535997e+00	7.473744e+01	UBB;PPP1R15A;HSPH1;HSP90AA1;DNAJA1
c2.all.v2024.1.Hs.symbols.gmt	JIANG_MELANOMA_TRM3_CD8	2/424	5.387462e-01	6.061621e-01	1.386630e+00	8.576458e-01	TMSB4X;UBB
c2.all.v2024.1.Hs.symbols.gmt	JIANG_MELANOMA_TRM4	4/203	1.093165e-02	7.756263e-02	5.458273e+00	2.465007e+01	ATF3;PPP1R15A;GPX1;NUCB2
c2.all.v2024.1.Hs.symbols.gmt	JIANG_MELANOMA_TRM5_CD8	5/189	1.264204e-03	1.624977e-02	7.299193e+00	4.870980e+01	PPP1R15A;RPL15;ATF3;DNAJA1;FTL
c2.all.v2024.1.Hs.symbols.gmt	JIANG_MELANOMA_TRM6_CD8	6/139	2.806590e-05	6.969699e-04	1.208453e+01	1.266575e+02	RPL39;RPL10A;RPL28;RPS2;RACK1;RPL31
c2.all.v2024.1.Hs.symbols.gmt	JIANG_MELANOMA_TRM7_CD8	2/90	5.591546e-02	1.912125e-01	6.721790e+00	1.938507e+01	RPS29;RPL15
c2.all.v2024.1.Hs.symbols.gmt	JIANG_MELANOMA_TRM8_CD4	30/426	1.188274e-28	4.131234e-26	2.588253e+01	1.664243e+03	RPS29;PPP1R15A;MT-ND5;RPL37A;RPS2;RPL31;RPL3;RPS27;MT-CYB;RPS3;TMSB4X;SYNE2;RPL21;RPL28;DNAJA1;RPL13A;MT-CO3;RPL39;MT-ND1;MT-ND3;RPS5;RPL18A;MT-ND2;RPS15A;RPL10A;MT-ATP6;RPL27A;HSP90AA1;RPL23A;RPL32
c2.all.v2024.1.Hs.symbols.gmt	JIANG_MELANOMA_TRM9_CD8	21/526	4.785617e-15	4.537635e-13	1.249548e+01	4.120155e+02	RPS29;MT-ND5;RPL37A;RPS27;MT-CYB;RPS3;TMSB4X;SYNE2;RPL21;RPL28;DNAJA1;MT-CO3;RPL39;MT-ND1;MT-ND3;MT-ND2;RPS15A;MT-CO2;MT-ATP6;RPL27A;MT-ND4
c2.all.v2024.1.Hs.symbols.gmt	JIANG_VHL_TARGETS	1/88	3.122118e-01	4.209914e-01	4.035722e+00	4.697877e+00	CFAP298
c2.all.v2024.1.Hs.symbols.gmt	JINESH_BLEBBISHIELD_TO_IMMUNE_CELL_FUSION_PBSHMS_DN	7/387	1.295245e-03	1.624977e-02	4.892472e+00	3.253032e+01	LCN2;MMP10;CP;PIP;FTL;AGR2;CXCL8
c2.all.v2024.1.Hs.symbols.gmt	JINESH_BLEBBISHIELD_TO_IMMUNE_CELL_FUSION_PBSHMS_UP	2/382	4.830179e-01	5.600568e-01	1.542671e+00	1.122604e+00	HSP90AA1;GADD45A
c2.all.v2024.1.Hs.symbols.gmt	JINESH_BLEBBISHIELD_TRANSFORMED_STEM_CELL_SPHERES_DN	4/302	3.955271e-02	1.670181e-01	3.631500e+00	1.173018e+01	ATF3;PPP1R15A;RPS3;CXCL8
c2.all.v2024.1.Hs.symbols.gmt	JINESH_BLEBBISHIELD_TRANSFORMED_STEM_CELL_SPHERES_UP	2/170	1.622183e-01	3.087476e-01	3.517604e+00	6.397861e+00	FTL;LCN2
c2.all.v2024.1.Hs.symbols.gmt	JINESH_BLEBBISHIELD_VS_LIVE_CONTROL_DN	6/289	1.446077e-03	1.764045e-02	5.651740e+00	3.695617e+01	RPS29;LCN2;RPL15;MMP10;RPL23A;RPL13A
c2.all.v2024.1.Hs.symbols.gmt	JINESH_BLEBBISHIELD_VS_LIVE_CONTROL_UP	3/380	2.180114e-01	3.549433e-01	2.200999e+00	3.352579e+00	RPL13A;RPS3;GADD45A
c2.all.v2024.1.Hs.symbols.gmt	JISON_SICKLE_CELL_DISEASE_DN	5/186	1.177625e-03	1.535329e-02	7.420857e+00	5.004815e+01	RPL10A;RPL21;MSMB;RPL23A;RPL13A
c2.all.v2024.1.Hs.symbols.gmt	JISON_SICKLE_CELL_DISEASE_UP	2/182	1.802701e-01	3.241495e-01	3.281950e+00	5.622960e+00	ATF3;GADD45A
c2.all.v2024.1.Hs.symbols.gmt	JOHANSSON_GLIOMAGENESIS_BY_PDGFB_UP	1/57	2.151460e-01	3.519958e-01	6.258814e+00	9.616282e+00	FTL
c2.all.v2024.1.Hs.symbols.gmt	JOHNSTONE_PARVB_TARGETS_1_UP	1/7	2.928011e-02	1.409738e-01	5.452694e+01	1.925263e+02	GAS5
c2.all.v2024.1.Hs.symbols.gmt	JOHNSTONE_PARVB_TARGETS_2_UP	4/145	3.383220e-03	3.344738e-02	7.715967e+00	4.389558e+01	MT-ATP6;MT-ND5;MT-ND3;MT-ND4
c2.all.v2024.1.Hs.symbols.gmt	JOHNSTONE_PARVB_TARGETS_3_DN	2/877	8.905411e-01	9.057380e-01	6.551777e-01	7.595218e-02	GAS5;NUCB2
c2.all.v2024.1.Hs.symbols.gmt	JOHNSTONE_PARVB_TARGETS_3_UP	1/433	8.437260e-01	8.644461e-01	8.036784e-01	1.365671e-01	NEAT1
c2.all.v2024.1.Hs.symbols.gmt	JOSEPH_RESPONSE_TO_SODIUM_BUTYRATE_UP	1/31	1.233756e-01	2.740804e-01	1.160787e+01	2.428973e+01	S100P
c2.all.v2024.1.Hs.symbols.gmt	KAAB_HEART_ATRIUM_VS_VENTRICLE_DN	1/262	6.733063e-01	7.162248e-01	1.339710e+00	5.299291e-01	GADD45A
c2.all.v2024.1.Hs.symbols.gmt	KAAB_HEART_ATRIUM_VS_VENTRICLE_UP	2/256	2.954709e-01	4.084508e-01	2.319811e+00	2.828278e+00	RPL3;RPS2
c2.all.v2024.1.Hs.symbols.gmt	KAMIKUBO_MYELOID_CEBPA_NETWORK	3/30	2.750120e-04	4.823952e-03	3.070055e+01	2.517044e+02	LYZ;LCN2;LTF
c2.all.v2024.1.Hs.symbols.gmt	KANG_FLUOROURACIL_RESISTANCE_DN	1/16	6.568265e-02	2.009003e-01	2.285682e+01	6.223731e+01	S100P
c2.all.v2024.1.Hs.symbols.gmt	KANNAN_TP53_TARGETS_UP	2/59	2.597644e-02	1.324862e-01	1.036028e+01	3.782089e+01	ATF3;GADD45A
c2.all.v2024.1.Hs.symbols.gmt	KAN_RESPONSE_TO_ARSENIC_TRIOXIDE	4/123	1.865670e-03	2.103669e-02	9.145634e+00	5.747240e+01	ATF3;PPP1R15A;CXCL8;MT-ND4
c2.all.v2024.1.Hs.symbols.gmt	KARLSSON_TGFB1_TARGETS_DN	3/194	4.945819e-02	1.805210e-01	4.375936e+00	1.315681e+01	NEAT1;DNAJA1;SYNE2
c2.all.v2024.1.Hs.symbols.gmt	KARLSSON_TGFB1_TARGETS_UP	1/123	4.075854e-01	4.983723e-01	2.878075e+00	2.583086e+00	HSPH1
c2.all.v2024.1.Hs.symbols.gmt	KATSANOU_ELAVL1_TARGETS_UP	2/173	1.666999e-01	3.123952e-01	3.455598e+00	6.190912e+00	LYZ;GADD45A
c2.all.v2024.1.Hs.symbols.gmt	KAUFFMANN_DNA_REPAIR_GENES	1/230	6.252054e-01	6.760904e-01	1.528748e+00	7.180146e-01	GADD45A
c2.all.v2024.1.Hs.symbols.gmt	KAUFFMANN_DNA_REPLICATION_GENES	1/146	4.630082e-01	5.422993e-01	2.420585e+00	1.863876e+00	CXCL8
c2.all.v2024.1.Hs.symbols.gmt	KAYO_AGING_MUSCLE_DN	3/124	1.578477e-02	9.799712e-02	6.919090e+00	2.870529e+01	TMSB4X;UBB;RPL31
c2.all.v2024.1.Hs.symbols.gmt	KAYO_AGING_MUSCLE_UP	1/242	6.440132e-01	6.924802e-01	1.451988e+00	6.389269e-01	AKAP9
c2.all.v2024.1.Hs.symbols.gmt	KEGG_ABC_TRANSPORTERS	1/44	1.705155e-01	3.170190e-01	8.134059e+00	1.438857e+01	CFTR
c2.all.v2024.1.Hs.symbols.gmt	KEGG_ALZHEIMERS_DISEASE	4/166	5.463067e-03	4.604038e-02	6.712401e+00	3.496990e+01	MT-CO3;MT-CO2;MT-ATP6;MT-CYB
c2.all.v2024.1.Hs.symbols.gmt	KEGG_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS	1/53	2.016727e-01	3.434199e-01	6.736898e+00	1.078651e+01	GPX1
c2.all.v2024.1.Hs.symbols.gmt	KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	1/88	3.122118e-01	4.209914e-01	4.035722e+00	4.697877e+00	HSP90AA1
c2.all.v2024.1.Hs.symbols.gmt	KEGG_ARACHIDONIC_ACID_METABOLISM	1/58	2.184790e-01	3.549433e-01	6.149686e+00	9.354074e+00	GPX1
c2.all.v2024.1.Hs.symbols.gmt	KEGG_BLADDER_CANCER	1/42	1.634300e-01	3.095469e-01	8.526835e+00	1.544526e+01	CXCL8
c2.all.v2024.1.Hs.symbols.gmt	KEGG_CARDIAC_MUSCLE_CONTRACTION	3/79	4.612269e-03	4.094125e-02	1.101164e+01	5.923202e+01	MT-CO3;MT-CO2;MT-CYB
c2.all.v2024.1.Hs.symbols.gmt	KEGG_CELL_CYCLE	1/125	4.126214e-01	5.015899e-01	2.831583e+00	2.506587e+00	GADD45A
c2.all.v2024.1.Hs.symbols.gmt	KEGG_CHEMOKINE_SIGNALING_PATHWAY	1/188	5.513009e-01	6.160823e-01	1.874781e+00	1.116384e+00	CXCL8
c2.all.v2024.1.Hs.symbols.gmt	KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION	1/264	6.761010e-01	7.188311e-01	1.329420e+00	5.203520e-01	CXCL8
c2.all.v2024.1.Hs.symbols.gmt	KEGG_EPITHELIAL_CELL_SIGNALING_IN_HELICOBACTER_PYLORI_INFECTION	1/68	2.510485e-01	3.775682e-01	5.236245e+00	7.237062e+00	CXCL8
c2.all.v2024.1.Hs.symbols.gmt	KEGG_GLUTATHIONE_METABOLISM	1/50	1.914179e-01	3.321944e-01	7.146168e+00	1.181473e+01	GPX1
c2.all.v2024.1.Hs.symbols.gmt	KEGG_HUNTINGTONS_DISEASE	5/182	1.069122e-03	1.448174e-02	7.589472e+00	5.191895e+01	MT-CO3;MT-CO2;GPX1;MT-ATP6;MT-CYB
c2.all.v2024.1.Hs.symbols.gmt	KEGG_LYSOSOME	1/121	4.025067e-01	4.944812e-01	2.926110e+00	2.662887e+00	NAPSA
c2.all.v2024.1.Hs.symbols.gmt	KEGG_MAPK_SIGNALING_PATHWAY	1/267	6.802488e-01	7.206698e-01	1.314274e+00	5.063854e-01	GADD45A
c2.all.v2024.1.Hs.symbols.gmt	KEGG_MEDICUS_ENV_FACTOR_ARSENIC_TO_ELECTRON_TRANSFER_IN_COMPLEX_IV	2/21	3.537385e-03	3.416197e-02	3.060222e+01	1.727302e+02	MT-CO3;MT-CO2
c2.all.v2024.1.Hs.symbols.gmt	KEGG_MEDICUS_PATHOGEN_EBV_EBNA1_TO_P53_MEDIATED_TRANSCRIPTION	1/10	4.156755e-02	1.693553e-01	3.730284e+01	1.186393e+02	GADD45A
c2.all.v2024.1.Hs.symbols.gmt	KEGG_MEDICUS_PATHOGEN_EBV_EBNA3C_TO_P53_MEDIATED_TRANSCRIPTION	1/10	4.156755e-02	1.693553e-01	3.730284e+01	1.186393e+02	GADD45A
c2.all.v2024.1.Hs.symbols.gmt	KEGG_MEDICUS_PATHOGEN_HBV_HBX_TO_CREB_MEDIATED_TRANSCRIPTION	1/13	5.370110e-02	1.861898e-01	2.834631e+01	8.289373e+01	CXCL8
c2.all.v2024.1.Hs.symbols.gmt	KEGG_MEDICUS_PATHOGEN_HCMV_US28_TO_GNAQ_PLCB_G_CALCINEURIN_SIGNALING_PATHWAY	1/19	7.751409e-02	2.176237e-01	1.914771e+01	4.896635e+01	CXCL8
c2.all.v2024.1.Hs.symbols.gmt	KEGG_MEDICUS_PATHOGEN_HCMV_US28_TO_GNB_G_PI3K_NFKB_SIGNALING_PATHWAY	1/31	1.233756e-01	2.740804e-01	1.160787e+01	2.428973e+01	CXCL8
c2.all.v2024.1.Hs.symbols.gmt	KEGG_MEDICUS_PATHOGEN_KSHV_VGPCR_TO_GNB_G_PI3K_JNK_SIGNALING_PATHWAY	1/29	1.158918e-01	2.689103e-01	1.242359e+01	2.677405e+01	CXCL8
c2.all.v2024.1.Hs.symbols.gmt	KEGG_MEDICUS_PATHOGEN_SARS_COV_2_S_TO_ANGII_AT1R_NOX2_SIGNALING_PATHWAY	1/14	5.771174e-02	1.926187e-01	2.624540e+01	7.485960e+01	CXCL8
c2.all.v2024.1.Hs.symbols.gmt	KEGG_MEDICUS_REFERENCE_26S_PROTEASOME_MEDIATED_PROTEIN_DEGRADATION	1/39	1.526892e-01	3.016190e-01	9.192513e+00	1.727596e+01	UBB
c2.all.v2024.1.Hs.symbols.gmt	KEGG_MEDICUS_REFERENCE_ACTIVATION_OF_PRC2.2_BY_UBIQUITINATION_OF_H2AK119	1/22	8.919728e-02	2.334470e-01	1.647370e+01	3.981536e+01	UBB
c2.all.v2024.1.Hs.symbols.gmt	KEGG_MEDICUS_REFERENCE_ACTIVATION_OF_PRC2.2_BY_UBIQUITINATION_OF_H2AK119_IN_GERMLINE_GENES	1/27	1.083448e-01	2.588857e-01	1.336243e+01	2.969714e+01	UBB
c2.all.v2024.1.Hs.symbols.gmt	KEGG_MEDICUS_REFERENCE_AUTOPHAGY_VESICLE_NUCLEATION_ELONGATION_MATURATION_SEQUESTOSOME_1_LIKE_RECEPTOR	1/14	5.771174e-02	1.926187e-01	2.624540e+01	7.485960e+01	UBB
c2.all.v2024.1.Hs.symbols.gmt	KEGG_MEDICUS_REFERENCE_CCR_CXCR_GNB_G_PI3K_RAC_SIGNALING_PATHWAY	1/31	1.233756e-01	2.740804e-01	1.160787e+01	2.428973e+01	CXCL8
c2.all.v2024.1.Hs.symbols.gmt	KEGG_MEDICUS_REFERENCE_CXCR_GNB_G_ERK_SIGNALING_PATHWAY	1/27	1.083448e-01	2.588857e-01	1.336243e+01	2.969714e+01	CXCL8
c2.all.v2024.1.Hs.symbols.gmt	KEGG_MEDICUS_REFERENCE_CXCR_GNB_G_PI3K_AKT_SIGNALING_PATHWAY	1/26	1.045474e-01	2.529999e-01	1.388707e+01	3.135860e+01	CXCL8
c2.all.v2024.1.Hs.symbols.gmt	KEGG_MEDICUS_REFERENCE_DNA_REPLICATION_TERMINATION	1/21	8.531924e-02	2.270101e-01	1.727807e+01	4.252748e+01	UBB
c2.all.v2024.1.Hs.symbols.gmt	KEGG_MEDICUS_REFERENCE_ELECTRON_TRANSFER_IN_COMPLEX_I	5/44	1.167020e-06	3.803757e-05	3.431928e+01	4.688377e+02	MT-ND5;MT-ND1;MT-ND3;MT-ND4;MT-ND2
c2.all.v2024.1.Hs.symbols.gmt	KEGG_MEDICUS_REFERENCE_ELECTRON_TRANSFER_IN_COMPLEX_III	1/11	4.562907e-02	1.752896e-01	3.374866e+01	1.041892e+02	MT-CYB
c2.all.v2024.1.Hs.symbols.gmt	KEGG_MEDICUS_REFERENCE_ELECTRON_TRANSFER_IN_COMPLEX_IV	2/19	2.896343e-03	3.002182e-02	3.410270e+01	1.993066e+02	MT-CO3;MT-CO2
c2.all.v2024.1.Hs.symbols.gmt	KEGG_MEDICUS_REFERENCE_FANCONI_ANEMIA_PATHWAY	1/19	7.751409e-02	2.176237e-01	1.914771e+01	4.896635e+01	UBB
c2.all.v2024.1.Hs.symbols.gmt	KEGG_MEDICUS_REFERENCE_FE3_FERRITIN_TRANSPORT	1/5	2.100202e-02	1.155942e-01	7.876827e+01	3.042926e+02	FTL
c2.all.v2024.1.Hs.symbols.gmt	KEGG_MEDICUS_REFERENCE_FE_TF_TRANSPORT	1/7	2.928011e-02	1.409738e-01	5.452694e+01	1.925263e+02	CP
c2.all.v2024.1.Hs.symbols.gmt	KEGG_MEDICUS_REFERENCE_GENE_SILENCING_BY_METHYLATION_OF_H3K27_AND_UBIQUITINATION_OF_H2AK119	1/40	1.562845e-01	3.038299e-01	8.959385e+00	1.662931e+01	UBB
c2.all.v2024.1.Hs.symbols.gmt	KEGG_MEDICUS_REFERENCE_GLUTATHIONE_BIOSYNTHESIS	1/11	4.562907e-02	1.752896e-01	3.374866e+01	1.041892e+02	GPX1
c2.all.v2024.1.Hs.symbols.gmt	KEGG_MEDICUS_REFERENCE_HOMOLOGOUS_RECOMBINATION_IN_ICLR	1/16	6.568265e-02	2.009003e-01	2.285682e+01	6.223731e+01	UBB
c2.all.v2024.1.Hs.symbols.gmt	KEGG_MEDICUS_REFERENCE_LESION_BYPASS_BY_TLS_AND_DSB_FORMATION	1/15	6.170557e-02	1.980274e-01	2.443426e+01	6.805873e+01	UBB
c2.all.v2024.1.Hs.symbols.gmt	KEGG_MEDICUS_REFERENCE_LOADING_OF_THE_SMC5_SMC6_COMPLEX	1/11	4.562907e-02	1.752896e-01	3.374866e+01	1.041892e+02	UBB
c2.all.v2024.1.Hs.symbols.gmt	KEGG_MEDICUS_REFERENCE_MITOCHONDRIAL_COMPLEX_UCP1_IN_THERMOGENESIS	1/62	2.316716e-01	3.644548e-01	5.748663e+00	8.407042e+00	MT-ATP6
c2.all.v2024.1.Hs.symbols.gmt	KEGG_MEDICUS_REFERENCE_RETROGRADE_AXONAL_TRANSPORT	1/43	1.669802e-01	3.123952e-01	8.325826e+00	1.490223e+01	DNAH12
c2.all.v2024.1.Hs.symbols.gmt	KEGG_MEDICUS_REFERENCE_TRAIP_DEPENDENT_REPLISOME_DISASSEMBLY	1/16	6.568265e-02	2.009003e-01	2.285682e+01	6.223731e+01	UBB
c2.all.v2024.1.Hs.symbols.gmt	KEGG_MEDICUS_REFERENCE_TRANSLATION_INITIATION	20/81	1.526746e-30	3.184792e-27	9.860179e+01	6.769448e+03	RPS29;RPL37A;RPS2;RPL31;RPL3;RPS27;RPS3;RPL21;RPL28;RPL15;RPL13A;RPL39;RPL23;RPS5;RPL18A;RPS15A;RPL10A;RPL27A;RPL23A;RPL32
c2.all.v2024.1.Hs.symbols.gmt	KEGG_MEDICUS_REFERENCE_UCHL1_MEDIATED_HYDROLYSIS	1/5	2.100202e-02	1.155942e-01	7.876827e+01	3.042926e+02	UBB
c2.all.v2024.1.Hs.symbols.gmt	KEGG_MEDICUS_VARIANT_FUS_DDIT3_FUSION_TO_NFKB_MEDIATED_TRANSCRIPTION	1/5	2.100202e-02	1.155942e-01	7.876827e+01	3.042926e+02	CXCL8
c2.all.v2024.1.Hs.symbols.gmt	KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_ELECTRON_TRANSFER_IN_COMPLEX_I	5/51	2.465957e-06	7.144424e-05	2.914369e+01	3.763304e+02	MT-ND5;MT-ND1;MT-ND3;MT-ND4;MT-ND2
c2.all.v2024.1.Hs.symbols.gmt	KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_ELECTRON_TRANSFER_IN_COMPLEX_IV	2/20	3.209312e-03	3.203170e-02	3.225785e+01	1.852149e+02	MT-CO3;MT-CO2
c2.all.v2024.1.Hs.symbols.gmt	KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_ELECTRON_TRANSFER_IN_COMPLEX_III	1/12	4.967357e-02	1.805210e-01	3.081260e+01	9.250813e+01	MT-CYB
c2.all.v2024.1.Hs.symbols.gmt	KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_RETROGRADE_AXONAL_TRANSPORT	1/45	1.740360e-01	3.187349e-01	7.950910e+00	1.390211e+01	DNAH12
c2.all.v2024.1.Hs.symbols.gmt	KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SNCA_TO_ELECTRON_TRANSFER_IN_COMPLEX_I	5/45	1.308519e-06	4.073987e-05	3.347038e+01	4.534103e+02	MT-ND5;MT-ND1;MT-ND3;MT-ND4;MT-ND2
c2.all.v2024.1.Hs.symbols.gmt	KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SOD1_TO_26S_PROTEASOME_MEDIATED_PROTEIN_DEGRADATION	1/41	1.598648e-01	3.051033e-01	8.737770e+00	1.602006e+01	UBB
c2.all.v2024.1.Hs.symbols.gmt	KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SOD1_TO_RETROGRADE_AXONAL_TRANSPORT	1/27	1.083448e-01	2.588857e-01	1.336243e+01	2.969714e+01	DNAH12
c2.all.v2024.1.Hs.symbols.gmt	KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_TDP43_TO_ELECTRON_TRANSFER_IN_COMPLEX_I	5/45	1.308519e-06	4.073987e-05	3.347038e+01	4.534103e+02	MT-ND5;MT-ND1;MT-ND3;MT-ND4;MT-ND2
c2.all.v2024.1.Hs.symbols.gmt	KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PINK1_TO_ELECTRON_TRANSFER_IN_COMPLEX_I	5/45	1.308519e-06	4.073987e-05	3.347038e+01	4.534103e+02	MT-ND5;MT-ND1;MT-ND3;MT-ND4;MT-ND2
c2.all.v2024.1.Hs.symbols.gmt	KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_TP53_TO_TRANSCRIPTION	1/9	3.748893e-02	1.619087e-01	4.169330e+01	1.369087e+02	GADD45A
c2.all.v2024.1.Hs.symbols.gmt	KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_UBQLN2_TO_26S_PROTEASOME_MEDIATED_PROTEIN_DEGRADATION	1/40	1.562845e-01	3.038299e-01	8.959385e+00	1.662931e+01	UBB
c2.all.v2024.1.Hs.symbols.gmt	KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_VCP_TO_26S_PROTEASOME_MEDIATED_PROTEIN_DEGRADATION	1/40	1.562845e-01	3.038299e-01	8.959385e+00	1.662931e+01	UBB
c2.all.v2024.1.Hs.symbols.gmt	KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY	2/62	2.847619e-02	1.409738e-01	9.845209e+00	3.503602e+01	HSP90AA1;CXCL8
c2.all.v2024.1.Hs.symbols.gmt	KEGG_OXIDATIVE_PHOSPHORYLATION	9/132	4.911879e-09	2.627225e-07	1.977103e+01	3.782516e+02	MT-CYB;MT-CO3;MT-CO2;MT-ND5;MT-ND1;MT-ATP6;MT-ND3;MT-ND4;MT-ND2
c2.all.v2024.1.Hs.symbols.gmt	KEGG_P53_SIGNALING_PATHWAY	1/68	2.510485e-01	3.775682e-01	5.236245e+00	7.237062e+00	GADD45A
c2.all.v2024.1.Hs.symbols.gmt	KEGG_PARKINSONS_DISEASE	10/130	1.998003e-10	1.302448e-08	2.266437e+01	5.061792e+02	MT-CYB;MT-CO3;UBB;MT-ND5;MT-CO2;MT-ND1;MT-ATP6;MT-ND3;MT-ND4;MT-ND2
c2.all.v2024.1.Hs.symbols.gmt	KEGG_PATHWAYS_IN_CANCER	2/325	4.013027e-01	4.941661e-01	1.819249e+00	1.661046e+00	HSP90AA1;CXCL8
c2.all.v2024.1.Hs.symbols.gmt	KEGG_PORPHYRIN_AND_CHLOROPHYLL_METABOLISM	1/41	1.598648e-01	3.051033e-01	8.737770e+00	1.602006e+01	CP
c2.all.v2024.1.Hs.symbols.gmt	KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION	1/85	3.033627e-01	4.138748e-01	4.179572e+00	4.985502e+00	HSP90AA1
c2.all.v2024.1.Hs.symbols.gmt	KEGG_PROSTATE_CANCER	1/89	3.151367e-01	4.222062e-01	3.989939e+00	4.607378e+00	HSP90AA1
c2.all.v2024.1.Hs.symbols.gmt	KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	1/213	5.968670e-01	6.535773e-01	1.652331e+00	8.527034e-01	TMSB4X
c2.all.v2024.1.Hs.symbols.gmt	KEGG_RIBOSOME	20/88	9.776948e-30	5.098678e-27	8.849758e+01	5.911419e+03	RPS29;RPL37A;RPS2;RPL31;RPL3;RPS27;RPS3;RPL21;RPL28;RPL15;RPL13A;RPL39;RPL23;RPS5;RPL18A;RPS15A;RPL10A;RPL27A;RPL23A;RPL32
c2.all.v2024.1.Hs.symbols.gmt	KEGG_RIG_I_LIKE_RECEPTOR_SIGNALING_PATHWAY	1/71	2.605548e-01	3.835690e-01	5.012743e+00	6.741850e+00	CXCL8
c2.all.v2024.1.Hs.symbols.gmt	KEGG_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY	1/102	3.520590e-01	4.541713e-01	3.476858e+00	3.629689e+00	CXCL8
c2.all.v2024.1.Hs.symbols.gmt	KEGG_VIBRIO_CHOLERAE_INFECTION	1/54	2.050624e-01	3.444123e-01	6.610675e+00	1.047423e+01	CFTR
c2.all.v2024.1.Hs.symbols.gmt	KERLEY_RESPONSE_TO_CISPLATIN_UP	1/45	1.740360e-01	3.187349e-01	7.950910e+00	1.390211e+01	GADD45A
c2.all.v2024.1.Hs.symbols.gmt	KESHELAVA_MULTIPLE_DRUG_RESISTANCE	2/82	4.737566e-02	1.793569e-01	7.392479e+00	2.254445e+01	ANXA2P2;RPL23
c2.all.v2024.1.Hs.symbols.gmt	KHETCHOUMIAN_TRIM24_TARGETS_UP	1/47	1.810327e-01	3.241495e-01	7.608246e+00	1.300308e+01	CP
c2.all.v2024.1.Hs.symbols.gmt	KIM_ALL_DISORDERS_CALB1_CORR_UP	3/547	4.096608e-01	5.005774e-01	1.514213e+00	1.351323e+00	UBB;DNAJA1;HSP90AA1
c2.all.v2024.1.Hs.symbols.gmt	KIM_ALL_DISORDERS_DURATION_CORR_DN	2/145	1.258934e-01	2.774918e-01	4.135135e+00	8.569324e+00	RPS29;GPX1
c2.all.v2024.1.Hs.symbols.gmt	KIM_ALL_DISORDERS_OLIGODENDROCYTE_NUMBER_CORR_UP	11/755	3.481370e-04	5.809710e-03	3.950354e+00	3.145634e+01	RPS29;UBB;GPX1;RPL10A;RPL28;RACK1;RPL3;RPS27;FTL;RPL32;RPS3
c2.all.v2024.1.Hs.symbols.gmt	KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_UP	7/680	2.541729e-02	1.309147e-01	2.726758e+00	1.001354e+01	UBB;GPX1;RPL10A;RPL3;RPS27;FTL;RPL32
c2.all.v2024.1.Hs.symbols.gmt	KIM_GASTRIC_CANCER_CHEMOSENSITIVITY	1/95	3.324294e-01	4.388910e-01	3.735591e+00	4.114110e+00	RPL13A
c2.all.v2024.1.Hs.symbols.gmt	KIM_LIVER_CANCER_POOR_SURVIVAL_DN	1/43	1.669802e-01	3.123952e-01	8.325826e+00	1.490223e+01	SFTPC
c2.all.v2024.1.Hs.symbols.gmt	KIM_LRRC3B_TARGETS	1/30	1.196416e-01	2.710169e-01	1.200190e+01	2.548310e+01	LYZ
c2.all.v2024.1.Hs.symbols.gmt	KIM_MYCN_AMPLIFICATION_TARGETS_DN	1/107	3.657293e-01	4.632128e-01	3.312872e+00	3.332291e+00	GOLGB1
c2.all.v2024.1.Hs.symbols.gmt	KIM_MYC_AMPLIFICATION_TARGETS_DN	2/98	6.494801e-02	2.009003e-01	6.162302e+00	1.684877e+01	CCDC146;NUCB2
c2.all.v2024.1.Hs.symbols.gmt	KIM_MYC_AMPLIFICATION_TARGETS_UP	3/202	5.455593e-02	1.887292e-01	4.198926e+00	1.221270e+01	RPL18A;RPS15A;LTF
c2.all.v2024.1.Hs.symbols.gmt	KIM_RESPONSE_TO_TSA_AND_DECITABINE_UP	4/136	2.687353e-03	2.860111e-02	8.243448e+00	4.879461e+01	ATF3;S100P;MUC1;TSPAN1
c2.all.v2024.1.Hs.symbols.gmt	KIM_WT1_TARGETS_12HR_DN	2/216	2.327521e-01	3.658786e-01	2.757450e+00	4.019758e+00	DNAAF1;RPS2
c2.all.v2024.1.Hs.symbols.gmt	KIM_WT1_TARGETS_12HR_UP	1/166	5.070107e-01	5.785691e-01	2.126129e+00	1.444116e+00	HSPH1
c2.all.v2024.1.Hs.symbols.gmt	KIM_WT1_TARGETS_8HR_DN	1/126	4.151235e-01	5.028732e-01	2.808893e+00	2.469520e+00	NEAT1
c2.all.v2024.1.Hs.symbols.gmt	KIM_WT1_TARGETS_8HR_UP	2/167	1.577596e-01	3.051033e-01	3.581857e+00	6.614553e+00	HSP90AA1;HSPH1
c2.all.v2024.1.Hs.symbols.gmt	KIM_WT1_TARGETS_DN	2/471	5.961138e-01	6.534384e-01	1.245114e+00	6.441271e-01	NEAT1;SFTPC
c2.all.v2024.1.Hs.symbols.gmt	KIM_WT1_TARGETS_UP	1/217	6.037199e-01	6.596960e-01	1.621506e+00	8.182850e-01	CXCL8
c2.all.v2024.1.Hs.symbols.gmt	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN	1/337	7.634147e-01	7.930693e-01	1.037536e+00	2.800870e-01	TMSB4X
c2.all.v2024.1.Hs.symbols.gmt	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP	3/1290	9.162432e-01	9.269075e-01	6.183055e-01	5.408530e-02	HSPH1;HSP90AA1;RPS2
c2.all.v2024.1.Hs.symbols.gmt	KLEIN_PRIMARY_EFFUSION_LYMPHOMA_UP	1/50	1.914179e-01	3.321944e-01	7.146168e+00	1.181473e+01	MUC1
c2.all.v2024.1.Hs.symbols.gmt	KOBAYASHI_EGFR_SIGNALING_24HR_DN	1/253	6.604319e-01	7.061307e-01	1.388034e+00	5.758416e-01	TCN1
c2.all.v2024.1.Hs.symbols.gmt	KOBAYASHI_EGFR_SIGNALING_24HR_UP	3/102	9.339591e-03	6.933234e-02	8.457396e+00	3.952558e+01	SYNE2;MUC1;S100P
c2.all.v2024.1.Hs.symbols.gmt	KOBAYASHI_RESPONSE_TO_ROMIDEPSIN	1/19	7.751409e-02	2.176237e-01	1.914771e+01	4.896635e+01	CXCL8
c2.all.v2024.1.Hs.symbols.gmt	KOINUMA_COLON_CANCER_MSI_DN	1/8	3.339314e-02	1.542150e-01	4.725455e+01	1.606373e+02	HSPH1
c2.all.v2024.1.Hs.symbols.gmt	KOINUMA_TARGETS_OF_SMAD2_OR_SMAD3	5/843	2.861584e-01	4.008908e-01	1.558153e+00	1.949576e+00	SYNE2;GADD45A;RPL3;MMP10;ATF3
c2.all.v2024.1.Hs.symbols.gmt	KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_DN	1/61	2.283943e-01	3.623045e-01	5.843947e+00	8.629651e+00	AKAP9
c2.all.v2024.1.Hs.symbols.gmt	KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP	3/130	1.788326e-02	1.050830e-01	6.591685e+00	2.652422e+01	HSP90AA1;GADD45A;CXCL8
c2.all.v2024.1.Hs.symbols.gmt	KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN	2/72	3.746101e-02	1.619087e-01	8.444892e+00	2.773686e+01	HSP90AA1;AKAP9
c2.all.v2024.1.Hs.symbols.gmt	KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP	2/118	8.941715e-02	2.334470e-01	5.099756e+00	1.231307e+01	GADD45A;CXCL8
c2.all.v2024.1.Hs.symbols.gmt	KONDO_EZH2_TARGETS	2/229	2.531094e-01	3.790744e-01	2.598337e+00	3.569942e+00	SERPINB3;CP
c2.all.v2024.1.Hs.symbols.gmt	KONG_E2F1_TARGETS	1/11	4.562907e-02	1.752896e-01	3.374866e+01	1.041892e+02	GAS5
c2.all.v2024.1.Hs.symbols.gmt	KONG_E2F3_TARGETS	2/100	6.727821e-02	2.042829e-01	6.036631e+00	1.629238e+01	RPL3;GAS5
c2.all.v2024.1.Hs.symbols.gmt	KORKOLA_TERATOMA	2/42	1.369162e-02	8.925226e-02	1.472039e+01	6.316476e+01	AGR2;LCN2
c2.all.v2024.1.Hs.symbols.gmt	KOYAMA_SEMA3B_TARGETS_DN	1/364	7.894212e-01	8.172370e-01	9.592788e-01	2.268265e-01	CCDC146
c2.all.v2024.1.Hs.symbols.gmt	KOYAMA_SEMA3B_TARGETS_UP	1/268	6.816196e-01	7.217556e-01	1.309301e+00	5.018334e-01	TMSB4X
c2.all.v2024.1.Hs.symbols.gmt	KRIEG_HYPOXIA_NOT_VIA_KDM3A	3/746	6.163782e-01	6.682770e-01	1.098691e+00	5.316508e-01	CP;GADD45A;MUC1
c2.all.v2024.1.Hs.symbols.gmt	KRIEG_HYPOXIA_VIA_KDM3A	1/53	2.016727e-01	3.434199e-01	6.736898e+00	1.078651e+01	PPP1R15A
c2.all.v2024.1.Hs.symbols.gmt	KRIEG_KDM3A_TARGETS_NOT_HYPOXIA	1/200	5.737754e-01	6.369854e-01	1.761047e+00	9.782919e-01	NEAT1
c2.all.v2024.1.Hs.symbols.gmt	KRIGE_AMINO_ACID_DEPRIVATION	4/29	6.610072e-06	1.745394e-04	4.304225e+01	5.133613e+02	ATF3;PPP1R15A;GADD45A;CXCL8
c2.all.v2024.1.Hs.symbols.gmt	KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_DN	6/1045	2.819107e-01	3.988105e-01	1.487968e+00	1.884013e+00	HSPH1;RPL27A;GAS5;HSP90AA1;DNAJA1;LYZ
c2.all.v2024.1.Hs.symbols.gmt	KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_UP	8/778	1.740174e-02	1.037144e-01	2.720135e+00	1.101977e+01	PPP1R15A;GADD45A;NEAT1;ATF3;GAS5;GOLGB1;CXCL8;S100P
c2.all.v2024.1.Hs.symbols.gmt	KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_DN	5/950	3.759107e-01	4.712439e-01	1.374866e+00	1.345174e+00	HSPH1;RPL27A;GAS5;HSP90AA1;DNAJA1
c2.all.v2024.1.Hs.symbols.gmt	KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_UP	9/942	1.834283e-02	1.069033e-01	2.519253e+00	1.007327e+01	PPP1R15A;GADD45A;NEAT1;ATF3;GAS5;LYZ;GOLGB1;CXCL8;S100P
c2.all.v2024.1.Hs.symbols.gmt	KUMAR_PATHOGEN_LOAD_BY_MACROPHAGES	1/274	6.897237e-01	7.281192e-01	1.280226e+00	4.755580e-01	BPIFB1
c2.all.v2024.1.Hs.symbols.gmt	KUMAR_TARGETS_OF_MLL_AF9_FUSION	2/408	5.179995e-01	5.882128e-01	1.442273e+00	9.486995e-01	SERPINB3;LTF
c2.all.v2024.1.Hs.symbols.gmt	KYNG_DNA_DAMAGE_BY_GAMMA_AND_UV_RADIATION	2/77	4.230794e-02	1.707048e-01	7.883837e+00	2.493485e+01	DNAJA1;GADD45A
c2.all.v2024.1.Hs.symbols.gmt	KYNG_DNA_DAMAGE_BY_UV	1/54	2.050624e-01	3.444123e-01	6.610675e+00	1.047423e+01	LCN2
c2.all.v2024.1.Hs.symbols.gmt	KYNG_DNA_DAMAGE_DN	3/182	4.227692e-02	1.707048e-01	4.671035e+00	1.477689e+01	DNAJA1;GADD45A;LCN2
c2.all.v2024.1.Hs.symbols.gmt	KYNG_RESPONSE_TO_H2O2	4/66	1.779464e-04	3.437002e-03	1.753180e+01	1.513701e+02	DNAJA1;GADD45A;RPL31;RPL21
c2.all.v2024.1.Hs.symbols.gmt	KYNG_RESPONSE_TO_H2O2_VIA_ERCC6	2/17	2.316249e-03	2.516508e-02	3.850654e+01	2.336502e+02	RPL31;RPL21
c2.all.v2024.1.Hs.symbols.gmt	KYNG_RESPONSE_TO_H2O2_VIA_ERCC6_DN	4/45	3.937171e-05	9.332885e-04	2.642848e+01	2.680498e+02	RPS5;RPL31;RACK1;RPL21
c2.all.v2024.1.Hs.symbols.gmt	KYNG_RESPONSE_TO_H2O2_VIA_ERCC6_UP	1/36	1.418120e-01	2.920236e-01	9.970701e+00	1.947530e+01	S100P
c2.all.v2024.1.Hs.symbols.gmt	KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_DN	2/186	1.863554e-01	3.283977e-01	3.210210e+00	5.393474e+00	SFTPA2;RPL28
c2.all.v2024.1.Hs.symbols.gmt	LAIHO_COLORECTAL_CANCER_SERRATED_DN	1/85	3.033627e-01	4.138748e-01	4.179572e+00	4.985502e+00	RPL37A
c2.all.v2024.1.Hs.symbols.gmt	LAMB_CCND1_TARGETS	1/20	8.142487e-02	2.220291e-01	1.816495e+01	4.555906e+01	HSPH1
c2.all.v2024.1.Hs.symbols.gmt	LANDIS_BREAST_CANCER_PROGRESSION_UP	2/46	1.627974e-02	9.988097e-02	1.339478e+01	5.515747e+01	LCN2;NUCB2
c2.all.v2024.1.Hs.symbols.gmt	LANDIS_ERBB2_BREAST_PRENEOPLASTIC_UP	1/20	8.142487e-02	2.220291e-01	1.816495e+01	4.555906e+01	LCN2
c2.all.v2024.1.Hs.symbols.gmt	LANDIS_ERBB2_BREAST_TUMORS_324_UP	2/152	1.358577e-01	2.868412e-01	3.941546e+00	7.867907e+00	LCN2;NUCB2
c2.all.v2024.1.Hs.symbols.gmt	LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_DN	4/807	4.474928e-01	5.297787e-01	1.317850e+00	1.059676e+00	NEAT1;RPL32;RPS3;RPL15
c2.all.v2024.1.Hs.symbols.gmt	LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_UP	1/186	5.474428e-01	6.129714e-01	1.895167e+00	1.141833e+00	RPL23
c2.all.v2024.1.Hs.symbols.gmt	LAU_APOPTOSIS_CDKN2A_UP	1/55	2.084377e-01	3.470081e-01	6.489084e+00	1.017563e+01	GADD45A
c2.all.v2024.1.Hs.symbols.gmt	LEE_AGING_MUSCLE_UP	2/38	1.130207e-02	7.991905e-02	1.633654e+01	7.323295e+01	ATF3;GADD45A
c2.all.v2024.1.Hs.symbols.gmt	LEE_AGING_NEOCORTEX_DN	1/68	2.510485e-01	3.775682e-01	5.236245e+00	7.237062e+00	CP
c2.all.v2024.1.Hs.symbols.gmt	LEE_AGING_NEOCORTEX_UP	1/77	2.792107e-01	3.967531e-01	4.618329e+00	5.892011e+00	GADD45A
c2.all.v2024.1.Hs.symbols.gmt	LEE_BMP2_TARGETS_DN	4/904	5.363135e-01	6.037507e-01	1.170538e+00	7.292875e-01	RPL3;HSP90AA1;GAS5;HSPH1
c2.all.v2024.1.Hs.symbols.gmt	LEE_BMP2_TARGETS_UP	8/780	1.764390e-02	1.039817e-01	2.712838e+00	1.095272e+01	TCIM;LCN2;NEAT1;LTF;MUC1;CP;LYZ;TSPAN1
c2.all.v2024.1.Hs.symbols.gmt	LEE_CALORIE_RESTRICTION_MUSCLE_DN	1/48	1.845090e-01	3.264510e-01	7.447734e+00	1.258710e+01	HSPH1
c2.all.v2024.1.Hs.symbols.gmt	LEE_LIVER_CANCER_ACOX1_UP	1/65	2.414213e-01	3.702976e-01	5.480537e+00	7.789005e+00	LCN2
c2.all.v2024.1.Hs.symbols.gmt	LEE_LIVER_CANCER_CIPROFIBRATE_UP	1/60	2.251031e-01	3.589947e-01	5.942435e+00	8.861339e+00	LCN2
c2.all.v2024.1.Hs.symbols.gmt	LEE_LIVER_CANCER_DENA_UP	1/60	2.251031e-01	3.589947e-01	5.942435e+00	8.861339e+00	LCN2
c2.all.v2024.1.Hs.symbols.gmt	LEE_LIVER_CANCER_E2F1_UP	2/63	2.933011e-02	1.409738e-01	9.684685e+00	3.417861e+01	LCN2;NUCB2
c2.all.v2024.1.Hs.symbols.gmt	LEE_LIVER_CANCER_MYC_DN	2/63	2.933011e-02	1.409738e-01	9.684685e+00	3.417861e+01	HSPH1;TCIM
c2.all.v2024.1.Hs.symbols.gmt	LEE_LIVER_CANCER_MYC_E2F1_UP	2/56	2.357182e-02	1.254358e-01	1.093206e+01	4.097012e+01	LCN2;NUCB2
c2.all.v2024.1.Hs.symbols.gmt	LEE_LIVER_CANCER_MYC_TGFA_UP	2/61	2.763254e-02	1.388796e-01	1.001113e+01	3.592755e+01	RACK1;LCN2
c2.all.v2024.1.Hs.symbols.gmt	LEE_LIVER_CANCER_MYC_UP	5/54	3.286796e-06	9.021391e-05	2.737368e+01	3.456091e+02	RPL13AP5;LCN2;RPL28;RACK1;RPL13A
c2.all.v2024.1.Hs.symbols.gmt	LEE_LIVER_CANCER_SURVIVAL_DN	4/180	7.243211e-03	5.766923e-02	6.176029e+00	3.043356e+01	RPS5;TMSB4X;RPS3;RPL31
c2.all.v2024.1.Hs.symbols.gmt	LEE_NEURAL_CREST_STEM_CELL_DN	1/122	4.050514e-01	4.964379e-01	2.901895e+00	2.622562e+00	SYNE2
c2.all.v2024.1.Hs.symbols.gmt	LEE_RECENT_THYMIC_EMIGRANT	3/239	8.119306e-02	2.220291e-01	3.536027e+00	8.878702e+00	RPS29;RPL18A;RPS15A
c2.all.v2024.1.Hs.symbols.gmt	LEE_TARGETS_OF_PTCH1_AND_SUFU_UP	3/56	1.734093e-03	1.998518e-02	1.576207e+01	1.002037e+02	RPS27;LYZ;RPL23
c2.all.v2024.1.Hs.symbols.gmt	LEIN_ASTROCYTE_MARKERS	1/43	1.669802e-01	3.123952e-01	8.325826e+00	1.490223e+01	LYZ
c2.all.v2024.1.Hs.symbols.gmt	LEIN_CEREBELLUM_MARKERS	1/85	3.033627e-01	4.138748e-01	4.179572e+00	4.985502e+00	SYNE2
c2.all.v2024.1.Hs.symbols.gmt	LEIN_CHOROID_PLEXUS_MARKERS	1/105	3.602958e-01	4.614602e-01	3.376583e+00	3.446917e+00	SYNE2
c2.all.v2024.1.Hs.symbols.gmt	LEIN_LOCALIZED_TO_DISTAL_AND_PROXIMAL_DENDRITES	1/18	7.358684e-02	2.123128e-01	2.024278e+01	5.281927e+01	MT-ATP6
c2.all.v2024.1.Hs.symbols.gmt	LEIN_LOCALIZED_TO_PROXIMAL_DENDRITES	1/37	1.454530e-01	2.960146e-01	9.697092e+00	1.869504e+01	TMSB4X
c2.all.v2024.1.Hs.symbols.gmt	LEI_MYB_TARGETS	9/323	9.427222e-06	2.458148e-04	7.696343e+00	8.906139e+01	SERPINB4;LCN2;MUC1;SERPINB3;DNAJA1;RPS15A;AGR2;CXCL8;S100P
c2.all.v2024.1.Hs.symbols.gmt	LENAOUR_DENDRITIC_CELL_MATURATION_DN	2/130	1.052047e-01	2.542956e-01	4.620991e+00	1.040576e+01	LYZ;CXCL8
c2.all.v2024.1.Hs.symbols.gmt	LEONARD_HYPOXIA	1/41	1.598648e-01	3.051033e-01	8.737770e+00	1.602006e+01	MUC1
c2.all.v2024.1.Hs.symbols.gmt	LE_EGR2_TARGETS_UP	1/110	3.737942e-01	4.694369e-01	3.221669e+00	3.170283e+00	ATF3
c2.all.v2024.1.Hs.symbols.gmt	LE_SKI_TARGETS_UP	1/17	6.964305e-02	2.057725e-01	2.147059e+01	5.720564e+01	AGR2
c2.all.v2024.1.Hs.symbols.gmt	LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_LARGE_VS_TINY_UP	1/41	1.598648e-01	3.051033e-01	8.737770e+00	1.602006e+01	LYZ
c2.all.v2024.1.Hs.symbols.gmt	LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_SMALL_VS_HUGE_DN	1/33	1.307967e-01	2.795512e-01	1.089255e+01	2.215666e+01	DNAJA1
c2.all.v2024.1.Hs.symbols.gmt	LIANG_SILENCED_BY_METHYLATION_2	1/58	2.184790e-01	3.549433e-01	6.149686e+00	9.354074e+00	LCN2
c2.all.v2024.1.Hs.symbols.gmt	LIAN_NEUTROPHIL_GRANULE_CONSTITUENTS	3/25	1.582032e-04	3.113320e-03	3.753139e+01	3.284608e+02	LYZ;LTF;LCN2
c2.all.v2024.1.Hs.symbols.gmt	LIAO_METASTASIS	3/540	4.016771e-01	4.943353e-01	1.534431e+00	1.399565e+00	NEAT1;GAS5;RACK1
c2.all.v2024.1.Hs.symbols.gmt	LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_DN	4/115	1.457670e-03	1.767848e-02	9.805391e+00	6.403819e+01	RSPH1;AGR2;BPIFB1;PIP
c2.all.v2024.1.Hs.symbols.gmt	LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP	1/83	2.974008e-01	4.100318e-01	4.281283e+00	5.191803e+00	CXCL8
c2.all.v2024.1.Hs.symbols.gmt	LIM_MAMMARY_LUMINAL_MATURE_UP	1/113	3.817576e-01	4.765687e-01	3.135330e+00	3.019227e+00	TSPAN1
c2.all.v2024.1.Hs.symbols.gmt	LIM_MAMMARY_STEM_CELL_DN	2/417	5.297442e-01	5.986166e-01	1.410447e+00	8.961429e-01	MUC1;LTF
c2.all.v2024.1.Hs.symbols.gmt	LINDGREN_BLADDER_CANCER_CLUSTER_1_UP	3/120	1.446769e-02	9.286028e-02	7.155935e+00	3.031138e+01	RPL27A;RPL10A;RPL15
c2.all.v2024.1.Hs.symbols.gmt	LINDGREN_BLADDER_CANCER_CLUSTER_2A_DN	1/141	4.514137e-01	5.326069e-01	2.507298e+00	1.994233e+00	LYZ
c2.all.v2024.1.Hs.symbols.gmt	LINDGREN_BLADDER_CANCER_CLUSTER_2B	1/389	8.109696e-01	8.353988e-01	8.965168e-01	1.878425e-01	LYZ
c2.all.v2024.1.Hs.symbols.gmt	LINDGREN_BLADDER_CANCER_CLUSTER_3_DN	2/226	2.484049e-01	3.757597e-01	2.633420e+00	3.667551e+00	AGR2;RACK1
c2.all.v2024.1.Hs.symbols.gmt	LINDGREN_BLADDER_CANCER_CLUSTER_3_UP	1/328	7.540587e-01	7.853052e-01	1.066490e+00	3.010542e-01	NUCB2
c2.all.v2024.1.Hs.symbols.gmt	LINDSTEDT_DENDRITIC_CELL_MATURATION_A	1/61	2.283943e-01	3.623045e-01	5.843947e+00	8.629651e+00	CXCL8
c2.all.v2024.1.Hs.symbols.gmt	LINDSTEDT_DENDRITIC_CELL_MATURATION_B	1/49	1.879707e-01	3.283977e-01	7.293842e+00	1.219143e+01	GADD45A
c2.all.v2024.1.Hs.symbols.gmt	LINDSTEDT_DENDRITIC_CELL_MATURATION_C	2/63	2.933011e-02	1.409738e-01	9.684685e+00	3.417861e+01	ATF3;MUC1
c2.all.v2024.1.Hs.symbols.gmt	LIN_MELANOMA_COPY_NUMBER_DN	1/41	1.598648e-01	3.051033e-01	8.737770e+00	1.602006e+01	RPL21
c2.all.v2024.1.Hs.symbols.gmt	LIN_SILENCED_BY_TUMOR_MICROENVIRONMENT	2/107	7.564684e-02	2.176237e-01	5.634303e+00	1.454596e+01	LCN2;S100P
c2.all.v2024.1.Hs.symbols.gmt	LIU_BREAST_CANCER	1/32	1.270940e-01	2.774918e-01	1.123886e+01	2.318384e+01	MT-ND4
c2.all.v2024.1.Hs.symbols.gmt	LIU_CDX2_TARGETS_UP	3/35	4.365956e-04	6.899533e-03	2.597150e+01	2.009286e+02	AGR2;LYZ;TSPAN1
c2.all.v2024.1.Hs.symbols.gmt	LIU_CMYB_TARGETS_UP	2/164	1.533253e-01	3.023029e-01	3.648482e+00	6.841611e+00	TSPAN1;NUCB2
c2.all.v2024.1.Hs.symbols.gmt	LIU_COMMON_CANCER_GENES	2/63	2.933011e-02	1.409738e-01	9.684685e+00	3.417861e+01	SFTPB;MT-ND3
c2.all.v2024.1.Hs.symbols.gmt	LIU_NASOPHARYNGEAL_CARCINOMA	1/72	2.636969e-01	3.854743e-01	4.942411e+00	6.588010e+00	RPL3
c2.all.v2024.1.Hs.symbols.gmt	LIU_OVARIAN_CANCER_TUMORS_AND_XENOGRAFTS_XDGS_DN	7/1714	5.959385e-01	6.534384e-01	1.023627e+00	5.298475e-01	RPL13AP5;TCIM;LCN2;CP;LYZ;FTL;CXCL8
c2.all.v2024.1.Hs.symbols.gmt	LIU_OVARIAN_CANCER_TUMORS_AND_XENOGRAFTS_XDGS_UP	3/252	9.166917e-02	2.367331e-01	3.349792e+00	8.004561e+00	PDIA3P1;ANXA2P2;PABPC3
c2.all.v2024.1.Hs.symbols.gmt	LIU_PROSTATE_CANCER_DN	3/493	3.474860e-01	4.507810e-01	1.685127e+00	1.781231e+00	SCGB1A1;ANXA2P2;SCGB3A1
c2.all.v2024.1.Hs.symbols.gmt	LIU_VAV3_PROSTATE_CARCINOGENESIS_UP	1/89	3.151367e-01	4.222062e-01	3.989939e+00	4.607378e+00	LTF
c2.all.v2024.1.Hs.symbols.gmt	LIU_VMYB_TARGETS_UP	1/125	4.126214e-01	5.015899e-01	2.831583e+00	2.506587e+00	NUCB2
c2.all.v2024.1.Hs.symbols.gmt	LI_AMPLIFIED_IN_LUNG_CANCER	13/183	8.931652e-13	7.165933e-11	2.130398e+01	5.910577e+02	LCN2;LTF;MUC1;RPL10A;RPL28;RPL37A;RPL27A;RPS2;RPL31;RPS27;RPL23A;RPS5;S100P
c2.all.v2024.1.Hs.symbols.gmt	LI_CISPLATIN_RESISTANCE_DN	1/33	1.307967e-01	2.795512e-01	1.089255e+01	2.215666e+01	MMP10
c2.all.v2024.1.Hs.symbols.gmt	LI_DCP2_BOUND_MRNA	1/89	3.151367e-01	4.222062e-01	3.989939e+00	4.607378e+00	RPS5
c2.all.v2024.1.Hs.symbols.gmt	LI_ESTROGENE_BIDIRECTIONAL_E2_RESPONSE	2/100	6.727821e-02	2.042829e-01	6.036631e+00	1.629238e+01	AGR2;MUC1
c2.all.v2024.1.Hs.symbols.gmt	LI_ESTROGENE_LATE_E2_RESPONSE_DN	1/80	2.883633e-01	4.028974e-01	4.443447e+00	5.525578e+00	TSPAN1
c2.all.v2024.1.Hs.symbols.gmt	LI_ESTROGENE_MCF7_E2_RESPONSE_UP	1/51	1.948505e-01	3.350851e-01	7.004342e+00	1.145576e+01	MSMB
c2.all.v2024.1.Hs.symbols.gmt	LI_INDUCED_T_TO_NATURAL_KILLER_UP	2/317	3.893497e-01	4.837791e-01	1.866064e+00	1.760216e+00	FTL;NAPSA
c2.all.v2024.1.Hs.symbols.gmt	LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP	1/183	5.415941e-01	6.083819e-01	1.926584e+00	1.181456e+00	GADD45A
c2.all.v2024.1.Hs.symbols.gmt	LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER	1/216	6.020176e-01	6.585258e-01	1.629105e+00	8.267199e-01	RPS27
c2.all.v2024.1.Hs.symbols.gmt	LOPES_METHYLATED_IN_COLON_CANCER_UP	1/28	1.121262e-01	2.639902e-01	1.287594e+01	2.817422e+01	SCGB3A1
c2.all.v2024.1.Hs.symbols.gmt	LOPEZ_MBD_TARGETS	9/953	1.961808e-02	1.109033e-01	2.488618e+00	9.783515e+00	LTF;AKAP9;NEAT1;RPL10A;RPL31;RPS2;RACK1;LYZ;NUCB2
c2.all.v2024.1.Hs.symbols.gmt	LUDWICZEK_TREATING_IRON_OVERLOAD	2/7	3.676633e-04	5.991763e-03	1.085676e+02	8.585896e+02	CP;LCN2
c2.all.v2024.1.Hs.symbols.gmt	LUI_TARGETS_OF_PAX8_PPARG_FUSION	5/34	3.091742e-07	1.111961e-05	4.597377e+01	6.891174e+02	RPL21;RPS2;DNAJA1;RPS5;RPL18A
c2.all.v2024.1.Hs.symbols.gmt	LUI_THYROID_CANCER_CLUSTER_3	5/28	1.114131e-07	4.648153e-06	5.772745e+01	9.242176e+02	RPL10A;RPL21;RPS2;RPS5;RPL18A
c2.all.v2024.1.Hs.symbols.gmt	LUI_THYROID_CANCER_CLUSTER_5	1/16	6.568265e-02	2.009003e-01	2.285682e+01	6.223731e+01	TSPAN1
c2.all.v2024.1.Hs.symbols.gmt	LUI_THYROID_CANCER_PAX8_PPARG_DN	6/46	4.014720e-08	1.903342e-06	4.000286e+01	6.812772e+02	RPL10A;RPL21;RPS2;DNAJA1;RPS5;RPL18A
c2.all.v2024.1.Hs.symbols.gmt	LU_IL4_SIGNALING	1/91	3.209496e-01	4.283435e-01	3.901409e+00	4.433839e+00	RPS2
c2.all.v2024.1.Hs.symbols.gmt	LU_TUMOR_VASCULATURE_UP	1/29	1.158918e-01	2.689103e-01	1.242359e+01	2.677405e+01	MUC1
c2.all.v2024.1.Hs.symbols.gmt	LY_AGING_MIDDLE_UP	2/14	1.562713e-03	1.831359e-02	4.775459e+01	3.085583e+02	MMP10;CXCL8
c2.all.v2024.1.Hs.symbols.gmt	LY_AGING_OLD_DN	1/56	2.117989e-01	3.500892e-01	6.371875e+00	9.889900e+00	CXCL8
c2.all.v2024.1.Hs.symbols.gmt	LY_AGING_PREMATURE_DN	1/30	1.196416e-01	2.710169e-01	1.200190e+01	2.548310e+01	CXCL8
c2.all.v2024.1.Hs.symbols.gmt	MACAEVA_PBMC_RESPONSE_TO_IR	1/106	3.630183e-01	4.614602e-01	3.344426e+00	3.388913e+00	GADD45A
c2.all.v2024.1.Hs.symbols.gmt	MACLACHLAN_BRCA1_TARGETS_UP	1/21	8.531924e-02	2.270101e-01	1.727807e+01	4.252748e+01	GADD45A
c2.all.v2024.1.Hs.symbols.gmt	MAGRANGEAS_MULTIPLE_MYELOMA_IGG_VS_IGA_DN	1/28	1.121262e-01	2.639902e-01	1.287594e+01	2.817422e+01	RPL13AP5
c2.all.v2024.1.Hs.symbols.gmt	MAHAJAN_RESPONSE_TO_IL1A_DN	1/70	2.573993e-01	3.818884e-01	5.085100e+00	6.901124e+00	RPL3
c2.all.v2024.1.Hs.symbols.gmt	MAHAJAN_RESPONSE_TO_IL1A_UP	1/77	2.792107e-01	3.967531e-01	4.618329e+00	5.892011e+00	SERPINB4
c2.all.v2024.1.Hs.symbols.gmt	MALIK_REPRESSED_BY_ESTROGEN	1/13	5.370110e-02	1.861898e-01	2.834631e+01	8.289373e+01	MUC1
c2.all.v2024.1.Hs.symbols.gmt	MALONEY_RESPONSE_TO_17AAG_DN	2/77	4.230794e-02	1.707048e-01	7.883837e+00	2.493485e+01	TMSB4X;RPL27A
c2.all.v2024.1.Hs.symbols.gmt	MANALO_HYPOXIA_UP	1/205	5.828077e-01	6.435876e-01	1.717597e+00	9.273273e-01	TCIM
c2.all.v2024.1.Hs.symbols.gmt	MANNE_COVID19_COMBINED_COHORT_VS_HEALTHY_DONOR_PLATELETS_DN	1/224	6.154361e-01	6.676026e-01	1.570219e+00	7.622219e-01	DNAH12
c2.all.v2024.1.Hs.symbols.gmt	MANNE_COVID19_COMBINED_COHORT_VS_HEALTHY_DONOR_PLATELETS_UP	1/179	5.336793e-01	6.014344e-01	1.970116e+00	1.237155e+00	LINGO1
c2.all.v2024.1.Hs.symbols.gmt	MANNE_COVID19_ICU_VS_HEALTHY_DONOR_PLATELETS_DN	1/159	4.920314e-01	5.664335e-01	2.220736e+00	1.574974e+00	DNAH12
c2.all.v2024.1.Hs.symbols.gmt	MANNE_COVID19_NONICU_VS_HEALTHY_DONOR_PLATELETS_DN	1/207	5.863674e-01	6.461502e-01	1.700807e+00	9.079055e-01	DNAH12
c2.all.v2024.1.Hs.symbols.gmt	MARCINIAK_ER_STRESS_RESPONSE_VIA_CHOP	1/22	8.919728e-02	2.334470e-01	1.647370e+01	3.981536e+01	PPP1R15A
c2.all.v2024.1.Hs.symbols.gmt	MARIADASON_RESPONSE_TO_BUTYRATE_CURCUMIN_SULINDAC_TSA_1	1/8	3.339314e-02	1.542150e-01	4.725455e+01	1.606373e+02	TMSB4X
c2.all.v2024.1.Hs.symbols.gmt	MARKEY_RB1_ACUTE_LOF_DN	4/233	1.731632e-02	1.035010e-01	4.738273e+00	1.921894e+01	MMP10;LYZ;GADD45A;NAPSA
c2.all.v2024.1.Hs.symbols.gmt	MARKEY_RB1_CHRONIC_LOF_DN	1/120	3.999512e-01	4.927929e-01	2.950731e+00	2.704087e+00	CP
c2.all.v2024.1.Hs.symbols.gmt	MARKS_ACETYLATED_NON_HISTONE_PROTEINS	1/12	4.967357e-02	1.805210e-01	3.081260e+01	9.250813e+01	HSP90AA1
c2.all.v2024.1.Hs.symbols.gmt	MARSON_BOUND_BY_E2F4_UNSTIMULATED	2/714	8.099175e-01	8.347272e-01	8.112470e-01	1.710295e-01	RPL3;UBB
c2.all.v2024.1.Hs.symbols.gmt	MARSON_BOUND_BY_FOXP3_STIMULATED	4/1024	6.356581e-01	6.855925e-01	1.027048e+00	4.653495e-01	GAS5;RPS29;UBB;HSPH1
c2.all.v2024.1.Hs.symbols.gmt	MARSON_BOUND_BY_FOXP3_UNSTIMULATED	3/1239	9.018617e-01	9.150211e-01	6.453855e-01	6.666454e-02	RPS29;UBB;HSPH1
c2.all.v2024.1.Hs.symbols.gmt	MARTENS_TRETINOIN_RESPONSE_DN	20/839	2.739388e-10	1.731625e-08	7.145129e+00	1.573223e+02	UBB;RPL37A;RPL31;RPL3;RPS27;RPS3;TMSB4X;RPL21;RPL15;RACK1;RPL13A;CXCL8;RPL21P28;RPL13AP20;RPL23;RPS5;RPL18A;RPL10A;RPL23A;RPL32
c2.all.v2024.1.Hs.symbols.gmt	MARTINELLI_IMMATURE_NEUTROPHIL_DN	1/13	5.370110e-02	1.861898e-01	2.834631e+01	8.289373e+01	CXCL8
c2.all.v2024.1.Hs.symbols.gmt	MARTINELLI_IMMATURE_NEUTROPHIL_UP	1/11	4.562907e-02	1.752896e-01	3.374866e+01	1.041892e+02	LCN2
c2.all.v2024.1.Hs.symbols.gmt	MARTINEZ_RB1_AND_TP53_TARGETS_DN	5/610	1.170812e-01	2.710169e-01	2.181387e+00	4.678830e+00	RPL21;RPL37A;RPL31;PIP;RPL23
c2.all.v2024.1.Hs.symbols.gmt	MARTINEZ_RB1_AND_TP53_TARGETS_UP	6/623	4.901743e-02	1.805210e-01	2.555040e+00	7.704926e+00	UBB;SERPINB4;TCIM;ATF3;CP;LYZ
c2.all.v2024.1.Hs.symbols.gmt	MARTINEZ_RB1_TARGETS_DN	7/569	1.055309e-02	7.590949e-02	3.281752e+00	1.493636e+01	UBB;SERPINB4;RPL21;RPL37A;RPL31;ATF3;PIP
c2.all.v2024.1.Hs.symbols.gmt	MARTINEZ_RB1_TARGETS_UP	4/690	3.351026e-01	4.401332e-01	1.550925e+00	1.695655e+00	CP;LYZ;TCIM;RPL23
c2.all.v2024.1.Hs.symbols.gmt	MARTINEZ_RESPONSE_TO_TRABECTEDIN_DN	1/272	6.870453e-01	7.263945e-01	1.289775e+00	4.841235e-01	HSPH1
c2.all.v2024.1.Hs.symbols.gmt	MARTINEZ_RESPONSE_TO_TRABECTEDIN_UP	3/71	3.415670e-03	3.345112e-02	1.230214e+01	6.986856e+01	ATF3;RPS27;LYZ
c2.all.v2024.1.Hs.symbols.gmt	MARTINEZ_TP53_TARGETS_DN	5/615	1.200545e-01	2.716200e-01	2.163018e+00	4.585186e+00	RPL21;RPL37A;RPL31;PIP;RPL23
c2.all.v2024.1.Hs.symbols.gmt	MARTINEZ_TP53_TARGETS_UP	6/624	4.933048e-02	1.805210e-01	2.550790e+00	7.675872e+00	UBB;SERPINB4;TCIM;ATF3;CP;LYZ
c2.all.v2024.1.Hs.symbols.gmt	MARTIN_NFKB_TARGETS_UP	1/43	1.669802e-01	3.123952e-01	8.325826e+00	1.490223e+01	CP
c2.all.v2024.1.Hs.symbols.gmt	MARTIN_VIRAL_GPCR_SIGNALING_UP	1/86	3.063248e-01	4.155997e-01	4.130500e+00	4.886833e+00	CP
c2.all.v2024.1.Hs.symbols.gmt	MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN	1/519	8.923860e-01	9.071721e-01	6.677169e-01	7.602395e-02	MT-ND3
c2.all.v2024.1.Hs.symbols.gmt	MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_UP	2/177	1.727090e-01	3.187349e-01	3.376222e+00	5.929143e+00	GAS5;RPL27A
c2.all.v2024.1.Hs.symbols.gmt	MARZEC_IL2_SIGNALING_UP	1/115	3.870107e-01	4.816852e-01	3.080284e+00	2.924122e+00	CXCL8
c2.all.v2024.1.Hs.symbols.gmt	MASRI_RESISTANCE_TO_TAMOXIFEN_AND_AROMATASE_INHIBITORS_UP	1/20	8.142487e-02	2.220291e-01	1.816495e+01	4.555906e+01	AGR2
c2.all.v2024.1.Hs.symbols.gmt	MASSARWEH_TAMOXIFEN_RESISTANCE_DN	1/256	6.647782e-01	7.096864e-01	1.371548e+00	5.600056e-01	TCN1
c2.all.v2024.1.Hs.symbols.gmt	MASSARWEH_TAMOXIFEN_RESISTANCE_UP	4/583	2.341346e-01	3.662742e-01	1.846472e+00	2.680817e+00	MUC1;S100P;TSPAN1;NUCB2
c2.all.v2024.1.Hs.symbols.gmt	MATSUDA_NATURAL_KILLER_DIFFERENTIATION	5/486	5.564873e-02	1.912125e-01	2.758982e+00	7.969860e+00	AKAP9;HSP90AA1;LYZ;NUCB2;NAPSA
c2.all.v2024.1.Hs.symbols.gmt	MATTHEWS_AP1_TARGETS	1/17	6.964305e-02	2.057725e-01	2.147059e+01	5.720564e+01	MMP10
c2.all.v2024.1.Hs.symbols.gmt	MATTIOLI_MGUS_VS_MULTIPLE_MYELOMA	1/17	6.964305e-02	2.057725e-01	2.147059e+01	5.720564e+01	CXCL8
c2.all.v2024.1.Hs.symbols.gmt	MATTIOLI_MGUS_VS_PCL	2/127	1.011891e-01	2.489156e-01	4.732099e+00	1.084012e+01	PPP1R15A;CXCL8
c2.all.v2024.1.Hs.symbols.gmt	MATZUK_MALE_REPRODUCTION_SERTOLI	1/28	1.121262e-01	2.639902e-01	1.287594e+01	2.817422e+01	DNAJA1
c2.all.v2024.1.Hs.symbols.gmt	MATZUK_MEIOTIC_AND_DNA_REPAIR	1/39	1.526892e-01	3.016190e-01	9.192513e+00	1.727596e+01	UBB
c2.all.v2024.1.Hs.symbols.gmt	MATZUK_SPERMATOCYTE	1/72	2.636969e-01	3.854743e-01	4.942411e+00	6.588010e+00	UBB
c2.all.v2024.1.Hs.symbols.gmt	MAYBURD_RESPONSE_TO_L663536_DN	1/56	2.117989e-01	3.500892e-01	6.371875e+00	9.889900e+00	RPL15
c2.all.v2024.1.Hs.symbols.gmt	MA_MYELOID_DIFFERENTIATION_UP	1/38	1.490787e-01	3.001720e-01	9.438075e+00	1.796331e+01	UBB
c2.all.v2024.1.Hs.symbols.gmt	MA_RAT_AGING_DN	8/161	4.227795e-07	1.445767e-05	1.404882e+01	2.061863e+02	RPS29;RPL39;HSPH1;MT-ND1;MT-ATP6;ATF3;HSP90AA1;DNAJA1
c2.all.v2024.1.Hs.symbols.gmt	MA_RAT_AGING_UP	5/107	9.259483e-05	1.970947e-03	1.318771e+01	1.224779e+02	TMSB4X;GADD45A;RACK1;LYZ;NAPSA
c2.all.v2024.1.Hs.symbols.gmt	MCBRYAN_PUBERTAL_BREAST_3_4WK_UP	3/214	6.265514e-02	2.001510e-01	3.958519e+00	1.096553e+01	GADD45A;LCN2;LTF
c2.all.v2024.1.Hs.symbols.gmt	MCBRYAN_PUBERTAL_BREAST_4_5WK_DN	2/202	2.109632e-01	3.500892e-01	2.951877e+00	4.593331e+00	NEAT1;CP
c2.all.v2024.1.Hs.symbols.gmt	MCBRYAN_PUBERTAL_BREAST_4_5WK_UP	3/270	1.070468e-01	2.584487e-01	3.121812e+00	6.975654e+00	RPL37A;LCN2;LTF
c2.all.v2024.1.Hs.symbols.gmt	MCBRYAN_PUBERTAL_BREAST_5_6WK_DN	3/133	1.898803e-02	1.086270e-01	6.439273e+00	2.552493e+01	NEAT1;RPL37A;AKAP9
c2.all.v2024.1.Hs.symbols.gmt	MCBRYAN_PUBERTAL_BREAST_5_6WK_UP	2/123	9.590463e-02	2.420875e-01	4.888778e+00	1.146126e+01	CFAP298;SFTPB
c2.all.v2024.1.Hs.symbols.gmt	MCBRYAN_PUBERTAL_BREAST_6_7WK_UP	2/199	2.063212e-01	3.462478e-01	2.997126e+00	4.730428e+00	CP;AKAP9
c2.all.v2024.1.Hs.symbols.gmt	MCBRYAN_PUBERTAL_TGFB1_TARGETS_DN	2/62	2.847619e-02	1.409738e-01	9.845209e+00	3.503602e+01	SFTPB;LCN2
c2.all.v2024.1.Hs.symbols.gmt	MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP	3/168	3.462186e-02	1.575345e-01	5.069404e+00	1.704977e+01	CP;RPL27A;LTF
c2.all.v2024.1.Hs.symbols.gmt	MCCABE_BOUND_BY_HOXC6	2/461	5.843608e-01	6.445336e-01	1.272799e+00	6.837946e-01	RPL27A;BPIFB1
c2.all.v2024.1.Hs.symbols.gmt	MCCLUNG_COCAINE_REWARD_5D	1/75	2.730444e-01	3.925366e-01	4.742741e+00	6.156651e+00	GADD45A
c2.all.v2024.1.Hs.symbols.gmt	MCCLUNG_COCAIN_REWARD_4WK	1/74	2.699417e-01	3.904982e-01	4.807487e+00	6.295641e+00	SERPINB3
c2.all.v2024.1.Hs.symbols.gmt	MCDOWELL_ACUTE_LUNG_INJURY_DN	2/47	1.695694e-02	1.019371e-01	1.309979e+01	5.340888e+01	SFTPC;SFTPB
c2.all.v2024.1.Hs.symbols.gmt	MCDOWELL_ACUTE_LUNG_INJURY_UP	2/47	1.695694e-02	1.019371e-01	1.309979e+01	5.340888e+01	LCN2;LTF
c2.all.v2024.1.Hs.symbols.gmt	MCLACHLAN_DENTAL_CARIES_UP	2/265	3.095432e-01	4.184752e-01	2.239653e+00	2.626346e+00	LYZ;CXCL8
c2.all.v2024.1.Hs.symbols.gmt	MEBARKI_HCC_PROGENITOR_FZD8CRD_DN	2/459	5.819807e-01	6.430146e-01	1.278482e+00	6.920653e-01	NEAT1;TCIM
c2.all.v2024.1.Hs.symbols.gmt	MEBARKI_HCC_PROGENITOR_FZD8CRD_UP	2/588	7.155435e-01	7.515729e-01	9.913366e-01	3.318131e-01	ATF3;LRRIQ1
c2.all.v2024.1.Hs.symbols.gmt	MEBARKI_HCC_PROGENITOR_WNT_DN	2/92	5.812907e-02	1.930848e-01	6.572644e+00	1.869976e+01	AGR2;S100P
c2.all.v2024.1.Hs.symbols.gmt	MEBARKI_HCC_PROGENITOR_WNT_DN_CTNNB1_DEPENDENT	1/31	1.233756e-01	2.740804e-01	1.160787e+01	2.428973e+01	AGR2
c2.all.v2024.1.Hs.symbols.gmt	MEBARKI_HCC_PROGENITOR_WNT_DN_CTNNB1_INDEPENDENT	1/16	6.568265e-02	2.009003e-01	2.285682e+01	6.223731e+01	S100P
c2.all.v2024.1.Hs.symbols.gmt	MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3	1/1074	9.906560e-01	9.911311e-01	3.142128e-01	2.949811e-03	ATF3
c2.all.v2024.1.Hs.symbols.gmt	MELLMAN_TUT1_TARGETS_UP	2/20	3.209312e-03	3.203170e-02	3.225785e+01	1.852149e+02	RPL31;RPL23
c2.all.v2024.1.Hs.symbols.gmt	MENSE_HYPOXIA_UP	3/99	8.609611e-03	6.530781e-02	8.721510e+00	4.146970e+01	ATF3;PPP1R15A;GADD45A
c2.all.v2024.1.Hs.symbols.gmt	MIDORIKAWA_AMPLIFIED_IN_LIVER_CANCER	2/55	2.279190e-02	1.225358e-01	1.113690e+01	4.211253e+01	RPL23;CFTR
c2.all.v2024.1.Hs.symbols.gmt	MIKKELSEN_ES_ICP_WITH_H3K27ME3	2/43	1.432032e-02	9.219811e-02	1.436503e+01	6.099500e+01	SFTPC;HOATZ
c2.all.v2024.1.Hs.symbols.gmt	MIKKELSEN_ES_ICP_WITH_H3K4ME3	1/728	9.568057e-01	9.614146e-01	4.712829e-01	2.080948e-02	TCIM
c2.all.v2024.1.Hs.symbols.gmt	MIKKELSEN_ES_LCP_WITH_H3K4ME3	1/146	4.630082e-01	5.422993e-01	2.420585e+00	1.863876e+00	MUC1
c2.all.v2024.1.Hs.symbols.gmt	MIKKELSEN_IPS_HCP_WITH_H3_UNMETHYLATED	1/86	3.063248e-01	4.155997e-01	4.130500e+00	4.886833e+00	FTL
c2.all.v2024.1.Hs.symbols.gmt	MIKKELSEN_IPS_LCP_WITH_H3K4ME3	1/175	5.256293e-01	5.949337e-01	2.015644e+00	1.296380e+00	MUC1
c2.all.v2024.1.Hs.symbols.gmt	MIKKELSEN_MCV6_LCP_WITH_H3K4ME3	1/162	4.985055e-01	5.707368e-01	2.179186e+00	1.517020e+00	MUC1
c2.all.v2024.1.Hs.symbols.gmt	MIKKELSEN_MEF_LCP_WITH_H3K4ME3	1/128	4.200961e-01	5.065436e-01	2.764580e+00	2.397642e+00	CP
c2.all.v2024.1.Hs.symbols.gmt	MIKKELSEN_NPC_ICP_WITH_H3K4ME3	1/449	8.541882e-01	8.728499e-01	7.744353e-01	1.220539e-01	TCIM
c2.all.v2024.1.Hs.symbols.gmt	MIKKELSEN_NPC_LCP_WITH_H3K4ME3	1/60	2.251031e-01	3.589947e-01	5.942435e+00	8.861339e+00	CP
c2.all.v2024.1.Hs.symbols.gmt	MIKKELSEN_PARTIALLY_REPROGRAMMED_TO_PLURIPOTENCY	1/10	4.156755e-02	1.693553e-01	3.730284e+01	1.186393e+02	SYNE2
c2.all.v2024.1.Hs.symbols.gmt	MILICIC_FAMILIAL_ADENOMATOUS_POLYPOSIS_UP	1/10	4.156755e-02	1.693553e-01	3.730284e+01	1.186393e+02	LCN2
c2.all.v2024.1.Hs.symbols.gmt	MILI_PSEUDOPODIA_CHEMOTAXIS_DN	4/457	1.291225e-01	2.795512e-01	2.373309e+00	4.858148e+00	RPL3;NEAT1;RACK1;GAS5
c2.all.v2024.1.Hs.symbols.gmt	MILI_PSEUDOPODIA_HAPTOTAXIS_DN	2/681	7.882826e-01	8.164635e-01	8.519579e-01	2.026796e-01	NEAT1;RACK1
c2.all.v2024.1.Hs.symbols.gmt	MILI_PSEUDOPODIA_HAPTOTAXIS_UP	3/523	3.821767e-01	4.768066e-01	1.585797e+00	1.525334e+00	DNAJA1;RPL31;RPL21
c2.all.v2024.1.Hs.symbols.gmt	MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_DN	1/24	9.690462e-02	2.420875e-01	1.507032e+01	3.517454e+01	FTL
c2.all.v2024.1.Hs.symbols.gmt	MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP	1/24	9.690462e-02	2.420875e-01	1.507032e+01	3.517454e+01	TCN1
c2.all.v2024.1.Hs.symbols.gmt	MISSIAGLIA_REGULATED_BY_METHYLATION_UP	4/125	1.978848e-03	2.219289e-02	8.994271e+00	5.599150e+01	ATF3;GADD45A;LCN2;S100P
c2.all.v2024.1.Hs.symbols.gmt	MITSIADES_RESPONSE_TO_APLIDIN_UP	3/445	2.918040e-01	4.058021e-01	1.872069e+00	2.305777e+00	DNAAF1;PPP1R15A;GADD45A
c2.all.v2024.1.Hs.symbols.gmt	MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_DN	1/235	6.331586e-01	6.832741e-01	1.495810e+00	6.836364e-01	CXCL8
c2.all.v2024.1.Hs.symbols.gmt	MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_UP	1/265	6.774895e-01	7.192076e-01	1.324333e+00	5.156440e-01	SYNE2
c2.all.v2024.1.Hs.symbols.gmt	MIZUKAMI_HYPOXIA_DN	1/6	2.514976e-02	1.299319e-01	6.444385e+01	2.373407e+02	CXCL8
c2.all.v2024.1.Hs.symbols.gmt	MMS_MOUSE_LYMPH_HIGH_4HRS_UP	1/36	1.418120e-01	2.920236e-01	9.970701e+00	1.947530e+01	GAS5
c2.all.v2024.1.Hs.symbols.gmt	MODY_HIPPOCAMPUS_PRENATAL	3/45	9.180319e-04	1.285245e-02	1.985156e+01	1.388275e+02	RPL32;RPS27;RPL23A
c2.all.v2024.1.Hs.symbols.gmt	MOHANKUMAR_HOXA1_TARGETS_DN	3/176	3.889975e-02	1.662805e-01	4.833892e+00	1.569452e+01	MUC1;LTF;S100P
c2.all.v2024.1.Hs.symbols.gmt	MONNIER_POSTRADIATION_TUMOR_ESCAPE_DN	5/385	2.394681e-02	1.267844e-01	3.507638e+00	1.309023e+01	TMSB4X;PPP1R15A;TCIM;RPL15;CP
c2.all.v2024.1.Hs.symbols.gmt	MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP	2/408	5.179995e-01	5.882128e-01	1.442273e+00	9.486995e-01	NEAT1;RACK1
c2.all.v2024.1.Hs.symbols.gmt	MOOTHA_HUMAN_MITODB_6_2002	1/432	8.430479e-01	8.641759e-01	8.055781e-01	1.375375e-01	RPL3
c2.all.v2024.1.Hs.symbols.gmt	MOOTHA_PGC	1/421	8.353950e-01	8.571736e-01	8.270712e-01	1.487492e-01	LCN2
c2.all.v2024.1.Hs.symbols.gmt	MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_UP	1/87	3.092745e-01	4.183830e-01	4.082563e+00	4.790994e+00	RPL37A
c2.all.v2024.1.Hs.symbols.gmt	MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP	2/376	4.747298e-01	5.523069e-01	1.567820e+00	1.168041e+00	RPL37A;BPIFA1
c2.all.v2024.1.Hs.symbols.gmt	MOREIRA_RESPONSE_TO_TSA_UP	1/28	1.121262e-01	2.639902e-01	1.287594e+01	2.817422e+01	TMSB4X
c2.all.v2024.1.Hs.symbols.gmt	MORI_IMMATURE_B_LYMPHOCYTE_UP	1/53	2.016727e-01	3.434199e-01	6.736898e+00	1.078651e+01	NEAT1
c2.all.v2024.1.Hs.symbols.gmt	MORI_LARGE_PRE_BII_LYMPHOCYTE_DN	1/60	2.251031e-01	3.589947e-01	5.942435e+00	8.861339e+00	NEAT1
c2.all.v2024.1.Hs.symbols.gmt	MORI_MATURE_B_LYMPHOCYTE_UP	1/95	3.324294e-01	4.388910e-01	3.735591e+00	4.114110e+00	NEAT1
c2.all.v2024.1.Hs.symbols.gmt	MORI_PRE_BI_LYMPHOCYTE_DN	1/80	2.883633e-01	4.028974e-01	4.443447e+00	5.525578e+00	NEAT1
c2.all.v2024.1.Hs.symbols.gmt	MORI_SMALL_PRE_BII_LYMPHOCYTE_DN	2/76	4.132052e-02	1.693553e-01	7.990024e+00	2.545938e+01	LYZ;HSPH1
c2.all.v2024.1.Hs.symbols.gmt	MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_DN	1/33	1.307967e-01	2.795512e-01	1.089255e+01	2.215666e+01	CXCL8
c2.all.v2024.1.Hs.symbols.gmt	MUELLER_METHYLATED_IN_GLIOBLASTOMA	2/43	1.432032e-02	9.219811e-02	1.436503e+01	6.099500e+01	LCN2;S100P
c2.all.v2024.1.Hs.symbols.gmt	MUELLER_PLURINET	2/299	3.620964e-01	4.614602e-01	1.980604e+00	2.011986e+00	HSPH1;GADD45A
c2.all.v2024.1.Hs.symbols.gmt	MULLIGHAN_MLL_SIGNATURE_1_DN	3/238	8.041015e-02	2.220291e-01	3.551205e+00	8.951220e+00	RPL13A;RPL31;CXCL8
c2.all.v2024.1.Hs.symbols.gmt	MULLIGHAN_MLL_SIGNATURE_2_DN	2/279	3.313214e-01	4.388910e-01	2.125298e+00	2.347746e+00	MSMB;CXCL8
c2.all.v2024.1.Hs.symbols.gmt	MULLIGHAN_MLL_SIGNATURE_2_UP	1/420	8.346813e-01	8.571736e-01	8.290810e-01	1.498194e-01	AKAP9
c2.all.v2024.1.Hs.symbols.gmt	MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_DN	1/125	4.126214e-01	5.015899e-01	2.831583e+00	2.506587e+00	RPL28
c2.all.v2024.1.Hs.symbols.gmt	MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_UP	1/265	6.774895e-01	7.192076e-01	1.324333e+00	5.156440e-01	HSP90AA1
c2.all.v2024.1.Hs.symbols.gmt	MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_DN	1/76	2.761341e-01	3.945313e-01	4.679711e+00	6.022174e+00	RPL28
c2.all.v2024.1.Hs.symbols.gmt	MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_UP	1/130	4.250268e-01	5.107177e-01	2.721636e+00	2.328640e+00	HSP90AA1
c2.all.v2024.1.Hs.symbols.gmt	MULLIGHAN_NPM1_SIGNATURE_3_DN	1/161	4.963565e-01	5.692137e-01	2.192863e+00	1.536015e+00	RPL28
c2.all.v2024.1.Hs.symbols.gmt	MULLIGHAN_NPM1_SIGNATURE_3_UP	1/335	7.613665e-01	7.913356e-01	1.043836e+00	2.845919e-01	HSP90AA1
c2.all.v2024.1.Hs.symbols.gmt	MUNSHI_MULTIPLE_MYELOMA_UP	1/77	2.792107e-01	3.967531e-01	4.618329e+00	5.892011e+00	UBB
c2.all.v2024.1.Hs.symbols.gmt	MURAKAMI_UV_RESPONSE_6HR_UP	1/34	1.344840e-01	2.842285e-01	1.056692e+01	2.120053e+01	GADD45A
c2.all.v2024.1.Hs.symbols.gmt	MURATA_VIRULENCE_OF_H_PILORI	1/22	8.919728e-02	2.334470e-01	1.647370e+01	3.981536e+01	MUC1
c2.all.v2024.1.Hs.symbols.gmt	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_17	2/19	2.896343e-03	3.002182e-02	3.410270e+01	1.993066e+02	HSP90AA1;MUC1
c2.all.v2024.1.Hs.symbols.gmt	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_24	2/14	1.562713e-03	1.831359e-02	4.775459e+01	3.085583e+02	HSP90AA1;MUC1
c2.all.v2024.1.Hs.symbols.gmt	NABA_ECM_AFFILIATED	5/170	7.878791e-04	1.149312e-02	8.144222e+00	5.819996e+01	SFTPA1;MUC1;SFTPB;SFTPA2;SFTPC
c2.all.v2024.1.Hs.symbols.gmt	NABA_ECM_REGULATORS	3/238	8.041015e-02	2.220291e-01	3.551205e+00	8.951220e+00	MMP10;SERPINB3;SERPINB4
c2.all.v2024.1.Hs.symbols.gmt	NABA_MATRISOME	10/1026	1.152827e-02	8.069790e-02	2.577195e+00	1.150190e+01	SFTPA1;SERPINB4;MUC1;SERPINB3;SFTPB;SFTPA2;MMP10;SFTPC;CXCL8;S100P
c2.all.v2024.1.Hs.symbols.gmt	NABA_MATRISOME_ASSOCIATED	10/751	1.295707e-03	1.624977e-02	3.579084e+00	2.379625e+01	SFTPA1;SERPINB4;MUC1;SERPINB3;SFTPB;SFTPA2;MMP10;SFTPC;CXCL8;S100P
c2.all.v2024.1.Hs.symbols.gmt	NABA_SECRETED_FACTORS	2/343	4.277928e-01	5.131546e-01	1.721934e+00	1.462122e+00	CXCL8;S100P
c2.all.v2024.1.Hs.symbols.gmt	NADLER_HYPERGLYCEMIA_AT_OBESITY	1/59	2.217980e-01	3.578273e-01	6.044289e+00	9.102627e+00	RPS27
c2.all.v2024.1.Hs.symbols.gmt	NADLER_OBESITY_DN	1/49	1.879707e-01	3.283977e-01	7.293842e+00	1.219143e+01	UBB
c2.all.v2024.1.Hs.symbols.gmt	NAGASHIMA_EGF_SIGNALING_UP	1/57	2.151460e-01	3.519958e-01	6.258814e+00	9.616282e+00	ATF3
c2.all.v2024.1.Hs.symbols.gmt	NAGASHIMA_NRG1_SIGNALING_DN	1/55	2.084377e-01	3.470081e-01	6.489084e+00	1.017563e+01	AKAP9
c2.all.v2024.1.Hs.symbols.gmt	NAGASHIMA_NRG1_SIGNALING_UP	3/172	3.672849e-02	1.619087e-01	4.948869e+00	1.635207e+01	ATF3;PPP1R15A;GADD45A
c2.all.v2024.1.Hs.symbols.gmt	NAKAJIMA_EOSINOPHIL	1/25	1.007341e-01	2.483821e-01	1.445455e+01	3.317710e+01	S100P
c2.all.v2024.1.Hs.symbols.gmt	NAKAMURA_ADIPOGENESIS_LATE_UP	1/98	3.409131e-01	4.450218e-01	3.620156e+00	3.895750e+00	ATF3
c2.all.v2024.1.Hs.symbols.gmt	NAKAMURA_BRONCHIAL_AND_BRONCHIOLAR_EPITHELIA	2/7	3.676633e-04	5.991763e-03	1.085676e+02	8.585896e+02	DNAAF1;SCGB1A1
c2.all.v2024.1.Hs.symbols.gmt	NAKAMURA_LUNG_CANCER_DIFFERENTIATION_MARKERS	5/13	1.534064e-09	8.648802e-08	1.597079e+02	3.241326e+03	DNAAF1;SFTPB;SFTPA2;SFTPC;SCGB1A1
c2.all.v2024.1.Hs.symbols.gmt	NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN	13/648	3.420732e-06	9.267073e-05	5.594498e+00	7.041043e+01	SERPINB4;SYNE2;LCN2;S100P;NEAT1;MUC1;RPL28;SERPINB3;RPL31;RPL15;CP;MT-ND4;TSPAN1
c2.all.v2024.1.Hs.symbols.gmt	NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_UP	1/284	7.027793e-01	7.407769e-01	1.234502e+00	4.354241e-01	HSP90AA1
c2.all.v2024.1.Hs.symbols.gmt	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP	1/83	2.974008e-01	4.100318e-01	4.281283e+00	5.191803e+00	LYZ
c2.all.v2024.1.Hs.symbols.gmt	NATSUME_RESPONSE_TO_INTERFERON_BETA_DN	2/51	1.978313e-02	1.115341e-01	1.203904e+01	4.722826e+01	FTL;RPS2
c2.all.v2024.1.Hs.symbols.gmt	NATSUME_RESPONSE_TO_INTERFERON_BETA_UP	1/70	2.573993e-01	3.818884e-01	5.085100e+00	6.901124e+00	DNAJA1
c2.all.v2024.1.Hs.symbols.gmt	NEBEN_AML_WITH_FLT3_OR_NRAS_DN	2/12	1.139667e-03	1.495185e-02	5.685586e+01	3.853132e+02	RPL28;RPS3
c2.all.v2024.1.Hs.symbols.gmt	NEMETH_INFLAMMATORY_RESPONSE_LPS_UP	1/84	3.003881e-01	4.122431e-01	4.229818e+00	5.087119e+00	ATF3
c2.all.v2024.1.Hs.symbols.gmt	NEWMAN_ERCC6_TARGETS_DN	1/39	1.526892e-01	3.016190e-01	9.192513e+00	1.727596e+01	NEAT1
c2.all.v2024.1.Hs.symbols.gmt	NEWMAN_ERCC6_TARGETS_UP	1/26	1.045474e-01	2.529999e-01	1.388707e+01	3.135860e+01	CXCL8
c2.all.v2024.1.Hs.symbols.gmt	NIKOLSKY_BREAST_CANCER_11Q12_Q14_AMPLICON	1/158	4.898550e-01	5.654884e-01	2.234938e+00	1.594954e+00	RPS3
c2.all.v2024.1.Hs.symbols.gmt	NIKOLSKY_BREAST_CANCER_12Q13_Q21_AMPLICON	1/46	1.775417e-01	3.214861e-01	7.775812e+00	1.344088e+01	LYZ
c2.all.v2024.1.Hs.symbols.gmt	NIKOLSKY_BREAST_CANCER_16P13_AMPLICON	1/119	3.973850e-01	4.916637e-01	2.975767e+00	2.746186e+00	RPS2
c2.all.v2024.1.Hs.symbols.gmt	NIKOLSKY_BREAST_CANCER_17Q11_Q21_AMPLICON	2/132	1.079058e-01	2.588857e-01	4.549757e+00	1.013002e+01	RPL23A;RPL23
c2.all.v2024.1.Hs.symbols.gmt	NIKOLSKY_BREAST_CANCER_1Q21_AMPLICON	1/38	1.490787e-01	3.001720e-01	9.438075e+00	1.796331e+01	MUC1
c2.all.v2024.1.Hs.symbols.gmt	NIKOLSKY_BREAST_CANCER_7Q21_Q22_AMPLICON	1/75	2.730444e-01	3.925366e-01	4.742741e+00	6.156651e+00	AKAP9
c2.all.v2024.1.Hs.symbols.gmt	NIKOLSKY_BREAST_CANCER_8P12_P11_AMPLICON	1/57	2.151460e-01	3.519958e-01	6.258814e+00	9.616282e+00	TCIM
c2.all.v2024.1.Hs.symbols.gmt	NIKOLSKY_MUTATED_AND_AMPLIFIED_IN_BREAST_CANCER	1/94	3.295776e-01	4.370622e-01	3.775716e+00	4.190831e+00	AKAP9
c2.all.v2024.1.Hs.symbols.gmt	NOJIMA_SFRP2_TARGETS_UP	2/32	8.106295e-03	6.286146e-02	1.955560e+01	9.416247e+01	PPP1R15A;GADD45A
c2.all.v2024.1.Hs.symbols.gmt	NOUZOVA_TRETINOIN_AND_H4_ACETYLATION	1/138	4.443385e-01	5.275413e-01	2.562353e+00	2.078500e+00	GOLGB1
c2.all.v2024.1.Hs.symbols.gmt	NUTT_GBM_VS_AO_GLIOMA_DN	2/46	1.627974e-02	9.988097e-02	1.339478e+01	5.515747e+01	RPL23A;RPL27A
c2.all.v2024.1.Hs.symbols.gmt	NUYTTEN_EZH2_TARGETS_DN	5/1023	4.375883e-01	5.216053e-01	1.271919e+00	1.051212e+00	ANKRD36B;SYNE2;RPL15;RPS3;RPS15A
c2.all.v2024.1.Hs.symbols.gmt	NUYTTEN_EZH2_TARGETS_UP	5/1033	4.459648e-01	5.291485e-01	1.258955e+00	1.016625e+00	GADD45A;GPX1;ATF3;DNAJA1;CXCL8
c2.all.v2024.1.Hs.symbols.gmt	NUYTTEN_NIPP1_TARGETS_DN	6/845	1.487978e-01	3.001720e-01	1.859955e+00	3.543525e+00	SYNE2;LCN2;PABPC3;DNAJA1;AGR2;S100P
c2.all.v2024.1.Hs.symbols.gmt	NUYTTEN_NIPP1_TARGETS_UP	3/768	6.361137e-01	6.855925e-01	1.066016e+00	4.822424e-01	ATF3;GADD45A;CXCL8
c2.all.v2024.1.Hs.symbols.gmt	ODONNELL_TARGETS_OF_MYC_AND_TFRC_DN	1/46	1.775417e-01	3.214861e-01	7.775812e+00	1.344088e+01	HSPH1
c2.all.v2024.1.Hs.symbols.gmt	ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP	2/83	4.841471e-02	1.805210e-01	7.301443e+00	2.210841e+01	NEAT1;LYZ
c2.all.v2024.1.Hs.symbols.gmt	ODONNELL_TFRC_TARGETS_DN	1/139	4.467069e-01	5.291485e-01	2.543736e+00	2.049877e+00	HSPH1
c2.all.v2024.1.Hs.symbols.gmt	ODONNELL_TFRC_TARGETS_UP	5/443	4.015229e-02	1.688663e-01	3.035558e+00	9.759549e+00	PPP1R15A;GADD45A;NEAT1;CP;LYZ
c2.all.v2024.1.Hs.symbols.gmt	OISHI_CHOLANGIOMA_STEM_CELL_LIKE_DN	5/274	6.219472e-03	5.069675e-02	4.977654e+00	2.528683e+01	MUC1;LYZ;NUCB2;AGR2;TSPAN1
c2.all.v2024.1.Hs.symbols.gmt	OKUMURA_INFLAMMATORY_RESPONSE_LPS	1/182	5.396279e-01	6.068269e-01	1.937287e+00	1.195065e+00	CXCL8
c2.all.v2024.1.Hs.symbols.gmt	ONDER_CDH1_SIGNALING_VIA_CTNNB1	1/84	3.003881e-01	4.122431e-01	4.229818e+00	5.087119e+00	CXCL8
c2.all.v2024.1.Hs.symbols.gmt	ONDER_CDH1_TARGETS_1_DN	5/170	7.878791e-04	1.149312e-02	8.144222e+00	5.819996e+01	HSPH1;LCN2;MMP10;DNAJA1;CXCL8
c2.all.v2024.1.Hs.symbols.gmt	ONDER_CDH1_TARGETS_1_UP	2/139	1.175025e-01	2.710169e-01	4.316757e+00	9.243454e+00	ATF3;FTL
c2.all.v2024.1.Hs.symbols.gmt	ONDER_CDH1_TARGETS_2_DN	6/473	1.531598e-02	9.594335e-02	3.398405e+00	1.420145e+01	LCN2;S100P;SERPINB3;MMP10;CXCL8;TSPAN1
c2.all.v2024.1.Hs.symbols.gmt	ONDER_CDH1_TARGETS_2_UP	1/257	6.662147e-01	7.108561e-01	1.366138e+00	5.548479e-01	FTL
c2.all.v2024.1.Hs.symbols.gmt	ONDER_CDH1_TARGETS_3_DN	3/59	2.015148e-03	2.235956e-02	1.492311e+01	9.262868e+01	MMP10;CXCL8;LCN2
c2.all.v2024.1.Hs.symbols.gmt	ONDER_CDH1_TARGETS_3_UP	1/18	7.358684e-02	2.123128e-01	2.024278e+01	5.281927e+01	FTL
c2.all.v2024.1.Hs.symbols.gmt	ONGUSAHA_BRCA1_TARGETS_UP	1/13	5.370110e-02	1.861898e-01	2.834631e+01	8.289373e+01	GADD45A
c2.all.v2024.1.Hs.symbols.gmt	ONKEN_UVEAL_MELANOMA_DN	9/533	4.328254e-04	6.892167e-03	4.570384e+00	3.539843e+01	RPL10A;RPL28;RPL31;RPL15;RPL3;RPL23;RPS5;RPL32;RPL18A
c2.all.v2024.1.Hs.symbols.gmt	ONKEN_UVEAL_MELANOMA_UP	5/790	2.433837e-01	3.724861e-01	1.667432e+00	2.356275e+00	SYNE2;HSPH1;AKAP9;RPL37A;NUCB2
c2.all.v2024.1.Hs.symbols.gmt	OSADA_ASCL1_TARGETS_UP	1/46	1.775417e-01	3.214861e-01	7.775812e+00	1.344088e+01	ATF3
c2.all.v2024.1.Hs.symbols.gmt	OSAWA_TNF_TARGETS	1/10	4.156755e-02	1.693553e-01	3.730284e+01	1.186393e+02	CXCL8
c2.all.v2024.1.Hs.symbols.gmt	OSMAN_BLADDER_CANCER_DN	13/431	3.380596e-08	1.639982e-06	8.581239e+00	1.476199e+02	RPL10A;RPL28;RPL15;RPL3;GAS5;RPL32;RPS27;RPL23A;RPS5;RPL13A;RPS3;RPL18A;CXCL8
c2.all.v2024.1.Hs.symbols.gmt	OSMAN_BLADDER_CANCER_UP	2/402	5.100643e-01	5.811000e-01	1.464285e+00	9.857835e-01	NEAT1;HSP90AA1
c2.all.v2024.1.Hs.symbols.gmt	OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN	2/281	3.344186e-01	4.401332e-01	2.109897e+00	2.311101e+00	GADD45A;S100P
c2.all.v2024.1.Hs.symbols.gmt	OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP	4/224	1.520391e-02	9.552820e-02	4.933702e+00	2.065347e+01	ATF3;PPP1R15A;CXCL8;RPL23
c2.all.v2024.1.Hs.symbols.gmt	OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_UP	1/69	2.542306e-01	3.790744e-01	5.159569e+00	7.066100e+00	UBB
c2.all.v2024.1.Hs.symbols.gmt	OUELLET_OVARIAN_CANCER_INVASIVE_VS_LMP_DN	1/12	4.967357e-02	1.805210e-01	3.081260e+01	9.250813e+01	RPS29
c2.all.v2024.1.Hs.symbols.gmt	OUILLETTE_CLL_13Q14_DELETION_UP	1/75	2.730444e-01	3.925366e-01	4.742741e+00	6.156651e+00	RPL31
c2.all.v2024.1.Hs.symbols.gmt	PACHER_TARGETS_OF_IGF1_AND_IGF2_UP	1/36	1.418120e-01	2.920236e-01	9.970701e+00	1.947530e+01	GADD45A
c2.all.v2024.1.Hs.symbols.gmt	PAL_PRMT5_TARGETS_DN	1/30	1.196416e-01	2.710169e-01	1.200190e+01	2.548310e+01	LCN2
c2.all.v2024.1.Hs.symbols.gmt	PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_DN	1/148	4.675778e-01	5.467305e-01	2.387546e+00	1.814988e+00	RACK1
c2.all.v2024.1.Hs.symbols.gmt	PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_UP	3/134	1.936454e-02	1.100331e-01	6.390014e+00	2.520421e+01	TMSB4X;LYZ;TCIM
c2.all.v2024.1.Hs.symbols.gmt	PARENT_MTOR_SIGNALING_UP	3/567	4.322938e-01	5.171286e-01	1.459210e+00	1.223766e+00	DNAAF1;CP;SYNE2
c2.all.v2024.1.Hs.symbols.gmt	PARK_APL_PATHOGENESIS_DN	3/48	1.108760e-03	1.492176e-02	1.854014e+01	1.261567e+02	LYZ;CXCL8;S100P
c2.all.v2024.1.Hs.symbols.gmt	PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_DN	1/172	5.195017e-01	5.892771e-01	2.051184e+00	1.343290e+00	NAPSA
c2.all.v2024.1.Hs.symbols.gmt	PATIL_LIVER_CANCER	5/660	1.483754e-01	3.001720e-01	2.010308e+00	3.835688e+00	LCN2;SERPINB3;LYZ;RPS5;S100P
c2.all.v2024.1.Hs.symbols.gmt	PEART_HDAC_PROLIFERATION_CLUSTER_DN	1/71	2.605548e-01	3.835690e-01	5.012743e+00	6.741850e+00	CXCL8
c2.all.v2024.1.Hs.symbols.gmt	PECE_MAMMARY_STEM_CELL_DN	1/144	4.583998e-01	5.396286e-01	2.454545e+00	1.914579e+00	NEAT1
c2.all.v2024.1.Hs.symbols.gmt	PECE_MAMMARY_STEM_CELL_UP	12/139	6.937145e-13	5.788354e-11	2.610992e+01	7.309921e+02	RPS29;RPL39;RPL10A;RPL28;RPS2;RPL27A;RPL15;GAS5;RPL23A;RPL13A;RPS3;RPL18A
c2.all.v2024.1.Hs.symbols.gmt	PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_4	2/108	7.686838e-02	2.176237e-01	5.581145e+00	1.431932e+01	AGR2;MSMB
c2.all.v2024.1.Hs.symbols.gmt	PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_7	2/399	5.060654e-01	5.784396e-01	1.475540e+00	1.004974e+00	SYNE2;TSPAN1
c2.all.v2024.1.Hs.symbols.gmt	PEDERSEN_TARGETS_OF_611CTF_ISOFORM_OF_ERBB2	1/75	2.730444e-01	3.925366e-01	4.742741e+00	6.156651e+00	TSPAN1
c2.all.v2024.1.Hs.symbols.gmt	PEDRIOLI_MIR31_TARGETS_DN	4/413	9.846322e-02	2.456869e-01	2.633659e+00	6.105012e+00	NEAT1;MMP10;TMSB4X;CXCL8
c2.all.v2024.1.Hs.symbols.gmt	PEDRIOLI_MIR31_TARGETS_UP	1/223	6.137836e-01	6.665032e-01	1.577348e+00	7.699237e-01	SFTPA2
c2.all.v2024.1.Hs.symbols.gmt	PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_UP	1/64	2.381851e-01	3.674956e-01	5.567098e+00	7.987156e+00	PPP1R15A
c2.all.v2024.1.Hs.symbols.gmt	PEPPER_CHRONIC_LYMPHOCYTIC_LEUKEMIA_UP	1/32	1.270940e-01	2.774918e-01	1.123886e+01	2.318384e+01	LYZ
c2.all.v2024.1.Hs.symbols.gmt	PEREZ_TP53_TARGETS	2/1201	9.661105e-01	9.697791e-01	4.709057e-01	1.623546e-02	LTF;AKAP9
c2.all.v2024.1.Hs.symbols.gmt	PEREZ_TP63_TARGETS	3/356	1.918608e-01	3.326863e-01	2.353027e+00	3.884813e+00	SYNE2;HSPH1;LINGO1
c2.all.v2024.1.Hs.symbols.gmt	PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_DN	2/162	1.503831e-01	3.016190e-01	3.694283e+00	6.999074e+00	GADD45A;CXCL8
c2.all.v2024.1.Hs.symbols.gmt	PHONG_TNF_RESPONSE_NOT_VIA_P38	1/341	7.674591e-01	7.956857e-01	1.025160e+00	2.713291e-01	GADD45A
c2.all.v2024.1.Hs.symbols.gmt	PHONG_TNF_RESPONSE_VIA_P38_COMPLETE	2/224	2.452703e-01	3.731830e-01	2.657334e+00	3.734601e+00	ATF3;PPP1R15A
c2.all.v2024.1.Hs.symbols.gmt	PHONG_TNF_RESPONSE_VIA_P38_PARTIAL	2/164	1.533253e-01	3.023029e-01	3.648482e+00	6.841611e+00	CXCL8;TCIM
c2.all.v2024.1.Hs.symbols.gmt	PHONG_TNF_TARGETS_UP	2/63	2.933011e-02	1.409738e-01	9.684685e+00	3.417861e+01	ATF3;CXCL8
c2.all.v2024.1.Hs.symbols.gmt	PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_DN	2/137	1.147386e-01	2.689103e-01	4.380872e+00	9.485020e+00	PPP1R15A;GADD45A
c2.all.v2024.1.Hs.symbols.gmt	PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP	2/211	2.249498e-01	3.589947e-01	2.823905e+00	4.212922e+00	CP;TCIM
c2.all.v2024.1.Hs.symbols.gmt	PID_AP1_PATHWAY	2/70	3.558664e-02	1.610276e-01	8.692247e+00	2.899547e+01	ATF3;CXCL8
c2.all.v2024.1.Hs.symbols.gmt	PID_AR_TF_PATHWAY	3/53	1.478956e-03	1.773047e-02	1.670070e+01	1.088287e+02	HSP90AA1;DNAJA1;RACK1
c2.all.v2024.1.Hs.symbols.gmt	PID_ATF2_PATHWAY	3/59	2.015148e-03	2.235956e-02	1.492311e+01	9.262868e+01	ATF3;GADD45A;CXCL8
c2.all.v2024.1.Hs.symbols.gmt	PID_AURORA_A_PATHWAY	1/31	1.233756e-01	2.740804e-01	1.160787e+01	2.428973e+01	GADD45A
c2.all.v2024.1.Hs.symbols.gmt	PID_AVB3_INTEGRIN_PATHWAY	1/74	2.699417e-01	3.904982e-01	4.807487e+00	6.295641e+00	HSP90AA1
c2.all.v2024.1.Hs.symbols.gmt	PID_BETA_CATENIN_NUC_PATHWAY	2/80	4.532280e-02	1.752896e-01	7.581511e+00	2.345678e+01	MT-CO2;CXCL8
c2.all.v2024.1.Hs.symbols.gmt	PID_BMP_PATHWAY	1/42	1.634300e-01	3.095469e-01	8.526835e+00	1.544526e+01	PPP1R15A
c2.all.v2024.1.Hs.symbols.gmt	PID_CMYB_PATHWAY	1/84	3.003881e-01	4.122431e-01	4.229818e+00	5.087119e+00	LYZ
c2.all.v2024.1.Hs.symbols.gmt	PID_CXCR4_PATHWAY	1/100	3.465095e-01	4.500740e-01	3.547067e+00	3.759341e+00	RACK1
c2.all.v2024.1.Hs.symbols.gmt	PID_DELTA_NP63_PATHWAY	1/47	1.810327e-01	3.241495e-01	7.608246e+00	1.300308e+01	RACK1
c2.all.v2024.1.Hs.symbols.gmt	PID_ERBB_NETWORK_PATHWAY	1/15	6.170557e-02	1.980274e-01	2.443426e+01	6.805873e+01	HSP90AA1
c2.all.v2024.1.Hs.symbols.gmt	PID_FOXO_PATHWAY	1/49	1.879707e-01	3.283977e-01	7.293842e+00	1.219143e+01	GADD45A
c2.all.v2024.1.Hs.symbols.gmt	PID_FRA_PATHWAY	1/37	1.454530e-01	2.960146e-01	9.697092e+00	1.869504e+01	CXCL8
c2.all.v2024.1.Hs.symbols.gmt	PID_HDAC_CLASSII_PATHWAY	1/34	1.344840e-01	2.842285e-01	1.056692e+01	2.120053e+01	HSP90AA1
c2.all.v2024.1.Hs.symbols.gmt	PID_HIF1A_PATHWAY	2/19	2.896343e-03	3.002182e-02	3.410270e+01	1.993066e+02	HSP90AA1;RACK1
c2.all.v2024.1.Hs.symbols.gmt	PID_HIF1_TFPATHWAY	1/66	2.446439e-01	3.725015e-01	5.396620e+00	7.598181e+00	CP
c2.all.v2024.1.Hs.symbols.gmt	PID_HNF3A_PATHWAY	3/44	8.594546e-04	1.227960e-02	2.033083e+01	1.435197e+02	SFTPA2;SFTPA1;SCGB1A1
c2.all.v2024.1.Hs.symbols.gmt	PID_IGF1_PATHWAY	1/29	1.158918e-01	2.689103e-01	1.242359e+01	2.677405e+01	RACK1
c2.all.v2024.1.Hs.symbols.gmt	PID_IL2_PI3K_PATHWAY	1/34	1.344840e-01	2.842285e-01	1.056692e+01	2.120053e+01	HSP90AA1
c2.all.v2024.1.Hs.symbols.gmt	PID_IL8_CXCR1_PATHWAY	1/28	1.121262e-01	2.639902e-01	1.287594e+01	2.817422e+01	CXCL8
c2.all.v2024.1.Hs.symbols.gmt	PID_IL8_CXCR2_PATHWAY	1/34	1.344840e-01	2.842285e-01	1.056692e+01	2.120053e+01	CXCL8
c2.all.v2024.1.Hs.symbols.gmt	PID_ILK_PATHWAY	1/45	1.740360e-01	3.187349e-01	7.950910e+00	1.390211e+01	HSP90AA1
c2.all.v2024.1.Hs.symbols.gmt	PID_LKB1_PATHWAY	1/47	1.810327e-01	3.241495e-01	7.608246e+00	1.300308e+01	HSP90AA1
c2.all.v2024.1.Hs.symbols.gmt	PID_LYSOPHOSPHOLIPID_PATHWAY	1/65	2.414213e-01	3.702976e-01	5.480537e+00	7.789005e+00	CXCL8
c2.all.v2024.1.Hs.symbols.gmt	PID_MYC_ACTIV_PATHWAY	1/79	2.853253e-01	4.005306e-01	4.500255e+00	5.643885e+00	HSP90AA1
c2.all.v2024.1.Hs.symbols.gmt	PID_MYC_REPRESS_PATHWAY	1/63	2.349352e-01	3.662742e-01	5.656428e+00	8.193028e+00	GADD45A
c2.all.v2024.1.Hs.symbols.gmt	PID_NFAT_TFPATHWAY	1/45	1.740360e-01	3.187349e-01	7.950910e+00	1.390211e+01	CXCL8
c2.all.v2024.1.Hs.symbols.gmt	PID_P38_MKK3_6PATHWAY	1/26	1.045474e-01	2.529999e-01	1.388707e+01	3.135860e+01	GADD45A
c2.all.v2024.1.Hs.symbols.gmt	PID_P53_DOWNSTREAM_PATHWAY	3/137	2.051883e-02	1.144446e-01	6.246633e+00	2.427699e+01	ATF3;GADD45A;GPX1
c2.all.v2024.1.Hs.symbols.gmt	PID_P53_REGULATION_PATHWAY	1/59	2.217980e-01	3.578273e-01	6.044289e+00	9.102627e+00	RPL23
c2.all.v2024.1.Hs.symbols.gmt	PID_P73PATHWAY	1/79	2.853253e-01	4.005306e-01	4.500255e+00	5.643885e+00	RACK1
c2.all.v2024.1.Hs.symbols.gmt	PID_PI3KCI_AKT_PATHWAY	1/35	1.381557e-01	2.876176e-01	1.026017e+01	2.030872e+01	HSP90AA1
c2.all.v2024.1.Hs.symbols.gmt	PID_PI3KCI_PATHWAY	1/48	1.845090e-01	3.264510e-01	7.447734e+00	1.258710e+01	HSP90AA1
c2.all.v2024.1.Hs.symbols.gmt	PID_REG_GR_PATHWAY	2/82	4.737566e-02	1.793569e-01	7.392479e+00	2.254445e+01	HSP90AA1;CXCL8
c2.all.v2024.1.Hs.symbols.gmt	PID_SMAD2_3NUCLEAR_PATHWAY	1/82	2.944010e-01	4.075119e-01	4.334011e+00	5.299683e+00	ATF3
c2.all.v2024.1.Hs.symbols.gmt	PID_SYNDECAN_2_PATHWAY	2/33	8.605657e-03	6.530781e-02	1.893393e+01	9.003721e+01	CXCL8;RACK1
c2.all.v2024.1.Hs.symbols.gmt	PID_SYNDECAN_3_PATHWAY	1/17	6.964305e-02	2.057725e-01	2.147059e+01	5.720564e+01	CXCL8
c2.all.v2024.1.Hs.symbols.gmt	PID_TAP63_PATHWAY	1/54	2.050624e-01	3.444123e-01	6.610675e+00	1.047423e+01	GADD45A
c2.all.v2024.1.Hs.symbols.gmt	PID_TELOMERASE_PATHWAY	1/67	2.478529e-01	3.751968e-01	5.315227e+00	7.414315e+00	HSP90AA1
c2.all.v2024.1.Hs.symbols.gmt	PID_TGFBR_PATHWAY	1/54	2.050624e-01	3.444123e-01	6.610675e+00	1.047423e+01	PPP1R15A
c2.all.v2024.1.Hs.symbols.gmt	PID_TNF_PATHWAY	1/46	1.775417e-01	3.214861e-01	7.775812e+00	1.344088e+01	RACK1
c2.all.v2024.1.Hs.symbols.gmt	PID_TOLL_ENDOGENOUS_PATHWAY	1/24	9.690462e-02	2.420875e-01	1.507032e+01	3.517454e+01	SFTPA1
c2.all.v2024.1.Hs.symbols.gmt	PID_VEGFR1_2_PATHWAY	1/69	2.542306e-01	3.790744e-01	5.159569e+00	7.066100e+00	HSP90AA1
c2.all.v2024.1.Hs.symbols.gmt	PID_VEGFR1_PATHWAY	1/26	1.045474e-01	2.529999e-01	1.388707e+01	3.135860e+01	HSP90AA1
c2.all.v2024.1.Hs.symbols.gmt	PLASARI_TGFB1_SIGNALING_VIA_NFIC_1HR_DN	1/109	3.711172e-01	4.672001e-01	3.251509e+00	3.223017e+00	AKAP9
c2.all.v2024.1.Hs.symbols.gmt	PLASARI_TGFB1_TARGETS_10HR_UP	1/196	5.664105e-01	6.311604e-01	1.797407e+00	1.021711e+00	PPP1R15A
c2.all.v2024.1.Hs.symbols.gmt	PODAR_RESPONSE_TO_ADAPHOSTIN_UP	5/148	4.200797e-04	6.740664e-03	9.402235e+00	7.310300e+01	PPP1R15A;GADD45A;NEAT1;DNAAF1;ATF3
c2.all.v2024.1.Hs.symbols.gmt	POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_DN	4/61	1.309447e-04	2.651949e-03	1.906063e+01	1.704160e+02	RPS29;RPL39;RPL10A;RPL21
c2.all.v2024.1.Hs.symbols.gmt	POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_UP	1/63	2.349352e-01	3.662742e-01	5.656428e+00	8.193028e+00	HSP90AA1
c2.all.v2024.1.Hs.symbols.gmt	POMEROY_MEDULLOBLASTOMA_PROGNOSIS_DN	2/44	1.496131e-02	9.469072e-02	1.402639e+01	5.894293e+01	RPL27A;RPL10A
c2.all.v2024.1.Hs.symbols.gmt	POMEROY_MEDULLOBLASTOMA_PROGNOSIS_UP	1/48	1.845090e-01	3.264510e-01	7.447734e+00	1.258710e+01	TMSB4X
c2.all.v2024.1.Hs.symbols.gmt	POOLA_INVASIVE_BREAST_CANCER_DN	1/133	4.323453e-01	5.171286e-01	2.659651e+00	2.230199e+00	LTF
c2.all.v2024.1.Hs.symbols.gmt	POOLA_INVASIVE_BREAST_CANCER_UP	2/292	3.513779e-01	4.541713e-01	2.028981e+00	2.122097e+00	LYZ;S100P
c2.all.v2024.1.Hs.symbols.gmt	PROVENZANI_METASTASIS_DN	2/142	1.216798e-01	2.740804e-01	4.224007e+00	8.897290e+00	FTL;LCN2
c2.all.v2024.1.Hs.symbols.gmt	PUIFFE_INVASION_INHIBITED_BY_ASCITES_DN	2/146	1.273057e-01	2.774918e-01	4.106331e+00	8.463822e+00	MSMB;CXCL8
c2.all.v2024.1.Hs.symbols.gmt	PUIFFE_INVASION_INHIBITED_BY_ASCITES_UP	1/79	2.853253e-01	4.005306e-01	4.500255e+00	5.643885e+00	PABPC3
c2.all.v2024.1.Hs.symbols.gmt	PUJANA_ATM_PCC_NETWORK	8/1394	2.377266e-01	3.674956e-01	1.467964e+00	2.108927e+00	RPL10A;RPL21;RPL31;RPS27;RPL23A;RPL23;RPL13A;RPS15A
c2.all.v2024.1.Hs.symbols.gmt	PUJANA_BRCA1_PCC_NETWORK	13/1626	1.941140e-02	1.100331e-01	2.103070e+00	8.290082e+00	HSPH1;RPL10A;RPL21;RPL27A;RPL31;RPL15;HSP90AA1;RPL23A;RPL23;RPS5;RPL13A;RPL18A;RPS15A
c2.all.v2024.1.Hs.symbols.gmt	PUJANA_CHEK2_PCC_NETWORK	3/761	6.299100e-01	6.802147e-01	1.076207e+00	4.973997e-01	HSP90AA1;HSPH1;RPL23
c2.all.v2024.1.Hs.symbols.gmt	PURBEY_TARGETS_OF_CTBP1_AND_SATB1_UP	1/77	2.792107e-01	3.967531e-01	4.618329e+00	5.892011e+00	NEAT1
c2.all.v2024.1.Hs.symbols.gmt	PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_DN	1/403	8.220681e-01	8.455789e-01	8.647756e-01	1.694372e-01	AGR2
c2.all.v2024.1.Hs.symbols.gmt	PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_UP	1/296	7.177302e-01	7.527327e-01	1.183718e+00	3.925938e-01	SFTPA1
c2.all.v2024.1.Hs.symbols.gmt	PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_UP	1/195	5.645497e-01	6.294231e-01	1.806731e+00	1.032956e+00	ANKRD36B
c2.all.v2024.1.Hs.symbols.gmt	QI_PLASMACYTOMA_DN	1/98	3.409131e-01	4.450218e-01	3.620156e+00	3.895750e+00	AGR2
c2.all.v2024.1.Hs.symbols.gmt	QI_PLASMACYTOMA_UP	2/254	2.923381e-01	4.062741e-01	2.338400e+00	2.875867e+00	MMP10;TMSB4X
c2.all.v2024.1.Hs.symbols.gmt	RADMACHER_AML_PROGNOSIS	3/81	4.946121e-03	4.344205e-02	1.073012e+01	5.696782e+01	SFTPB;LCN2;S100P
c2.all.v2024.1.Hs.symbols.gmt	RAO_BOUND_BY_SALL4	1/226	6.187202e-01	6.701196e-01	1.556150e+00	7.471107e-01	UBB
c2.all.v2024.1.Hs.symbols.gmt	RAO_BOUND_BY_SALL4_ISOFORM_A	2/194	1.986112e-01	3.401501e-01	3.075676e+00	4.971542e+00	SERPINB3;CFTR
c2.all.v2024.1.Hs.symbols.gmt	RAO_BOUND_BY_SALL4_ISOFORM_B	1/526	8.956114e-01	9.100075e-01	6.586088e-01	7.261075e-02	GADD45A
c2.all.v2024.1.Hs.symbols.gmt	RASHI_NFKB1_TARGETS	1/18	7.358684e-02	2.123128e-01	2.024278e+01	5.281927e+01	LCN2
c2.all.v2024.1.Hs.symbols.gmt	RASHI_RESPONSE_TO_IONIZING_RADIATION_1	2/39	1.188044e-02	8.179077e-02	1.590018e+01	7.048330e+01	ATF3;GADD45A
c2.all.v2024.1.Hs.symbols.gmt	RASHI_RESPONSE_TO_IONIZING_RADIATION_2	3/125	1.612426e-02	9.951245e-02	6.862295e+00	2.832364e+01	ATF3;LCN2;CFTR
c2.all.v2024.1.Hs.symbols.gmt	RASHI_RESPONSE_TO_IONIZING_RADIATION_5	1/134	4.347643e-01	5.191867e-01	2.639608e+00	2.198665e+00	RPS5
c2.all.v2024.1.Hs.symbols.gmt	RASHI_RESPONSE_TO_IONIZING_RADIATION_6	1/97	3.380971e-01	4.430092e-01	3.657837e+00	3.966639e+00	LYZ
c2.all.v2024.1.Hs.symbols.gmt	RAY_ALZHEIMERS_DISEASE	1/13	5.370110e-02	1.861898e-01	2.834631e+01	8.289373e+01	CXCL8
c2.all.v2024.1.Hs.symbols.gmt	RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_DN	1/266	6.788720e-01	7.199426e-01	1.319285e+00	5.109888e-01	HSPH1
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT	2/103	7.082498e-02	2.083793e-01	5.857409e+00	1.550775e+01	UBB;CFTR
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_ABC_TRANSPORTER_DISORDERS	2/78	4.330418e-02	1.740511e-01	7.780427e+00	2.442670e+01	UBB;CFTR
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_ACTIVATED_NOTCH1_TRANSMITS_SIGNAL_TO_THE_NUCLEUS	1/31	1.233756e-01	2.740804e-01	1.160787e+01	2.428973e+01	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_ACTIVATED_TAK1_MEDIATES_P38_MAPK_ACTIVATION	1/23	9.305905e-02	2.367331e-01	1.574082e+01	3.737691e+01	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_ACTIVATION_OF_IRF3_IRF7_MEDIATED_BY_TBK1_IKK_IKBKE	1/18	7.358684e-02	2.123128e-01	2.024278e+01	5.281927e+01	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_ACTIVATION_OF_MATRIX_METALLOPROTEINASES	1/33	1.307967e-01	2.795512e-01	1.089255e+01	2.215666e+01	MMP10
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S	6/60	2.046033e-07	7.621475e-06	2.970803e+01	4.575688e+02	RPS29;RPS2;RPS27;RPS5;RPS3;RPS15A
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_ADAPTIVE_IMMUNE_SYSTEM	1/828	9.721791e-01	9.745150e-01	4.123916e-01	1.163572e-02	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT	10/260	1.562586e-07	6.268376e-06	1.083793e+01	1.698494e+02	MT-CYB;MT-CO3;UBB;MT-ND5;MT-CO2;MT-ND1;MT-ATP6;MT-ND3;MT-ND4;MT-ND2
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_AGGREPHAGY	3/44	8.594546e-04	1.227960e-02	2.033083e+01	1.435197e+02	UBB;HSP90AA1;CFTR
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_ALPHA_PROTEIN_KINASE_1_SIGNALING_PATHWAY	1/11	4.562907e-02	1.752896e-01	3.374866e+01	1.041892e+02	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_AMYLOID_FIBER_FORMATION	3/110	1.145889e-02	8.068189e-02	7.825162e+00	3.497057e+01	UBB;LYZ;LTF
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_ANCHORING_OF_THE_BASAL_BODY_TO_THE_PLASMA_MEMBRANE	2/97	6.379344e-02	2.009003e-01	6.227112e+00	1.713767e+01	HSP90AA1;AKAP9
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_ANTIGEN_PROCESSING_CROSS_PRESENTATION	1/106	3.630183e-01	4.614602e-01	3.344426e+00	3.388913e+00	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION	1/308	7.319367e-01	7.649399e-01	1.136898e+00	3.547819e-01	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_ANTIMICROBIAL_PEPTIDES	5/98	6.094914e-05	1.352552e-03	1.446303e+01	1.403705e+02	LCN2;BPIFA1;BPIFB1;LTF;LYZ
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES	1/151	4.743601e-01	5.521848e-01	2.339634e+00	1.744872e+00	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_APC_CDC20_MEDIATED_DEGRADATION_OF_NEK2A	1/26	1.045474e-01	2.529999e-01	1.388707e+01	3.135860e+01	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_APC_C_CDC20_MEDIATED_DEGRADATION_OF_CYCLIN_B	1/24	9.690462e-02	2.420875e-01	1.507032e+01	3.517454e+01	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1	1/74	2.699417e-01	3.904982e-01	4.807487e+00	6.295641e+00	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_APC_C_MEDIATED_DEGRADATION_OF_CELL_CYCLE_PROTEINS	1/88	3.122118e-01	4.209914e-01	4.035722e+00	4.697877e+00	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_APOPTOSIS	1/179	5.336793e-01	6.014344e-01	1.970116e+00	1.237155e+00	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_ARACHIDONIC_ACID_METABOLISM	1/59	2.217980e-01	3.578273e-01	6.044289e+00	9.102627e+00	GPX1
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_ASPARAGINE_N_LINKED_GLYCOSYLATION	2/307	3.742670e-01	4.694653e-01	1.928031e+00	1.894842e+00	UBB;GOLGB1
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_ASSEMBLY_OF_THE_HIV_VIRION	1/16	6.568265e-02	2.009003e-01	2.285682e+01	6.223731e+01	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_ASYMMETRIC_LOCALIZATION_OF_PCP_PROTEINS	1/64	2.381851e-01	3.674956e-01	5.567098e+00	7.987156e+00	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_ATF4_ACTIVATES_GENES_IN_RESPONSE_TO_ENDOPLASMIC_RETICULUM_STRESS	2/27	5.815765e-03	4.833341e-02	2.339534e+01	1.204201e+02	ATF3;CXCL8
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_ATTENUATION_PHASE	3/28	2.232717e-04	4.234042e-03	3.311143e+01	2.783718e+02	UBB;HSPH1;HSP90AA1
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_AUF1_HNRNP_D0_BINDS_AND_DESTABILIZES_MRNA	1/55	2.084377e-01	3.470081e-01	6.489084e+00	1.017563e+01	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_AURKA_ACTIVATION_BY_TPX2	2/72	3.746101e-02	1.619087e-01	8.444892e+00	2.773686e+01	HSP90AA1;AKAP9
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_AUTOPHAGY	3/158	2.964040e-02	1.421376e-01	5.397870e+00	1.899304e+01	UBB;HSP90AA1;CFTR
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_BACTERIAL_INFECTION_PATHWAYS	3/71	3.415670e-03	3.345112e-02	1.230214e+01	6.986856e+01	UBB;HSP90AA1;LTF
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_BETA_CATENIN_INDEPENDENT_WNT_SIGNALING	1/146	4.630082e-01	5.422993e-01	2.420585e+00	1.863876e+00	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_BINDING_AND_UPTAKE_OF_LIGANDS_BY_SCAVENGER_RECEPTORS	3/98	8.374035e-03	6.445844e-02	8.813235e+00	4.215035e+01	FTL;HSP90AA1;HSPH1
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_BUDDING_AND_MATURATION_OF_HIV_VIRION	1/28	1.121262e-01	2.639902e-01	1.287594e+01	2.817422e+01	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_CALNEXIN_CALRETICULIN_CYCLE	1/26	1.045474e-01	2.529999e-01	1.388707e+01	3.135860e+01	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_CARDIAC_CONDUCTION	1/130	4.250268e-01	5.107177e-01	2.721636e+00	2.328640e+00	AKAP9
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_CARGO_RECOGNITION_FOR_CLATHRIN_MEDIATED_ENDOCYTOSIS	2/105	7.322290e-02	2.123128e-01	5.743700e+00	1.501545e+01	UBB;CFTR
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_CELLULAR_RESPONSES_TO_STIMULI	30/828	2.857332e-20	3.506115e-18	1.261406e+01	5.676557e+02	RPS29;UBB;PPP1R15A;RPL37A;RPS2;RPL31;RPL3;RPS27;RPS3;RPL21;RPL28;RPL15;ATF3;DNAJA1;RPL13A;CXCL8;MT-CO3;RPL39;HSPH1;RPL23;RPS5;RPL18A;RPS15A;MT-CO2;GPX1;RPL10A;RPL27A;HSP90AA1;RPL23A;RPL32
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_CELLULAR_RESPONSE_TO_CHEMICAL_STRESS	4/210	1.225607e-02	8.365174e-02	5.271561e+00	2.320401e+01	MT-CO3;UBB;GPX1;MT-CO2
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS	3/101	9.092376e-03	6.793272e-02	8.543647e+00	4.015786e+01	UBB;HSPH1;HSP90AA1
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_CELLULAR_RESPONSE_TO_HYPOXIA	1/75	2.730444e-01	3.925366e-01	4.742741e+00	6.156651e+00	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_CELLULAR_RESPONSE_TO_STARVATION	21/157	5.385507e-26	9.361807e-24	4.706524e+01	2.738420e+03	RPS29;RPL37A;RPS2;RPL31;RPL3;RPS27;RPS3;RPL21;RPL28;RPL15;ATF3;RPL13A;RPL39;RPL23;RPS5;RPL18A;RPS15A;RPL10A;RPL27A;RPL23A;RPL32
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_CELLULAR_SENESCENCE	2/197	2.032330e-01	3.444123e-01	3.028064e+00	4.824924e+00	UBB;CXCL8
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_CELL_CELL_COMMUNICATION	2/155	1.401813e-01	2.915436e-01	3.863985e+00	7.592029e+00	SFTPA2;SFTPA1
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_CELL_CYCLE	5/694	1.715046e-01	3.185740e-01	1.908147e+00	3.364341e+00	UBB;SYNE2;AKAP9;HSP90AA1;RPS27
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_CELL_CYCLE_CHECKPOINTS	2/291	3.498418e-01	4.527109e-01	2.036083e+00	2.138445e+00	UBB;RPS27
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_CELL_CYCLE_MITOTIC	4/561	2.143584e-01	3.519958e-01	1.921299e+00	2.959004e+00	UBB;RPS27;HSP90AA1;AKAP9
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_CELL_DEATH_SIGNALLING_VIA_NRAGE_NRIF_AND_NADE	1/76	2.761341e-01	3.945313e-01	4.679711e+00	6.022174e+00	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_CHAPERONE_MEDIATED_AUTOPHAGY	3/22	1.069075e-04	2.198395e-03	4.331134e+01	3.960192e+02	UBB;HSP90AA1;CFTR
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_CHEMOKINE_RECEPTORS_BIND_CHEMOKINES	1/57	2.151460e-01	3.519958e-01	6.258814e+00	9.616282e+00	CXCL8
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_CHROMATIN_MODIFYING_ENZYMES	1/272	6.870453e-01	7.263945e-01	1.289775e+00	4.841235e-01	RPS2
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_CILIUM_ASSEMBLY	2/201	2.094146e-01	3.480788e-01	2.966809e+00	4.638425e+00	HSP90AA1;AKAP9
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_CIRCADIAN_CLOCK	1/70	2.573993e-01	3.818884e-01	5.085100e+00	6.901124e+00	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS	1/330	7.561689e-01	7.867174e-01	1.059919e+00	2.962373e-01	CXCL8
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION	1/381	8.043228e-01	8.306027e-01	9.157034e-01	1.993986e-01	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_CLATHRIN_MEDIATED_ENDOCYTOSIS	2/145	1.258934e-01	2.774918e-01	4.135135e+00	8.569324e+00	UBB;CFTR
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_CLEC7A_DECTIN_1_SIGNALING	1/100	3.465095e-01	4.500740e-01	3.547067e+00	3.759341e+00	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_COBALAMIN_CBL_VITAMIN_B12_TRANSPORT_AND_METABOLISM	1/22	8.919728e-02	2.334470e-01	1.647370e+01	3.981536e+01	TCN1
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_COLLAGEN_DEGRADATION	1/64	2.381851e-01	3.674956e-01	5.567098e+00	7.987156e+00	MMP10
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_COMPLEX_III_ASSEMBLY	1/25	1.007341e-01	2.483821e-01	1.445455e+01	3.317710e+01	MT-CYB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_COMPLEX_IV_ASSEMBLY	2/48	1.764599e-02	1.039817e-01	1.281749e+01	5.174739e+01	MT-CO3;MT-CO2
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_COMPLEX_I_BIOGENESIS	5/68	1.033925e-05	2.662677e-04	2.132499e+01	2.448016e+02	MT-ND5;MT-ND1;MT-ND3;MT-ND4;MT-ND2
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_CONSTITUTIVE_SIGNALING_BY_EGFRVIII	1/15	6.170557e-02	1.980274e-01	2.443426e+01	6.805873e+01	HSP90AA1
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_CONSTITUTIVE_SIGNALING_BY_LIGAND_RESPONSIVE_EGFR_CANCER_VARIANTS	2/19	2.896343e-03	3.002182e-02	3.410270e+01	1.993066e+02	UBB;HSP90AA1
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_CONSTITUTIVE_SIGNALING_BY_OVEREXPRESSED_ERBB2	1/11	4.562907e-02	1.752896e-01	3.374866e+01	1.041892e+02	HSP90AA1
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_COPI_MEDIATED_ANTEROGRADE_TRANSPORT	1/102	3.520590e-01	4.541713e-01	3.476858e+00	3.629689e+00	GOLGB1
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_CRISTAE_FORMATION	1/33	1.307967e-01	2.795512e-01	1.089255e+01	2.215666e+01	MT-ATP6
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY	1/85	3.033627e-01	4.138748e-01	4.179572e+00	4.985502e+00	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_CYCLIN_D_ASSOCIATED_EVENTS_IN_G1	1/47	1.810327e-01	3.241495e-01	7.608246e+00	1.300308e+01	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM	5/789	2.425939e-01	3.715499e-01	1.669636e+00	2.364817e+00	UBB;MUC1;LCN2;HSP90AA1;CXCL8
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_CYTOPROTECTION_BY_HMOX1	2/60	2.679926e-02	1.359365e-01	1.018272e+01	3.685515e+01	MT-CO3;MT-CO2
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_CYTOSOLIC_SENSORS_OF_PATHOGEN_ASSOCIATED_DNA	1/64	2.381851e-01	3.674956e-01	5.567098e+00	7.987156e+00	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_C_TYPE_LECTIN_RECEPTORS_CLRS	2/140	1.188908e-01	2.710169e-01	4.285394e+00	9.125961e+00	UBB;MUC1
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_DDX58_IFIH1_MEDIATED_INDUCTION_OF_INTERFERON_ALPHA_BETA	2/82	4.737566e-02	1.793569e-01	7.392479e+00	2.254445e+01	UBB;HSP90AA1
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_DEACTIVATION_OF_THE_BETA_CATENIN_TRANSACTIVATING_COMPLEX	1/42	1.634300e-01	3.095469e-01	8.526835e+00	1.544526e+01	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_DEATH_RECEPTOR_SIGNALING	3/154	2.776261e-02	1.388796e-01	5.541398e+00	1.986073e+01	UBB;RACK1;LINGO1
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_DECTIN_1_MEDIATED_NONCANONICAL_NF_KB_SIGNALING	1/62	2.316716e-01	3.644548e-01	5.748663e+00	8.407042e+00	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_DECTIN_2_FAMILY	1/26	1.045474e-01	2.529999e-01	1.388707e+01	3.135860e+01	MUC1
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_DEFECTIVE_C1GALT1C1_CAUSES_TNPS	1/17	6.964305e-02	2.057725e-01	2.147059e+01	5.720564e+01	MUC1
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_DEFECTIVE_CFTR_CAUSES_CYSTIC_FIBROSIS	2/61	2.763254e-02	1.388796e-01	1.001113e+01	3.592755e+01	UBB;CFTR
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_DEFECTIVE_CSF2RB_CAUSES_SMDP5	4/8	2.085567e-08	1.061096e-06	2.441381e+02	4.317739e+03	SFTPA2;SFTPC;SFTPA1;SFTPB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_DEFECTIVE_GALNT3_CAUSES_HFTC	1/16	6.568265e-02	2.009003e-01	2.285682e+01	6.223731e+01	MUC1
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_DEGRADATION_OF_AXIN	1/55	2.084377e-01	3.470081e-01	6.489084e+00	1.017563e+01	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_DEGRADATION_OF_BETA_CATENIN_BY_THE_DESTRUCTION_COMPLEX	1/85	3.033627e-01	4.138748e-01	4.179572e+00	4.985502e+00	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_DEGRADATION_OF_DVL	1/57	2.151460e-01	3.519958e-01	6.258814e+00	9.616282e+00	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_DEGRADATION_OF_GLI1_BY_THE_PROTEASOME	1/60	2.251031e-01	3.589947e-01	5.942435e+00	8.861339e+00	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX	1/140	4.490652e-01	5.307366e-01	2.525387e+00	2.021792e+00	MMP10
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_DETOXIFICATION_OF_REACTIVE_OXYGEN_SPECIES	1/37	1.454530e-01	2.960146e-01	9.697092e+00	1.869504e+01	GPX1
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_DEUBIQUITINATION	2/299	3.620964e-01	4.614602e-01	1.980604e+00	2.011986e+00	UBB;CFTR
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_DEVELOPMENTAL_BIOLOGY	22/1432	9.806539e-08	4.261759e-06	4.551981e+00	7.345819e+01	RPS29;UBB;RPL37A;RPS2;RPL31;RPL3;RPS27;RPS3;RPL21;RPL28;RPL15;RPL13A;RPL39;RPL23;RPS5;RPL18A;RPS15A;RPL10A;RPL27A;HSP90AA1;RPL23A;RPL32
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS	1/68	2.510485e-01	3.775682e-01	5.236245e+00	7.237062e+00	MUC1
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_DISEASES_ASSOCIATED_WITH_SURFACTANT_METABOLISM	4/10	6.216180e-08	2.818903e-06	1.690034e+02	2.804362e+03	SFTPA2;SFTPC;SFTPA1;SFTPB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_DISEASES_OF_CARBOHYDRATE_METABOLISM	1/34	1.344840e-01	2.842285e-01	1.056692e+01	2.120053e+01	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_DISEASES_OF_GLYCOSYLATION	1/143	4.560809e-01	5.372020e-01	2.471883e+00	1.940638e+00	MUC1
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_DISEASES_OF_METABOLISM	6/250	6.854240e-04	1.043646e-02	6.564960e+00	4.782884e+01	UBB;SFTPA1;MUC1;SFTPB;SFTPA2;SFTPC
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_DISEASES_OF_SIGNAL_TRANSDUCTION_BY_GROWTH_FACTOR_RECEPTORS_AND_SECOND_MESSENGERS	4/464	1.343349e-01	2.842285e-01	2.336477e+00	4.690289e+00	UBB;HSP90AA1;GOLGB1;AKAP9
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_DISORDERS_OF_TRANSMEMBRANE_TRANSPORTERS	3/177	3.945262e-02	1.669334e-01	4.805972e+00	1.553605e+01	UBB;CP;CFTR
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_DNA_DAMAGE_BYPASS	1/48	1.845090e-01	3.264510e-01	7.447734e+00	1.258710e+01	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_DNA_DAMAGE_RECOGNITION_IN_GG_NER	1/38	1.490787e-01	3.001720e-01	9.438075e+00	1.796331e+01	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_DNA_DOUBLE_STRAND_BREAK_REPAIR	1/170	5.153733e-01	5.858685e-01	2.075576e+00	1.375824e+00	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_DNA_DOUBLE_STRAND_BREAK_RESPONSE	1/78	2.822744e-01	3.988105e-01	4.558530e+00	5.765973e+00	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_DNA_REPAIR	1/332	7.582612e-01	7.885010e-01	1.053428e+00	2.915122e-01	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_DNA_REPLICATION	1/187	5.493760e-01	6.144763e-01	1.884919e+00	1.129014e+00	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_DNA_REPLICATION_PRE_INITIATION	1/159	4.920314e-01	5.664335e-01	2.220736e+00	1.574974e+00	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_DOWNREGULATION_OF_ERBB2_ERBB3_SIGNALING	1/13	5.370110e-02	1.861898e-01	2.834631e+01	8.289373e+01	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_DOWNREGULATION_OF_ERBB2_SIGNALING	2/29	6.690229e-03	5.347057e-02	2.169189e+01	1.086136e+02	UBB;HSP90AA1
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_DOWNREGULATION_OF_ERBB4_SIGNALING	1/9	3.748893e-02	1.619087e-01	4.169330e+01	1.369087e+02	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_DOWNREGULATION_OF_SMAD2_3_SMAD4_TRANSCRIPTIONAL_ACTIVITY	1/31	1.233756e-01	2.740804e-01	1.160787e+01	2.428973e+01	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_DOWNREGULATION_OF_TGF_BETA_RECEPTOR_SIGNALING	2/26	5.399779e-03	4.578837e-02	2.435135e+01	1.271481e+02	PPP1R15A;UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_DOWNSTREAM_SIGNALING_EVENTS_OF_B_CELL_RECEPTOR_BCR	1/81	2.913885e-01	4.054946e-01	4.388049e+00	5.410894e+00	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_DUAL_INCISION_IN_GG_NER	1/41	1.598648e-01	3.051033e-01	8.737770e+00	1.602006e+01	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_DUAL_INCISION_IN_TC_NER	1/63	2.349352e-01	3.662742e-01	5.656428e+00	8.193028e+00	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_E3_UBIQUITIN_LIGASES_UBIQUITINATE_TARGET_PROTEINS	1/59	2.217980e-01	3.578273e-01	6.044289e+00	9.102627e+00	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_EGFR_DOWNREGULATION	1/31	1.233756e-01	2.740804e-01	1.160787e+01	2.428973e+01	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_ENDOSOMAL_SORTING_COMPLEX_REQUIRED_FOR_TRANSPORT_ESCRT	1/31	1.233756e-01	2.740804e-01	1.160787e+01	2.428973e+01	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_ENOS_ACTIVATION	1/10	4.156755e-02	1.693553e-01	3.730284e+01	1.186393e+02	HSP90AA1
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_ER_QUALITY_CONTROL_COMPARTMENT_ERQC	1/21	8.531924e-02	2.270101e-01	1.727807e+01	4.252748e+01	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_ER_TO_GOLGI_ANTEROGRADE_TRANSPORT	1/156	4.854746e-01	5.613637e-01	2.263889e+00	1.635950e+00	GOLGB1
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_ESR_MEDIATED_SIGNALING	1/220	6.087838e-01	6.624533e-01	1.599125e+00	7.936334e-01	HSP90AA1
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_ESTROGEN_DEPENDENT_GENE_EXPRESSION	1/149	4.698481e-01	5.484629e-01	2.371361e+00	1.791197e+00	HSP90AA1
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_EUKARYOTIC_TRANSLATION_ELONGATION	20/94	4.215668e-29	1.758777e-26	8.134809e+01	5.314972e+03	RPS29;RPL37A;RPS2;RPL31;RPL3;RPS27;RPS3;RPL21;RPL28;RPL15;RPL13A;RPL39;RPL23;RPS5;RPL18A;RPS15A;RPL10A;RPL27A;RPL23A;RPL32
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_EUKARYOTIC_TRANSLATION_INITIATION	20/120	8.460008e-27	1.764758e-24	6.023163e+01	3.615972e+03	RPS29;RPL37A;RPS2;RPL31;RPL3;RPS27;RPS3;RPL21;RPL28;RPL15;RPL13A;RPL39;RPL23;RPS5;RPL18A;RPS15A;RPL10A;RPL27A;RPL23A;RPL32
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_EVASION_BY_RSV_OF_HOST_INTERFERON_RESPONSES	1/35	1.381557e-01	2.876176e-01	1.026017e+01	2.030872e+01	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION	1/300	7.225466e-01	7.562630e-01	1.167695e+00	3.794697e-01	MMP10
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_EXTRA_NUCLEAR_ESTROGEN_SIGNALING	1/75	2.730444e-01	3.925366e-01	4.742741e+00	6.156651e+00	HSP90AA1
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_FANCONI_ANEMIA_PATHWAY	1/39	1.526892e-01	3.016190e-01	9.192513e+00	1.727596e+01	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_FATTY_ACID_METABOLISM	1/176	5.276546e-01	5.965786e-01	2.004068e+00	1.281227e+00	GPX1
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_FCERI_MEDIATED_NF_KB_ACTIVATION	1/136	4.395716e-01	5.233712e-01	2.600410e+00	2.137420e+00	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_FCGAMMA_RECEPTOR_FCGR_DEPENDENT_PHAGOCYTOSIS	1/143	4.560809e-01	5.372020e-01	2.471883e+00	1.940638e+00	HSP90AA1
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_FC_EPSILON_RECEPTOR_FCERI_SIGNALING	1/186	5.474428e-01	6.129714e-01	1.895167e+00	1.141833e+00	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_FLT3_SIGNALING	1/38	1.490787e-01	3.001720e-01	9.438075e+00	1.796331e+01	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_FLT3_SIGNALING_BY_CBL_MUTANTS	1/7	2.928011e-02	1.409738e-01	5.452694e+01	1.925263e+02	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_FLT3_SIGNALING_IN_DISEASE	2/28	6.245956e-03	5.069675e-02	2.251147e+01	1.142642e+02	UBB;GOLGB1
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_FORMATION_OF_ATP_BY_CHEMIOSMOTIC_COUPLING	1/20	8.142487e-02	2.220291e-01	1.816495e+01	4.555906e+01	MT-ATP6
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_FORMATION_OF_INCISION_COMPLEX_IN_GG_NER	1/43	1.669802e-01	3.123952e-01	8.325826e+00	1.490223e+01	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_FORMATION_OF_TC_NER_PRE_INCISION_COMPLEX	1/51	1.948505e-01	3.350851e-01	7.004342e+00	1.145576e+01	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_FOXO_MEDIATED_TRANSCRIPTION	1/66	2.446439e-01	3.725015e-01	5.396620e+00	7.598181e+00	GADD45A
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_FOXO_MEDIATED_TRANSCRIPTION_OF_CELL_CYCLE_GENES	1/17	6.964305e-02	2.057725e-01	2.147059e+01	5.720564e+01	GADD45A
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_G1_S_DNA_DAMAGE_CHECKPOINTS	1/68	2.510485e-01	3.775682e-01	5.236245e+00	7.237062e+00	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_G2_M_CHECKPOINTS	1/167	5.091146e-01	5.803351e-01	2.113263e+00	1.426626e+00	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_GAMMA_CARBOXYLATION_HYPUSINYLATION_HYDROXYLATION_AND_ARYLSULFATASE_ACTIVATION	1/61	2.283943e-01	3.623045e-01	5.843947e+00	8.629651e+00	RPL27A
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_GAP_FILLING_DNA_REPAIR_SYNTHESIS_AND_LIGATION_IN_GG_NER	1/25	1.007341e-01	2.483821e-01	1.445455e+01	3.317710e+01	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_GENE_SILENCING_BY_RNA	1/139	4.467069e-01	5.291485e-01	2.543736e+00	2.049877e+00	HSP90AA1
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_GLOBAL_GENOME_NUCLEOTIDE_EXCISION_REPAIR_GG_NER	1/84	3.003881e-01	4.122431e-01	4.229818e+00	5.087119e+00	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_GLYCOGEN_METABOLISM	1/25	1.007341e-01	2.483821e-01	1.445455e+01	3.317710e+01	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_GLYCOGEN_STORAGE_DISEASES	1/16	6.568265e-02	2.009003e-01	2.285682e+01	6.223731e+01	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_GLYCOGEN_SYNTHESIS	1/14	5.771174e-02	1.926187e-01	2.624540e+01	7.485960e+01	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_GOLGI_ASSOCIATED_VESICLE_BIOGENESIS	2/56	2.357182e-02	1.254358e-01	1.093206e+01	4.097012e+01	FTL;GOLGB1
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_GPCR_LIGAND_BINDING	1/463	8.627722e-01	8.796397e-01	7.505073e-01	1.107783e-01	CXCL8
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_G_ALPHA_I_SIGNALLING_EVENTS	1/314	7.387723e-01	7.709250e-01	1.114833e+00	3.375328e-01	CXCL8
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_HDR_THROUGH_HOMOLOGOUS_RECOMBINATION_HRR	1/70	2.573993e-01	3.818884e-01	5.085100e+00	6.901124e+00	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_HEDGEHOG_LIGAND_BIOGENESIS	1/65	2.414213e-01	3.702976e-01	5.480537e+00	7.789005e+00	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_HEDGEHOG_OFF_STATE	1/113	3.817576e-01	4.765687e-01	3.135330e+00	3.019227e+00	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_HEDGEHOG_ON_STATE	1/86	3.063248e-01	4.155997e-01	4.130500e+00	4.886833e+00	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_HEMOSTASIS	1/679	9.464550e-01	9.533101e-01	5.064766e-01	2.787232e-02	TMSB4X
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_HIV_INFECTION	1/231	6.268096e-01	6.774740e-01	1.522046e+00	7.109666e-01	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_HIV_LIFE_CYCLE	1/149	4.698481e-01	5.484629e-01	2.371361e+00	1.791197e+00	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_HOMOLOGY_DIRECTED_REPAIR	1/140	4.490652e-01	5.307366e-01	2.525387e+00	2.021792e+00	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_HOST_INTERACTIONS_OF_HIV_FACTORS	1/131	4.274766e-01	5.130704e-01	2.700658e+00	2.295169e+00	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_HSF1_ACTIVATION	3/31	3.035454e-04	5.258631e-03	2.962199e+01	2.399375e+02	UBB;HSPH1;HSP90AA1
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_HSF1_DEPENDENT_TRANSACTIVATION	3/38	5.575907e-04	8.680106e-03	2.377349e+01	1.781083e+02	UBB;HSPH1;HSP90AA1
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_HSP90_CHAPERONE_CYCLE_FOR_STEROID_HORMONE_RECEPTORS_SHR_IN_THE_PRESENCE_OF_LIGAND	2/57	2.436262e-02	1.276895e-01	1.073460e+01	3.987587e+01	HSP90AA1;DNAJA1
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_IKK_COMPLEX_RECRUITMENT_MEDIATED_BY_RIP1	1/23	9.305905e-02	2.367331e-01	1.574082e+01	3.737691e+01	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_INACTIVATION_OF_CSF3_G_CSF_SIGNALING	1/25	1.007341e-01	2.483821e-01	1.445455e+01	3.317710e+01	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_INFECTION_WITH_MYCOBACTERIUM_TUBERCULOSIS	2/27	5.815765e-03	4.833341e-02	2.339534e+01	1.204201e+02	UBB;LTF
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_INFECTIOUS_DISEASE	23/1081	9.359251e-11	6.507799e-09	6.533216e+00	1.508655e+02	RPS29;UBB;LTF;RPL37A;RPS2;RPL31;RPL3;RPS27;RPS3;RPL21;RPL28;RPL15;RPL13A;RPL39;RPL23;RPS5;RPL18A;RPS15A;RPL10A;RPL27A;HSP90AA1;RPL23A;RPL32
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_INFLUENZA_INFECTION	21/157	5.385507e-26	9.361807e-24	4.706524e+01	2.738420e+03	RPS29;RPL37A;RPS2;RPL31;RPL3;RPS27;RPS3;RPL21;RPL28;RPL15;RPL13A;RPL39;RPL23;RPS5;RPL18A;RPS15A;RPL10A;RPL27A;HSP90AA1;RPL23A;RPL32
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_INLA_MEDIATED_ENTRY_OF_LISTERIA_MONOCYTOGENES_INTO_HOST_CELLS	1/9	3.748893e-02	1.619087e-01	4.169330e+01	1.369087e+02	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_INLB_MEDIATED_ENTRY_OF_LISTERIA_MONOCYTOGENES_INTO_HOST_CELL	1/15	6.170557e-02	1.980274e-01	2.443426e+01	6.805873e+01	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_INNATE_IMMUNE_SYSTEM	14/1128	2.751919e-04	4.823952e-03	3.391491e+00	2.780359e+01	TCN1;UBB;SFTPA1;LCN2;LTF;BPIFA1;MUC1;BPIFB1;SERPINB3;SFTPA2;HSP90AA1;LYZ;FTL;S100P
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_INTERFERON_ALPHA_BETA_SIGNALING	1/78	2.822744e-01	3.988105e-01	4.558530e+00	5.765973e+00	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_INTERFERON_SIGNALING	1/273	6.883873e-01	7.274448e-01	1.284983e+00	4.798172e-01	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_INTERLEUKIN_10_SIGNALING	1/45	1.740360e-01	3.187349e-01	7.950910e+00	1.390211e+01	CXCL8
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_INTERLEUKIN_17_SIGNALING	1/71	2.605548e-01	3.835690e-01	5.012743e+00	6.741850e+00	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_INTERLEUKIN_1_FAMILY_SIGNALING	1/152	4.766019e-01	5.541759e-01	2.324085e+00	1.722319e+00	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_INTERLEUKIN_1_SIGNALING	1/114	3.843897e-01	4.792809e-01	3.107564e+00	2.971137e+00	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_INTERLEUKIN_3_INTERLEUKIN_5_AND_GM_CSF_SIGNALING	1/48	1.845090e-01	3.264510e-01	7.447734e+00	1.258710e+01	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_INTERLEUKIN_4_AND_INTERLEUKIN_13_SIGNALING	4/111	1.279111e-03	1.624977e-02	1.017209e+01	6.776232e+01	HSP90AA1;MUC1;CXCL8;LCN2
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_INTRACELLULAR_SIGNALING_BY_SECOND_MESSENGERS	1/313	7.376451e-01	7.701340e-01	1.118451e+00	3.403362e-01	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_ION_CHANNEL_TRANSPORT	1/183	5.415941e-01	6.083819e-01	1.926584e+00	1.181456e+00	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_IRAK1_RECRUITS_IKK_COMPLEX	1/14	5.771174e-02	1.926187e-01	2.624540e+01	7.485960e+01	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_IRAK2_MEDIATED_ACTIVATION_OF_TAK1_COMPLEX	1/10	4.156755e-02	1.693553e-01	3.730284e+01	1.186393e+02	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_IRON_UPTAKE_AND_TRANSPORT	4/58	1.074958e-04	2.198395e-03	2.011258e+01	1.837899e+02	FTL;UBB;CP;LCN2
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_ISG15_ANTIVIRAL_MECHANISM	1/74	2.699417e-01	3.904982e-01	4.807487e+00	6.295641e+00	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_JNK_C_JUN_KINASES_PHOSPHORYLATION_AND_ACTIVATION_MEDIATED_BY_ACTIVATED_HUMAN_TAK1	1/22	8.919728e-02	2.334470e-01	1.647370e+01	3.981536e+01	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_JOSEPHIN_DOMAIN_DUBS	1/12	4.967357e-02	1.805210e-01	3.081260e+01	9.250813e+01	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_KEAP1_NFE2L2_PATHWAY	1/125	4.126214e-01	5.015899e-01	2.831583e+00	2.506587e+00	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_LATE_ENDOSOMAL_MICROAUTOPHAGY	2/34	9.118486e-03	6.793272e-02	1.835052e+01	8.620068e+01	UBB;CFTR
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_LATE_SARS_COV_2_INFECTION_EVENTS	1/70	2.573993e-01	3.818884e-01	5.085100e+00	6.901124e+00	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_LISTERIA_MONOCYTOGENES_ENTRY_INTO_HOST_CELLS	1/20	8.142487e-02	2.220291e-01	1.816495e+01	4.555906e+01	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_MAP3K8_TPL2_DEPENDENT_MAPK1_3_ACTIVATION	1/16	6.568265e-02	2.009003e-01	2.285682e+01	6.223731e+01	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_MAPK6_MAPK4_SIGNALING	2/93	5.924721e-02	1.961741e-01	6.500517e+00	1.837070e+01	MMP10;UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_MAPK_FAMILY_SIGNALING_CASCADES	2/327	4.042743e-01	4.960683e-01	1.807905e+00	1.637350e+00	MMP10;UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_MATERNAL_TO_ZYGOTIC_TRANSITION_MZT	1/128	4.200961e-01	5.065436e-01	2.764580e+00	2.397642e+00	RPS2
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_MEIOSIS	1/120	3.999512e-01	4.927929e-01	2.950731e+00	2.704087e+00	SYNE2
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_MEIOTIC_SYNAPSIS	1/78	2.822744e-01	3.988105e-01	4.558530e+00	5.765973e+00	SYNE2
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_MEMBRANE_TRAFFICKING	4/630	2.777387e-01	3.962811e-01	1.704219e+00	2.183232e+00	FTL;UBB;GOLGB1;CFTR
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES	20/366	5.877463e-17	6.130193e-15	1.727442e+01	6.455939e+02	RPS29;RPL37A;RPS2;RPL31;RPL3;RPS27;RPS3;RPL21;RPL28;RPL15;RPL13A;RPL39;RPL23;RPS5;RPL18A;RPS15A;RPL10A;RPL27A;RPL23A;RPL32
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_METABOLISM_OF_CARBOHYDRATES	1/288	7.078480e-01	7.457429e-01	1.217103e+00	4.205406e-01	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_METABOLISM_OF_COFACTORS	1/25	1.007341e-01	2.483821e-01	1.445455e+01	3.317710e+01	HSP90AA1
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_METABOLISM_OF_LIPIDS	1/757	9.619712e-01	9.661396e-01	4.526015e-01	1.754770e-02	GPX1
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_METABOLISM_OF_NITRIC_OXIDE_NOS3_ACTIVATION_AND_REGULATION	1/14	5.771174e-02	1.926187e-01	2.624540e+01	7.485960e+01	HSP90AA1
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_METABOLISM_OF_RNA	21/724	2.320441e-12	1.792755e-10	8.896301e+00	2.383254e+02	RPS29;UBB;RPL37A;RPS2;RPL31;RPL3;RPS27;RPS3;RPL21;RPL28;RPL15;RPL13A;RPL39;RPL23;RPS5;RPL18A;RPS15A;RPL10A;RPL27A;RPL23A;RPL32
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_METABOLISM_OF_VITAMINS_AND_COFACTORS	2/198	2.047764e-01	3.444123e-01	3.012516e+00	4.777358e+00	TCN1;HSP90AA1
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_METABOLISM_OF_WATER_SOLUBLE_VITAMINS_AND_COFACTORS	1/127	4.176151e-01	5.044268e-01	2.786561e+00	2.433212e+00	TCN1
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_METALLOPROTEASE_DUBS	1/37	1.454530e-01	2.960146e-01	9.697092e+00	1.869504e+01	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_METAL_ION_SLC_TRANSPORTERS	1/24	9.690462e-02	2.420875e-01	1.507032e+01	3.517454e+01	CP
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_METAL_SEQUESTRATION_BY_ANTIMICROBIAL_PROTEINS	2/6	2.633436e-04	4.735645e-03	1.326997e+02	1.093718e+03	LCN2;LTF
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_MISCELLANEOUS_TRANSPORT_AND_BINDING_EVENTS	1/26	1.045474e-01	2.529999e-01	1.388707e+01	3.135860e+01	PIP
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_MITOCHONDRIAL_BIOGENESIS	1/96	3.352693e-01	4.401332e-01	3.696307e+00	4.039403e+00	MT-ATP6
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_MITOCHONDRIAL_PROTEIN_DEGRADATION	5/98	6.094914e-05	1.352552e-03	1.446303e+01	1.403705e+02	MT-CO2;MT-ND5;MT-ND1;MT-ATP6;MT-ND2
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_MITOPHAGY	1/39	1.526892e-01	3.016190e-01	9.192513e+00	1.727596e+01	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_MITOTIC_G1_PHASE_AND_G1_S_TRANSITION	1/149	4.698481e-01	5.484629e-01	2.371361e+00	1.791197e+00	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_MITOTIC_G2_G2_M_PHASES	3/200	5.325858e-02	1.861898e-01	4.241834e+00	1.243959e+01	UBB;HSP90AA1;AKAP9
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_MITOTIC_METAPHASE_AND_ANAPHASE	2/236	2.640951e-01	3.857860e-01	2.519968e+00	3.355201e+00	UBB;RPS27
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_MITOTIC_PROMETAPHASE	3/204	5.586844e-02	1.912125e-01	4.156870e+00	1.199155e+01	HSP90AA1;RPS27;AKAP9
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_MITOTIC_SPINDLE_CHECKPOINT	1/111	3.764599e-01	4.713657e-01	3.192368e+00	3.118764e+00	RPS27
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_MODULATION_BY_MTB_OF_HOST_IMMUNE_SYSTEM	1/7	2.928011e-02	1.409738e-01	5.452694e+01	1.925263e+02	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_MUSCLE_CONTRACTION	1/203	5.792178e-01	6.406406e-01	1.734720e+00	9.472902e-01	AKAP9
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_MYD88_INDEPENDENT_TLR4_CASCADE	1/109	3.711172e-01	4.672001e-01	3.251509e+00	3.223017e+00	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_MYOCLONIC_EPILEPSY_OF_LAFORA	1/9	3.748893e-02	1.619087e-01	4.169330e+01	1.369087e+02	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_M_DECAY_DEGRADATION_OF_MATERNAL_MRNAS_BY_MATERNALLY_STORED_FACTORS	1/33	1.307967e-01	2.795512e-01	1.089255e+01	2.215666e+01	RPS2
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_M_PHASE	4/417	1.010929e-01	2.489156e-01	2.607701e+00	5.976108e+00	UBB;RPS27;HSP90AA1;AKAP9
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_NEDDYLATION	1/245	6.485674e-01	6.963003e-01	1.433975e+00	6.208960e-01	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_NEGATIVE_REGULATION_OF_FGFR1_SIGNALING	1/33	1.307967e-01	2.795512e-01	1.089255e+01	2.215666e+01	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_NEGATIVE_REGULATION_OF_FGFR2_SIGNALING	1/34	1.344840e-01	2.842285e-01	1.056692e+01	2.120053e+01	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_NEGATIVE_REGULATION_OF_FGFR3_SIGNALING	1/29	1.158918e-01	2.689103e-01	1.242359e+01	2.677405e+01	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_NEGATIVE_REGULATION_OF_FGFR4_SIGNALING	1/31	1.233756e-01	2.740804e-01	1.160787e+01	2.428973e+01	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_NEGATIVE_REGULATION_OF_FLT3	1/15	6.170557e-02	1.980274e-01	2.443426e+01	6.805873e+01	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_NEGATIVE_REGULATION_OF_MAPK_PATHWAY	1/43	1.669802e-01	3.123952e-01	8.325826e+00	1.490223e+01	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_NEGATIVE_REGULATION_OF_MET_ACTIVITY	1/21	8.531924e-02	2.270101e-01	1.727807e+01	4.252748e+01	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_NEGATIVE_REGULATION_OF_NOTCH4_SIGNALING	1/54	2.050624e-01	3.444123e-01	6.610675e+00	1.047423e+01	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_NEGATIVE_REGULATORS_OF_DDX58_IFIH1_SIGNALING	1/35	1.381557e-01	2.876176e-01	1.026017e+01	2.030872e+01	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_NERVOUS_SYSTEM_DEVELOPMENT	22/575	2.332730e-15	2.317178e-13	1.208046e+01	4.070117e+02	RPS29;UBB;RPL37A;RPS2;RPL31;RPL3;RPS27;RPS3;RPL21;RPL28;RPL15;RPL13A;RPL39;RPL23;RPS5;RPL18A;RPS15A;RPL10A;RPL27A;HSP90AA1;RPL23A;RPL32
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_NEUTROPHIL_DEGRANULATION	8/478	9.640261e-04	1.331761e-02	4.517203e+00	3.136923e+01	TCN1;LCN2;LTF;SERPINB3;HSP90AA1;LYZ;FTL;S100P
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_NF_KB_IS_ACTIVATED_AND_SIGNALS_SURVIVAL	1/13	5.370110e-02	1.861898e-01	2.834631e+01	8.289373e+01	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_NOD1_2_SIGNALING_PATHWAY	1/36	1.418120e-01	2.920236e-01	9.970701e+00	1.947530e+01	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_NONSENSE_MEDIATED_DECAY_NMD	20/116	4.090323e-27	1.066552e-24	6.273968e+01	3.812137e+03	RPS29;RPL37A;RPS2;RPL31;RPL3;RPS27;RPS3;RPL21;RPL28;RPL15;RPL13A;RPL39;RPL23;RPS5;RPL18A;RPS15A;RPL10A;RPL27A;RPL23A;RPL32
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_NOTCH1_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION	1/48	1.845090e-01	3.264510e-01	7.447734e+00	1.258710e+01	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_NOTCH2_ACTIVATION_AND_TRANSMISSION_OF_SIGNAL_TO_THE_NUCLEUS	1/22	8.919728e-02	2.334470e-01	1.647370e+01	3.981536e+01	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_NOTCH3_ACTIVATION_AND_TRANSMISSION_OF_SIGNAL_TO_THE_NUCLEUS	1/25	1.007341e-01	2.483821e-01	1.445455e+01	3.317710e+01	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_NRIF_SIGNALS_CELL_DEATH_FROM_THE_NUCLEUS	1/16	6.568265e-02	2.009003e-01	2.285682e+01	6.223731e+01	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_NUCLEAR_EVENTS_MEDIATED_BY_NFE2L2	1/96	3.352693e-01	4.401332e-01	3.696307e+00	4.039403e+00	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_NUCLEOTIDE_BINDING_DOMAIN_LEUCINE_RICH_REPEAT_CONTAINING_RECEPTOR_NLR_SIGNALING_PATHWAYS	1/56	2.117989e-01	3.500892e-01	6.371875e+00	9.889900e+00	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_NUCLEOTIDE_EXCISION_REPAIR	1/108	3.684290e-01	4.655014e-01	3.281905e+00	3.277006e+00	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_N_GLYCAN_TRIMMING_IN_THE_ER_AND_CALNEXIN_CALRETICULIN_CYCLE	1/35	1.381557e-01	2.876176e-01	1.026017e+01	2.030872e+01	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_ONCOGENE_INDUCED_SENESCENCE	1/35	1.381557e-01	2.876176e-01	1.026017e+01	2.030872e+01	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_ONCOGENIC_MAPK_SIGNALING	1/82	2.944010e-01	4.075119e-01	4.334011e+00	5.299683e+00	AKAP9
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_ORC1_REMOVAL_FROM_CHROMATIN	1/71	2.605548e-01	3.835690e-01	5.012743e+00	6.741850e+00	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_ORGANELLE_BIOGENESIS_AND_MAINTENANCE	3/297	1.318382e-01	2.814888e-01	2.832095e+00	5.738333e+00	MT-ATP6;HSP90AA1;AKAP9
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_OVARIAN_TUMOR_DOMAIN_PROTEASES	1/39	1.526892e-01	3.016190e-01	9.192513e+00	1.727596e+01	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_OXIDATIVE_STRESS_INDUCED_SENESCENCE	1/125	4.126214e-01	5.015899e-01	2.831583e+00	2.506587e+00	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_O_LINKED_GLYCOSYLATION	1/111	3.764599e-01	4.713657e-01	3.192368e+00	3.118764e+00	MUC1
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS	1/62	2.316716e-01	3.644548e-01	5.748663e+00	8.407042e+00	MUC1
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_P75NTR_RECRUITS_SIGNALLING_COMPLEXES	1/13	5.370110e-02	1.861898e-01	2.834631e+01	8.289373e+01	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_P75NTR_REGULATES_AXONOGENESIS	1/10	4.156755e-02	1.693553e-01	3.730284e+01	1.186393e+02	LINGO1
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_P75NTR_SIGNALS_VIA_NF_KB	1/16	6.568265e-02	2.009003e-01	2.285682e+01	6.223731e+01	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_P75_NTR_RECEPTOR_MEDIATED_SIGNALLING	2/97	6.379344e-02	2.009003e-01	6.227112e+00	1.713767e+01	UBB;LINGO1
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_PCP_CE_PATHWAY	1/92	3.238378e-01	4.305453e-01	3.858596e+00	4.350615e+00	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS	1/197	5.682635e-01	6.328871e-01	1.788178e+00	1.010625e+00	CXCL8
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_PERK_REGULATES_GENE_EXPRESSION	2/32	8.106295e-03	6.286146e-02	1.955560e+01	9.416247e+01	ATF3;CXCL8
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_PEROXISOMAL_PROTEIN_IMPORT	1/63	2.349352e-01	3.662742e-01	5.656428e+00	8.193028e+00	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_PEXOPHAGY	1/11	4.562907e-02	1.752896e-01	3.374866e+01	1.041892e+02	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_PHASE_2_PLATEAU_PHASE	1/15	6.170557e-02	1.980274e-01	2.443426e+01	6.805873e+01	AKAP9
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_PHASE_3_RAPID_REPOLARISATION	1/9	3.748893e-02	1.619087e-01	4.169330e+01	1.369087e+02	AKAP9
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_PINK1_PRKN_MEDIATED_MITOPHAGY	1/32	1.270940e-01	2.774918e-01	1.123886e+01	2.318384e+01	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_PIWI_INTERACTING_RNA_PIRNA_BIOGENESIS	1/29	1.158918e-01	2.689103e-01	1.242359e+01	2.677405e+01	HSP90AA1
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_PLASMA_LIPOPROTEIN_ASSEMBLY_REMODELING_AND_CLEARANCE	1/75	2.730444e-01	3.925366e-01	4.742741e+00	6.156651e+00	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_PLASMA_LIPOPROTEIN_CLEARANCE	1/37	1.454530e-01	2.960146e-01	9.697092e+00	1.869504e+01	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION	1/261	6.719000e-01	7.154586e-01	1.344915e+00	5.347997e-01	TMSB4X
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION	7/1475	4.348127e-01	5.191867e-01	1.204173e+00	1.002884e+00	UBB;MUC1;CFTR;RPS2;RPL27A;CP;GOLGB1
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_POTENTIAL_THERAPEUTICS_FOR_SARS	1/154	4.810570e-01	5.581117e-01	2.293595e+00	1.678383e+00	HSP90AA1
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_PREVENTION_OF_PHAGOSOMAL_LYSOSOMAL_FUSION	1/9	3.748893e-02	1.619087e-01	4.169330e+01	1.369087e+02	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_PROCESSING_OF_DNA_DOUBLE_STRAND_BREAK_ENDS	1/97	3.380971e-01	4.430092e-01	3.657837e+00	3.966639e+00	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_PROGRAMMED_CELL_DEATH	2/211	2.249498e-01	3.589947e-01	2.823905e+00	4.212922e+00	UBB;HSP90AA1
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_PROTEIN_HYDROXYLATION	1/20	8.142487e-02	2.220291e-01	1.816495e+01	4.555906e+01	RPL27A
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_PROTEIN_LOCALIZATION	1/164	5.027761e-01	5.749950e-01	2.152333e+00	1.479966e+00	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_PROTEIN_METHYLATION	1/17	6.964305e-02	2.057725e-01	2.147059e+01	5.720564e+01	RPS2
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_PROTEIN_UBIQUITINATION	1/79	2.853253e-01	4.005306e-01	4.500255e+00	5.643885e+00	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_PTEN_REGULATION	1/139	4.467069e-01	5.291485e-01	2.543736e+00	2.049877e+00	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_PTK6_REGULATES_RTKS_AND_THEIR_EFFECTORS_AKT1_AND_DOK1	1/9	3.748893e-02	1.619087e-01	4.169330e+01	1.369087e+02	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_PYRUVATE_METABOLISM	1/49	1.879707e-01	3.283977e-01	7.293842e+00	1.219143e+01	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_RAS_PROCESSING	1/24	9.690462e-02	2.420875e-01	1.507032e+01	3.517454e+01	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_RECOGNITION_OF_DNA_DAMAGE_BY_PCNA_CONTAINING_REPLICATION_COMPLEX	1/30	1.196416e-01	2.710169e-01	1.200190e+01	2.548310e+01	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_RECRUITMENT_OF_MITOTIC_CENTROSOME_PROTEINS_AND_COMPLEXES	2/81	4.634500e-02	1.773865e-01	7.485807e+00	2.299372e+01	HSP90AA1;AKAP9
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES	2/95	6.150575e-02	1.980274e-01	6.360890e+00	1.773813e+01	HSP90AA1;AKAP9
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_REGULATED_NECROSIS	2/59	2.597644e-02	1.324862e-01	1.036028e+01	3.782089e+01	UBB;HSP90AA1
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_REGULATION_OF_BACH1_ACTIVITY	1/11	4.562907e-02	1.752896e-01	3.374866e+01	1.041892e+02	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS	21/172	3.964004e-25	6.360702e-23	4.237635e+01	2.381016e+03	RPS29;UBB;RPL37A;RPS2;RPL31;RPL3;RPS27;RPS3;RPL21;RPL28;RPL15;RPL13A;RPL39;RPL23;RPS5;RPL18A;RPS15A;RPL10A;RPL27A;RPL23A;RPL32
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_REGULATION_OF_FZD_BY_UBIQUITINATION	1/21	8.531924e-02	2.270101e-01	1.727807e+01	4.252748e+01	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE	2/82	4.737566e-02	1.793569e-01	7.392479e+00	2.254445e+01	UBB;HSPH1
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_REGULATION_OF_INNATE_IMMUNE_RESPONSES_TO_CYTOSOLIC_DNA	1/15	6.170557e-02	1.980274e-01	2.443426e+01	6.805873e+01	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS	1/124	4.101087e-01	5.005774e-01	2.854641e+00	2.544435e+00	CP
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS	1/87	3.092745e-01	4.183830e-01	4.082563e+00	4.790994e+00	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_REGULATION_OF_NF_KAPPA_B_SIGNALING	1/18	7.358684e-02	2.123128e-01	2.024278e+01	5.281927e+01	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_REGULATION_OF_PLK1_ACTIVITY_AT_G2_M_TRANSITION	3/87	6.033736e-03	4.974851e-02	9.965499e+00	5.092758e+01	UBB;HSP90AA1;AKAP9
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_REGULATION_OF_PTEN_LOCALIZATION	1/9	3.748893e-02	1.619087e-01	4.169330e+01	1.369087e+02	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_REGULATION_OF_PTEN_STABILITY_AND_ACTIVITY	1/69	2.542306e-01	3.790744e-01	5.159569e+00	7.066100e+00	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_REGULATION_OF_PYRUVATE_METABOLISM	1/33	1.307967e-01	2.795512e-01	1.089255e+01	2.215666e+01	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_REGULATION_OF_RAS_BY_GAPS	1/68	2.510485e-01	3.775682e-01	5.236245e+00	7.237062e+00	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_REGULATION_OF_RUNX2_EXPRESSION_AND_ACTIVITY	1/72	2.636969e-01	3.854743e-01	4.942411e+00	6.588010e+00	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_REGULATION_OF_RUNX3_EXPRESSION_AND_ACTIVITY	1/55	2.084377e-01	3.470081e-01	6.489084e+00	1.017563e+01	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_REGULATION_OF_SIGNALING_BY_CBL	1/22	8.919728e-02	2.334470e-01	1.647370e+01	3.981536e+01	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_REGULATION_OF_TBK1_IKK_IKBKE_MEDIATED_ACTIVATION_OF_IRF3_IRF7	1/14	5.771174e-02	1.926187e-01	2.624540e+01	7.485960e+01	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_REGULATION_OF_TBK1_IKK_MEDIATED_ACTIVATION_OF_IRF3_IRF7_UPON_TLR3_LIGATION	1/11	4.562907e-02	1.752896e-01	3.374866e+01	1.041892e+02	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_REGULATION_OF_TLR_BY_ENDOGENOUS_LIGAND	2/22	3.880433e-03	3.658769e-02	2.910811e+01	1.616026e+02	SFTPA2;SFTPA1
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_REGULATION_OF_TP53_ACTIVITY	1/160	4.941985e-01	5.673628e-01	2.206712e+00	1.555330e+00	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_METHYLATION	1/19	7.751409e-02	2.176237e-01	1.914771e+01	4.896635e+01	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION	1/92	3.238378e-01	4.305453e-01	3.858596e+00	4.350615e+00	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_REGULATION_OF_TP53_EXPRESSION_AND_DEGRADATION	1/37	1.454530e-01	2.960146e-01	9.697092e+00	1.869504e+01	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_REPRODUCTION	1/158	4.898550e-01	5.654884e-01	2.234938e+00	1.594954e+00	SYNE2
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_RESOLUTION_OF_SISTER_CHROMATID_COHESION	1/127	4.176151e-01	5.044268e-01	2.786561e+00	2.433212e+00	RPS27
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_RESPIRATORY_ELECTRON_TRANSPORT	8/158	3.662493e-07	1.294909e-05	1.433082e+01	2.123821e+02	MT-CYB;MT-CO3;MT-CO2;MT-ND5;MT-ND1;MT-ND3;MT-ND4;MT-ND2
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_PATHWAY	2/120	9.199593e-02	2.367331e-01	5.013228e+00	1.196162e+01	UBB;HSP90AA1
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_RESPIRATORY_SYNCYTIAL_VIRUS_RSV_GENOME_REPLICATION_TRANSCRIPTION_AND_TRANSLATION	1/16	6.568265e-02	2.009003e-01	2.285682e+01	6.223731e+01	HSP90AA1
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_RESPONSE_OF_EIF2AK1_HRI_TO_HEME_DEFICIENCY	2/15	1.798165e-03	2.049711e-02	4.421522e+01	2.794839e+02	ATF3;PPP1R15A
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY	21/102	3.315227e-30	3.457782e-27	7.902446e+01	5.364103e+03	RPS29;RPL37A;RPS2;RPL31;RPL3;RPS27;RPS3;RPL21;RPL28;RPL15;ATF3;RPL13A;RPL39;RPL23;RPS5;RPL18A;RPS15A;RPL10A;RPL27A;RPL23A;RPL32
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_RESPONSE_OF_MTB_TO_PHAGOCYTOSIS	1/23	9.305905e-02	2.367331e-01	1.574082e+01	3.737691e+01	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2	1/132	4.299161e-01	5.151091e-01	2.679998e+00	2.262361e+00	TMSB4X
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_RHOBTB2_GTPASE_CYCLE	1/23	9.305905e-02	2.367331e-01	1.574082e+01	3.737691e+01	HSP90AA1
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_RHOBTB_GTPASE_CYCLE	1/35	1.381557e-01	2.876176e-01	1.026017e+01	2.030872e+01	HSP90AA1
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_RHOQ_GTPASE_CYCLE	1/59	2.217980e-01	3.578273e-01	6.044289e+00	9.102627e+00	CFTR
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_RHO_GTPASES_ACTIVATE_FORMINS	1/140	4.490652e-01	5.307366e-01	2.525387e+00	2.021792e+00	RPS27
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_RHO_GTPASE_CYCLE	2/450	5.711485e-01	6.357608e-01	1.304679e+00	7.307587e-01	HSP90AA1;CFTR
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_RHO_GTPASE_EFFECTORS	2/323	3.983243e-01	4.922420e-01	1.830734e+00	1.685170e+00	RPS27;CFTR
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_RIPK1_MEDIATED_REGULATED_NECROSIS	2/32	8.106295e-03	6.286146e-02	1.955560e+01	9.416247e+01	UBB;HSP90AA1
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_RMTS_METHYLATE_HISTONE_ARGININES	1/78	2.822744e-01	3.988105e-01	4.558530e+00	5.765973e+00	RPS2
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION	4/1387	8.465626e-01	8.665013e-01	7.445266e-01	1.240166e-01	MT-CO3;UBB;GADD45A;MT-CO2
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_RRNA_MODIFICATION_IN_THE_NUCLEUS_AND_CYTOSOL	1/60	2.251031e-01	3.589947e-01	5.942435e+00	8.861339e+00	RPS2
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_RRNA_PROCESSING	20/205	5.929402e-22	8.245822e-20	3.250614e+01	1.588801e+03	RPS29;RPL37A;RPS2;RPL31;RPL3;RPS27;RPS3;RPL21;RPL28;RPL15;RPL13A;RPL39;RPL23;RPS5;RPL18A;RPS15A;RPL10A;RPL27A;RPL23A;RPL32
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_RSV_HOST_INTERACTIONS	1/98	3.409131e-01	4.450218e-01	3.620156e+00	3.895750e+00	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_RUNX1_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_DIFFERENTIATION_OF_HSCS	1/129	4.225667e-01	5.089342e-01	2.742941e+00	2.362791e+00	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_SARS_COV_1_ACTIVATES_MODULATES_INNATE_IMMUNE_RESPONSES	1/41	1.598648e-01	3.051033e-01	8.737770e+00	1.602006e+01	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_SARS_COV_1_HOST_INTERACTIONS	7/98	1.971538e-07	7.615977e-06	2.061593e+01	3.182951e+02	RPS29;UBB;RPS2;RPS27;RPS5;RPS3;RPS15A
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_SARS_COV_1_INFECTION	7/143	2.552428e-06	7.195088e-05	1.379121e+01	1.776096e+02	RPS29;UBB;RPS2;RPS27;RPS5;RPS3;RPS15A
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY	6/37	1.027406e-08	5.357920e-07	5.145323e+01	9.464124e+02	RPS29;RPS2;RPS27;RPS5;RPS3;RPS15A
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_SARS_COV_2_ACTIVATES_MODULATES_INNATE_AND_ADAPTIVE_IMMUNE_RESPONSES	2/126	9.986036e-02	2.483821e-01	4.770325e+00	1.099074e+01	UBB;HSP90AA1
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_SARS_COV_2_HOST_INTERACTIONS	8/204	2.514916e-06	7.186458e-05	1.095302e+01	1.412203e+02	RPS29;UBB;RPS2;HSP90AA1;RPS27;RPS5;RPS3;RPS15A
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_SARS_COV_2_INFECTION	8/299	4.036481e-05	9.460786e-04	7.351401e+00	7.437819e+01	RPS29;UBB;RPS2;HSP90AA1;RPS27;RPS5;RPS3;RPS15A
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY	6/51	7.588901e-08	3.368180e-06	3.559887e+01	5.836077e+02	RPS29;RPS2;RPS27;RPS5;RPS3;RPS15A
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_SARS_COV_INFECTIONS	8/471	8.767836e-04	1.244198e-02	4.586908e+00	3.228839e+01	RPS29;UBB;RPS2;HSP90AA1;RPS27;RPS5;RPS3;RPS15A
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_SCAVENGING_BY_CLASS_A_RECEPTORS	1/19	7.751409e-02	2.176237e-01	1.914771e+01	4.896635e+01	FTL
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_SCAVENGING_BY_CLASS_F_RECEPTORS	2/6	2.633436e-04	4.735645e-03	1.326997e+02	1.093718e+03	HSP90AA1;HSPH1
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_SCF_BETA_TRCP_MEDIATED_DEGRADATION_OF_EMI1	1/55	2.084377e-01	3.470081e-01	6.489084e+00	1.017563e+01	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_SCF_SKP2_MEDIATED_DEGRADATION_OF_P27_P21	1/60	2.251031e-01	3.589947e-01	5.942435e+00	8.861339e+00	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_SELECTIVE_AUTOPHAGY	3/90	6.626920e-03	5.337357e-02	9.622514e+00	4.827245e+01	UBB;HSP90AA1;CFTR
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_SELENOAMINO_ACID_METABOLISM	20/118	5.902729e-27	1.368121e-24	6.146019e+01	3.711850e+03	RPS29;RPL37A;RPS2;RPL31;RPL3;RPS27;RPS3;RPL21;RPL28;RPL15;RPL13A;RPL39;RPL23;RPS5;RPL18A;RPS15A;RPL10A;RPL27A;RPL23A;RPL32
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_SEMA3A_PAK_DEPENDENT_AXON_REPULSION	1/16	6.568265e-02	2.009003e-01	2.285682e+01	6.223731e+01	HSP90AA1
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_SEMAPHORIN_INTERACTIONS	1/64	2.381851e-01	3.674956e-01	5.567098e+00	7.987156e+00	HSP90AA1
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_SENESCENCE_ASSOCIATED_SECRETORY_PHENOTYPE_SASP	2/111	8.057038e-02	2.220291e-01	5.427496e+00	1.366982e+01	UBB;CXCL8
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_SEPARATION_OF_SISTER_CHROMATIDS	2/191	1.940028e-01	3.350851e-01	3.124795e+00	5.124296e+00	UBB;RPS27
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_SIGNALING_BY_ALK_IN_CANCER	1/93	3.267137e-01	4.335400e-01	3.816708e+00	4.269640e+00	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_SIGNALING_BY_BRAF_AND_RAF1_FUSIONS	1/65	2.414213e-01	3.702976e-01	5.480537e+00	7.789005e+00	AKAP9
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_SIGNALING_BY_CSF1_M_CSF_IN_MYELOID_CELLS	1/31	1.233756e-01	2.740804e-01	1.160787e+01	2.428973e+01	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_SIGNALING_BY_CSF3_G_CSF	1/30	1.196416e-01	2.710169e-01	1.200190e+01	2.548310e+01	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_SIGNALING_BY_EGFR	1/53	2.016727e-01	3.434199e-01	6.736898e+00	1.078651e+01	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_SIGNALING_BY_EGFR_IN_CANCER	2/25	4.998126e-03	4.344205e-02	2.538873e+01	1.345271e+02	UBB;HSP90AA1
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_SIGNALING_BY_ERBB2	2/50	1.905920e-02	1.086270e-01	1.228782e+01	4.866231e+01	UBB;HSP90AA1
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_SIGNALING_BY_ERBB2_ECD_MUTANTS	1/16	6.568265e-02	2.009003e-01	2.285682e+01	6.223731e+01	HSP90AA1
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_SIGNALING_BY_ERBB2_IN_CANCER	1/26	1.045474e-01	2.529999e-01	1.388707e+01	3.135860e+01	HSP90AA1
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_SIGNALING_BY_ERBB4	1/58	2.184790e-01	3.549433e-01	6.149686e+00	9.354074e+00	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_SIGNALING_BY_FGFR	1/89	3.151367e-01	4.222062e-01	3.989939e+00	4.607378e+00	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_SIGNALING_BY_FGFR1	1/52	1.982688e-01	3.398429e-01	6.868023e+00	1.111336e+01	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_SIGNALING_BY_FGFR2	1/73	2.668259e-01	3.878738e-01	4.874018e+00	6.439352e+00	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_SIGNALING_BY_FGFR3	1/40	1.562845e-01	3.038299e-01	8.959385e+00	1.662931e+01	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_SIGNALING_BY_FGFR4	1/41	1.598648e-01	3.051033e-01	8.737770e+00	1.602006e+01	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_SIGNALING_BY_FLT3_FUSION_PROTEINS	1/19	7.751409e-02	2.176237e-01	1.914771e+01	4.896635e+01	GOLGB1
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_SIGNALING_BY_GPCR	1/702	9.515878e-01	9.580174e-01	4.893448e-01	2.428293e-02	CXCL8
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_SIGNALING_BY_HEDGEHOG	1/150	4.721089e-01	5.501783e-01	2.355391e+00	1.767829e+00	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_SIGNALING_BY_INTERLEUKINS	5/473	5.064437e-02	1.834100e-01	2.837244e+00	8.463291e+00	UBB;MUC1;LCN2;HSP90AA1;CXCL8
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_SIGNALING_BY_MET	1/79	2.853253e-01	4.005306e-01	4.500255e+00	5.643885e+00	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_SIGNALING_BY_NOTCH	1/246	6.500726e-01	6.971987e-01	1.428069e+00	6.150282e-01	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_SIGNALING_BY_NOTCH1	1/74	2.699417e-01	3.904982e-01	4.807487e+00	6.295641e+00	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_SIGNALING_BY_NOTCH1_HD_DOMAIN_MUTANTS_IN_CANCER	1/15	6.170557e-02	1.980274e-01	2.443426e+01	6.805873e+01	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_SIGNALING_BY_NOTCH1_PEST_DOMAIN_MUTANTS_IN_CANCER	1/58	2.184790e-01	3.549433e-01	6.149686e+00	9.354074e+00	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_SIGNALING_BY_NOTCH2	1/33	1.307967e-01	2.795512e-01	1.089255e+01	2.215666e+01	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_SIGNALING_BY_NOTCH3	1/49	1.879707e-01	3.283977e-01	7.293842e+00	1.219143e+01	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_SIGNALING_BY_NOTCH4	1/82	2.944010e-01	4.075119e-01	4.334011e+00	5.299683e+00	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_SIGNALING_BY_NUCLEAR_RECEPTORS	1/296	7.177302e-01	7.527327e-01	1.183718e+00	3.925938e-01	HSP90AA1
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_SIGNALING_BY_PTK6	1/54	2.050624e-01	3.444123e-01	6.610675e+00	1.047423e+01	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES	2/532	6.624847e-01	7.076002e-01	1.098836e+00	4.524542e-01	UBB;HSP90AA1
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3	3/720	5.921631e-01	6.504751e-01	1.139891e+00	5.972721e-01	HSP90AA1;RPS27;CFTR
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_SIGNALING_BY_ROBO_RECEPTORS	21/218	6.559533e-23	9.773705e-21	3.243828e+01	1.656900e+03	RPS29;UBB;RPL37A;RPS2;RPL31;RPL3;RPS27;RPS3;RPL21;RPL28;RPL15;RPL13A;RPL39;RPL23;RPS5;RPL18A;RPS15A;RPL10A;RPL27A;RPL23A;RPL32
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_SIGNALING_BY_TGFB_FAMILY_MEMBERS	2/161	1.489165e-01	3.001720e-01	3.717614e+00	7.079711e+00	UBB;PPP1R15A
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX	2/94	6.037280e-02	1.980274e-01	6.429949e+00	1.805026e+01	PPP1R15A;UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR	1/166	5.070107e-01	5.785691e-01	2.126129e+00	1.444116e+00	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_SIGNALING_BY_VEGF	1/106	3.630183e-01	4.614602e-01	3.344426e+00	3.388913e+00	HSP90AA1
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_SIGNALING_BY_WNT	1/330	7.561689e-01	7.867174e-01	1.059919e+00	2.962373e-01	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_SIGNAL_REGULATORY_PROTEIN_FAMILY_INTERACTIONS	2/16	2.049389e-03	2.261918e-02	4.116403e+01	2.548141e+02	SFTPA2;SFTPA1
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT	1/249	6.545500e-01	7.002007e-01	1.410635e+00	5.978373e-01	CP
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_SLC_TRANSPORTER_DISORDERS	1/99	3.437172e-01	4.481213e-01	3.583241e+00	3.826671e+00	CP
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_SMAD2_SMAD3_SMAD4_HETEROTRIMER_REGULATES_TRANSCRIPTION	1/36	1.418120e-01	2.920236e-01	9.970701e+00	1.947530e+01	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_SPRY_REGULATION_OF_FGF_SIGNALING	1/16	6.568265e-02	2.009003e-01	2.285682e+01	6.223731e+01	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE	20/113	2.327993e-27	6.937418e-25	6.476155e+01	3.971488e+03	RPS29;RPL37A;RPS2;RPL31;RPL3;RPS27;RPS3;RPL21;RPL28;RPL15;RPL13A;RPL39;RPL23;RPS5;RPL18A;RPS15A;RPL10A;RPL27A;RPL23A;RPL32
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_STABILIZATION_OF_P53	1/57	2.151460e-01	3.519958e-01	6.258814e+00	9.616282e+00	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_STIMULI_SENSING_CHANNELS	1/106	3.630183e-01	4.614602e-01	3.344426e+00	3.388913e+00	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_SUPPRESSION_OF_PHAGOSOMAL_MATURATION	1/13	5.370110e-02	1.861898e-01	2.834631e+01	8.289373e+01	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_SURFACTANT_METABOLISM	5/30	1.604722e-07	6.315942e-06	5.319498e+01	8.322432e+02	SFTPA1;SFTPB;SFTPC;SFTPA2;NAPSA
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE	1/92	3.238378e-01	4.305453e-01	3.858596e+00	4.350615e+00	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_SYNTHESIS_OF_12_EICOSATETRAENOIC_ACID_DERIVATIVES	1/7	2.928011e-02	1.409738e-01	5.452694e+01	1.925263e+02	GPX1
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_SYNTHESIS_OF_15_EICOSATETRAENOIC_ACID_DERIVATIVES	1/6	2.514976e-02	1.299319e-01	6.444385e+01	2.373407e+02	GPX1
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_SYNTHESIS_OF_5_EICOSATETRAENOIC_ACIDS	1/9	3.748893e-02	1.619087e-01	4.169330e+01	1.369087e+02	GPX1
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_SYNTHESIS_OF_ACTIVE_UBIQUITIN_ROLES_OF_E1_AND_E2_ENZYMES	1/30	1.196416e-01	2.710169e-01	1.200190e+01	2.548310e+01	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_SYNTHESIS_OF_DNA	1/121	4.025067e-01	4.944812e-01	2.926110e+00	2.662887e+00	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_S_PHASE	1/163	5.006453e-01	5.728722e-01	2.165677e+00	1.498340e+00	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_TAK1_DEPENDENT_IKK_AND_NF_KAPPA_B_ACTIVATION	1/44	1.705155e-01	3.170190e-01	8.134059e+00	1.438857e+01	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT	1/233	6.299975e-01	6.802147e-01	1.508815e+00	6.971319e-01	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_TCR_SIGNALING	1/124	4.101087e-01	5.005774e-01	2.854641e+00	2.544435e+00	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS	1/23	9.305905e-02	2.367331e-01	1.574082e+01	3.737691e+01	MUC1
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_TERMINATION_OF_TRANSLESION_DNA_SYNTHESIS	1/32	1.270940e-01	2.774918e-01	1.123886e+01	2.318384e+01	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_TETRAHYDROBIOPTERIN_BH4_SYNTHESIS_RECYCLING_SALVAGE_AND_REGULATION	1/10	4.156755e-02	1.693553e-01	3.730284e+01	1.186393e+02	HSP90AA1
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS	2/47	1.695694e-02	1.019371e-01	1.309979e+01	5.340888e+01	PPP1R15A;UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_TGF_BETA_RECEPTOR_SIGNALING_IN_EMT_EPITHELIAL_TO_MESENCHYMAL_TRANSITION	1/16	6.568265e-02	2.009003e-01	2.285682e+01	6.223731e+01	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_THE_ROLE_OF_GTSE1_IN_G2_M_PROGRESSION_AFTER_G2_CHECKPOINT	2/79	4.430917e-02	1.752896e-01	7.679686e+00	2.393423e+01	UBB;HSP90AA1
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_TICAM1_DEPENDENT_ACTIVATION_OF_IRF3_IRF7	1/13	5.370110e-02	1.861898e-01	2.834631e+01	8.289373e+01	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_TICAM1_RIP1_MEDIATED_IKK_COMPLEX_RECRUITMENT	1/19	7.751409e-02	2.176237e-01	1.914771e+01	4.896635e+01	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_TICAM1_TRAF6_DEPENDENT_INDUCTION_OF_TAK1_COMPLEX	1/11	4.562907e-02	1.752896e-01	3.374866e+01	1.041892e+02	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_TNFR1_INDUCED_NF_KAPPA_B_SIGNALING_PATHWAY	2/33	8.605657e-03	6.530781e-02	1.893393e+01	9.003721e+01	UBB;RACK1
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_TNFR1_MEDIATED_CERAMIDE_PRODUCTION	1/6	2.514976e-02	1.299319e-01	6.444385e+01	2.373407e+02	RACK1
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_TNFR2_NON_CANONICAL_NF_KB_PATHWAY	1/101	3.492901e-01	4.522776e-01	3.511613e+00	3.693699e+00	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_TNF_SIGNALING	2/57	2.436262e-02	1.276895e-01	1.073460e+01	3.987587e+01	UBB;RACK1
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_TOLL_LIKE_RECEPTOR_9_TLR9_CASCADE	1/109	3.711172e-01	4.672001e-01	3.251509e+00	3.223017e+00	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_TOLL_LIKE_RECEPTOR_CASCADES	3/170	3.566707e-02	1.610422e-01	5.008417e+00	1.669570e+01	SFTPA2;UBB;SFTPA1
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_TOLL_LIKE_RECEPTOR_TLR1_TLR2_CASCADE	3/115	1.291285e-02	8.524116e-02	7.475677e+00	3.251570e+01	SFTPA2;UBB;SFTPA1
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_TP53_REGULATES_METABOLIC_GENES	2/84	4.946205e-02	1.805210e-01	7.212613e+00	2.168508e+01	MT-CO3;MT-CO2
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_CELL_CYCLE_GENES	1/49	1.879707e-01	3.283977e-01	7.293842e+00	1.219143e+01	GADD45A
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_G2_CELL_CYCLE_ARREST	1/18	7.358684e-02	2.123128e-01	2.024278e+01	5.281927e+01	GADD45A
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_TRAF6_MEDIATED_INDUCTION_OF_TAK1_COMPLEX_WITHIN_TLR4_COMPLEX	1/16	6.568265e-02	2.009003e-01	2.285682e+01	6.223731e+01	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION_IN_TLR7_8_OR_9_SIGNALING	1/13	5.370110e-02	1.861898e-01	2.834631e+01	8.289373e+01	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_TRANSCRIPTIONAL_ACTIVITY_OF_SMAD2_SMAD3_SMAD4_HETEROTRIMER	1/51	1.948505e-01	3.350851e-01	7.004342e+00	1.145576e+01	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX1	1/237	6.362929e-01	6.855925e-01	1.483024e+00	6.704699e-01	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX2	1/119	3.973850e-01	4.916637e-01	2.975767e+00	2.746186e+00	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX3	1/96	3.352693e-01	4.401332e-01	3.696307e+00	4.039403e+00	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_TRANSCRIPTIONAL_REGULATION_BY_TP53	4/360	6.684402e-02	2.035571e-01	3.032591e+00	8.204352e+00	MT-CO3;UBB;GADD45A;MT-CO2
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_TRANSCRIPTION_COUPLED_NUCLEOTIDE_EXCISION_REPAIR_TC_NER	1/76	2.761341e-01	3.945313e-01	4.679711e+00	6.022174e+00	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_TRANSLATION	20/295	8.684493e-19	1.006436e-16	2.179718e+01	9.064921e+02	RPS29;RPL37A;RPS2;RPL31;RPL3;RPS27;RPS3;RPL21;RPL28;RPL15;RPL13A;RPL39;RPL23;RPS5;RPL18A;RPS15A;RPL10A;RPL27A;RPL23A;RPL32
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_TRANSLATION_OF_SARS_COV_1_STRUCTURAL_PROTEINS	1/29	1.158918e-01	2.689103e-01	1.242359e+01	2.677405e+01	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_TRANSLATION_OF_SARS_COV_2_STRUCTURAL_PROTEINS	1/57	2.151460e-01	3.519958e-01	6.258814e+00	9.616282e+00	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_TRANSLESION_SYNTHESIS_BY_POLH	1/19	7.751409e-02	2.176237e-01	1.914771e+01	4.896635e+01	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_TRANSLESION_SYNTHESIS_BY_POLK	1/17	6.964305e-02	2.057725e-01	2.147059e+01	5.720564e+01	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_TRANSLESION_SYNTHESIS_BY_Y_FAMILY_DNA_POLYMERASES_BYPASSES_LESIONS_ON_DNA_TEMPLATE	1/39	1.526892e-01	3.016190e-01	9.192513e+00	1.727596e+01	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_TRANSPORT_OF_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS	1/84	3.003881e-01	4.122431e-01	4.229818e+00	5.087119e+00	CP
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_TRANSPORT_OF_RCBL_WITHIN_THE_BODY	1/8	3.339314e-02	1.542150e-01	4.725455e+01	1.606373e+02	TCN1
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_TRANSPORT_OF_SMALL_MOLECULES	6/736	9.232447e-02	2.367331e-01	2.148443e+00	5.118550e+00	UBB;LCN2;CFTR;CP;PIP;FTL
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION	1/187	5.493760e-01	6.144763e-01	1.884919e+00	1.129014e+00	GOLGB1
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_TRANS_GOLGI_NETWORK_VESICLE_BUDDING	2/72	3.746101e-02	1.619087e-01	8.444892e+00	2.773686e+01	FTL;GOLGB1
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES	2/221	2.405719e-01	3.702976e-01	2.694022e+00	3.838271e+00	UBB;CFTR
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_UCH_PROTEINASES	1/102	3.520590e-01	4.541713e-01	3.476858e+00	3.629689e+00	UBB
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_UNFOLDED_PROTEIN_RESPONSE_UPR	2/93	5.924721e-02	1.961741e-01	6.500517e+00	1.837070e+01	ATF3;CXCL8
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_UPTAKE_AND_ACTIONS_OF_BACTERIAL_TOXINS	1/29	1.158918e-01	2.689103e-01	1.242359e+01	2.677405e+01	HSP90AA1
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_UPTAKE_AND_FUNCTION_OF_DIPHTHERIA_TOXIN	1/6	2.514976e-02	1.299319e-01	6.444385e+01	2.373407e+02	HSP90AA1
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_UPTAKE_OF_DIETARY_COBALAMINS_INTO_ENTEROCYTES	1/10	4.156755e-02	1.693553e-01	3.730284e+01	1.186393e+02	TCN1
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_VEGFR2_MEDIATED_VASCULAR_PERMEABILITY	1/27	1.083448e-01	2.588857e-01	1.336243e+01	2.969714e+01	HSP90AA1
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_VESICLE_MEDIATED_TRANSPORT	6/725	8.740688e-02	2.322685e-01	2.182412e+00	5.318935e+00	UBB;HSPH1;CFTR;HSP90AA1;GOLGB1;FTL
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_VIRAL_INFECTION_PATHWAYS	22/888	1.408801e-11	1.049557e-09	7.604612e+00	1.900065e+02	RPS29;UBB;RPL37A;RPS2;RPL31;RPL3;RPS27;RPS3;RPL21;RPL28;RPL15;RPL13A;RPL39;RPL23;RPS5;RPL18A;RPS15A;RPL10A;RPL27A;HSP90AA1;RPL23A;RPL32
c2.all.v2024.1.Hs.symbols.gmt	REACTOME_VLDLR_INTERNALISATION_AND_DEGRADATION	1/16	6.568265e-02	2.009003e-01	2.285682e+01	6.223731e+01	UBB
c2.all.v2024.1.Hs.symbols.gmt	REN_ALVEOLAR_RHABDOMYOSARCOMA_DN	1/407	8.251190e-01	8.482988e-01	8.561083e-01	1.645677e-01	NUCB2
c2.all.v2024.1.Hs.symbols.gmt	REN_ALVEOLAR_RHABDOMYOSARCOMA_UP	2/99	6.610963e-02	2.016150e-01	6.098822e+00	1.656709e+01	SYNE2;RPL31
c2.all.v2024.1.Hs.symbols.gmt	REN_MIF_TARGETS_DN	1/5	2.100202e-02	1.155942e-01	7.876827e+01	3.042926e+02	CXCL8
c2.all.v2024.1.Hs.symbols.gmt	RHEIN_ALL_GLUCOCORTICOID_THERAPY_DN	5/368	2.016987e-02	1.134080e-01	3.674556e+00	1.434387e+01	CFAP298;NUCB2;RPL31;RPL3;RPL23
c2.all.v2024.1.Hs.symbols.gmt	RHEIN_ALL_GLUCOCORTICOID_THERAPY_UP	3/76	4.137805e-03	3.848016e-02	1.146266e+01	6.290237e+01	LYZ;CXCL8;LTF
c2.all.v2024.1.Hs.symbols.gmt	RICKMAN_HEAD_AND_NECK_CANCER_A	1/105	3.602958e-01	4.614602e-01	3.376583e+00	3.446917e+00	TCIM
c2.all.v2024.1.Hs.symbols.gmt	RICKMAN_HEAD_AND_NECK_CANCER_C	1/116	3.896207e-01	4.837791e-01	3.053476e+00	2.878150e+00	SERPINB4
c2.all.v2024.1.Hs.symbols.gmt	RICKMAN_HEAD_AND_NECK_CANCER_D	7/40	3.242424e-10	1.989322e-08	5.645757e+01	1.233571e+03	TCN1;LTF;BPIFA1;BPIFB1;MSMB;SCGB3A1;AGR2
c2.all.v2024.1.Hs.symbols.gmt	RICKMAN_HEAD_AND_NECK_CANCER_E	1/87	3.092745e-01	4.183830e-01	4.082563e+00	4.790994e+00	CP
c2.all.v2024.1.Hs.symbols.gmt	RICKMAN_METASTASIS_DN	2/263	3.064201e-01	4.155997e-01	2.256989e+00	2.669563e+00	ANXA2P3;MUC1
c2.all.v2024.1.Hs.symbols.gmt	RICKMAN_TUMOR_DIFFERENTIATED_MODERATELY_VS_POORLY_UP	1/125	4.126214e-01	5.015899e-01	2.831583e+00	2.506587e+00	RPS15A
c2.all.v2024.1.Hs.symbols.gmt	RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN	1/384	8.068420e-01	8.319686e-01	9.084146e-01	1.949706e-01	MMP10
c2.all.v2024.1.Hs.symbols.gmt	RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_UP	2/242	2.735147e-01	3.926715e-01	2.456425e+00	3.184510e+00	RPS27;RPL23
c2.all.v2024.1.Hs.symbols.gmt	RIGGINS_TAMOXIFEN_RESISTANCE_DN	1/221	6.104575e-01	6.632366e-01	1.591800e+00	7.856278e-01	MUC1
c2.all.v2024.1.Hs.symbols.gmt	RIGGI_EWING_SARCOMA_PROGENITOR_UP	1/437	8.464091e-01	8.665013e-01	7.961666e-01	1.327627e-01	LINGO1
c2.all.v2024.1.Hs.symbols.gmt	RIZKI_TUMOR_INVASIVENESS_3D_UP	1/209	5.898970e-01	6.486690e-01	1.684338e+00	8.890060e-01	CXCL8
c2.all.v2024.1.Hs.symbols.gmt	RODRIGUES_DCC_TARGETS_DN	1/119	3.973850e-01	4.916637e-01	2.975767e+00	2.746186e+00	GADD45A
c2.all.v2024.1.Hs.symbols.gmt	RODRIGUES_NTN1_AND_DCC_TARGETS	1/35	1.381557e-01	2.876176e-01	1.026017e+01	2.030872e+01	NEAT1
c2.all.v2024.1.Hs.symbols.gmt	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_DN	2/542	6.725017e-01	7.157340e-01	1.078006e+00	4.276995e-01	UBB;SYNE2
c2.all.v2024.1.Hs.symbols.gmt	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP	4/721	3.650521e-01	4.632128e-01	1.481768e+00	1.493200e+00	GAS5;HSP90AA1;CXCL8;ANXA2P2
c2.all.v2024.1.Hs.symbols.gmt	RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN	6/807	1.275694e-01	2.777764e-01	1.951620e+00	4.018570e+00	UBB;SYNE2;AKAP9;NEAT1;RPL15;GOLGB1
c2.all.v2024.1.Hs.symbols.gmt	RODWELL_AGING_KIDNEY_NO_BLOOD_DN	1/148	4.675778e-01	5.467305e-01	2.387546e+00	1.814988e+00	MT-ND4
c2.all.v2024.1.Hs.symbols.gmt	RODWELL_AGING_KIDNEY_NO_BLOOD_UP	4/224	1.520391e-02	9.552820e-02	4.933702e+00	2.065347e+01	ANXA2P3;ERICH3;LTF;TSPAN1
c2.all.v2024.1.Hs.symbols.gmt	RODWELL_AGING_KIDNEY_UP	8/501	1.300917e-03	1.624977e-02	4.302095e+00	2.858607e+01	ANXA2P3;ERICH3;LTF;RPL28;RPS2;LYZ;RPL13A;TSPAN1
c2.all.v2024.1.Hs.symbols.gmt	ROESSLER_LIVER_CANCER_METASTASIS_DN	1/51	1.948505e-01	3.350851e-01	7.004342e+00	1.145576e+01	RPS3
c2.all.v2024.1.Hs.symbols.gmt	ROESSLER_LIVER_CANCER_METASTASIS_UP	1/106	3.630183e-01	4.614602e-01	3.344426e+00	3.388913e+00	LTF
c2.all.v2024.1.Hs.symbols.gmt	ROSS_AML_WITH_AML1_ETO_FUSION	1/79	2.853253e-01	4.005306e-01	4.500255e+00	5.643885e+00	TCN1
c2.all.v2024.1.Hs.symbols.gmt	ROVERSI_GLIOMA_COPY_NUMBER_DN	2/54	2.202297e-02	1.190153e-01	1.134955e+01	4.330613e+01	SFTPA2;SFTPA1
c2.all.v2024.1.Hs.symbols.gmt	ROY_WOUND_BLOOD_VESSEL_DN	1/23	9.305905e-02	2.367331e-01	1.574082e+01	3.737691e+01	S100P
c2.all.v2024.1.Hs.symbols.gmt	RUAN_RESPONSE_TO_TNF_TROGLITAZONE_UP	1/17	6.964305e-02	2.057725e-01	2.147059e+01	5.720564e+01	CP
c2.all.v2024.1.Hs.symbols.gmt	RUAN_RESPONSE_TO_TNF_UP	1/13	5.370110e-02	1.861898e-01	2.834631e+01	8.289373e+01	CP
c2.all.v2024.1.Hs.symbols.gmt	RUIZ_TNC_TARGETS_DN	1/143	4.560809e-01	5.372020e-01	2.471883e+00	1.940638e+00	CXCL8
c2.all.v2024.1.Hs.symbols.gmt	RUIZ_TNC_TARGETS_UP	1/156	4.854746e-01	5.613637e-01	2.263889e+00	1.635950e+00	GOLGB1
c2.all.v2024.1.Hs.symbols.gmt	RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN	1/320	7.454354e-01	7.771006e-01	1.093595e+00	3.212839e-01	RPL28
c2.all.v2024.1.Hs.symbols.gmt	RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP	1/341	7.674591e-01	7.956857e-01	1.025160e+00	2.713291e-01	ANXA2P2
c2.all.v2024.1.Hs.symbols.gmt	RUTELLA_RESPONSE_TO_HGF_DN	1/240	6.409448e-01	6.898920e-01	1.464247e+00	6.513147e-01	RPL28
c2.all.v2024.1.Hs.symbols.gmt	RUTELLA_RESPONSE_TO_HGF_UP	1/421	8.353950e-01	8.571736e-01	8.270712e-01	1.487492e-01	ANXA2P2
c2.all.v2024.1.Hs.symbols.gmt	RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN	2/250	2.860680e-01	4.008908e-01	2.376475e+00	2.974220e+00	RPL28;ANXA2P2
c2.all.v2024.1.Hs.symbols.gmt	RYAN_MANTLE_CELL_LYMPHOMA_NOTCH_DIRECT_UP	1/148	4.675778e-01	5.467305e-01	2.387546e+00	1.814988e+00	SFTPB
c2.all.v2024.1.Hs.symbols.gmt	SABATES_COLORECTAL_ADENOMA_DN	1/299	7.213502e-01	7.557692e-01	1.171660e+00	3.827001e-01	CP
c2.all.v2024.1.Hs.symbols.gmt	SABATES_COLORECTAL_ADENOMA_SIZE_UP	1/24	9.690462e-02	2.420875e-01	1.507032e+01	3.517454e+01	NEAT1
c2.all.v2024.1.Hs.symbols.gmt	SABATES_COLORECTAL_ADENOMA_UP	5/140	3.254488e-04	5.564640e-03	9.960976e+00	7.998968e+01	TCN1;LCN2;MMP10;CXCL8;S100P
c2.all.v2024.1.Hs.symbols.gmt	SAGIV_CD24_TARGETS_DN	3/45	9.180319e-04	1.285245e-02	1.985156e+01	1.388275e+02	ATF3;PPP1R15A;CXCL8
c2.all.v2024.1.Hs.symbols.gmt	SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP	1/82	2.944010e-01	4.075119e-01	4.334011e+00	5.299683e+00	HSP90AA1
c2.all.v2024.1.Hs.symbols.gmt	SAKAI_TUMOR_INFILTRATING_MONOCYTES_DN	1/81	2.913885e-01	4.054946e-01	4.388049e+00	5.410894e+00	DNAJA1
c2.all.v2024.1.Hs.symbols.gmt	SALVADOR_MARTIN_PEDIATRIC_TBD_ANTI_TNF_THERAPY_NONRESPONDER_PRE_TREATMENT_UP	5/29	1.341747e-07	5.488008e-06	5.536872e+01	8.761614e+02	MT-CO3;MT-ND1;MT-ATP6;MT-CYB;MT-ND2
c2.all.v2024.1.Hs.symbols.gmt	SANA_RESPONSE_TO_IFNG_DN	3/87	6.033736e-03	4.974851e-02	9.965499e+00	5.092758e+01	MMP10;GADD45A;RPL10A
c2.all.v2024.1.Hs.symbols.gmt	SANA_TNF_SIGNALING_DN	1/85	3.033627e-01	4.138748e-01	4.179572e+00	4.985502e+00	TMSB4X
c2.all.v2024.1.Hs.symbols.gmt	SANA_TNF_SIGNALING_UP	3/83	5.294207e-03	4.563519e-02	1.046258e+01	5.483587e+01	MMP10;DNAJA1;CXCL8
c2.all.v2024.1.Hs.symbols.gmt	SANSOM_APC_TARGETS_DN	2/366	4.607434e-01	5.411659e-01	1.611575e+00	1.248832e+00	AGR2;NAPSA
c2.all.v2024.1.Hs.symbols.gmt	SANSOM_APC_TARGETS_REQUIRE_MYC	1/225	6.170817e-01	6.686921e-01	1.563153e+00	7.546181e-01	RPL31
c2.all.v2024.1.Hs.symbols.gmt	SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_DN	2/145	1.258934e-01	2.774918e-01	4.135135e+00	8.569324e+00	ATF3;NEAT1
c2.all.v2024.1.Hs.symbols.gmt	SARTIPY_BLUNTED_BY_INSULIN_RESISTANCE_DN	1/18	7.358684e-02	2.123128e-01	2.024278e+01	5.281927e+01	GADD45A
c2.all.v2024.1.Hs.symbols.gmt	SATO_SILENCED_BY_DEACETYLATION_IN_PANCREATIC_CANCER	2/47	1.695694e-02	1.019371e-01	1.309979e+01	5.340888e+01	ATF3;CXCL8
c2.all.v2024.1.Hs.symbols.gmt	SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1	1/422	8.361057e-01	8.574811e-01	8.250709e-01	1.476879e-01	SFTPA2
c2.all.v2024.1.Hs.symbols.gmt	SATO_SILENCED_EPIGENETICALLY_IN_PANCREATIC_CANCER	1/47	1.810327e-01	3.241495e-01	7.608246e+00	1.300308e+01	S100P
c2.all.v2024.1.Hs.symbols.gmt	SAUL_SEN_MAYO	3/124	1.578477e-02	9.799712e-02	6.919090e+00	2.870529e+01	MMP10;SERPINB4;CXCL8
c2.all.v2024.1.Hs.symbols.gmt	SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_UP	2/111	8.057038e-02	2.220291e-01	5.427496e+00	1.366982e+01	NEAT1;TSPAN1
c2.all.v2024.1.Hs.symbols.gmt	SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_DN	2/411	5.219356e-01	5.917161e-01	1.431508e+00	9.307827e-01	MMP10;LYZ
c2.all.v2024.1.Hs.symbols.gmt	SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_UP	4/450	1.239983e-01	2.751707e-01	2.411296e+00	5.033550e+00	AGR2;TCIM;NAPSA;TSPAN1
c2.all.v2024.1.Hs.symbols.gmt	SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_UP	1/160	4.941985e-01	5.673628e-01	2.206712e+00	1.555330e+00	CFTR
c2.all.v2024.1.Hs.symbols.gmt	SCHEIDEREIT_IKK_INTERACTING_PROTEINS	2/53	2.126512e-02	1.161232e-01	1.157045e+01	4.455420e+01	UBB;HSP90AA1
c2.all.v2024.1.Hs.symbols.gmt	SCHLINGEMANN_SKIN_CARCINOGENESIS_TPA_UP	2/40	1.247157e-02	8.365174e-02	1.548649e+01	6.789746e+01	SCGB1A1;BPIFA1
c2.all.v2024.1.Hs.symbols.gmt	SCHLOSSER_SERUM_RESPONSE_DN	1/705	9.522203e-01	9.581918e-01	4.871927e-01	2.385240e-02	LYZ
c2.all.v2024.1.Hs.symbols.gmt	SCHLOSSER_SERUM_RESPONSE_UP	1/126	4.151235e-01	5.028732e-01	2.808893e+00	2.469520e+00	SFTPC
c2.all.v2024.1.Hs.symbols.gmt	SCHOEN_NFKB_SIGNALING	1/34	1.344840e-01	2.842285e-01	1.056692e+01	2.120053e+01	CXCL8
c2.all.v2024.1.Hs.symbols.gmt	SCHRAETS_MLL_TARGETS_UP	1/33	1.307967e-01	2.795512e-01	1.089255e+01	2.215666e+01	MMP10
c2.all.v2024.1.Hs.symbols.gmt	SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_DN	1/85	3.033627e-01	4.138748e-01	4.179572e+00	4.985502e+00	MMP10
c2.all.v2024.1.Hs.symbols.gmt	SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP	1/352	7.782318e-01	8.064538e-01	9.925757e-01	2.488694e-01	FTL
c2.all.v2024.1.Hs.symbols.gmt	SCIAN_INVERSED_TARGETS_OF_TP53_AND_TP73_DN	1/30	1.196416e-01	2.710169e-01	1.200190e+01	2.548310e+01	ATF3
c2.all.v2024.1.Hs.symbols.gmt	SCIAN_INVERSED_TARGETS_OF_TP53_AND_TP73_UP	1/11	4.562907e-02	1.752896e-01	3.374866e+01	1.041892e+02	FTL
c2.all.v2024.1.Hs.symbols.gmt	SCIBETTA_KDM5B_TARGETS_UP	1/19	7.751409e-02	2.176237e-01	1.914771e+01	4.896635e+01	GADD45A
c2.all.v2024.1.Hs.symbols.gmt	SEIDEN_ONCOGENESIS_BY_MET	1/89	3.151367e-01	4.222062e-01	3.989939e+00	4.607378e+00	HSP90AA1
c2.all.v2024.1.Hs.symbols.gmt	SEKI_INFLAMMATORY_RESPONSE_LPS_DN	1/23	9.305905e-02	2.367331e-01	1.574082e+01	3.737691e+01	LYZ
c2.all.v2024.1.Hs.symbols.gmt	SEKI_INFLAMMATORY_RESPONSE_LPS_UP	1/76	2.761341e-01	3.945313e-01	4.679711e+00	6.022174e+00	TCIM
c2.all.v2024.1.Hs.symbols.gmt	SEMENZA_HIF1_TARGETS	1/36	1.418120e-01	2.920236e-01	9.970701e+00	1.947530e+01	CP
c2.all.v2024.1.Hs.symbols.gmt	SENESE_HDAC1_AND_HDAC2_TARGETS_UP	3/243	8.435788e-02	2.270101e-01	3.476580e+00	8.596494e+00	TCN1;RPL27A;CXCL8
c2.all.v2024.1.Hs.symbols.gmt	SENESE_HDAC1_TARGETS_UP	4/451	1.247249e-01	2.761954e-01	2.405796e+00	5.008014e+00	TCN1;NEAT1;RPL27A;CXCL8
c2.all.v2024.1.Hs.symbols.gmt	SENESE_HDAC2_TARGETS_UP	3/116	1.321572e-02	8.696526e-02	7.409475e+00	3.205597e+01	TCN1;RPL27A;CXCL8
c2.all.v2024.1.Hs.symbols.gmt	SENESE_HDAC3_TARGETS_UP	6/495	1.872488e-02	1.086270e-01	3.242367e+00	1.289782e+01	TCN1;SERPINB4;NEAT1;ATF3;MT-ND4;CXCL8
c2.all.v2024.1.Hs.symbols.gmt	SENGUPTA_EBNA1_ANTICORRELATED	1/161	4.963565e-01	5.692137e-01	2.192863e+00	1.536015e+00	NAPSA
c2.all.v2024.1.Hs.symbols.gmt	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_DN	17/358	1.584909e-13	1.377550e-11	1.438648e+01	4.240139e+02	SERPINB4;ERICH3;LCN2;LTF;S100P;MUC1;DNAAF1;SERPINB3;SNTN;HOATZ;MSMB;BPIFB1;DNAH12;RSPH1;AGR2;SCGB1A1;TSPAN1
c2.all.v2024.1.Hs.symbols.gmt	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN	6/175	1.012134e-04	2.111312e-03	9.502308e+00	8.740488e+01	SERPINB4;SNTN;LCN2;SERPINB3;SCGB3A1;S100P
c2.all.v2024.1.Hs.symbols.gmt	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP	7/404	1.655393e-03	1.929134e-02	4.679569e+00	2.996663e+01	ANKRD36B;CFTR;NEAT1;MMP10;HSP90AA1;CP;CXCL8
c2.all.v2024.1.Hs.symbols.gmt	SERVITJA_ISLET_HNF1A_TARGETS_UP	2/167	1.577596e-01	3.051033e-01	3.581857e+00	6.614553e+00	ATF3;LYZ
c2.all.v2024.1.Hs.symbols.gmt	SESTO_RESPONSE_TO_UV_C0	4/109	1.195843e-03	1.549396e-02	1.036587e+01	6.975096e+01	DNAJA1;RPS27;SERPINB4;HSPH1
c2.all.v2024.1.Hs.symbols.gmt	SESTO_RESPONSE_TO_UV_C1	2/74	3.937255e-02	1.669332e-01	8.211184e+00	2.656060e+01	HSP90AA1;LCN2
c2.all.v2024.1.Hs.symbols.gmt	SESTO_RESPONSE_TO_UV_C3	2/22	3.880433e-03	3.658769e-02	2.910811e+01	1.616026e+02	ATF3;CXCL8
c2.all.v2024.1.Hs.symbols.gmt	SESTO_RESPONSE_TO_UV_C6	1/39	1.526892e-01	3.016190e-01	9.192513e+00	1.727596e+01	GADD45A
c2.all.v2024.1.Hs.symbols.gmt	SESTO_RESPONSE_TO_UV_C7	3/70	3.281320e-03	3.259445e-02	1.248496e+01	7.140786e+01	TCN1;RPL3;MMP10
c2.all.v2024.1.Hs.symbols.gmt	SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE	2/101	6.845368e-02	2.057725e-01	5.975689e+00	1.602440e+01	ATF3;HSP90AA1
c2.all.v2024.1.Hs.symbols.gmt	SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE	1/67	2.478529e-01	3.751968e-01	5.315227e+00	7.414315e+00	ATF3
c2.all.v2024.1.Hs.symbols.gmt	SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12	3/318	1.523814e-01	3.016190e-01	2.641042e+00	4.968773e+00	ANKRD36B;SERPINB3;SERPINB4
c2.all.v2024.1.Hs.symbols.gmt	SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4	2/197	2.032330e-01	3.444123e-01	3.028064e+00	4.824924e+00	SFTPA2;SFTPB
c2.all.v2024.1.Hs.symbols.gmt	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6	1/458	8.597655e-01	8.774319e-01	7.588849e-01	1.146642e-01	DNAJA1
c2.all.v2024.1.Hs.symbols.gmt	SHEPARD_BMYB_MORPHOLINO_DN	1/202	5.774113e-01	6.396601e-01	1.743408e+00	9.574806e-01	GOLGB1
c2.all.v2024.1.Hs.symbols.gmt	SHEPARD_BMYB_MORPHOLINO_UP	3/212	6.126820e-02	1.980274e-01	3.996674e+00	1.116069e+01	HSP90AA1;RPS27;CFAP298
c2.all.v2024.1.Hs.symbols.gmt	SHEPARD_BMYB_TARGETS	1/76	2.761341e-01	3.945313e-01	4.679711e+00	6.022174e+00	GOLGB1
c2.all.v2024.1.Hs.symbols.gmt	SHEPARD_CRASH_AND_BURN_MUTANT_DN	2/191	1.940028e-01	3.350851e-01	3.124795e+00	5.124296e+00	GOLGB1;AKAP9
c2.all.v2024.1.Hs.symbols.gmt	SHEPARD_CRASH_AND_BURN_MUTANT_UP	3/205	5.653034e-02	1.926187e-01	4.136153e+00	1.188308e+01	ATF3;HSP90AA1;TCIM
c2.all.v2024.1.Hs.symbols.gmt	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM1	1/260	6.704877e-01	7.143194e-01	1.350159e+00	5.397261e-01	NAPSA
c2.all.v2024.1.Hs.symbols.gmt	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM2	1/168	5.112097e-01	5.814522e-01	2.100551e+00	1.409418e+00	ATF3
c2.all.v2024.1.Hs.symbols.gmt	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM3	2/74	3.937255e-02	1.669332e-01	8.211184e+00	2.656060e+01	LCN2;NUCB2
c2.all.v2024.1.Hs.symbols.gmt	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM4	2/288	3.452264e-01	4.498078e-01	2.057686e+00	2.188462e+00	SYNE2;GPX1
c2.all.v2024.1.Hs.symbols.gmt	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM6	1/55	2.084377e-01	3.470081e-01	6.489084e+00	1.017563e+01	MMP10
c2.all.v2024.1.Hs.symbols.gmt	SHIPP_DLBCL_CURED_VS_FATAL_UP	1/39	1.526892e-01	3.016190e-01	9.192513e+00	1.727596e+01	DNAH12
c2.all.v2024.1.Hs.symbols.gmt	SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_UP	1/45	1.740360e-01	3.187349e-01	7.950910e+00	1.390211e+01	HSP90AA1
c2.all.v2024.1.Hs.symbols.gmt	SHI_SPARC_TARGETS_UP	1/24	9.690462e-02	2.420875e-01	1.507032e+01	3.517454e+01	PPP1R15A
c2.all.v2024.1.Hs.symbols.gmt	SIG_PIP3_SIGNALING_IN_CARDIAC_MYOCTES	1/67	2.478529e-01	3.751968e-01	5.315227e+00	7.414315e+00	GADD45A
c2.all.v2024.1.Hs.symbols.gmt	SILIGAN_BOUND_BY_EWS_FLT1_FUSION	1/46	1.775417e-01	3.214861e-01	7.775812e+00	1.344088e+01	LTF
c2.all.v2024.1.Hs.symbols.gmt	SIMBULAN_UV_RESPONSE_NORMAL_UP	1/9	3.748893e-02	1.619087e-01	4.169330e+01	1.369087e+02	CXCL8
c2.all.v2024.1.Hs.symbols.gmt	SMID_BREAST_CANCER_BASAL_DN	8/699	9.634274e-03	7.084071e-02	3.042122e+00	1.412283e+01	TCN1;PIP;MUC1;DNAAF1;MSMB;NUCB2;AGR2;TSPAN1
c2.all.v2024.1.Hs.symbols.gmt	SMID_BREAST_CANCER_BASAL_UP	5/662	1.496965e-01	3.011254e-01	2.004006e+00	3.805899e+00	SERPINB4;LCN2;SERPINB3;CP;CXCL8
c2.all.v2024.1.Hs.symbols.gmt	SMID_BREAST_CANCER_ERBB2_UP	3/152	2.684843e-02	1.359365e-01	5.616043e+00	2.031630e+01	PIP;MUC1;TSPAN1
c2.all.v2024.1.Hs.symbols.gmt	SMID_BREAST_CANCER_LUMINAL_B_DN	4/587	2.377792e-01	3.674956e-01	1.833473e+00	2.633624e+00	LYZ;CXCL8;LCN2;LTF
c2.all.v2024.1.Hs.symbols.gmt	SMID_BREAST_CANCER_LUMINAL_B_UP	2/169	1.607295e-01	3.064732e-01	3.538766e+00	6.468979e+00	AGR2;MSMB
c2.all.v2024.1.Hs.symbols.gmt	SMID_BREAST_CANCER_NORMAL_LIKE_UP	1/485	8.752618e-01	8.915020e-01	7.157001e-01	9.535431e-02	LYZ
c2.all.v2024.1.Hs.symbols.gmt	SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN	2/324	3.998143e-01	4.927929e-01	1.824974e+00	1.673054e+00	CP;CXCL8
c2.all.v2024.1.Hs.symbols.gmt	SMID_BREAST_CANCER_RELAPSE_IN_BONE_UP	4/99	8.356180e-04	1.210485e-02	1.145651e+01	8.119617e+01	AGR2;MUC1;MSMB;TSPAN1
c2.all.v2024.1.Hs.symbols.gmt	SMID_BREAST_CANCER_RELAPSE_IN_BRAIN_DN	1/82	2.944010e-01	4.075119e-01	4.334011e+00	5.299683e+00	AGR2
c2.all.v2024.1.Hs.symbols.gmt	SMID_BREAST_CANCER_RELAPSE_IN_BRAIN_UP	1/41	1.598648e-01	3.051033e-01	8.737770e+00	1.602006e+01	CP
c2.all.v2024.1.Hs.symbols.gmt	SMID_BREAST_CANCER_RELAPSE_IN_PLEURA_DN	3/32	3.339214e-04	5.617420e-03	2.861656e+01	2.290643e+02	CP;LTF;S100P
c2.all.v2024.1.Hs.symbols.gmt	SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP	1/160	4.941985e-01	5.673628e-01	2.206712e+00	1.555330e+00	CXCL8
c2.all.v2024.1.Hs.symbols.gmt	SMIRNOV_RESPONSE_TO_IR_2HR_UP	3/53	1.478956e-03	1.773047e-02	1.670070e+01	1.088287e+02	ATF3;PPP1R15A;GADD45A
c2.all.v2024.1.Hs.symbols.gmt	SMIRNOV_RESPONSE_TO_IR_6HR_UP	2/168	1.592432e-01	3.051033e-01	3.560182e+00	6.541202e+00	ATF3;GADD45A
c2.all.v2024.1.Hs.symbols.gmt	SMITH_LIVER_CANCER	1/47	1.810327e-01	3.241495e-01	7.608246e+00	1.300308e+01	CXCL8
c2.all.v2024.1.Hs.symbols.gmt	SMITH_TERT_TARGETS_UP	1/145	4.607088e-01	5.411659e-01	2.437448e+00	1.888995e+00	ATF3
c2.all.v2024.1.Hs.symbols.gmt	SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_DN	2/590	7.173042e-01	7.527327e-01	9.878757e-01	3.282269e-01	DNAJA1;RPL15
c2.all.v2024.1.Hs.symbols.gmt	SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP	5/484	5.486075e-02	1.891562e-01	2.770746e+00	8.043357e+00	RPL39;PABPC3;RPL37A;RPL27A;RPL23
c2.all.v2024.1.Hs.symbols.gmt	SPIRA_SMOKERS_LUNG_CANCER_UP	1/39	1.526892e-01	3.016190e-01	9.192513e+00	1.727596e+01	CXCL8
c2.all.v2024.1.Hs.symbols.gmt	STAEGE_EWING_FAMILY_TUMOR	1/32	1.270940e-01	2.774918e-01	1.123886e+01	2.318384e+01	LINGO1
c2.all.v2024.1.Hs.symbols.gmt	STAMBOLSKY_RESPONSE_TO_VITAMIN_D3_UP	2/84	4.946205e-02	1.805210e-01	7.212613e+00	2.168508e+01	RPS27;CP
c2.all.v2024.1.Hs.symbols.gmt	STARK_PREFRONTAL_CORTEX_22Q11_DELETION_DN	2/524	6.542979e-01	7.002007e-01	1.116074e+00	4.734303e-01	RPL15;LCN2
c2.all.v2024.1.Hs.symbols.gmt	STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP	1/206	5.845913e-01	6.445336e-01	1.709161e+00	9.175500e-01	LINGO1
c2.all.v2024.1.Hs.symbols.gmt	STEARMAN_LUNG_CANCER_EARLY_VS_LATE_DN	2/63	2.933011e-02	1.409738e-01	9.684685e+00	3.417861e+01	LYZ;LCN2
c2.all.v2024.1.Hs.symbols.gmt	STEARMAN_TUMOR_FIELD_EFFECT_UP	2/39	1.188044e-02	8.179077e-02	1.590018e+01	7.048330e+01	LYZ;LCN2
c2.all.v2024.1.Hs.symbols.gmt	STEGER_ADIPOGENESIS_UP	1/21	8.531924e-02	2.270101e-01	1.727807e+01	4.252748e+01	CP
c2.all.v2024.1.Hs.symbols.gmt	STEIN_ESR1_TARGETS	1/83	2.974008e-01	4.100318e-01	4.281283e+00	5.191803e+00	MT-ND4
c2.all.v2024.1.Hs.symbols.gmt	STEIN_ESRRA_TARGETS	1/529	8.969643e-01	9.109384e-01	6.547792e-01	7.120020e-02	ANXA2P3
c2.all.v2024.1.Hs.symbols.gmt	STEIN_ESRRA_TARGETS_DN	1/105	3.602958e-01	4.614602e-01	3.376583e+00	3.446917e+00	ANXA2P3
c2.all.v2024.1.Hs.symbols.gmt	STONER_ESOPHAGEAL_CARCINOGENESIS_UP	1/37	1.454530e-01	2.960146e-01	9.697092e+00	1.869504e+01	PPP1R15A
c2.all.v2024.1.Hs.symbols.gmt	STOSSI_RESPONSE_TO_ESTRADIOL	3/46	9.790819e-04	1.343661e-02	1.939432e+01	1.343812e+02	TCN1;CXCL8;MSMB
c2.all.v2024.1.Hs.symbols.gmt	SUBTIL_PROGESTIN_TARGETS	2/36	1.018406e-02	7.376373e-02	1.728515e+01	7.928582e+01	ATF3;GADD45A
c2.all.v2024.1.Hs.symbols.gmt	SUNG_METASTASIS_STROMA_UP	1/110	3.737942e-01	4.694369e-01	3.221669e+00	3.170283e+00	NEAT1
c2.all.v2024.1.Hs.symbols.gmt	SWEET_KRAS_ONCOGENIC_SIGNATURE	6/89	2.152041e-06	6.322756e-05	1.936476e+01	2.526926e+02	GADD45A;LCN2;RPS2;RACK1;SFTPB;RPL3
c2.all.v2024.1.Hs.symbols.gmt	SWEET_KRAS_TARGETS_UP	1/83	2.974008e-01	4.100318e-01	4.281283e+00	5.191803e+00	TCIM
c2.all.v2024.1.Hs.symbols.gmt	SWEET_LUNG_CANCER_KRAS_DN	3/422	2.653412e-01	3.873350e-01	1.976807e+00	2.622706e+00	CP;SCGB1A1;BPIFB1
c2.all.v2024.1.Hs.symbols.gmt	SWEET_LUNG_CANCER_KRAS_UP	10/484	3.903415e-05	9.332885e-04	5.662946e+00	5.748499e+01	GADD45A;LCN2;MUC1;HSPH1;RPL28;RACK1;SFTPB;RPL3;NUCB2;NAPSA
c2.all.v2024.1.Hs.symbols.gmt	TAKAO_RESPONSE_TO_UVB_RADIATION_UP	5/87	3.439953e-05	8.343886e-04	1.639963e+01	1.685466e+02	UBB;RPL10A;RPL21;RPL27A;RPS5
c2.all.v2024.1.Hs.symbols.gmt	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN	2/150	1.329926e-01	2.836630e-01	3.994995e+00	8.059751e+00	TCN1;S100P
c2.all.v2024.1.Hs.symbols.gmt	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN	5/132	2.479293e-04	4.564721e-03	1.058983e+01	8.792069e+01	TCN1;LTF;NEAT1;SCGB3A1;S100P
c2.all.v2024.1.Hs.symbols.gmt	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP	2/183	1.817885e-01	3.249451e-01	3.263718e+00	5.564350e+00	TCN1;NEAT1
c2.all.v2024.1.Hs.symbols.gmt	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN	1/45	1.740360e-01	3.187349e-01	7.950910e+00	1.390211e+01	NEAT1
c2.all.v2024.1.Hs.symbols.gmt	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN	1/206	5.845913e-01	6.445336e-01	1.709161e+00	9.175500e-01	S100P
c2.all.v2024.1.Hs.symbols.gmt	TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_UP	1/81	2.913885e-01	4.054946e-01	4.388049e+00	5.410894e+00	NUCB2
c2.all.v2024.1.Hs.symbols.gmt	TARTE_PLASMA_CELL_VS_PLASMABLAST_UP	14/398	1.345663e-09	7.797370e-08	1.017245e+01	2.077863e+02	RPL39;SERPINB4;LCN2;CFTR;RPL28;RPL37A;RPS2;RPL23A;LYZ;RPS15A;FTL;RPL18A;CXCL8;S100P
c2.all.v2024.1.Hs.symbols.gmt	TAVAZOIE_METASTASIS	1/108	3.684290e-01	4.655014e-01	3.281905e+00	3.277006e+00	AKAP9
c2.all.v2024.1.Hs.symbols.gmt	TENEDINI_MEGAKARYOCYTE_MARKERS	1/62	2.316716e-01	3.644548e-01	5.748663e+00	8.407042e+00	CXCL8
c2.all.v2024.1.Hs.symbols.gmt	TERAMOTO_OPN_TARGETS_CLUSTER_7	1/18	7.358684e-02	2.123128e-01	2.024278e+01	5.281927e+01	PPP1R15A
c2.all.v2024.1.Hs.symbols.gmt	THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP	2/76	4.132052e-02	1.693553e-01	7.990024e+00	2.545938e+01	RPS27;CXCL8
c2.all.v2024.1.Hs.symbols.gmt	THUM_SYSTOLIC_HEART_FAILURE_UP	6/430	9.947144e-03	7.280611e-02	3.750088e+00	1.728967e+01	GADD45A;NEAT1;RPL3;GAS5;CP;LYZ
c2.all.v2024.1.Hs.symbols.gmt	TIAN_TNF_SIGNALING_NOT_VIA_NFKB	1/22	8.919728e-02	2.334470e-01	1.647370e+01	3.981536e+01	PPP1R15A
c2.all.v2024.1.Hs.symbols.gmt	TIAN_TNF_SIGNALING_VIA_NFKB	1/26	1.045474e-01	2.529999e-01	1.388707e+01	3.135860e+01	CXCL8
c2.all.v2024.1.Hs.symbols.gmt	TIEN_INTESTINE_PROBIOTICS_24HR_DN	18/215	1.297131e-18	1.424114e-16	2.681742e+01	1.104513e+03	AGR2;PPP1R15A;RPL39;HSPH1;RPL37A;RPS2;RPL27A;RACK1;RPL3;ATF3;RPS27;RPL23A;NUCB2;FTL;RPL13A;RPS3;RPL23;S100P
c2.all.v2024.1.Hs.symbols.gmt	TIEN_INTESTINE_PROBIOTICS_24HR_UP	1/561	9.103584e-01	9.222961e-01	6.164807e-01	5.789797e-02	DNAJA1
c2.all.v2024.1.Hs.symbols.gmt	TIEN_INTESTINE_PROBIOTICS_2HR_UP	1/30	1.196416e-01	2.710169e-01	1.200190e+01	2.548310e+01	RPL23
c2.all.v2024.1.Hs.symbols.gmt	TIEN_INTESTINE_PROBIOTICS_6HR_UP	8/53	5.796776e-11	4.169681e-09	4.762872e+01	1.122663e+03	RPL39;RPL37A;RPS2;RPL27A;RPS27;RPL23A;RPL23;FTL
c2.all.v2024.1.Hs.symbols.gmt	TOMIDA_METASTASIS_UP	1/26	1.045474e-01	2.529999e-01	1.388707e+01	3.135860e+01	TMSB4X
c2.all.v2024.1.Hs.symbols.gmt	TOMLINS_PROSTATE_CANCER_UP	2/40	1.247157e-02	8.365174e-02	1.548649e+01	6.789746e+01	RPL31;RACK1
c2.all.v2024.1.Hs.symbols.gmt	TONG_INTERACT_WITH_PTTG1	1/57	2.151460e-01	3.519958e-01	6.258814e+00	9.616282e+00	RPL31
c2.all.v2024.1.Hs.symbols.gmt	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP	1/159	4.920314e-01	5.664335e-01	2.220736e+00	1.574974e+00	ANXA2P3
c2.all.v2024.1.Hs.symbols.gmt	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP	2/184	1.833089e-01	3.264510e-01	3.245687e+00	5.506575e+00	TCN1;CXCL8
c2.all.v2024.1.Hs.symbols.gmt	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP	1/203	5.792178e-01	6.406406e-01	1.734720e+00	9.472902e-01	MMP10
c2.all.v2024.1.Hs.symbols.gmt	TOOKER_GEMCITABINE_RESISTANCE_UP	2/80	4.532280e-02	1.752896e-01	7.581511e+00	2.345678e+01	RPL28;RPL15
c2.all.v2024.1.Hs.symbols.gmt	TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_UP	1/274	6.897237e-01	7.281192e-01	1.280226e+00	4.755580e-01	NEAT1
c2.all.v2024.1.Hs.symbols.gmt	TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C	2/454	5.759873e-01	6.387611e-01	1.292907e+00	7.132576e-01	SYNE2;RPL23
c2.all.v2024.1.Hs.symbols.gmt	TRAYNOR_RETT_SYNDROM_UP	1/40	1.562845e-01	3.038299e-01	8.959385e+00	1.662931e+01	MMP10
c2.all.v2024.1.Hs.symbols.gmt	TSENG_IRS1_TARGETS_UP	1/116	3.896207e-01	4.837791e-01	3.053476e+00	2.878150e+00	GAS5
c2.all.v2024.1.Hs.symbols.gmt	TSUNODA_CISPLATIN_RESISTANCE_DN	2/50	1.905920e-02	1.086270e-01	1.228782e+01	4.866231e+01	TCIM;S100P
c2.all.v2024.1.Hs.symbols.gmt	TUOMISTO_TUMOR_SUPPRESSION_BY_COL13A1_UP	1/20	8.142487e-02	2.220291e-01	1.816495e+01	4.555906e+01	LYZ
c2.all.v2024.1.Hs.symbols.gmt	TURASHVILI_BREAST_CARCINOMA_DUCTAL_VS_LOBULAR_DN	1/7	2.928011e-02	1.409738e-01	5.452694e+01	1.925263e+02	NEAT1
c2.all.v2024.1.Hs.symbols.gmt	TURASHVILI_BREAST_CARCINOMA_DUCTAL_VS_LOBULAR_UP	2/24	4.610932e-03	4.094125e-02	2.651832e+01	1.426507e+02	S100P;BPIFB1
c2.all.v2024.1.Hs.symbols.gmt	TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN	4/206	1.148731e-02	8.068189e-02	5.376673e+00	2.401498e+01	ATF3;CP;TCIM;LTF
c2.all.v2024.1.Hs.symbols.gmt	TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_DN	2/73	3.841218e-02	1.648720e-01	8.326403e+00	2.713892e+01	ATF3;RPL31
c2.all.v2024.1.Hs.symbols.gmt	TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_DN	2/92	5.812907e-02	1.930848e-01	6.572644e+00	1.869976e+01	CP;PIP
c2.all.v2024.1.Hs.symbols.gmt	TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_UP	1/69	2.542306e-01	3.790744e-01	5.159569e+00	7.066100e+00	LYZ
c2.all.v2024.1.Hs.symbols.gmt	TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN	2/74	3.937255e-02	1.669332e-01	8.211184e+00	2.656060e+01	NEAT1;LYZ
c2.all.v2024.1.Hs.symbols.gmt	TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_UP	1/96	3.352693e-01	4.401332e-01	3.696307e+00	4.039403e+00	PIP
c2.all.v2024.1.Hs.symbols.gmt	TURASHVILI_BREAST_NORMAL_DUCTAL_VS_LOBULAR_UP	1/66	2.446439e-01	3.725015e-01	5.396620e+00	7.598181e+00	ATF3
c2.all.v2024.1.Hs.symbols.gmt	UDAYAKUMAR_MED1_TARGETS_DN	2/244	2.766541e-01	3.950037e-01	2.435943e+00	3.130156e+00	ATF3;GADD45A
c2.all.v2024.1.Hs.symbols.gmt	UEDA_CENTRAL_CLOCK	2/90	5.591546e-02	1.912125e-01	6.721790e+00	1.938507e+01	HSPH1;GADD45A
c2.all.v2024.1.Hs.symbols.gmt	UEDA_PERIFERAL_CLOCK	3/171	3.619576e-02	1.619087e-01	4.978466e+00	1.652260e+01	HSP90AA1;DNAJA1;HSPH1
c2.all.v2024.1.Hs.symbols.gmt	UNTERMAN_IPF_VS_CTRL_B_CELL_DN	1/36	1.418120e-01	2.920236e-01	9.970701e+00	1.947530e+01	PPP1R15A
c2.all.v2024.1.Hs.symbols.gmt	UNTERMAN_PROGRESSIVE_VS_STABLE_IPF_MONOCYTE_DN	1/27	1.083448e-01	2.588857e-01	1.336243e+01	2.969714e+01	CXCL8
c2.all.v2024.1.Hs.symbols.gmt	UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN	2/36	1.018406e-02	7.376373e-02	1.728515e+01	7.928582e+01	ATF3;CXCL8
c2.all.v2024.1.Hs.symbols.gmt	VALK_AML_CLUSTER_1	1/29	1.158918e-01	2.689103e-01	1.242359e+01	2.677405e+01	ATF3
c2.all.v2024.1.Hs.symbols.gmt	VALK_AML_WITH_CEBPA	2/37	1.073657e-02	7.643853e-02	1.679749e+01	7.616148e+01	LCN2;LTF
c2.all.v2024.1.Hs.symbols.gmt	VANASSE_BCL2_TARGETS_DN	1/61	2.283943e-01	3.623045e-01	5.843947e+00	8.629651e+00	LYZ
c2.all.v2024.1.Hs.symbols.gmt	VANDESLUIS_COMMD1_TARGETS_GROUP_3_DN	2/37	1.073657e-02	7.643853e-02	1.679749e+01	7.616148e+01	TMSB4X;CP
c2.all.v2024.1.Hs.symbols.gmt	VANHARANTA_UTERINE_FIBROID_DN	1/67	2.478529e-01	3.751968e-01	5.315227e+00	7.414315e+00	ATF3
c2.all.v2024.1.Hs.symbols.gmt	VANOEVELEN_MYOGENESIS_SIN3A_TARGETS	1/221	6.104575e-01	6.632366e-01	1.591800e+00	7.856278e-01	FTL
c2.all.v2024.1.Hs.symbols.gmt	VANTVEER_BREAST_CANCER_BRCA1_DN	1/41	1.598648e-01	3.051033e-01	8.737770e+00	1.602006e+01	RPL23A
c2.all.v2024.1.Hs.symbols.gmt	VANTVEER_BREAST_CANCER_METASTASIS_DN	1/109	3.711172e-01	4.672001e-01	3.251509e+00	3.223017e+00	CP
c2.all.v2024.1.Hs.symbols.gmt	VARELA_ZMPSTE24_TARGETS_DN	1/42	1.634300e-01	3.095469e-01	8.526835e+00	1.544526e+01	LYZ
c2.all.v2024.1.Hs.symbols.gmt	VARELA_ZMPSTE24_TARGETS_UP	2/44	1.496131e-02	9.469072e-02	1.402639e+01	5.894293e+01	ATF3;GADD45A
c2.all.v2024.1.Hs.symbols.gmt	VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN	1/135	4.371730e-01	5.214082e-01	2.619864e+00	2.167744e+00	CXCL8
c2.all.v2024.1.Hs.symbols.gmt	VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_DN	3/146	2.420495e-02	1.276895e-01	5.852459e+00	2.177816e+01	S100P;MUC1;CFTR
c2.all.v2024.1.Hs.symbols.gmt	VECCHI_GASTRIC_CANCER_EARLY_DN	1/382	8.051662e-01	8.310622e-01	9.132611e-01	1.979097e-01	BPIFA1
c2.all.v2024.1.Hs.symbols.gmt	VECCHI_GASTRIC_CANCER_EARLY_UP	6/436	1.060020e-02	7.598630e-02	3.696798e+00	1.680891e+01	HSPH1;LCN2;CFTR;NEAT1;GAS5;CXCL8
c2.all.v2024.1.Hs.symbols.gmt	VERHAAK_AML_WITH_NPM1_MUTATED_DN	4/250	2.178738e-02	1.183554e-01	4.408067e+00	1.686713e+01	TCN1;S100P;LCN2;LTF
c2.all.v2024.1.Hs.symbols.gmt	VIETOR_IFRD1_TARGETS	1/24	9.690462e-02	2.420875e-01	1.507032e+01	3.517454e+01	RPS15A
c2.all.v2024.1.Hs.symbols.gmt	VILIMAS_NOTCH1_TARGETS_DN	1/27	1.083448e-01	2.588857e-01	1.336243e+01	2.969714e+01	LYZ
c2.all.v2024.1.Hs.symbols.gmt	VILLANUEVA_LIVER_CANCER_KRT19_DN	1/63	2.349352e-01	3.662742e-01	5.656428e+00	8.193028e+00	GADD45A
c2.all.v2024.1.Hs.symbols.gmt	VISALA_AGING_LYMPHOCYTE_UP	1/7	2.928011e-02	1.409738e-01	5.452694e+01	1.925263e+02	TMSB4X
c2.all.v2024.1.Hs.symbols.gmt	VISALA_RESPONSE_TO_HEAT_SHOCK_AND_AGING_DN	1/13	5.370110e-02	1.861898e-01	2.834631e+01	8.289373e+01	PDIA3P1
c2.all.v2024.1.Hs.symbols.gmt	VISALA_RESPONSE_TO_HEAT_SHOCK_AND_AGING_UP	1/15	6.170557e-02	1.980274e-01	2.443426e+01	6.805873e+01	NEAT1
c2.all.v2024.1.Hs.symbols.gmt	WACKER_HYPOXIA_TARGETS_OF_VHL	1/13	5.370110e-02	1.861898e-01	2.834631e+01	8.289373e+01	CP
c2.all.v2024.1.Hs.symbols.gmt	WAGSCHAL_EHMT2_TARGETS_UP	1/14	5.771174e-02	1.926187e-01	2.624540e+01	7.485960e+01	CFTR
c2.all.v2024.1.Hs.symbols.gmt	WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_8D	1/646	9.381374e-01	9.465753e-01	5.331895e-01	3.404885e-02	UBB
c2.all.v2024.1.Hs.symbols.gmt	WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_8D	3/865	7.146974e-01	7.514409e-01	9.418262e-01	3.163557e-01	GADD45A;RPS2;RACK1
c2.all.v2024.1.Hs.symbols.gmt	WALLACE_PROSTATE_CANCER_RACE_DN	1/86	3.063248e-01	4.155997e-01	4.130500e+00	4.886833e+00	RPL37A
c2.all.v2024.1.Hs.symbols.gmt	WALLACE_PROSTATE_CANCER_RACE_UP	4/303	3.995630e-02	1.683815e-01	3.619209e+00	1.165374e+01	SFTPA2;LYZ;SCGB1A1;TCIM
c2.all.v2024.1.Hs.symbols.gmt	WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_UP	2/140	1.188908e-01	2.710169e-01	4.285394e+00	9.125961e+00	LYZ;MUC1
c2.all.v2024.1.Hs.symbols.gmt	WAMUNYOKOLI_OVARIAN_CANCER_LMP_UP	4/270	2.787858e-02	1.391261e-01	4.073523e+00	1.458279e+01	AGR2;MT-ATP6;MUC1;HSP90AA1
c2.all.v2024.1.Hs.symbols.gmt	WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_DN	1/37	1.454530e-01	2.960146e-01	9.697092e+00	1.869504e+01	SERPINB3
c2.all.v2024.1.Hs.symbols.gmt	WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_UP	2/26	5.399779e-03	4.578837e-02	2.435135e+01	1.271481e+02	AGR2;LYZ
c2.all.v2024.1.Hs.symbols.gmt	WANG_BARRETTS_ESOPHAGUS_UP	2/52	2.051847e-02	1.144446e-01	1.180011e+01	4.586029e+01	TMSB4X;S100P
c2.all.v2024.1.Hs.symbols.gmt	WANG_CISPLATIN_RESPONSE_AND_XPC_DN	1/219	6.071030e-01	6.615155e-01	1.606517e+00	8.017436e-01	GADD45A
c2.all.v2024.1.Hs.symbols.gmt	WANG_CLIM2_TARGETS_UP	2/270	3.173391e-01	4.248841e-01	2.197443e+00	2.522191e+00	NEAT1;GAS5
c2.all.v2024.1.Hs.symbols.gmt	WANG_ESOPHAGUS_CANCER_VS_NORMAL_DN	1/101	3.492901e-01	4.522776e-01	3.511613e+00	3.693699e+00	NUCB2
c2.all.v2024.1.Hs.symbols.gmt	WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP	1/121	4.025067e-01	4.944812e-01	2.926110e+00	2.662887e+00	ATF3
c2.all.v2024.1.Hs.symbols.gmt	WANG_HCP_PROSTATE_CANCER	5/106	8.856217e-05	1.904543e-03	1.331824e+01	1.242833e+02	PPP1R15A;MUC1;RPL28;ATF3;S100P
c2.all.v2024.1.Hs.symbols.gmt	WANG_LMO4_TARGETS_DN	4/361	6.738304e-02	2.043038e-01	3.023969e+00	8.156740e+00	NEAT1;GADD45A;RPL23;AKAP9
c2.all.v2024.1.Hs.symbols.gmt	WANG_LMO4_TARGETS_UP	3/371	2.081124e-01	3.470081e-01	2.255689e+00	3.540703e+00	NEAT1;AGR2;GAS5
c2.all.v2024.1.Hs.symbols.gmt	WANG_LSD1_TARGETS_DN	1/37	1.454530e-01	2.960146e-01	9.697092e+00	1.869504e+01	GADD45A
c2.all.v2024.1.Hs.symbols.gmt	WANG_METHYLATED_IN_BREAST_CANCER	1/35	1.381557e-01	2.876176e-01	1.026017e+01	2.030872e+01	GADD45A
c2.all.v2024.1.Hs.symbols.gmt	WANG_NEOPLASTIC_TRANSFORMATION_BY_CCND1_MYC	1/22	8.919728e-02	2.334470e-01	1.647370e+01	3.981536e+01	ATF3
c2.all.v2024.1.Hs.symbols.gmt	WANG_RECURRENT_LIVER_CANCER_UP	1/20	8.142487e-02	2.220291e-01	1.816495e+01	4.555906e+01	RPL10A
c2.all.v2024.1.Hs.symbols.gmt	WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN	3/371	2.081124e-01	3.470081e-01	2.255689e+00	3.540703e+00	HSP90AA1;DNAJA1;HSPH1
c2.all.v2024.1.Hs.symbols.gmt	WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_UP	4/392	8.520478e-02	2.270101e-01	2.778707e+00	6.843115e+00	RPL28;CCDC146;RPL31;RPL21
c2.all.v2024.1.Hs.symbols.gmt	WANG_SMARCE1_TARGETS_DN	2/385	4.871323e-01	5.629684e-01	1.530392e+00	1.100688e+00	HSPH1;CXCL8
c2.all.v2024.1.Hs.symbols.gmt	WANG_SMARCE1_TARGETS_UP	4/294	3.640889e-02	1.619087e-01	3.732876e+00	1.236680e+01	GAS5;SERPINB3;SERPINB4;TCIM
c2.all.v2024.1.Hs.symbols.gmt	WANG_TARGETS_OF_MLL_CBP_FUSION_UP	1/45	1.740360e-01	3.187349e-01	7.950910e+00	1.390211e+01	RPL23A
c2.all.v2024.1.Hs.symbols.gmt	WANG_TUMOR_INVASIVENESS_DN	2/211	2.249498e-01	3.589947e-01	2.823905e+00	4.212922e+00	RPL3;CP
c2.all.v2024.1.Hs.symbols.gmt	WANG_TUMOR_INVASIVENESS_UP	11/384	6.896861e-07	2.320460e-05	8.011070e+00	1.136533e+02	RPS29;HSPH1;RPL21;RPL28;RPL27A;RPL32;RPS5;RPL13A;RPS3;RPL18A;RPS15A
c2.all.v2024.1.Hs.symbols.gmt	WARTERS_IR_RESPONSE_5GY	2/50	1.905920e-02	1.086270e-01	1.228782e+01	4.866231e+01	ATF3;GADD45A
c2.all.v2024.1.Hs.symbols.gmt	WATANABE_COLON_CANCER_MSI_VS_MSS_DN	1/69	2.542306e-01	3.790744e-01	5.159569e+00	7.066100e+00	CFTR
c2.all.v2024.1.Hs.symbols.gmt	WATANABE_COLON_CANCER_MSI_VS_MSS_UP	1/30	1.196416e-01	2.710169e-01	1.200190e+01	2.548310e+01	AGR2
c2.all.v2024.1.Hs.symbols.gmt	WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_UP	2/113	8.306880e-02	2.253336e-01	5.329657e+00	1.326065e+01	RPS27;CFTR
c2.all.v2024.1.Hs.symbols.gmt	WEIGEL_OXIDATIVE_STRESS_BY_TBH_AND_H2O2	1/35	1.381557e-01	2.876176e-01	1.026017e+01	2.030872e+01	RPL13A
c2.all.v2024.1.Hs.symbols.gmt	WEI_MIR34A_TARGETS	1/146	4.630082e-01	5.422993e-01	2.420585e+00	1.863876e+00	RPL28
c2.all.v2024.1.Hs.symbols.gmt	WEI_MYCN_TARGETS_WITH_E_BOX	1/792	9.673973e-01	9.701878e-01	4.318781e-01	1.431506e-02	HSPH1
c2.all.v2024.1.Hs.symbols.gmt	WELCH_GATA1_TARGETS	1/25	1.007341e-01	2.483821e-01	1.445455e+01	3.317710e+01	FTL
c2.all.v2024.1.Hs.symbols.gmt	WENG_POR_TARGETS_GLOBAL_DN	1/25	1.007341e-01	2.483821e-01	1.445455e+01	3.317710e+01	HSPH1
c2.all.v2024.1.Hs.symbols.gmt	WENG_POR_TARGETS_LIVER_DN	1/23	9.305905e-02	2.367331e-01	1.574082e+01	3.737691e+01	HSPH1
c2.all.v2024.1.Hs.symbols.gmt	WESTON_VEGFA_TARGETS	1/95	3.324294e-01	4.388910e-01	3.735591e+00	4.114110e+00	MMP10
c2.all.v2024.1.Hs.symbols.gmt	WESTON_VEGFA_TARGETS_3HR	1/66	2.446439e-01	3.725015e-01	5.396620e+00	7.598181e+00	MMP10
c2.all.v2024.1.Hs.symbols.gmt	WEST_ADRENOCORTICAL_TUMOR_DN	4/546	2.011636e-01	3.434199e-01	1.975798e+00	3.168461e+00	UBB;RPL39;RPL23A;RPL23
c2.all.v2024.1.Hs.symbols.gmt	WEST_ADRENOCORTICAL_TUMOR_UP	1/298	7.201487e-01	7.548895e-01	1.175653e+00	3.859640e-01	GADD45A
c2.all.v2024.1.Hs.symbols.gmt	WHITESIDE_CISPLATIN_RESISTANCE_DN	2/13	1.343168e-03	1.657898e-02	5.190952e+01	3.432633e+02	RPS5;RPL13A
c2.all.v2024.1.Hs.symbols.gmt	WHITFIELD_CELL_CYCLE_G1_S	2/133	1.092633e-01	2.607818e-01	4.514952e+00	9.996080e+00	NEAT1;SERPINB3
c2.all.v2024.1.Hs.symbols.gmt	WHITFIELD_CELL_CYCLE_G2	1/168	5.112097e-01	5.814522e-01	2.100551e+00	1.409418e+00	MUC1
c2.all.v2024.1.Hs.symbols.gmt	WHITFIELD_CELL_CYCLE_G2_M	2/198	2.047764e-01	3.444123e-01	3.012516e+00	4.777358e+00	DNAJA1;GADD45A
c2.all.v2024.1.Hs.symbols.gmt	WHITFIELD_CELL_CYCLE_M_G1	1/126	4.151235e-01	5.028732e-01	2.808893e+00	2.469520e+00	RPL13A
c2.all.v2024.1.Hs.symbols.gmt	WHITFIELD_CELL_CYCLE_S	1/150	4.721089e-01	5.501783e-01	2.355391e+00	1.767829e+00	NEAT1
c2.all.v2024.1.Hs.symbols.gmt	WIEDERSCHAIN_TARGETS_OF_BMI1_AND_PCGF2	1/57	2.151460e-01	3.519958e-01	6.258814e+00	9.616282e+00	GADD45A
c2.all.v2024.1.Hs.symbols.gmt	WIELAND_UP_BY_HBV_INFECTION	1/103	3.548162e-01	4.560360e-01	3.442781e+00	3.567256e+00	LYZ
c2.all.v2024.1.Hs.symbols.gmt	WIERENGA_PML_INTERACTOME	3/42	7.495543e-04	1.124871e-02	2.136218e+01	1.537229e+02	RPL3;RPS27;RPS3
c2.all.v2024.1.Hs.symbols.gmt	WIERENGA_STAT5A_TARGETS_DN	3/193	4.883827e-02	1.805210e-01	4.399108e+00	1.328197e+01	GPX1;LYZ;LCN2
c2.all.v2024.1.Hs.symbols.gmt	WIERENGA_STAT5A_TARGETS_GROUP1	1/127	4.176151e-01	5.044268e-01	2.786561e+00	2.433212e+00	MUC1
c2.all.v2024.1.Hs.symbols.gmt	WIERENGA_STAT5A_TARGETS_GROUP2	1/54	2.050624e-01	3.444123e-01	6.610675e+00	1.047423e+01	CXCL8
c2.all.v2024.1.Hs.symbols.gmt	WIERENGA_STAT5A_TARGETS_UP	2/202	2.109632e-01	3.500892e-01	2.951877e+00	4.593331e+00	MUC1;CXCL8
c2.all.v2024.1.Hs.symbols.gmt	WILCOX_RESPONSE_TO_PROGESTERONE_DN	1/62	2.316716e-01	3.644548e-01	5.748663e+00	8.407042e+00	AKAP9
c2.all.v2024.1.Hs.symbols.gmt	WILLERT_WNT_SIGNALING	1/23	9.305905e-02	2.367331e-01	1.574082e+01	3.737691e+01	RPL27A
c2.all.v2024.1.Hs.symbols.gmt	WILLIAMS_ESR2_TARGETS_DN	1/11	4.562907e-02	1.752896e-01	3.374866e+01	1.041892e+02	RPL21
c2.all.v2024.1.Hs.symbols.gmt	WINNEPENNINCKX_MELANOMA_METASTASIS_UP	1/162	4.985055e-01	5.707368e-01	2.179186e+00	1.517020e+00	DNAJA1
c2.all.v2024.1.Hs.symbols.gmt	WINTER_HYPOXIA_METAGENE	6/243	5.908149e-04	9.129184e-03	6.760618e+00	5.025849e+01	MT-CO2;HSPH1;MUC1;CP;FTL;CXCL8
c2.all.v2024.1.Hs.symbols.gmt	WINTER_HYPOXIA_UP	1/95	3.324294e-01	4.388910e-01	3.735591e+00	4.114110e+00	CXCL8
c2.all.v2024.1.Hs.symbols.gmt	WINZEN_DEGRADED_VIA_KHSRP	1/100	3.465095e-01	4.500740e-01	3.547067e+00	3.759341e+00	CXCL8
c2.all.v2024.1.Hs.symbols.gmt	WNT_SIGNALING	1/89	3.151367e-01	4.222062e-01	3.989939e+00	4.607378e+00	RPL13A
c2.all.v2024.1.Hs.symbols.gmt	WONG_ADULT_TISSUE_STEM_MODULE	2/721	8.142490e-01	8.383630e-01	8.030915e-01	1.650265e-01	ATF3;PPP1R15A
c2.all.v2024.1.Hs.symbols.gmt	WONG_EMBRYONIC_STEM_CELL_CORE	5/335	1.400554e-02	9.101418e-02	4.047592e+00	1.727635e+01	RPL10A;RPL27A;RPS27;RPS5;RPS3
c2.all.v2024.1.Hs.symbols.gmt	WONG_ENDMETRIUM_CANCER_UP	2/25	4.998126e-03	4.344205e-02	2.538873e+01	1.345271e+02	LCN2;LTF
c2.all.v2024.1.Hs.symbols.gmt	WONG_MITOCHONDRIA_GENE_MODULE	1/218	6.054150e-01	6.601650e-01	1.613978e+00	8.099602e-01	CP
c2.all.v2024.1.Hs.symbols.gmt	WOOD_EBV_EBNA1_TARGETS_DN	1/48	1.845090e-01	3.264510e-01	7.447734e+00	1.258710e+01	S100P
c2.all.v2024.1.Hs.symbols.gmt	WOO_LIVER_CANCER_RECURRENCE_UP	1/105	3.602958e-01	4.614602e-01	3.376583e+00	3.446917e+00	CXCL8
c2.all.v2024.1.Hs.symbols.gmt	WP_10Q22Q23_COPY_NUMBER_VARIATION	1/64	2.381851e-01	3.674956e-01	5.567098e+00	7.987156e+00	RSPH1
c2.all.v2024.1.Hs.symbols.gmt	WP_13Q1212_COPY_NUMBER_VARIATION	1/34	1.344840e-01	2.842285e-01	1.056692e+01	2.120053e+01	LINGO1
c2.all.v2024.1.Hs.symbols.gmt	WP_17Q12_COPY_NUMBER_VARIATION_SYNDROME	1/99	3.437172e-01	4.481213e-01	3.583241e+00	3.826671e+00	RPL23
c2.all.v2024.1.Hs.symbols.gmt	WP_5Q35_COPY_NUMBER_VARIATION	2/111	8.057038e-02	2.220291e-01	5.427496e+00	1.366982e+01	MT-CO3;MT-CO2
c2.all.v2024.1.Hs.symbols.gmt	WP_7Q1123_COPY_NUMBER_VARIATION_SYNDROME	1/106	3.630183e-01	4.614602e-01	3.344426e+00	3.388913e+00	MT-ATP6
c2.all.v2024.1.Hs.symbols.gmt	WP_ADHD_AND_AUTISM_ASD_PATHWAYS	1/367	7.921301e-01	8.192283e-01	9.512953e-01	2.216799e-01	TCN1
c2.all.v2024.1.Hs.symbols.gmt	WP_ADIPOGENESIS	1/131	4.274766e-01	5.130704e-01	2.700658e+00	2.295169e+00	GADD45A
c2.all.v2024.1.Hs.symbols.gmt	WP_ALLOGRAFT_REJECTION	1/89	3.151367e-01	4.222062e-01	3.989939e+00	4.607378e+00	CXCL8
c2.all.v2024.1.Hs.symbols.gmt	WP_ALTERED_GLYCOSYLATION_OF_MUC1_IN_TUMOR_MICROENVIRONMENT	1/9	3.748893e-02	1.619087e-01	4.169330e+01	1.369087e+02	MUC1
c2.all.v2024.1.Hs.symbols.gmt	WP_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS	1/38	1.490787e-01	3.001720e-01	9.438075e+00	1.796331e+01	GPX1
c2.all.v2024.1.Hs.symbols.gmt	WP_ANDROGEN_RECEPTOR_SIGNALING	1/91	3.209496e-01	4.283435e-01	3.901409e+00	4.433839e+00	RACK1
c2.all.v2024.1.Hs.symbols.gmt	WP_ANGIOTENSIN_II_RECEPTOR_TYPE_1_PATHWAY	1/28	1.121262e-01	2.639902e-01	1.287594e+01	2.817422e+01	RACK1
c2.all.v2024.1.Hs.symbols.gmt	WP_ANTIVIRAL_AND_ANTIINFLAMMATORY_EFFECTS_OF_NRF2_ON_SARSCOV2_PATHWAY	1/32	1.270940e-01	2.774918e-01	1.123886e+01	2.318384e+01	CXCL8
c2.all.v2024.1.Hs.symbols.gmt	WP_ARSENIC_METABOLISM_AND_REACTIVE_OXYGEN_SPECIES_GENERATION	1/11	4.562907e-02	1.752896e-01	3.374866e+01	1.041892e+02	MT-ND1
c2.all.v2024.1.Hs.symbols.gmt	WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2586	1/46	1.775417e-01	3.214861e-01	7.775812e+00	1.344088e+01	HSP90AA1
c2.all.v2024.1.Hs.symbols.gmt	WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2873	1/45	1.740360e-01	3.187349e-01	7.950910e+00	1.390211e+01	HSP90AA1
c2.all.v2024.1.Hs.symbols.gmt	WP_ATM_SIGNALING	1/40	1.562845e-01	3.038299e-01	8.959385e+00	1.662931e+01	GADD45A
c2.all.v2024.1.Hs.symbols.gmt	WP_BLADDER_CANCER	1/40	1.562845e-01	3.038299e-01	8.959385e+00	1.662931e+01	CXCL8
c2.all.v2024.1.Hs.symbols.gmt	WP_BRAINDERIVED_NEUROTROPHIC_FACTOR_BDNF_SIGNALING	2/144	1.244849e-01	2.759569e-01	4.164343e+00	8.676705e+00	RACK1;LINGO1
c2.all.v2024.1.Hs.symbols.gmt	WP_BREAST_CANCER_PATHWAY	1/154	4.810570e-01	5.581117e-01	2.293595e+00	1.678383e+00	GADD45A
c2.all.v2024.1.Hs.symbols.gmt	WP_BURN_WOUND_HEALING	3/113	1.231922e-02	8.365174e-02	7.611676e+00	3.346545e+01	GAS5;CXCL8;MIR4485
c2.all.v2024.1.Hs.symbols.gmt	WP_CANCER_PATHWAYS	3/507	3.637083e-01	4.620558e-01	1.637303e+00	1.655973e+00	HSP90AA1;GADD45A;CXCL8
c2.all.v2024.1.Hs.symbols.gmt	WP_CCL18_SIGNALING	2/52	2.051847e-02	1.144446e-01	1.180011e+01	4.586029e+01	ATF3;MT-CO2
c2.all.v2024.1.Hs.symbols.gmt	WP_CELLS_AND_MOLECULES_INVOLVED_IN_LOCAL_ACUTE_INFLAMMATORY_RESPONSE	1/17	6.964305e-02	2.057725e-01	2.147059e+01	5.720564e+01	CXCL8
c2.all.v2024.1.Hs.symbols.gmt	WP_CELL_CYCLE	1/120	3.999512e-01	4.927929e-01	2.950731e+00	2.704087e+00	GADD45A
c2.all.v2024.1.Hs.symbols.gmt	WP_CHROMOSOMAL_AND_MICROSATELLITE_INSTABILITY_IN_COLORECTAL_CANCER	1/73	2.668259e-01	3.878738e-01	4.874018e+00	6.439352e+00	GADD45A
c2.all.v2024.1.Hs.symbols.gmt	WP_CHRONIC_HYPERGLYCEMIA_IMPAIRMENT_OF_NEURON_FUNCTION	1/46	1.775417e-01	3.214861e-01	7.775812e+00	1.344088e+01	MMP10
c2.all.v2024.1.Hs.symbols.gmt	WP_CILIARY_LANDSCAPE	1/215	6.003080e-01	6.570003e-01	1.636775e+00	8.352666e-01	LCN2
c2.all.v2024.1.Hs.symbols.gmt	WP_CILIOPATHIES	3/184	4.343448e-02	1.742391e-01	4.619142e+00	1.448795e+01	DNAAF1;RSPH1;CFAP298
c2.all.v2024.1.Hs.symbols.gmt	WP_CIRCADIAN_RHYTHM_GENES	1/201	5.755972e-01	6.386680e-01	1.752184e+00	9.678136e-01	SFTPC
c2.all.v2024.1.Hs.symbols.gmt	WP_COMPLEMENT_SYSTEM	2/96	6.264599e-02	2.001510e-01	6.293293e+00	1.743403e+01	SFTPA2;SFTPA1
c2.all.v2024.1.Hs.symbols.gmt	WP_CONSTITUTIVE_ANDROSTANE_RECEPTOR_PATHWAY	1/31	1.233756e-01	2.740804e-01	1.160787e+01	2.428973e+01	HSP90AA1
c2.all.v2024.1.Hs.symbols.gmt	WP_CORTICOTROPINRELEASING_HORMONE_SIGNALING	2/92	5.812907e-02	1.930848e-01	6.572644e+00	1.869976e+01	HSP90AA1;CXCL8
c2.all.v2024.1.Hs.symbols.gmt	WP_COVID19_ADVERSE_OUTCOME_PATHWAY	1/15	6.170557e-02	1.980274e-01	2.443426e+01	6.805873e+01	CXCL8
c2.all.v2024.1.Hs.symbols.gmt	WP_COVID19_STRUCTURAL_COVERAGE_MAP	1/26	1.045474e-01	2.529999e-01	1.388707e+01	3.135860e+01	UBB
c2.all.v2024.1.Hs.symbols.gmt	WP_CYTOKINECYTOKINE_RECEPTOR_INTERACTION	1/254	6.618868e-01	7.073237e-01	1.382495e+00	5.705015e-01	CXCL8
c2.all.v2024.1.Hs.symbols.gmt	WP_CYTOPLASMIC_RIBOSOMAL_PROTEINS	20/88	9.776948e-30	5.098678e-27	8.849758e+01	5.911419e+03	RPS29;RPL37A;RPS2;RPL31;RPL3;RPS27;RPS3;RPL21;RPL28;RPL15;RPL13A;RPL39;RPL23;RPS5;RPL18A;RPS15A;RPL10A;RPL27A;RPL23A;RPL32
c2.all.v2024.1.Hs.symbols.gmt	WP_DNA_DAMAGE_RESPONSE	1/69	2.542306e-01	3.790744e-01	5.159569e+00	7.066100e+00	GADD45A
c2.all.v2024.1.Hs.symbols.gmt	WP_DUAL_HIJACK_MODEL_OF_VIF_IN_HIV_INFECTION	1/8	3.339314e-02	1.542150e-01	4.725455e+01	1.606373e+02	UBB
c2.all.v2024.1.Hs.symbols.gmt	WP_EBSTEINBARR_VIRUS_LMP1_SIGNALING	2/23	4.238325e-03	3.848016e-02	2.775299e+01	1.516309e+02	HSP90AA1;CXCL8
c2.all.v2024.1.Hs.symbols.gmt	WP_EGFEGFR_SIGNALING	1/162	4.985055e-01	5.707368e-01	2.179186e+00	1.517020e+00	MT-CO2
c2.all.v2024.1.Hs.symbols.gmt	WP_ELECTRON_TRANSPORT_CHAIN_OXPHOS_SYSTEM_IN_MITOCHONDRIA	9/105	6.386997e-10	3.806650e-08	2.533391e+01	5.363591e+02	MT-CYB;MT-CO3;MT-CO2;MT-ND5;MT-ND1;MT-ATP6;MT-ND3;MT-ND4;MT-ND2
c2.all.v2024.1.Hs.symbols.gmt	WP_ENDOMETRIAL_CANCER	1/63	2.349352e-01	3.662742e-01	5.656428e+00	8.193028e+00	GADD45A
c2.all.v2024.1.Hs.symbols.gmt	WP_ENDOPLASMIC_RETICULUM_STRESS_RESPONSE_IN_CORONAVIRUS_INFECTION	1/46	1.775417e-01	3.214861e-01	7.775812e+00	1.344088e+01	PPP1R15A
c2.all.v2024.1.Hs.symbols.gmt	WP_ENDOTHELIN_PATHWAYS	1/33	1.307967e-01	2.795512e-01	1.089255e+01	2.215666e+01	MT-CO2
c2.all.v2024.1.Hs.symbols.gmt	WP_ENVELOPE_PROTEINS_AND_THEIR_POTENTIAL_ROLES_IN_EDMD_PHYSIOPATHOLOGY	1/46	1.775417e-01	3.214861e-01	7.775812e+00	1.344088e+01	SYNE2
c2.all.v2024.1.Hs.symbols.gmt	WP_EXERCISEINDUCED_CIRCADIAN_REGULATION	1/48	1.845090e-01	3.264510e-01	7.447734e+00	1.258710e+01	DNAJA1
c2.all.v2024.1.Hs.symbols.gmt	WP_EXTRAFOLLICULAR_AND_FOLLICULAR_B_CELL_ACTIVATION_BY_SARSCOV2	1/74	2.699417e-01	3.904982e-01	4.807487e+00	6.295641e+00	NEAT1
c2.all.v2024.1.Hs.symbols.gmt	WP_FATTY_ACIDS_AND_LIPOPROTEINS_TRANSPORT_IN_HEPATOCYTES	1/381	8.043228e-01	8.306027e-01	9.157034e-01	1.993986e-01	CFTR
c2.all.v2024.1.Hs.symbols.gmt	WP_FERROPTOSIS	2/64	3.019419e-02	1.441306e-01	9.529297e+00	3.335355e+01	FTL;CP
c2.all.v2024.1.Hs.symbols.gmt	WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING	1/302	7.249242e-01	7.583710e-01	1.159842e+00	3.731076e-01	HSP90AA1
c2.all.v2024.1.Hs.symbols.gmt	WP_FOLATE_METABOLISM	1/69	2.542306e-01	3.790744e-01	5.159569e+00	7.066100e+00	GPX1
c2.all.v2024.1.Hs.symbols.gmt	WP_G1_TO_S_CELL_CYCLE_CONTROL	1/64	2.381851e-01	3.674956e-01	5.567098e+00	7.987156e+00	GADD45A
c2.all.v2024.1.Hs.symbols.gmt	WP_GASTRIC_CANCER_NETWORK_1	1/28	1.121262e-01	2.639902e-01	1.287594e+01	2.817422e+01	S100P
c2.all.v2024.1.Hs.symbols.gmt	WP_GASTRIN_SIGNALING	1/115	3.870107e-01	4.816852e-01	3.080284e+00	2.924122e+00	CXCL8
c2.all.v2024.1.Hs.symbols.gmt	WP_GENES_TARGETED_BY_MIRNAS_IN_ADIPOCYTES	1/18	7.358684e-02	2.123128e-01	2.024278e+01	5.281927e+01	TMSB4X
c2.all.v2024.1.Hs.symbols.gmt	WP_GLUCOCORTICOID_RECEPTOR_PATHWAY	2/70	3.558664e-02	1.610276e-01	8.692247e+00	2.899547e+01	HSP90AA1;S100P
c2.all.v2024.1.Hs.symbols.gmt	WP_GLUTATHIONE_METABOLISM	1/19	7.751409e-02	2.176237e-01	1.914771e+01	4.896635e+01	GPX1
c2.all.v2024.1.Hs.symbols.gmt	WP_G_PROTEIN_SIGNALING	1/91	3.209496e-01	4.283435e-01	3.901409e+00	4.433839e+00	AKAP9
c2.all.v2024.1.Hs.symbols.gmt	WP_HDAC6_INTERACTIONS_IN_THE_CENTRAL_NERVOUS_SYSTEM	3/113	1.231922e-02	8.365174e-02	7.611676e+00	3.346545e+01	HSP90AA1;DNAJA1;CFTR
c2.all.v2024.1.Hs.symbols.gmt	WP_HEMATOPOIETIC_STEM_CELL_DIFFERENTIATION	1/63	2.349352e-01	3.662742e-01	5.656428e+00	8.193028e+00	MUC1
c2.all.v2024.1.Hs.symbols.gmt	WP_HEPATITIS_B_INFECTION	1/151	4.743601e-01	5.521848e-01	2.339634e+00	1.744872e+00	CXCL8
c2.all.v2024.1.Hs.symbols.gmt	WP_HEPATITIS_C_AND_HEPATOCELLULAR_CARCINOMA	1/56	2.117989e-01	3.500892e-01	6.371875e+00	9.889900e+00	CXCL8
c2.all.v2024.1.Hs.symbols.gmt	WP_HYPERTROPHY_MODEL	1/20	8.142487e-02	2.220291e-01	1.816495e+01	4.555906e+01	ATF3
c2.all.v2024.1.Hs.symbols.gmt	WP_IL18_SIGNALING	3/273	1.097030e-01	2.615320e-01	3.086765e+00	6.821684e+00	ATF3;TMSB4X;CXCL8
c2.all.v2024.1.Hs.symbols.gmt	WP_IL26_SIGNALING	2/47	1.695694e-02	1.019371e-01	1.309979e+01	5.340888e+01	MT-CO2;CXCL8
c2.all.v2024.1.Hs.symbols.gmt	WP_IL3_SIGNALING	1/49	1.879707e-01	3.283977e-01	7.293842e+00	1.219143e+01	CXCL8
c2.all.v2024.1.Hs.symbols.gmt	WP_IMATINIB_AND_CHRONIC_MYELOID_LEUKEMIA	1/20	8.142487e-02	2.220291e-01	1.816495e+01	4.555906e+01	GADD45A
c2.all.v2024.1.Hs.symbols.gmt	WP_IMMUNE_INFILTRATION_IN_PANCREATIC_CANCER	1/39	1.526892e-01	3.016190e-01	9.192513e+00	1.727596e+01	CXCL8
c2.all.v2024.1.Hs.symbols.gmt	WP_INTERFERON_TYPE_I_SIGNALING	1/54	2.050624e-01	3.444123e-01	6.610675e+00	1.047423e+01	RACK1
c2.all.v2024.1.Hs.symbols.gmt	WP_IRON_METABOLISM_DISORDERS	2/17	2.316249e-03	2.516508e-02	3.850654e+01	2.336502e+02	FTL;CP
c2.all.v2024.1.Hs.symbols.gmt	WP_LNCRNA_IN_CANONICAL_WNT_SIGNALING_AND_COLORECTAL_CANCER	1/98	3.409131e-01	4.450218e-01	3.620156e+00	3.895750e+00	ATF3
c2.all.v2024.1.Hs.symbols.gmt	WP_LTF_DANGER_SIGNAL_RESPONSE_PATHWAY	2/19	2.896343e-03	3.002182e-02	3.410270e+01	1.993066e+02	CXCL8;LTF
c2.all.v2024.1.Hs.symbols.gmt	WP_LUNG_FIBROSIS	4/63	1.485024e-04	2.950249e-03	1.841826e+01	1.623553e+02	SFTPC;SFTPA2;SFTPA1;CXCL8
c2.all.v2024.1.Hs.symbols.gmt	WP_MACROPHAGESTIMULATING_PROTEIN_MSP_SIGNALING	1/108	3.684290e-01	4.655014e-01	3.281905e+00	3.277006e+00	CXCL8
c2.all.v2024.1.Hs.symbols.gmt	WP_MACROPHAGE_MARKERS	1/9	3.748893e-02	1.619087e-01	4.169330e+01	1.369087e+02	LYZ
c2.all.v2024.1.Hs.symbols.gmt	WP_MALE_INFERTILITY	3/145	2.377884e-02	1.262154e-01	5.893797e+00	2.203667e+01	GPX1;MSMB;LTF
c2.all.v2024.1.Hs.symbols.gmt	WP_MAPK_SIGNALING	1/246	6.500726e-01	6.971987e-01	1.428069e+00	6.150282e-01	GADD45A
c2.all.v2024.1.Hs.symbols.gmt	WP_MATRIX_METALLOPROTEINASES	1/30	1.196416e-01	2.710169e-01	1.200190e+01	2.548310e+01	MMP10
c2.all.v2024.1.Hs.symbols.gmt	WP_MEASLES_VIRUS_INFECTION	1/136	4.395716e-01	5.233712e-01	2.600410e+00	2.137420e+00	RACK1
c2.all.v2024.1.Hs.symbols.gmt	WP_MELANOMA	1/68	2.510485e-01	3.775682e-01	5.236245e+00	7.237062e+00	GADD45A
c2.all.v2024.1.Hs.symbols.gmt	WP_MIRNA_REGULATION_OF_DNA_DAMAGE_RESPONSE	1/98	3.409131e-01	4.450218e-01	3.620156e+00	3.895750e+00	GADD45A
c2.all.v2024.1.Hs.symbols.gmt	WP_MIRNA_ROLE_IN_IMMUNE_RESPONSE_IN_SEPSIS	2/65	3.106834e-02	1.476277e-01	9.378804e+00	3.255914e+01	CXCL8;LCN2
c2.all.v2024.1.Hs.symbols.gmt	WP_MITOCHONDRIAL_COMPLEX_III_ASSEMBLY	1/16	6.568265e-02	2.009003e-01	2.285682e+01	6.223731e+01	MT-CYB
c2.all.v2024.1.Hs.symbols.gmt	WP_MITOCHONDRIAL_COMPLEX_IV_ASSEMBLY	2/34	9.118486e-03	6.793272e-02	1.835052e+01	8.620068e+01	MT-CO3;MT-CO2
c2.all.v2024.1.Hs.symbols.gmt	WP_MITOCHONDRIAL_COMPLEX_I_ASSEMBLY_MODEL_OXPHOS_SYSTEM	4/56	9.366266e-05	1.973538e-03	2.088066e+01	1.936851e+02	MT-ND1;MT-ND2;MT-ND5;MT-ND4
c2.all.v2024.1.Hs.symbols.gmt	WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS	1/156	4.854746e-01	5.613637e-01	2.263889e+00	1.635950e+00	ATF3
c2.all.v2024.1.Hs.symbols.gmt	WP_NANOPARTICLE_TRIGGERED_REGULATED_NECROSIS	1/12	4.967357e-02	1.805210e-01	3.081260e+01	9.250813e+01	FTL
c2.all.v2024.1.Hs.symbols.gmt	WP_NETWORK_MAP_OF_SARSCOV2_SIGNALING	1/218	6.054150e-01	6.601650e-01	1.613978e+00	8.099602e-01	CXCL8
c2.all.v2024.1.Hs.symbols.gmt	WP_NEURODEGENERATION_WITH_BRAIN_IRON_ACCUMULATION_NBIA_SUBTYPES_PATHWAY	2/44	1.496131e-02	9.469072e-02	1.402639e+01	5.894293e+01	FTL;CP
c2.all.v2024.1.Hs.symbols.gmt	WP_NEUROINFLAMMATION	1/13	5.370110e-02	1.861898e-01	2.834631e+01	8.289373e+01	MT-CO2
c2.all.v2024.1.Hs.symbols.gmt	WP_NOCGMPPKG_MEDIATED_NEUROPROTECTION	1/47	1.810327e-01	3.241495e-01	7.608246e+00	1.300308e+01	AKAP9
c2.all.v2024.1.Hs.symbols.gmt	WP_NONALCOHOLIC_FATTY_LIVER_DISEASE	4/155	4.290095e-03	3.874086e-02	7.203381e+00	3.926884e+01	MT-CO3;MT-CO2;CXCL8;MT-CYB
c2.all.v2024.1.Hs.symbols.gmt	WP_NONGENOMIC_ACTIONS_OF_125_DIHYDROXYVITAMIN_D3	1/75	2.730444e-01	3.925366e-01	4.742741e+00	6.156651e+00	CXCL8
c2.all.v2024.1.Hs.symbols.gmt	WP_NONSMALL_CELL_LUNG_CANCER	1/72	2.636969e-01	3.854743e-01	4.942411e+00	6.588010e+00	GADD45A
c2.all.v2024.1.Hs.symbols.gmt	WP_NOVEL_INTRACELLULAR_COMPONENTS_OF_RIGILIKE_RECEPTOR_PATHWAY	1/60	2.251031e-01	3.589947e-01	5.942435e+00	8.861339e+00	CXCL8
c2.all.v2024.1.Hs.symbols.gmt	WP_NRF2_PATHWAY	2/141	1.202832e-01	2.718427e-01	4.254480e+00	9.010590e+00	FTL;HSP90AA1
c2.all.v2024.1.Hs.symbols.gmt	WP_NUCLEAR_RECEPTORS_METAPATHWAY	3/314	1.483911e-01	3.001720e-01	2.675447e+00	5.104495e+00	FTL;HSP90AA1;S100P
c2.all.v2024.1.Hs.symbols.gmt	WP_NUCLEOTIDEBINDING_OLIGOMERIZATION_DOMAIN_NOD_PATHWAY	1/41	1.598648e-01	3.051033e-01	8.737770e+00	1.602006e+01	HSP90AA1
c2.all.v2024.1.Hs.symbols.gmt	WP_OMEGA6FATTY_ACIDS_IN_SENESCENCE	1/57	2.151460e-01	3.519958e-01	6.258814e+00	9.616282e+00	GPX1
c2.all.v2024.1.Hs.symbols.gmt	WP_OREXIN_RECEPTOR_PATHWAY	1/200	5.737754e-01	6.369854e-01	1.761047e+00	9.782919e-01	CXCL8
c2.all.v2024.1.Hs.symbols.gmt	WP_OVARIAN_INFERTILITY	1/39	1.526892e-01	3.016190e-01	9.192513e+00	1.727596e+01	SYNE2
c2.all.v2024.1.Hs.symbols.gmt	WP_OVERVIEW_OF_NANOPARTICLE_EFFECTS	1/19	7.751409e-02	2.176237e-01	1.914771e+01	4.896635e+01	CXCL8
c2.all.v2024.1.Hs.symbols.gmt	WP_OVERVIEW_OF_PROINFLAMMATORY_AND_PROFIBROTIC_MEDIATORS	1/127	4.176151e-01	5.044268e-01	2.786561e+00	2.433212e+00	CXCL8
c2.all.v2024.1.Hs.symbols.gmt	WP_OXIDATIVE_DAMAGE_RESPONSE	1/40	1.562845e-01	3.038299e-01	8.959385e+00	1.662931e+01	GADD45A
c2.all.v2024.1.Hs.symbols.gmt	WP_OXIDATIVE_PHOSPHORYLATION	6/60	2.046033e-07	7.621475e-06	2.970803e+01	4.575688e+02	MT-ND5;MT-ND1;MT-ATP6;MT-ND3;MT-ND4;MT-ND2
c2.all.v2024.1.Hs.symbols.gmt	WP_OXIDATIVE_STRESS_RESPONSE	1/33	1.307967e-01	2.795512e-01	1.089255e+01	2.215666e+01	GPX1
c2.all.v2024.1.Hs.symbols.gmt	WP_P53_TRANSCRIPTIONAL_GENE_NETWORK	2/96	6.264599e-02	2.001510e-01	6.293293e+00	1.743403e+01	GADD45A;GPX1
c2.all.v2024.1.Hs.symbols.gmt	WP_PANCREATIC_ADENOCARCINOMA_PATHWAY	1/89	3.151367e-01	4.222062e-01	3.989939e+00	4.607378e+00	GADD45A
c2.all.v2024.1.Hs.symbols.gmt	WP_PANCREATIC_CANCER_SUBTYPES	4/48	5.092066e-05	1.180228e-03	2.464343e+01	2.436063e+02	SERPINB4;AGR2;SERPINB3;LYZ
c2.all.v2024.1.Hs.symbols.gmt	WP_PARKINSONS_DISEASE_PATHWAY	1/71	2.605548e-01	3.835690e-01	5.012743e+00	6.741850e+00	UBB
c2.all.v2024.1.Hs.symbols.gmt	WP_PATHOGENESIS_OF_SARSCOV2_MEDIATED_BY_NSP9NSP10_COMPLEX	1/21	8.531924e-02	2.270101e-01	1.727807e+01	4.252748e+01	CXCL8
c2.all.v2024.1.Hs.symbols.gmt	WP_PDGF_PATHWAY	1/40	1.562845e-01	3.038299e-01	8.959385e+00	1.662931e+01	MT-CO2
c2.all.v2024.1.Hs.symbols.gmt	WP_PHOTODYNAMIC_THERAPYINDUCED_AP1_SURVIVAL_SIGNALING	1/51	1.948505e-01	3.350851e-01	7.004342e+00	1.145576e+01	HSP90AA1
c2.all.v2024.1.Hs.symbols.gmt	WP_PHOTODYNAMIC_THERAPYINDUCED_NFKB_SURVIVAL_SIGNALING	1/35	1.381557e-01	2.876176e-01	1.026017e+01	2.030872e+01	CXCL8
c2.all.v2024.1.Hs.symbols.gmt	WP_PHOTODYNAMIC_THERAPYINDUCED_UNFOLDED_PROTEIN_RESPONSE	2/27	5.815765e-03	4.833341e-02	2.339534e+01	1.204201e+02	ATF3;PPP1R15A
c2.all.v2024.1.Hs.symbols.gmt	WP_PHYSICOCHEMICAL_FEATURES_AND_TOXICITYASSOCIATED_PATHWAYS	2/66	3.195246e-02	1.509068e-01	9.232977e+00	3.179381e+01	TMSB4X;GPX1
c2.all.v2024.1.Hs.symbols.gmt	WP_PI3KAKT_SIGNALING	1/339	7.654455e-01	7.947831e-01	1.031311e+00	2.756667e-01	HSP90AA1
c2.all.v2024.1.Hs.symbols.gmt	WP_PLEURAL_MESOTHELIOMA	1/439	8.477336e-01	8.672743e-01	7.924621e-01	1.309059e-01	ATF3
c2.all.v2024.1.Hs.symbols.gmt	WP_POLYCYSTIC_KIDNEY_DISEASE_PATHWAY	1/85	3.033627e-01	4.138748e-01	4.179572e+00	4.985502e+00	CFTR
c2.all.v2024.1.Hs.symbols.gmt	WP_POSTCOVID_NEUROINFLAMMATION	1/23	9.305905e-02	2.367331e-01	1.574082e+01	3.737691e+01	CXCL8
c2.all.v2024.1.Hs.symbols.gmt	WP_PREGNANE_X_RECEPTOR_PATHWAY	1/32	1.270940e-01	2.774918e-01	1.123886e+01	2.318384e+01	HSP90AA1
c2.all.v2024.1.Hs.symbols.gmt	WP_PRIMARY_OVARIAN_INSUFFICIENCY	1/174	5.235954e-01	5.929533e-01	2.027354e+00	1.311771e+00	GAS5
c2.all.v2024.1.Hs.symbols.gmt	WP_PROSTAGLANDIN_SIGNALING	1/33	1.307967e-01	2.795512e-01	1.089255e+01	2.215666e+01	CXCL8
c2.all.v2024.1.Hs.symbols.gmt	WP_PROSTAGLANDIN_SYNTHESIS_AND_REGULATION	1/45	1.740360e-01	3.187349e-01	7.950910e+00	1.390211e+01	SCGB1A1
c2.all.v2024.1.Hs.symbols.gmt	WP_PROTEASOME_DEGRADATION	1/62	2.316716e-01	3.644548e-01	5.748663e+00	8.407042e+00	UBB
c2.all.v2024.1.Hs.symbols.gmt	WP_REGULATION_OF_ACTIN_CYTOSKELETON	1/150	4.721089e-01	5.501783e-01	2.355391e+00	1.767829e+00	TMSB4X
c2.all.v2024.1.Hs.symbols.gmt	WP_RESISTIN_AS_A_REGULATOR_OF_INFLAMMATION	1/33	1.307967e-01	2.795512e-01	1.089255e+01	2.215666e+01	CXCL8
c2.all.v2024.1.Hs.symbols.gmt	WP_RETT_SYNDROME	1/48	1.845090e-01	3.264510e-01	7.447734e+00	1.258710e+01	SYNE2
c2.all.v2024.1.Hs.symbols.gmt	WP_SARSCOV2_INNATE_IMMUNITY_EVASION_AND_CELLSPECIFIC_IMMUNE_RESPONSE	1/66	2.446439e-01	3.725015e-01	5.396620e+00	7.598181e+00	CXCL8
c2.all.v2024.1.Hs.symbols.gmt	WP_SELENIUM_METABOLISM_AND_SELENOPROTEINS	1/47	1.810327e-01	3.241495e-01	7.608246e+00	1.300308e+01	GPX1
c2.all.v2024.1.Hs.symbols.gmt	WP_SELENIUM_MICRONUTRIENT_NETWORK	1/86	3.063248e-01	4.155997e-01	4.130500e+00	4.886833e+00	GPX1
c2.all.v2024.1.Hs.symbols.gmt	WP_SENESCENCEASSOCIATED_SECRETORY_PHENOTYPE_SASP	2/112	8.181660e-02	2.225758e-01	5.378134e+00	1.346295e+01	UBB;CXCL8
c2.all.v2024.1.Hs.symbols.gmt	WP_SMALL_CELL_LUNG_CANCER	1/96	3.352693e-01	4.401332e-01	3.696307e+00	4.039403e+00	GADD45A
c2.all.v2024.1.Hs.symbols.gmt	WP_SPINAL_CORD_INJURY	2/117	8.813607e-02	2.334470e-01	5.144144e+00	1.249447e+01	GADD45A;CXCL8
c2.all.v2024.1.Hs.symbols.gmt	WP_SUDDEN_INFANT_DEATH_SYNDROME_SIDS_SUSCEPTIBILITY_PATHWAYS	1/159	4.920314e-01	5.664335e-01	2.220736e+00	1.574974e+00	CXCL8
c2.all.v2024.1.Hs.symbols.gmt	WP_TAR_SYNDROME	1/63	2.349352e-01	3.662742e-01	5.656428e+00	8.193028e+00	CFTR
c2.all.v2024.1.Hs.symbols.gmt	WP_TH17_CELL_DIFFERENTIATION_PATHWAY	1/69	2.542306e-01	3.790744e-01	5.159569e+00	7.066100e+00	HSP90AA1
c2.all.v2024.1.Hs.symbols.gmt	WP_THYMIC_STROMAL_LYMPHOPOIETIN_TSLP_SIGNALING	1/47	1.810327e-01	3.241495e-01	7.608246e+00	1.300308e+01	CXCL8
c2.all.v2024.1.Hs.symbols.gmt	WP_TLR4_SIGNALING_AND_TOLERANCE	1/28	1.121262e-01	2.639902e-01	1.287594e+01	2.817422e+01	CXCL8
c2.all.v2024.1.Hs.symbols.gmt	WP_TNFALPHA_SIGNALING	1/92	3.238378e-01	4.305453e-01	3.858596e+00	4.350615e+00	HSP90AA1
c2.all.v2024.1.Hs.symbols.gmt	WP_TOLLLIKE_RECEPTOR_SIGNALING	1/103	3.548162e-01	4.560360e-01	3.442781e+00	3.567256e+00	CXCL8
c2.all.v2024.1.Hs.symbols.gmt	WP_TP53_NETWORK	1/19	7.751409e-02	2.176237e-01	1.914771e+01	4.896635e+01	GADD45A
c2.all.v2024.1.Hs.symbols.gmt	WP_TRANSSULFURATION_ONECARBON_METABOLISM_AND_RELATED_PATHWAYS	1/67	2.478529e-01	3.751968e-01	5.315227e+00	7.414315e+00	GPX1
c2.all.v2024.1.Hs.symbols.gmt	WP_TROP2_REGULATORY_SIGNALING	1/49	1.879707e-01	3.283977e-01	7.293842e+00	1.219143e+01	RACK1
c2.all.v2024.1.Hs.symbols.gmt	WP_TYROBP_CAUSAL_NETWORK_IN_MICROGLIA	1/60	2.251031e-01	3.589947e-01	5.942435e+00	8.861339e+00	GPX1
c2.all.v2024.1.Hs.symbols.gmt	WP_UNFOLDED_PROTEIN_RESPONSE	1/24	9.690462e-02	2.420875e-01	1.507032e+01	3.517454e+01	PPP1R15A
c2.all.v2024.1.Hs.symbols.gmt	WP_VEGFAVEGFR2_SIGNALING	10/431	1.453440e-05	3.652862e-04	6.390638e+00	7.118527e+01	TMSB4X;GPX1;RPL10A;RACK1;MMP10;HSP90AA1;DNAJA1;RPL13A;RPL18A;CXCL8
c2.all.v2024.1.Hs.symbols.gmt	WP_VITAMIN_B12_DISORDERS	1/13	5.370110e-02	1.861898e-01	2.834631e+01	8.289373e+01	TCN1
c2.all.v2024.1.Hs.symbols.gmt	WP_VITAMIN_B12_METABOLISM	1/54	2.050624e-01	3.444123e-01	6.610675e+00	1.047423e+01	TCN1
c2.all.v2024.1.Hs.symbols.gmt	WP_VITAMIN_D_RECEPTOR_PATHWAY	1/185	5.455015e-01	6.117829e-01	1.905526e+00	1.154843e+00	GADD45A
c2.all.v2024.1.Hs.symbols.gmt	WU_ALZHEIMER_DISEASE_DN	1/19	7.751409e-02	2.176237e-01	1.914771e+01	4.896635e+01	RPL37A
c2.all.v2024.1.Hs.symbols.gmt	WU_CELL_MIGRATION	2/183	1.817885e-01	3.249451e-01	3.263718e+00	5.564350e+00	AGR2;S100P
c2.all.v2024.1.Hs.symbols.gmt	XU_CREBBP_TARGETS_DN	1/40	1.562845e-01	3.038299e-01	8.959385e+00	1.662931e+01	NUCB2
c2.all.v2024.1.Hs.symbols.gmt	XU_GH1_AUTOCRINE_TARGETS_DN	3/131	1.824739e-02	1.069033e-01	6.540091e+00	2.618478e+01	AGR2;TMSB4X;HSPH1
c2.all.v2024.1.Hs.symbols.gmt	XU_HGF_TARGETS_INDUCED_BY_AKT1_48HR_UP	1/13	5.370110e-02	1.861898e-01	2.834631e+01	8.289373e+01	MMP10
c2.all.v2024.1.Hs.symbols.gmt	XU_RESPONSE_TO_TRETINOIN_AND_NSC682994_UP	1/15	6.170557e-02	1.980274e-01	2.443426e+01	6.805873e+01	CXCL8
c2.all.v2024.1.Hs.symbols.gmt	YAGI_AML_WITH_INV_16_TRANSLOCATION	8/411	3.590907e-04	5.944945e-03	5.283588e+00	4.190908e+01	RPS29;RPL37A;RPL27A;RPL31;RPL32;RPS27;RPL23A;RPL13A
c2.all.v2024.1.Hs.symbols.gmt	YAMASHITA_LIVER_CANCER_STEM_CELL_DN	1/76	2.761341e-01	3.945313e-01	4.679711e+00	6.022174e+00	GADD45A
c2.all.v2024.1.Hs.symbols.gmt	YAMASHITA_LIVER_CANCER_STEM_CELL_UP	2/47	1.695694e-02	1.019371e-01	1.309979e+01	5.340888e+01	GADD45A;LINGO1
c2.all.v2024.1.Hs.symbols.gmt	YAMASHITA_LIVER_CANCER_WITH_EPCAM_UP	5/53	2.992438e-06	8.322968e-05	2.793935e+01	3.553724e+02	RPL28;RPL31;RPL23A;RPL13A;RPS3
c2.all.v2024.1.Hs.symbols.gmt	YAMASHITA_METHYLATED_IN_PROSTATE_CANCER	2/66	3.195246e-02	1.509068e-01	9.232977e+00	3.179381e+01	MMP10;SCGB1A1
c2.all.v2024.1.Hs.symbols.gmt	YAMAZAKI_TCEB3_TARGETS_DN	2/201	2.094146e-01	3.480788e-01	2.966809e+00	4.638425e+00	AGR2;HSP90AA1
c2.all.v2024.1.Hs.symbols.gmt	YANAGISAWA_LUNG_CANCER_RECURRENCE	2/9	6.268065e-04	9.614106e-03	7.960901e+01	5.871063e+02	TMSB4X;RPL39
c2.all.v2024.1.Hs.symbols.gmt	YANG_BCL3_TARGETS_UP	2/333	4.131477e-01	5.016450e-01	1.774693e+00	1.568740e+00	MMP10;CP
c2.all.v2024.1.Hs.symbols.gmt	YANG_BREAST_CANCER_ESR1_BULK_UP	1/26	1.045474e-01	2.529999e-01	1.388707e+01	3.135860e+01	TSPAN1
c2.all.v2024.1.Hs.symbols.gmt	YANG_BREAST_CANCER_ESR1_LASER_UP	1/32	1.270940e-01	2.774918e-01	1.123886e+01	2.318384e+01	AGR2
c2.all.v2024.1.Hs.symbols.gmt	YAO_HOXA10_TARGETS_VIA_PROGESTERONE_UP	2/83	4.841471e-02	1.805210e-01	7.301443e+00	2.210841e+01	LCN2;LTF
c2.all.v2024.1.Hs.symbols.gmt	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_1	1/69	2.542306e-01	3.790744e-01	5.159569e+00	7.066100e+00	NAPSA
c2.all.v2024.1.Hs.symbols.gmt	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_11	1/100	3.465095e-01	4.500740e-01	3.547067e+00	3.759341e+00	NUCB2
c2.all.v2024.1.Hs.symbols.gmt	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_16	1/79	2.853253e-01	4.005306e-01	4.500255e+00	5.643885e+00	AGR2
c2.all.v2024.1.Hs.symbols.gmt	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_2	1/58	2.184790e-01	3.549433e-01	6.149686e+00	9.354074e+00	AKAP9
c2.all.v2024.1.Hs.symbols.gmt	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_3	1/23	9.305905e-02	2.367331e-01	1.574082e+01	3.737691e+01	GADD45A
c2.all.v2024.1.Hs.symbols.gmt	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_5	2/31	7.620522e-03	6.021367e-02	2.021942e+01	9.860831e+01	ATF3;LCN2
c2.all.v2024.1.Hs.symbols.gmt	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_6	1/79	2.853253e-01	4.005306e-01	4.500255e+00	5.643885e+00	LTF
c2.all.v2024.1.Hs.symbols.gmt	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_8	1/50	1.914179e-01	3.321944e-01	7.146168e+00	1.181473e+01	HSPH1
c2.all.v2024.1.Hs.symbols.gmt	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_9	1/78	2.822744e-01	3.988105e-01	4.558530e+00	5.765973e+00	LYZ
c2.all.v2024.1.Hs.symbols.gmt	YAUCH_HEDGEHOG_SIGNALING_PARACRINE_DN	1/259	6.690694e-01	7.131726e-01	1.355444e+00	5.447090e-01	CFTR
c2.all.v2024.1.Hs.symbols.gmt	YEGNASUBRAMANIAN_PROSTATE_CANCER	1/135	4.371730e-01	5.214082e-01	2.619864e+00	2.167744e+00	AGR2
c2.all.v2024.1.Hs.symbols.gmt	YIH_RESPONSE_TO_ARSENITE_C2	1/14	5.771174e-02	1.926187e-01	2.624540e+01	7.485960e+01	GADD45A
c2.all.v2024.1.Hs.symbols.gmt	YIH_RESPONSE_TO_ARSENITE_C4	1/17	6.964305e-02	2.057725e-01	2.147059e+01	5.720564e+01	CXCL8
c2.all.v2024.1.Hs.symbols.gmt	YORDY_RECIPROCAL_REGULATION_BY_ETS1_AND_SP100_DN	1/72	2.636969e-01	3.854743e-01	4.942411e+00	6.588010e+00	HSPH1
c2.all.v2024.1.Hs.symbols.gmt	YOSHIMURA_MAPK8_TARGETS_DN	2/379	4.788837e-01	5.565189e-01	1.555146e+00	1.145050e+00	HSPH1;GADD45A
c2.all.v2024.1.Hs.symbols.gmt	YOSHIMURA_MAPK8_TARGETS_UP	15/1281	3.050308e-04	5.258631e-03	3.207013e+00	2.596109e+01	UBB;SFTPA1;LCN2;CFTR;GPX1;MUC1;MT-ATP6;RPL28;DNAAF1;SFTPB;MSMB;MMP10;LYZ;PIP;RPL32
c2.all.v2024.1.Hs.symbols.gmt	ZAMORA_NOS2_TARGETS_DN	2/82	4.737566e-02	1.793569e-01	7.392479e+00	2.254445e+01	FTL;CP
c2.all.v2024.1.Hs.symbols.gmt	ZAMORA_NOS2_TARGETS_UP	2/57	2.436262e-02	1.276895e-01	1.073460e+01	3.987587e+01	HSPH1;RACK1
c2.all.v2024.1.Hs.symbols.gmt	ZERBINI_RESPONSE_TO_SULINDAC_UP	3/9	6.069088e-06	1.623092e-04	1.300105e+02	1.561726e+03	ATF3;GADD45A;CXCL8
c2.all.v2024.1.Hs.symbols.gmt	ZHANG_BREAST_CANCER_PROGENITORS_UP	4/434	1.126285e-01	2.648738e-01	2.502762e+00	5.465183e+00	DNAJA1;RPS3;RPL15;AKAP9
c2.all.v2024.1.Hs.symbols.gmt	ZHANG_GATA6_TARGETS_DN	1/63	2.349352e-01	3.662742e-01	5.656428e+00	8.193028e+00	MUC1
c2.all.v2024.1.Hs.symbols.gmt	ZHANG_PROLIFERATING_VS_QUIESCENT	4/49	5.526781e-05	1.253137e-03	2.410072e+01	2.362671e+02	HSP90AA1;GPX1;GADD45A;CXCL8
c2.all.v2024.1.Hs.symbols.gmt	ZHANG_RESPONSE_TO_CANTHARIDIN_DN	1/67	2.478529e-01	3.751968e-01	5.315227e+00	7.414315e+00	RPL15
c2.all.v2024.1.Hs.symbols.gmt	ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP	4/223	1.497984e-02	9.469072e-02	4.956405e+00	2.082211e+01	ATF3;MMP10;CXCL8;TCIM
c2.all.v2024.1.Hs.symbols.gmt	ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_UP	1/93	3.267137e-01	4.335400e-01	3.816708e+00	4.269640e+00	TMSB4X
c2.all.v2024.1.Hs.symbols.gmt	ZHAN_MULTIPLE_MYELOMA_DN	2/42	1.369162e-02	8.925226e-02	1.472039e+01	6.316476e+01	LYZ;LCN2
c2.all.v2024.1.Hs.symbols.gmt	ZHAN_MULTIPLE_MYELOMA_HP_UP	1/50	1.914179e-01	3.321944e-01	7.146168e+00	1.181473e+01	RPL13A
c2.all.v2024.1.Hs.symbols.gmt	ZHAN_MULTIPLE_MYELOMA_MS_DN	1/45	1.740360e-01	3.187349e-01	7.950910e+00	1.390211e+01	RPS2
c2.all.v2024.1.Hs.symbols.gmt	ZHAN_MULTIPLE_MYELOMA_PR_DN	1/49	1.879707e-01	3.283977e-01	7.293842e+00	1.219143e+01	SYNE2
c2.all.v2024.1.Hs.symbols.gmt	ZHAN_MULTIPLE_MYELOMA_SPIKED	1/24	9.690462e-02	2.420875e-01	1.507032e+01	3.517454e+01	NEAT1
c2.all.v2024.1.Hs.symbols.gmt	ZHAN_MULTIPLE_MYELOMA_UP	1/64	2.381851e-01	3.674956e-01	5.567098e+00	7.987156e+00	ATF3
c2.all.v2024.1.Hs.symbols.gmt	ZHAN_V1_LATE_DIFFERENTIATION_GENES_UP	1/33	1.307967e-01	2.795512e-01	1.089255e+01	2.215666e+01	NUCB2
c2.all.v2024.1.Hs.symbols.gmt	ZHENG_BOUND_BY_FOXP3	3/498	3.532847e-01	4.554708e-01	1.667736e+00	1.735248e+00	TMSB4X;MT-ATP6;SYNE2
c2.all.v2024.1.Hs.symbols.gmt	ZHENG_FOXP3_TARGETS_IN_THYMUS_DN	1/13	5.370110e-02	1.861898e-01	2.834631e+01	8.289373e+01	AGR2
c2.all.v2024.1.Hs.symbols.gmt	ZHENG_FOXP3_TARGETS_IN_T_LYMPHOCYTE_DN	1/38	1.490787e-01	3.001720e-01	9.438075e+00	1.796331e+01	SYNE2
c2.all.v2024.1.Hs.symbols.gmt	ZHENG_GLIOBLASTOMA_PLASTICITY_UP	1/249	6.545500e-01	7.002007e-01	1.410635e+00	5.978373e-01	CP
c2.all.v2024.1.Hs.symbols.gmt	ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_DN	1/71	2.605548e-01	3.835690e-01	5.012743e+00	6.741850e+00	RPL13A
c2.all.v2024.1.Hs.symbols.gmt	ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_UP	1/186	5.474428e-01	6.129714e-01	1.895167e+00	1.141833e+00	ATF3
c2.all.v2024.1.Hs.symbols.gmt	ZHONG_SECRETOME_OF_LUNG_CANCER_AND_ENDOTHELIUM	2/67	3.284644e-02	1.542150e-01	9.091603e+00	3.105612e+01	CP;RPL10A
c2.all.v2024.1.Hs.symbols.gmt	ZHONG_SECRETOME_OF_LUNG_CANCER_AND_FIBROBLAST	4/131	2.346774e-03	2.536461e-02	8.568671e+00	5.188085e+01	CP;RPL18A;RACK1;RPL10A
c2.all.v2024.1.Hs.symbols.gmt	ZHONG_SECRETOME_OF_LUNG_CANCER_AND_MACROPHAGE	3/76	4.137805e-03	3.848016e-02	1.146266e+01	6.290237e+01	CP;RACK1;RPL10A
c2.all.v2024.1.Hs.symbols.gmt	ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP	2/517	6.470072e-01	6.949831e-01	1.131596e+00	4.926945e-01	PPP1R15A;CXCL8
c2.all.v2024.1.Hs.symbols.gmt	ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP	2/452	5.735728e-01	6.369854e-01	1.298767e+00	7.219462e-01	PPP1R15A;CFTR
c2.all.v2024.1.Hs.symbols.gmt	ZHOU_INFLAMMATORY_RESPONSE_LPS_UP	3/406	2.471239e-01	3.751968e-01	2.056710e+00	2.875004e+00	PPP1R15A;SNTN;CFTR
c2.all.v2024.1.Hs.symbols.gmt	ZHOU_TNF_SIGNALING_30MIN	1/51	1.948505e-01	3.350851e-01	7.004342e+00	1.145576e+01	PDIA3P1
c2.all.v2024.1.Hs.symbols.gmt	ZHOU_TNF_SIGNALING_4HR	2/50	1.905920e-02	1.086270e-01	1.228782e+01	4.866231e+01	GADD45A;RPL27A
c2.all.v2024.1.Hs.symbols.gmt	ZHU_CMV_24_HR_DN	2/84	4.946205e-02	1.805210e-01	7.212613e+00	2.168508e+01	FTL;GPX1
c2.all.v2024.1.Hs.symbols.gmt	ZHU_CMV_8_HR_UP	1/41	1.598648e-01	3.051033e-01	8.737770e+00	1.602006e+01	DNAJA1
c2.all.v2024.1.Hs.symbols.gmt	ZHU_CMV_ALL_DN	2/119	9.070379e-02	2.365101e-01	5.056124e+00	1.213549e+01	FTL;GPX1
c2.all.v2024.1.Hs.symbols.gmt	ZHU_CMV_ALL_UP	1/107	3.657293e-01	4.632128e-01	3.312872e+00	3.332291e+00	DNAJA1
c2.all.v2024.1.Hs.symbols.gmt	ZHU_SKIL_TARGETS_UP	2/20	3.209312e-03	3.203170e-02	3.225785e+01	1.852149e+02	PPP1R15A;GADD45A
c2.all.v2024.1.Hs.symbols.gmt	ZWANG_CLASS_1_TRANSIENTLY_INDUCED_BY_EGF	3/550	4.130732e-01	5.016450e-01	1.505707e+00	1.331241e+00	SERPINB4;GADD45A;PIP
c2.all.v2024.1.Hs.symbols.gmt	ZWANG_CLASS_2_TRANSIENTLY_INDUCED_BY_EGF	1/54	2.050624e-01	3.444123e-01	6.610675e+00	1.047423e+01	ANXA2P3
c2.all.v2024.1.Hs.symbols.gmt	ZWANG_CLASS_3_TRANSIENTLY_INDUCED_BY_EGF	3/232	7.578350e-02	2.176237e-01	3.645047e+00	9.403764e+00	ATF3;PPP1R15A;CXCL8
c2.all.v2024.1.Hs.symbols.gmt	ZWANG_DOWN_BY_2ND_EGF_PULSE	5/321	1.182824e-02	8.179077e-02	4.229350e+00	1.876675e+01	RPS29;ANKRD36B;HSP90B2P;GAS5;MT-ND4
c2.all.v2024.1.Hs.symbols.gmt	ZWANG_EGF_INTERVAL_DN	2/238	2.672350e-01	3.881979e-01	2.498429e+00	3.296994e+00	MT-CYB;AKAP9
c2.all.v2024.1.Hs.symbols.gmt	ZWANG_EGF_PERSISTENTLY_DN	1/62	2.316716e-01	3.644548e-01	5.748663e+00	8.407042e+00	TSPAN1
c2.all.v2024.1.Hs.symbols.gmt	ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY	7/1959	7.341853e-01	7.669057e-01	8.844266e-01	2.732823e-01	VMO1;RPL21;DNAAF1;MSMB;LINGO1;RPL3;SCGB1A1
